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Abstract  
Pseudomonas aeruginosa is a versatile and prevalent opportunistic pathogen.  It encodes a large 
arsenal of pathogenicity factors, and secrets a plethora of proteins using specialised protein 
secretion systems.  The type VI secretion system (T6SS) delivers proteins directly into neighbouring 
bacteria or eukaryotic cells using a mechanism homologous to the T4 bacteriophage tail spike. 
 
Three T6SS are encoded on the P. aeruginosa genome.  The study of the H1-T6SS has been facilitated 
by the fact it can be activated by the manipulation of the RetS/Gac/Rsm regulatory cascade by 
deletion of retS. However, the precise signals required for activation of this cascade, resulting in H1-
T6SS activation, are unknown.  This work investigates the role of subinhibitory concentrations of 
antibiotics in activating the system, and shows that kanamycin is able to induce production of core 
H1-T6SS components.  This activation requires a functional Gac/Rsm cascade, but it is not known if 
this is due to direct signalling via the cascade, or due to a dominant effect of RsmA repression. 
 
The H2-T6SS is characterized in this work. We highlight key differences between the H2-T6SS cluster 
in PAO1 and PA14, including the presence of additional core T6SS components and putative secreted 
effectors. A strain is generated in which expression of the PA14 H2-T6SS cluster can be activated and 
tightly controlled by arabinose inducible promoters.  The activity of the promoters is confirmed by 
the H2-T6SS dependent secretion of Hcp2 specifically upon arabinose induction.   
 
We further consider two putative H2-T6SS secreted substrates, VgrG14 and Rhs14.  Production of 
these proteins is observed following arabinose induction, but their secretion is not detected.  The 
Rhs14 protein is characterised, and its possible role as a H2-T6SS dependent effector is discussed.  
Finally, the H2-T6SS system in PA14 is shown to inhibit the internalisation of P. aeruginosa PA14, in 
contrast to the previously published observations of the H2-T6SS promoting internalisation of PAO1. 
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Chapter 1 Introduction 
 
1.1 Pseudomonas aeruginosa  
 
Pseudomonas aeruginosa is a Gram negative, rod-shaped bacterium, with a cell diameter of 0.5-1.0 
μm and length of 1.5-3.0 μm.  It has an optimum growth temperature of 37 °C, but it is able to grow 
between 4 °C and 42 °C.  P. aeruginosa has relatively simple nutritional requirements, often reported 
to grow in distilled water (Favero et al., 1971).   P. aeruginosa is a facultative anaerobe, able to use 
nitrate as a terminal electron acceptor, in the absence of oxygen.  A single polar flagellum allows P. 
aeruginosa to swim, and type IV pili allow cells to twitch and swarm on solid and semi-solid surfaces 
(Garrity, 1989; Kohler et al., 2000). 
 
The genome sequence of P. aeruginosa PAO1 was published in 2000, allowing the genetic make-up 
of this organism to be interrogated and exploited (Stover et al., 2000; Winsor et al., 2011).  The 6.3 
Mbp genome is among the largest of bacterial genomes, encoding 5570 open reading frames, similar 
in number to the eukaryotic yeast Saccharomyces cerevisiae, equipping P. aeruginosa with an 
enormous potential for diversity. 
 
Pseudomonas spp. are remarkably metabolically diverse, and are able to utilise 146 different organic 
compounds for growth (Stanier et al., 1966).  The ability of Pseudomonas spp. to degrade a wide 
range of substrates, including aromatic compounds and halogen derivatives has made them a useful 
tool for bioremediation.  For example, Pseudomonas putida is able to degrade phenolic compounds 
polluting soils and industrial effluents (Krastanov et al., 2013).   
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P. aeruginosa also shows enormous environmental versatility, and can be isolated from terrestrial, 
freshwater and marine environments (Khan et al., 2007), as well as being ubiquitous in man-made 
environments (Bonten et al., 1999; Pirnay et al., 2003). P. aeruginosa can either exist in these 
environments as planktonic, unicellular organisms, or as sessile cells attached to surfaces in 
multicellular aggregates known as biofilms (Coggan and Wolfgang, 2012).  The formation of biofilms 
is clinically relevant as discussed further in Section 1.4. 
 
P. aeruginosa has a large host range, capable of infecting plants, animals, and humans.  It causes 
soft-rot disease in plants, leading to economic losses in tobacco, lettuce and sugar cane (Elrod and 
Braun, 1942), and Arabidopsis thaliana is a useful plant model for the study of P. aeruginosa 
pathogenicity (Rahme et al., 1997).  The observation that P. aeruginosa uses many of the same 
virulence factors to infect both plants and animals makes plant infection models highly relevant 
(Rahme et al., 2000).  P. aeruginosa infects a large range of insects and animals which are widely 
used as models of infection, including the Galleria mellonella (Miyata et al., 2003), Drosophila 
melanogaster (Apidianakis and Rahme, 2009), Caenorhabditis elegans (Tan et al., 1999) and mice 
(Hoffmann et al., 2005).    
 
P. aeruginosa can be a commensal of healthy humans, but has become a prevalent opportunistic 
human pathogen.  The various types of infections caused by P. aeruginosa are described in Section 
1.2.   The ability of P. aeruginosa to cause infections is facilitated by its large arsenal of cell-
associated and extracellular virulence factors, which allow it to communicate with host cells, to 
attack and defend, and to acquire nutrients during infection.  P. aeruginosa encodes for a large 
number of protein secretion systems,  facilitating the secretion of a number of diverse proteins 
(Bleves et al., 2010).  The mechanisms P. aeruginosa employs to secrete proteins are reviewed in 
Section 1.6.  
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A large proportion, around 8.4% of the genes encoded on the P. aeruginosa PAO1 genome are 
predicted to be devoted to regulatory mechanisms (Stover et al., 2000), many of which are involved 
in the regulation of pathogenicity.  P. aeruginosa encodes many complex regulatory networks, which 
allow appropriate and timely deployment of pathogenicity factors.  These mechanisms contribute to 
the success of this organism as an opportunistic pathogen, and are described in detail in Sections 1.8 
and 1.9. 
 
1.2 P. aeruginosa the opportunistic pathogen 
 
1.2.1 Opportunistic infections   
 
In addition to being an environmental organism, P. aeruginosa is a common opportunistic pathogen 
of humans, and infections can be acquired in the community or in hospital.  Community-acquired 
infections include outer ear, skin and soft tissue infections in those with diabetes mellitus, ulcerative 
keratitis in contact lens users, and soft tissue infections associated with burn wounds (Driscoll et al., 
2007).  
 
Hospital-acquired P. aeruginosa infections can be life threatening with high levels of morbidity and 
mortality. P. aeruginosa infects a range of sites, including the lungs, surgical wounds, urinary tract, 
and can cause septicaemia (Driscoll et al., 2007).  P. aeruginosa is responsible for 11-13.8% of 
nosocomial infections where a microbiological cause is identified in three studies from Korea, Italy 
and Switzerland (Kim et al., 2000; Lizioli et al., 2003; Pittet et al., 1999), and is the second most 
common cause of healthcare associated pneumonias in the United States (Kollef et al., 2005).  P. 
aeruginosa is therefore clearly responsible for a large proportion of the infectious disease burden in 
hospitals. 
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Infections caused by P. aeruginosa are a particular problem for those with immune deficiencies 
including cancer, HIV, and recipients of organ transplantation.  P. aeruginosa is responsible for 14-
21% of bacteraemia in patients with acute leukaemia, a higher rate compared to non-cancerous 
patients (Chatzinikolaou et al., 2000).   In individuals infected with HIV the incidence of P. aeruginosa 
bacteraemia is ten times higher compared to those not infected by the virus (Vidal et al., 1999).   
 
1.2.2 P. aeruginosa infections and Cystic Fibrosis  
 
The class of P. aeruginosa infections with the most striking morbidity and mortality occur in Cystic 
Fibrosis (CF) patients, where P. aeruginosa airway infection is the cause of death in around 80% of 
cases (Anon, 2007).  P. aeruginosa is able to colonise the CF lung, leading to chronic, long term 
infection, severe pneumonia and death from pulmonary failure (O'Sullivan and Freedman, 2009).  A 
study of young children with CF used a combination of culture techniques and serological screening 
to show that 97.5% of CF patients were colonised with P. aeruginosa by the age of three (Burns et 
al., 2001).  
 
CF is a genetic disease caused by an inherited mutation in the gene encoding the Cystic Fibrosis 
Transmembrane Conductance Regulator (CFTR), a chloride channel and regulatory protein 
(Rosenfeld et al., 2003).  Patients with CF have an altered pulmonary environment in which P. 
aeruginosa is able to colonise and survive (Mehta, 2005).  The ‘low volume’ hypothesis describes 
how the loss of regulation of chloride channels and the resulting compensatory excess sodium and 
water reabsorption into cells lead to dehydration of the airway surface (Worlitzsch et al., 2002).  In 
healthy individuals the normal mucocilliary clearance mechanism of the lungs is effective in clearing 
invading microorganisms, preventing infection.  In the CF lung, the lubricating layer between 
epithelial cells and mucus is reduced, cilia become compressed, and the normal mucocilliary 
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clearance mechanism is inhibited, resulting in an environment conducive to persistent P. aeruginosa 
infection (Worlitzsch et al., 2002).   
 
1.2.3 Antibiotic resistance 
 
P. aeruginosa infections are resistant to commonly used antibiotics, and this resistance can be 
intrinsic or acquired by P. aeruginosa during infection.  P. aeruginosa is naturally resistant to many 
antibiotics due to the low permeability of the bacterial outer membrane (Hancock, 1997).  Water 
filled channels in this membrane, known as porins, allow small molecules, including antibiotics, to 
pass through.  In E. coli general porins OmpF and OmpC allow non-specific uptake of molecules (Cai 
and Inouye, 2002). In contrast, P. aeruginosa produces highly specialised porins for specific 
molecules, which do not readily allow non-specific uptake of antibiotics, resulting in a slower rate of 
uptake (Hancock and Brinkman, 2002).  Two P. aeruginosa porins are believed to allow limited non-
specific transport of substrates.  OprF is a major P. aeruginosa porin with a copy number of 
approximately 200,000 per cell (Nestorovich et al., 2006), responsible for the outer membrane 
transit of molecules between 200 and 3,000 Da (Bellido et al., 1992).  OprD, despite being a specific 
porin for amino acid transport, may allow passage of small molecules below 200 Da (Huang and 
Hancock, 1993). This slower rate of antibiotic uptake results in resistance since antibiotics are not 
able to accumulate to active concentrations inside the cell. Mutations inactivating the OprD porin 
lead to carbapenem resistance by blocking uptake of this molecule  (Wolter et al., 2004).   
 
Efflux pumps export multiple antimicrobials, preventing molecules from reaching their target sites, 
and thus enhancing the antibiotic resistance of P. aeruginosa.  Characterised efflux pumps from P. 
aeruginosa include MexA/B, MexC/D, MexF/E and MexY/X, which have overlapping specificities for 
antibiotics from different classes (Masuda et al., 2000).  The slower rate of uptake through P. 
aeruginosa porins allows multi drug efflux pumps to work efficiently, since they are not 
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overwhelmed by large antibiotic concentrations (Lambert, 2002).  Mutations leading to the over 
expression of efflux pumps have been reported in clinical isolates, which increase their intrinsic 
resistance due to hyper-export of antimicrobials (Saito et al., 1999).  The combination of slow 
diffusion of antibiotics across the cell membranes and active and efficient efflux via these pumps 
result in the high levels of intrinsic resistance of P. aeruginosa to antibiotics.  
 
Resistance to beta-lactam antibiotics can be achieved through mutations allowing the constitutive 
expression of a chromosomal beta-lactamase AmpC (Bagge et al., 2002).  Plasmid borne Beta-
lactamases and carbapenemases can be acquired by P. aeruginosa through horizontal gene transfer 
(Woodford et al., 1998).  Bacterial enzymes, which transfer acetyl, phosphate, or adenylyl groups 
onto the aminoglycoside, inactivating it.  These modifying enzymes are present on plasmids, which 
may be acquired during treatment (Poole, 2005).  Mutations in key residues of antibiotic targets can 
change the active site conformation and inhibit the antimicrobial activity, while maintaining the 
function of the protein.  An example in P. aeruginosa is the mutation of the gyrA gene encoding a 
subunit of DNA gyrase, a target of the quinolones (Akasaka et al., 2001).    
 
Data published by the Health Protection Agency show that the number of reported cases of P. 
aeruginosa bacteraemia has remained relatively stable at around 3000 cases per year between 2007 
and 2011.  However, the percentage of P. aeruginosa isolates reported as not being sensitive to a 
combination therapy of piperacillin/tazobactam has risen from 5% in 2007 to 7% in 2011 (Figure 1.1) 
(Anon, 2012).  In the same period, the percentage of P. aeruginosa bacteraemia isolates not 
sensitive to imipenem (14%), meropenem (9%), ceftazidime (8%) ciprofloxacin (11%) and gentamicin 
(6%) have remained constant, indicating that around 10% of P. aeruginosa isolates are resistant to at 
least one commonly used antibiotic.   
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Figure 1.1 Annual reports of P. aeruginosa bacteraemia 2007-2011. 
Number of P. aeruginosa bacteraemia reports to the Health Protection Agency (UK) between 
2007 and 2011 (grey bars, primary axis).  The percentage of those isolates resistant to a 
combination therapy of piperacillin and taazobactam is indicated by the black line (secondary 
axis). 
 
There are many mechanisms by which P. aeruginosa is able to develop antibiotic resistance, and the 
emergence of multi drug resistant strains is a concern.  Long-term antibiotic treatment leads to the 
emergence of multi-drug resistant strains, which contributes to the difficulty in eradicating 
infections.  The spread of antibiotic resistance could ultimately render all current antimicrobials 
ineffective against the most minor P. aeruginosa infections.  Currently, P. aeruginosa infections are 
treated using combination therapy of the aminoglycoside tobramycin and the polymyxin antibiotic 
colistin, which has been shown to be more efficient than mono-therapy, and leads to a significant 
reduction in cell counts (Herrmann et al., 2010).  
 
1.3 P. aeruginosa pathogenicity factors: cell associated  
 
The ability of P. aeruginosa to cause the large range of diseases described previously is due to its 
arsenal of pathogenicity factors, which are both cell-associated and extracellular.  The cell-
associated pathogenicity factors described here are summarised in Figure 1.2. Cell associated 
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virulence factors are important in infection since they mediate the initial contact and recognition 
with host cells, leading to adherence and colonisation, essential early stages of infection.   
 
 
Figure 1.2 P. aeruginosa cell associated pathogenicity factors.   
Cellular localisation of lipopolysaccharide (LPS), Cup fimbriae, Type IV pili and flagellum of P. 
aeruginosa. Not to scale.  LPS is present on the entire cell surface, and the exact number and 
location of Cup fimbriae are not known.  Type IV pili are located at the cell pole, as is the single 
flagellum. 
 
Type IV pili 
 
P. aeruginosa encodes type IV pili, which are a major extracellular appendage involved in 
attachment and motility.  Type IV pili are 5 to 7 nm thick rod-like fibres with variable length (Mattick, 
2002).   The type IV pili account for 90% of the adherence capacity of P. aeruginosa (Hahn, 1997).  
The pilus is located at the cell pole, and is involved in the movement of P. aeruginosa cells across a 
semi-solid surface by a process known as twitching motility.  Pilus mediated twitching motility allows 
P. aeruginosa to spread across a surface, aiding colonisation.  This is achieved by the extension of a 
pilus from the cell, which is tethered to the surface, and then retracted by the bacterium, leading to 
movement of the cell (Bradley, 1980).  Type IV pili are also involved in attachment of P. aeruginosa 
to host cells through specific binding to carbohydrate moiety of glycosphingolipids asialo-G(M1) and 
asialo-G(M2) (Hahn, 1997).  Type IV pili are assembled by a machine similar to the T2SS, as described 
further in Section 1.6, and play a role in biofilm formation, described in Section 1.4. 
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Flagella 
 
P. aeruginosa has a single polar flagellum, which facilitates swimming motility.  The importance of 
the flagella is clear from the observation that non flagellated strains of P. aeruginosa are less virulent 
(Montie et al., 1982).   Subsequently, the flagellum has been implicated in adhesion, invasion and 
inflammation.  Flagellin, the major component of the flagellar filament, mediates adhesion to 
corneal cells, and to host mucins (Hazlett and Rudner, 1994; Scharfman et al., 2001), and flagellin is 
potent in causing inflammation in the lungs of mice (Liaudet et al., 2003).  Additionally, flagellin is 
recognised by Toll-like receptor (TLR) 5 on human epithelial cells (Zhang et al., 2005). 
 
Fimbriae  
 
P. aeruginosa possesses a range of fimbriae which are important in the attachment of cells to 
surfaces.  These are known as Cup fimbriae, and are assembled by the chaperone-usher pathway 
(Vallet et al., 2001).  The minimum requirements of a Cup pathway consists of a major fimbrial 
subunit, a chaperone and an usher, important in the assembly of the pilus fibre.  Five such Cup 
fimbriae (cupA-E) are encoded by P. aeruginosa genomes (Filloux, 2011).  Cup pathways may contain 
additional components, including minor pilins and modified pilins with additional receptor binding 
domains that act as adhesins (Vallet et al., 2001).   
  
Endotoxin  
 
P. aeruginosa lipopolysaccharide (LPS) is a major component of the outer surface of the outer 
membrane.  LPS is an endotoxin composed of lipid A region, a core LPS region, and the O-antigen, 
which is cell surface located.  Variation in the O-antigen yields two forms of LPS, either smooth 
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(expressing long O-side chains) or rough (expressing few, short O-side chains).  The O-antigen is 
highly immunogenic, and smooth-LPS is an essential virulence factor since these isolates are 
significantly more virulent (Cryz et al., 1984).  LPS can be recognised by the TLR4 receptor on 
eukaryotic cells.  The A-antigen in P. aeruginosa strains isolated from CF patients shows 
modifications leading to increased recognition by TLR4 (Ernst et al., 2003). 
 
1.4 P. aeruginosa biofilm formation  
 
As well as living planktonically as isolated single cells, bacteria can also form multicellular 
communities known as biofilms.  Biofilm formation involves adhesion to a surface, and thus the 
previously described cell-associated factors, many of which are important in adhesion, also play a 
role in biofilm formation.  Biofilm formation is important in environmental and infection settings.  
This section describes the characteristics of biofilms, components important in biofilm formation, 
and the complex developmental cycle involved.  Additionally, the influence of biofilms on antibiotic 
resistance is discussed.   
 
Biofilms are a particular problem in the healthcare setting.  Indwelling medical devices are often 
colonised by P. aeruginosa biofilms, presenting a common route of infection (Morris et al., 1999).  
Biofilms can also occur during infections within the body, and it is estimated that 65% of human 
bacterial infections involve biofilms (Potera, 1999) 
 
1.4.1 Biofilm characteristics 
 
Biofilms are multicellular, matrix- enclosed, surface associated aggregates of cells. The mature 
biofilm structure can form tower or mushroom shapes protruding from the colonised surface into 
the surrounding liquid (Lawrence et al., 1991).  These structures are interspersed with open water 
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channels and pores (Sauer, 2003).   The matrix within which cells are enclosed is a slime-like 
substance made from extracellular polymeric substances (EPS).  EPS is produced by the bacteria and 
provides structural support to the biofilm (Flemming and Wingender, 2010).  Water channels and 
pores allow the exchange of nutrients and oxygen by cells deep within the biofilm community (Hall-
Stoodley et al., 2004).  Biofilm bacteria are protected from predatory cells, adverse environmental 
conditions, and starvation.  Bacteria within biofilm communities have a competitive advantage over 
their planktonic counterparts, allowing P. aeruginosa cells to persist under conditions in which 
planktonic cells would normally be eradicated.  Although the majority of studies mentioned here 
discuss mono-species P. aeruginosa biofilms, it is likely that mixed species biofilms occur in natural 
settings.   
 
1.4.2 Components of the biofilm matrix 
 
The EPS which makes up the matrix of P. aeruginosa biofilms is composed of polysaccharides, 
proteins and nucleic acids and is essential for the colonisation of surfaces (Sutherland, 2001).  EPS is 
highly varied, and the matrix changes in composition during the various stages of biofilm 
development.   
 
Alginate 
 
P. aeruginosa produces a capsular polysaccharide called alginate, a high molecular weight polymer 
(Linker and Jones, 1964).  P. aeruginosa alginate is a linear polymer of β-1,4 linked D-manuronic acid 
and L-guluronic acid residues.  The alternative sigma factor encoded by algT is essential for alginate 
production (Flynn and Ohman, 1988).  The synthesis of alginate depends on an operon of 12 genes  
responsible for synthesis, polymerisation and export which are silent in non-mucoid P. aeruginosa 
but is active in mucoid strains. (Deretic et al., 1987) 
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P. aeruginosa cells overproducing alginate form a characteristic ‘mucoid’ colony morphology, where 
colonies are slimy and encased in a viscous material, as shown in Figure 1.3 (Rao et al., 2011).  
Specific genetic events lead to emergence of alginate overproducers, and a selective process occurs 
in the cystic fibrosis lung where these alginate overproducers successfully compete and 
predominate.  The majority of these strains carry mutations in the mucA gene, resulting in defective 
MucA, unable to carry out its role as an anti-sigma factor, leading to alginate overproduction (Xie et 
al., 1996).  The selection of these mutants suggests that the overproduction of alginate is 
advantageous during CF lung infections. Alginate is able to hold a large amount of water, and thus 
maintain an aqueous environment within the matrix, allowing bacterial cells to survive longer during 
periods of desiccation (Chang et al., 2007). 
 
 
 
Figure 1.3 P. aeruginosa mucoid colony morphology 
CF P. aeruginosa isolates streaked on L agar.  Strain 383 (left), shows a non-mucoid morphology, 
while strain 2192 (right) shows a characteristic mucoid morphology.  Reproduced from (Rao et 
al., 2011) 
 
 
The role of alginate in biofilm production is not clear, as it is not essential for in vitro biofilm 
formation (Stapper et al., 2004).  However, it has an important role in shaping biofilms and increases 
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antibiotic resistance when over produced (Hentzer et al., 2001).  This information has led to the 
search for alternative polysaccharides responsible for biofilm production in the absence of alginate.   
 
Psl and Pel polysaccharide   
 
The search for alternative polysaccharides has identified several biosynthetic operons, one of which, 
a polysaccharide synthesis locus, psl, was important for biofilm integrity (Friedman and Kolter, 
2004b; Jackson et al., 2004).  psl is a repeating pentasaccharide containing D-mannose, D-glucose 
and L-rhamnose, the product of an 11 gene operon, which show homology to carbohydrate 
synthesis genes (Byrd et al., 2009; Matsukawa and Greenberg, 2004).  Psl has been shown to have a 
role in initial adherence of bacterial to surfaces (Ma et al., 2006), and is a component of mature 
biofilms, affecting their structure and stability (Ma et al., 2009b).   
 
Psl polysaccharide is not required for biofilm formation in PA14 since this strain lacks part of the psl 
operon.  A second aggregative polysaccharide component of the biofilm matrix was discovered in a 
transposon screen for poor biofilm formation in P. aeruginosa PA14.  The disruption of a gene 
cluster, later named pel, resulted in an obvious defect in biofilm formation at the air liquid interface, 
the pellicle, important in the early and late stages of biofilm formation (Friedman and Kolter, 2004a; 
Vasseur et al., 2005). The Pel polysaccharide locus contains seven genes, homologous to 
polysaccharide biosynthesis genes.  The cluster lacks some essential genes, and may interact with 
other systems for complete polysaccharide synthesis (Franklin et al., 2011).  The Psl polysaccharide 
seems to be dominant over the Pel polysaccharide, since in the presence of both loci, Psl 
predominates, and disruption of Pel has only a small impact on biofilm formation (Colvin et al., 
2012).  
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eDNA 
 
Nucleic acids are found in abundance in the biofilm matrix, principally DNA, which is a critical 
component.  The extracellular DNA (eDNA) isolated from P. aeruginosa biofilms is derived from 
genomic DNA, and its presence can be explained by autolysis of cells and release of cytosolic DNA 
(Allesen-Holm et al., 2006).  The structure of early biofilms can be disrupted by exposure to DNase1, 
showing that DNA is a major component, however more developed biofilms are more tolerant to 
DNase treatment (Whitchurch et al., 2002).  Large amounts of DNA can be observed throughout 
biofilms at 48h of growth, by confocal laser scanning microscopy.  However, at 144h the biofilms 
contain less DNA, and it is concentrated in the interior of stalks or mushroom shaped caps, not 
evenly distributed as at 48h (Allesen-Holm et al., 2006).  
 
Accessory biofilm components 
 
Several components have been shown to have accessory roles in the biofilm matrix.  LPS is 
important in biofilm formation, and affects adherence of cells, and cell-free LPS is a major 
component of the matrix (Lau et al., 2009).  A number of carbohydrate binding proteins, including 
CdrA and cytotoxic lectins, may be important in the interaction of molecules within the biofilm 
matrix, and formation of a stable matrix (Borlee et al., 2010; Tielker et al., 2005).  CdrA is secreted 
via a two-partner secretion mechanism, and is described in more detail in Section 1.6.  Two lectins, 
LecA and LecB, are important in biofilm formation, but their mode of transport is not understood.  
 
1.4.3 The biofilm development cycle  
 
Biofilm formation is characterised by distinct steps, which result in the formation of mature, 
complex, biofilm structures.   As outlined in Figure 1.4, five distinct stages are involved: reversible 
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attachment (1), irreversible attachment (2), maturation 1 (3), maturation 2 (4), and dispersal (5) 
(Sauer, 2003; Sauer et al., 2002).   
 
 
Figure 1.4 Stages of P. aeruginosa biofilm formation 
Five distinct stages of biofilm formation are shown.  Stage 1: Reversible attachment.  Stage 2: 
Irreversible attachment.  Stage 3: Early maturation.  Stage 4: Late maturation.  Stage 5: Biofilm 
dispersal.  Following stage 5, cells are released from the biofilm and return to a planktonic 
lifestyle, and are able to reinitiate the biofilm formation process. Upper diagram originally 
published by Biomed central and reproduced with permission from (Sauer, 2003). 
 
Analysis of DNA microarrays and proteomics approaches have shown that the different stages of 
biofilm formation represent distinct episodes in the lifestyle of P. aeruginosa, and bacteria in each 
stage are physiologically distinct from cells in other stages of the process.  The formation of a mature 
biofilm is a complex developmental process (O'Toole et al., 2000). 
 
Reversible attachment 
 
The reversible attachment phase is the initial event in biofilm formation, where bacteria become 
associated with, but not attached to, the surface.  The ability of P. aeruginosa cells to swim increases 
their ability to locate a surface.  Under certain conditions (glucose minimal media) non-motile strains 
were deficient in biofilm formation, but in other conditions (citrate minimal medium) they were 
proficient, therefore the dependency on flagella is conditional (Klausen et al., 2003b; O'Toole and 
Kolter, 1998).  Once a cell is located at a surface, it is not yet committed to biofilm formation.  Cells 
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may be enclosed in only small amounts of matrix, and are able to leave the surface and resume a 
planktonic lifestyle (O'Toole and Kolter, 1998).   
 
sadB has been shown to be involved in the regulation of the frequency by which P. aeruginosa cells 
attach to and detach from surfaces (Caiazza and O'Toole, 2004).  A sadB mutant is able to attach to a 
surface, but unable to form microcolonies despite being proficient in twitching and swarming 
motility.  The production of SadB is regulated by intracellular levels of the second messenger c-di-
GMP as discussed in Section 1.8 (Merritt et al., 2007). 
 
Irreversible attachment 
 
The transition from reversible to irreversible attachment of the bacterial cell to the surface is 
essential for biofilm formation, as cells must maintain a strong contact with the surface.  Attachment 
is dependent on type IV pili, with hyperpiliated strains rapidly forming strongly adherent biofilms 
(Deziel et al., 2001).  Flagella may enhance attachment to the surface (Sauer et al., 2002).   The cup 
fimbrial genes are also necessary for initial biofilm development, as was discovered in a transposon 
screen in non-piliated P. aeruginosa used to overcome the dominant impact of type 4 pili (Vallet et 
al., 2001).   
 
Following attachment to a surface bacteria need to increase in number in order to form a nascent 
microcolony. This increase can come from division of cells attached to the surface, or by recruiting 
new cells into the developing biofilm from the aqueous environment (Tolker-Nielsen et al., 2000).  
The process of biofilm maturation is thus a combination of an increase in cell number and the 
rearrangement of cells, and continued production of matrix components until the complex 
architecture, and associated channels, are formed.   
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The production by bacteria of extracellular polymeric substances (EPS) facilitates irreversible 
attachment, and the production of EPS is a hallmark of the early stages of biofilm formation.  Using 
an algC::lacZ fusion it was shown that cells attached to Teflon mesh or a glass surface for 15 minutes 
showed increased expression of the alginate biosynthesis gene algC (Davies et al., 1993; Davies and 
Geesey, 1995).  These extracellular polymers act as a sticky slime-like substance, attaching cells to 
the surface and each other (Sutherland, 2001).   
 
Analysis of global gene expression during initial biofilm formation has been performed in P. putida.  
After 6 hours of attachment to silicone, 2-D protein gel electrophoresis and cDNA subtractive 
hybridisation was performed  (Sauer and Camper, 2001).  This experiment found 45 differences in 
the protein profile of planktonic and sessile cells, and 40 differences in mRNA production.  Proteins 
involved in amino acid metabolism, and flagellar synthesis were downregulated following 6 hours of 
attachment.  Conversely, proteins involved in the synthesis of type IV pili and lipopolysaccharides 
were upregulated (Sauer and Camper, 2001). 
 
Biofilm maturation 
 
Time lapse confocal laser scanning microscopy has proven a powerful tool for visualisation of the 
biofilm maturation process.  The structure of the mature biofilm is dependent on the growth 
medium used.  When citrate was the sole carbon source, initial microcolonies formed from clonal 
growth of sessile cells, which then spread evenly across the surface by means of type IV pili, forming 
flat biofilms.  Biofilms grown with glucose as the sole carbon source formed differentiated motile 
and non-motile subpopulations.  The non-motile population form microcolonies at distinct foci, 
which act as the stalks of mushroom shaped structures.  The motile sub population climb on these 
stalks by means of type IV pili mediated motility and aggregate to form mushroom caps, as 
illustrated by Figure 1.5 (Klausen et al., 2003a; Klausen et al., 2003b).  This is likely due to differences 
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in the iron concentrations of the media since citrate chelates iron (Harmsen et al., 2010).   Twitching 
motility is induced in P. aeruginosa biofilms by iron limitation, and so iron limited biofilms are likely 
to be flat as they lack the non-motile sub-population required for stalk formation (Patriquin et al., 
2008) . 
 
 
Figure 1.5 Formation of mushroom-shaped structures in P. aeruginosa biofilms 
Confocal laser scanning microscopy images of mushroom shaped structures consisting of 
fluorescent yellow P. aeruginosa wild type cells forming the mushroom caps, and cyan florescent 
P. aeruginosa pilA mutants forming stalks.  Images show 4-day old biofilms initiated with 1:1 
mixtures of each strain grown on citrate minimal media.  Reproduced with permission from 
(Klausen et al., 2003a).  Panel A shows vertical CLSM sections, while panel B shows the 
corresponding 3-D CLSM images.  Red scale bar indicates 20 µm. 
 
Microarray analysis has been performed to investigate differences in gene expression between P. 
aeruginosa planktonic cells and mature biofilm cells.  73 genes were differentially expressed in these 
two conditions, many of which were of unknown function.     34 genes were up-regulated in biofilm 
conditions, which related to the increased expression of bacteriophage genes with unknown 
relevance.  39 genes were down-regulated in biofilm conditions, including type IV pili and flagella 
genes (Whiteley et al., 2001).   
 
Analysis of the proteome by 2D gel electrophoresis shows over 50% of detectable proteins had a six 
fold or greater change in expression level when planktonic cells were compared to mature biofilm 
cells (Sauer et al., 2002).   
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Biofilm dispersal 
 
The final stage, dispersal, is characterised by individual cells, or cell clumps, detaching from the 
surface, leaving void spaces behind (Sauer et al., 2002).  Dispersing P. aeruginosa cells revert to their 
planktonic lifestyle, re-initiating biofilm formation on uncolonised surfaces, completing the life cycle 
(Stoodley et al., 2001).  The proteome of cells in the late stages of biofilm formation was more 
similar to that of planktonic cells than mature biofilm cells, with cells reverting to the planktonic 
lifestyle (Sauer et al., 2002). 
 
Bacteria possess mechanisms to allow dispersal from biofilms, including reducing in adhesiveness 
and breakdown of the biofilm matrix.  The enzyme alginate lyase is produced by P. aeruginosa and is 
involved in detachment of P. aeruginosa due to alginate degradation (Boyd and Chakrabarty, 1994).  
Dispersal has been observed from microcolonies once they have reached a certain size (Purevdorj-
Gage et al., 2005).  Biofilm dispersal can be triggered by environmental factors such as shifts in 
carbon availability (Sauer et al., 2004) iron availability (Banin et al., 2006) and in response to nitric 
oxide (Barraud et al., 2006).  Biofilm dispersal has been linked to the second messenger cyclic di-
GMP.  Decreased c-di-GMP levels are related to motile lifestyle and to cell dispersal from biofilms 
(Simm et al., 2004).  Regulation by c-di-GMP is discussed in more detail in Section 1.8. 
 
1.4.4 Antibiotic resistance in P. aeruginosa biofilms  
 
P. aeruginosa is intrinsically resistant to many antimicrobials, and can acquire resistance to others, 
as described previously.  However, biofilm cells can be up to 1000 fold more resistant to antibiotics 
than planktonic cells, making biofilms very hard to eradicate (Hoyle and Costerton, 1991). Several 
hypotheses exist as to why biofilms are highly resistant to antibiotics.  Firstly, the ability of 
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antibiotics to penetrate the biofilm matrix may be reduced, especially in deeper areas of the biofilm 
(Stewart, 2002).  Oxygen limitation and low metabolic activity in the interior of the biofilm may also 
affect antibiotic activity (Walters et al., 2003).  The nature of biofilms also results in decreased 
susceptibility to eradication by the immune system, contributing to the persistence of biofilm 
infections (Jensen et al., 2010).   
  
Periplasmic glucans synthesised by the ndvB locus have been shown to be a genetic cause of 
antibiotic resistance in P. aeruginosa biofilms.  A ndvB mutant produces biofilms with comparable 
architecture to wild type biofilms, but do not show high levels resistance to antibiotics (Mah et al., 
2003).  These periplasmic glucans interact physically with antibiotics, and are proposed to prevent 
antibiotics reaching their active site by sequestration in the periplasm.  Periplasmic glucans are 
capable of binding to and sequestering tobramycin or kanamycin within biofilms, and preventing 
them from reaching their target (Mah et al., 2003; Sadovskaya et al., 2010).   
 
 
1.5 Extracellular pathogenicity factors  
 
In addition to cell-associated virulence factors, and their contribution to biofilm formation as already 
described, P. aeruginosa also produces a range of extracellular pathogenicity factors.  These factors 
are essential for the progression of infection, and allow P. aeruginosa to cause substantial damage 
to, or invade host cells, sequester nutrients from the environment, and interact with the immune 
system.  This section briefly describes some of the non-protein extracellular pathogenicity factors 
produced by P. aeruginosa; siderophores, pyocyanin, hydrogen cyanide and rhamnolipids. 
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Siderophores 
 
Pyoverdin and pyochelin are siderophores produced by P. aeruginosa, which allow it to acquire iron 
under iron limiting conditions by sequestering it from host proteins and delivering it into the 
bacterial cytosol for incorporation into bacteria proteins.  Specific cell receptors such as FpvA allow 
re-uptake of the siderophore-iron complex, dependant on the TonB energy transducer (Beare et al., 
2003).  Additionally, pyoverdin is a yellow/green pigment that is fluorescent under UV light, 
characteristic of P. aeruginosa.  
 
Pyoverdin is required for full virulence in animal models and it regulates the production of virulence 
factors.  Pyoverdin-deficient mutants demonstrate no virulence in a burned mouse model, and 
virulence was restored when purified pyoverdin was supplemented during infection (Meyer et al., 
1996).  Secreted pyoverdin regulates the production of three virulence factors, exotoxin A, and 
endoprotease, and pyoverdin itself (Lamont et al., 2002).  This regulation is dependent on a 
transmembrane signalling system including an outer membrane receptor for iron bound pyoverdin, 
a signal-transducing protein and a sigma factor (Lamont et al., 2002).  
 
Pyocyanin 
 
Pyocyanin is a blue/green redox active secondary metabolite that generates reactive oxygen species, 
essential for full virulence in a mouse model (Lau et al., 2004)  Pyocyanin is zwitterionic, and can 
penetrate host cell membranes and interrupt eukaryotic cellular pathways (Lau et al., 2004).  
Additionally, pyocyanin has a potent antibacterial effect, with Gram positive organisms being more 
susceptible (Baron and Rowe, 1981).   Pyocyanin has been shown to interfere with ciliary beating 
potentially reducing muco-cilliary clearance of P. aeruginosa (Kanthakumar et al., 1993)  
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Hydrogen cyanide 
 
Hydrogen cyanide is a potent toxin, inhibiting mitochondrial respiration by  binding to the ferric iron 
of  cytochrome oxidase enzyme  (Lenney and Gilchrist, 2011).  Hydrogen cyanide is responsible for 
killing in the nematode C. elegans model, and mutants not producing cyanide are avirulent in this 
host (Gallagher and Manoil, 2001).  Biologically significant amounts of cyanide are present in sputum 
from the airways of P. aeruginosa infected CF patients (Ryall et al., 2008; Sanderson et al., 2008).  
Due to inhibition of mitochondrial respiration, cyanide induces anaerobic respiration, causing a toxic 
build-up of lactic acid (Baud et al., 1996).  Cyanide levels reported in CF sputa are within the toxin 
range (Ryall et al., 2008). 
 
Rhamnolipids 
 
P. aeruginosa produces rhamnolipids, which are ramose containing glycolipid surfactants with a 
detergent-like structure (Jarvis and Johnson, 1949).  Their role remains highly speculative, and they 
are involved in a plethora of phenotypes.  Rhamnolipids emulsify hydrophobic substrates and allow 
them to be taken up by P. aeruginosa (Noordman and Janssen, 2002), and have antimicrobial 
properties against a range of bacteria (Ito et al., 1971).   
 
Rhamnolipids have several roles in the virulence of P. aeruginosa.  They integrate into the epithelial 
cell membrane,  disrupting tight junctions and disrupting epithelia (Zulianello et al., 2006), as well as 
killing polymorphonuclear leukocytes and macrophages, and inhibiting phagocytosis (Jensen et al., 
2007; McClure and Schiller, 1992, 1996).  Rhamnolipids have been detected in the sputum of CF 
patients (Kownatzki et al., 1987), where they may promote persistent infections by reducing muco-
ciliary clearance of P. aeruginosa (Read et al., 1992). 
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Figure 1.6 P. aeruginosa PA14 swarming motility requires rhamnolipids  
Wild type P. aeruginosa PA14 and PA14 Δ rhlA mutant, defective in rhamnolipid production, 
spotted onto 0.5% swarm agar and incubated for 16h.  The dotted line indicates the colony 
formed by the non-swarming rhlA mutant.  Reproduced with permission from (Caiazza et al., 
2005) 
 
Rhamnolipids are also important for biofilm formation by P. aeruginosa by maintaining the fluid 
channels in mature biofilms allowing water and oxygen flow (Davey et al., 2003), and in the 
formation of biofilm structures since disruption of rhamnolipids synthesis results in flat biofilms 
(Pamp and Tolker-Nielsen, 2007).  Rhamnolipids have been implicated in swarming motility where 
they are postulated to reduce the surface tension allowing P. aeruginosa to swarm on semi-solid 
surfaces, since disruption of rhamnolipids synthesis results in loss of the characteristic swarming 
patterns, as shown in Figure 1.6 (Caiazza et al., 2005). 
 
1.6 P. aeruginosa pathogenicity factors: Secreted proteins  
 
A large number of secreted proteins contribute to the pathogenicity of P. aeruginosa, and are 
delivered from the bacterial cytoplasm by dedicated protein secretion systems.  This section 
describes these secretion systems, explaining how proteins are exported across the bacterial 
membranes, and in some cases, the host cell membrane.  The nature and effects of the many P. 
aeruginosa secreted proteins and their role in virulence will be discussed.  The T6SS is considered 
separately in section 1.7. 
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Protein secretion systems in Gram negative bacteria have been classified, and there are currently six 
types.  These are named Type I Secretion System (T1SS) through to the Type VI Secretion System 
(T6SS).  Secretion systems export proteins in one- or two-steps, as shown in Figure 1.7.  One-step 
mechanisms involve secretion of proteins across both bacterial membranes in a single step by 
dedicated machinery, and periplasmic intermediates do not accumulate in a secretion mutant.  The 
T1SS, T3SS, T4SS and T6SS work in this way.  Two-step mechanisms involve initial secretion across 
the membrane using universal transporters, and separate dedicated machinery is used for transport 
across the outer membrane.  The T2SS and T5SS secrete proteins in two steps. The recently 
described T7SS from my Mycobacterium tuberculosis is not included here due to the fact is not 
found in Gram negative bacteria, but is involved in the secretion of proteins across the inner 
membrane and the highly impermeable cell wall of the Gram positive mycobacteria (Abdallah et al., 
2007). 
 
 
Figure 1.7 One and Two-step protein secretion mechanisms  
Gram negative protein secretion systems are either a one- or two-step process. One-step 
secretion (left) involves transport across the bacterial inner membrane (IM) and outer 
membrane (OM) in a single step, while two-step secretion (right) involves initial transport into 
the periplasm via Sec or Tat, and dedicated machinery for outer membrane transport. 
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1.6.1 Inner Membrane Translocation  
 
Protein export by two-step mechanisms (T2SS and T5SS) first requires translocation across the 
bacterial inner membrane.  The Sec (secretion) and Tat (twin-arginine-translocation) systems 
provide a route across the inner membrane for substrates of both the T2SS and T5SS, as well as for 
periplasmic-localised or outer membrane proteins.   Once in the periplasm, T2SS and T5SS substrates 
are available for secretion across the outer membrane by dedicated machinery. 
 
Despite their common function, the mechanisms used by the Sec and Tat systems to transport 
proteins are different.   The Sec system transports unfolded single linear polypeptides and is 
essential for viability, while the substrates of the Tat system are folded in the cytoplasm prior to 
transport including folded proteins carrying co-factors (Weiner et al., 1998) and multi-protein 
complexes (Theuer et al., 1993).   
 
Proteins are targeted to the Sec or Tat systems by a cleavable N terminal signal sequence.  The signal 
sequences for targeting to the Sec and Tat systems are structurally similar, but not identical, as 
illustrated by Figure 1.8.  Targeting to the Sec translocon is mediated by a 20 amino acid N terminal 
sequence, made up of three parts.   The amino terminal n-region of the signal sequence is positively 
charged,  and followed by a hydrophobic core h-region, terminating with a polar carboxyl-terminal c-
region (von Heijne, 1990).   The c-region is required for recognition by signal peptidase which cleaves 
the signal peptide to yield the mature protein, typically at an ‘A-x-A’ motif (Paetzel et al., 2002).  
Proteins targeted to the Tat translocon possess an N terminal signal sequence which also possess a 
positively charged n-region which is much longer compared to the sec sequence.  Tat substrates also 
have a hydrophobic h-region, and a short polar c-region for recognition by the signal peptidase.  
Proteins targeted to the Tat machinery have two conserved arginine residues within their signal 
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sequence, located between the n and h regions, and important for substrate recognition (Berks, 
1996).   
 
Figure 1.8 Sec and Tat signal sequences 
Amino terminal n-regions, hydrophobic h-region and carboxy terminal c-regions shown for Sec 
and Tat signal sequences.  Black arrow indicates the site of cleavage by signal peptidase, white 
arrow indicates the location of the Tat specific twin arginine sequences as shown. 
 
The Sec Translocon 
 
Proteins can be targeted to the Sec translocon co-translationally or post-translationally, as indicated 
by Figure 1.9.  The co-translational route involves a protein known as signal recognition particle, SRP, 
which binds to the signal sequence of a Sec targeted protein as it emerges from the ribosome.  The 
entire Ribosome-SRP-nascent polypeptide complex is targeted to the Sec machinery (Luirink et al., 
2005).  A signal recognition particle receptor transfers the nascent polypeptide to the Sec machinery.  
Proteins transported in this way generally end up inserted into the inner membrane (Luirink et al., 
2005).  The post-translational route is used by the majority of Sec-targeted secreted, periplasmic and 
outer membrane proteins, and involves recognition of substrates by the secretion specific 
chaperone SecB. SecB binds to proteins post-translationally, following release from the ribosome 
complex, and maintains them in a secretion competent unfolded state as well as targeting them to 
the Sec machinery at the inner membrane (Driessen, 2001). 
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Figure 1.9 Targeting of proteins to the Sec translocon 
Proteins can be targeted to the Sec machinery co-translationally (left) or post-translationally 
(right).  IM denotes the inner membrane, where the SecYEG channel is located (green ring).  The 
details of each mechanism are included in the text.  Red oval: signal recognition particle (SRP), 
green oval: SecB. Blue rectangle represents SRP receptor, and the yellow pentagon represents 
SecA.  The white stacked ovals represent the ribosome, with an emerging Sec targeted 
polypeptide. 
 
The Sec translocon consists of three integral membrane proteins, SecY, SecE and SecG, and a 
cytoplasmic ATPase, SecA (de Keyzer et al., 2003).  SecA associates with SecYEG and receives the 
Sec-targeted polypeptide from the ribosome or the SecB chaperone.  SecA threads the unfolded 
protein through the SecYEG membrane channel, using energy from ATP hydrolysis and the proton 
motive force (Hartl et al., 1990).  The SecYEG channel is only opened once a Sec-targeted 
polypeptide is bound, and unwanted leakage through the pore is avoided by providing a tight seal 
around the translocating protein (Van den Berg et al., 2004).  Sec targeted polypeptides are exported 
in a ‘step-wise’ manner into the periplasm, with multiple cycles of SecA binding and ATP hydrolysis 
contributing to translocation (van der Wolk et al., 1997). 
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The Tat Translocon 
 
Since the Sec translocon is limited to unfolded protein transport, the Tat system provides a vital 
route across the periplasm for folded proteins.  These include proteins containing co-factors or 
multi-protein complexes which are incompatible with the Sec translocon (De Buck et al., 2007; 
Weiner et al., 1998).   During the study of periplasmic hydrogenases from Desulfovibrio vulgaris it 
became clear that a Sec-independent system was present, since only one subunit of this 
hydrogenase contained a signal sequence, but both subunits were required for their translocation.  
This indicated that these proteins were secreted as a complex in a folded state (Vandongen et al., 
1988). 
 
The mechanism of translocation by the Tat system is summarised in Figure 1.10.  The minimal Tat 
translocon is composed of two subunits, TatA and TatC, while a third component, TatB, is also found 
in the more complex Proteobacteria (Lee et al., 2002; Sargent et al., 1999).  TatB is very similar to 
TatA, and may be specialised for more stable TatC interactions (Yen et al., 2002).  TatB is not 
essential, since TatA can complement for the lack of TatB (De Keersmaeker et al., 2005). TatC is an 
integral membrane protein, with six transmembrane domains, able to bind twin arginine signal 
sequence domains (Alami et al., 2003; Holzapfel et al., 2007).  Following substrate binding a 
conformational change occurs in TatC that pulls the substrate through the membrane, facilitated by 
weakening of the membrane by TatA and the proton motive force.  TatA proteins, when purified 
following overexpression, form ring-like structures with a variable diameter, which may allow 
transient weakening and disruption of the membrane for substrate transport (Bruser and Sanders, 
2003; Gohlke et al., 2005).  Transport via the Tat translocons is proposed to be in a single step, after 
which the membrane quickly re-seals, consistent with a large proton flux accompanying Tat 
transport (Alder and Theg, 2003).   
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Figure 1.10 Targeting of proteins to the tat translocon 
Tat targeted proteins, containing a twin-arginine motif (RR) are released form the ribosome 
(white ovals) and are folded in the cytoplasm.  The signal sequence is then recognised by TatBC 
(blue) and exported across the inner membrane (IM) in a Tat A dependent manner (green).  
Once in the periplasmic space, the signal sequence is cleaved by signal peptidase (red) to release 
the mature protein.  
 
1.6.2 The Type I Secretion System (T1SS) 
 
T1SS is among the simplest protein secretion systems, delivering unfolded proteins through the 
bacterial envelope in a single step, thus independent of the Sec and Tat translocons.  The Type I 
machinery is a three component translocator, illustrated by Figure 1.11  The T1SS spans the bacterial 
inner and outer membranes, allowing transport of proteins from the cytoplasm directly into the 
extracellular medium.  Two components, located at the inner membrane, are the ABC (ATP binding 
cassette) protein and an adaptor protein which extends into the periplasm.  The third component, 
located at the outer membrane, forms a beta barrel pore with α-helical projections into the 
periplasm (Koronakis et al., 2000).  The periplasmic sections of the outer membrane pore and the 
inner membrane adaptor protein interact and form a continuous channel across the cell envelope 
(Holland et al., 2005).   
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Proteins targeted to the T1SS contain a non-cleavable C terminal secretion signal, although the 
amino acid sequence of this signal is not highly conserved (Mackman et al., 1986).  The signal is 
believed to partly rely on the helical secondary structure of the C terminal 60 residues of the protein 
(Zhang et al., 1995).  This C terminal signal sequence interacts with the ABC protein and the adapter 
protein (Benabdelhak et al., 2003) which is thought to induce a conformational change in the ABC 
transporter, promoting ATP binding and hydrolysis, and providing the energy required for the 
translocation of the substrate through the pore (Letoffe et al., 1996). 
 
 
Figure 1.11 Model of the T1SS 
The three components of the P. aeruginosa Apr T1SS.  The AprD ATPase (green) is located in the 
inner membrane (IM), while AprF (blue) is located in the outer membrane (OM) and forms a   β-
barrel with alpha helical projections.  ArpF and ArpE are linked by the AprE adaptor protein (red). 
 
 
P. aeruginosa encodes two T1SSs.  The first is encoded by the apr genes, responsible for the 
secretion of an alkaline protease AprA, and a protein of unknown function AprX, (Duong et al., 2001; 
Guzzo et al., 1991). AprA alkaline protease is responsible for the degradation of host tissues, 
allowing bacterial invasion and subsequent systemic infection (Heck et al., 1986; Matsumoto, 2004).  
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The apr T1SS is composed of the AprD ABC transporter, the AprE adapter protein and the AprF outer 
membrane component.   
 
The second characterised P. aeruginosa T1SS is the HasAp system, which is involved in the secretion 
of a haemophore (Letoffe et al., 1998).   HasAp is important for the scavenging of iron from 
haemoglobin, allowing iron acquisition by P. aeruginosa in the iron limited environment of host 
tissues (Letoffe et al., 1998).  In this system the ABC transporter is HasD, the adaptor is HasE, and the 
outer membrane protein is HasF.  A fourth protein, HasR, is an outer membrane receptor which 
allows for the internalisation of the HasAp-heam complex (Letoffe et al., 1998). 
 
1.6.3 The Type II Secretion System (T2SS) 
 
Components and Assembly of the T2SS 
 
The Type Two Secretion System (T2SS) is able to secrete proteins to the external environment in a 
two-step process dependant on Sec or Tat for initial inner membrane translocation.  T2SS substrates 
carry the required N terminus secretion signal for targeting to Sec or Tat, which is cleaved by signal 
peptidase after translocation across the inner membrane.  Once in the periplasm, substrates are 
targeted to the dedicated T2SS machinery for transport across the outer membrane.  A prerequisite 
for T2SS dependent secretion is for substrates to be properly folded before leaving the periplasm, 
which suggests that the as yet poorly defined signal for targeting to the T2SS is dependent on the 
final 3D conformation of the protein (Francetic and Pugsley, 2005; Voulhoux et al., 2000).  The T2SS 
system is composed of between 11 and 16 proteins, and several T2SS proteins have homologous 
counterparts in the type IV pilus apparatus, suggesting an evolutionary link between these two 
systems (Peabody et al., 2003).  Comparison of T2SS and type IV pilus assembly are shown in Figure 
1.12. 
45 
 
 
Type IV pili are long, extracellular appendages, typically 50-80 Å in diameter and up to 4 µm in 
length, exposed on the surface of P. aeruginosa cells.  These appendages allow P. aeruginosa to 
move by twitching motility mediated by extension, tethering and retraction of the Type IV pili 
(Bradley, 1980).  The pilus structure is composed of multiple copies of a single subunit, known as the 
pilin, which oligomerise in a helical conformation (Forest and Tainer, 1997).  The pilus extends from 
the cell via an outer membrane pore, the secretin, driven by the energy for an assembly ATPase, and 
is retracted by the action of a retraction ATPase (Chiang et al., 2008).  This pilus extension and 
retraction mechanism is responsible for the twitching motility of P. aeruginosa.  Our understanding 
of pilus biogenesis has been instrumental in the characterisation of the T2SS. 
 
 
Figure 1.12 The P. aeruginosa T2SS  
Comparison of the T2SS (left) with the type IV pilus assembly apparatus (right).  Corresponding 
components in the two systems share the same colour.  Both systems contain an outer 
membrane (OM) secretin (blue), and an inner membrane (IM) ATPase (Red).  While the type Iv 
pilus is made up of many rectangular orange pilin subunits and extends from the surface of the 
cell, the T2SS pseudopilus is shorter, and contained within the periplasm.  Additional 
components are referred to in the text. Reproduced with permission from Elsevier (Filloux, 
2004). 
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The T2SS was originally described as the terminal branch of the general secretory pathway, while the 
initial branch is provided by Sec or Tat.  The nomenclature used here is that of the P. aeruginosa 
T2SS general secretory pathway (Gsp) throughout.  The T2SS machinery is made up of three distinct 
protein sub-complexes spanning the bacterial membranes.  At the inner membrane a multi protein 
platform contains several proteins (GspCEFLM), and a cytosolic traffic ATPase (GspE), associates with 
this platform (Camberg and Sandkvist, 2005).   A second sub-complex, the pseudopilin, is 
homologous to the long Type IV pilus structure, but does not extend to the exterior of the cell 
(Durand et al., 2003).  The third sub-complex is the secretin GspD, which forms an outer membrane 
channel providing substrates with access to the external environment. 
 
 
Figure 1.13 The P. aeruginosa T2SS pseudopillus 
Transmission electron micrograph of P. aeruginosa PAO1 overexpressing GspG, following 
immunogold labelling with antibodies raised against the pilin subunits.  The location of the 
flagellum, type IV pilus and T2SS pseudopilus are indicated by arrows.  Reproduced with 
permission from (Durand et al., 2003) 
 
The similarity between T2SS and type IV pilus assembly is shown by the fact that six of the 12 
conserved T2SS genes encode proteins dedicated to the formation of pilus-like structure known as 
the pseudopilus, however this structure is much shorter than the Type 4 pilus counterpart (Bally et 
al., 1992).  Five of these genes encode pseudopilins (GspG-K), which are subunits of the pseudopilus.  
GspG is the most abundant pseudopilin and  is co-translationally recognised by SRP and utilises the 
sec pathway for inner membrane translocation (Arts et al., 2007).  The sixth gene encodes a prepilin 
peptidase, GspO, involved in processing of the pilins and pseudopillins (Nunn and Lory, 1991).  When 
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GspG, the major pseudopilin, is overproduced it is able to form long fibre-like structures resembling 
the type IV pilus, observed by transmission electron microscopy, shown in Figure 1.13 (Durand et al., 
2003).   Overexpression of the four minor pseudopilins do not result in the production of comparable 
structures, but GspK is proposed to be the tip of the pseudopilus, preventing its extension beyond 
the cell envelope, since gspK mutants produce exposed, long, fibres (Durand et al., 2005). 
 
 
Figure 1.14 The V. cholerae GspD secretin  
A cut-out side view of the cryo electron microscopy structure of V. cholera GspD, revealing the 
periplasmic vestibule, a constriction, the periplasmic gate (yellow), and an extracellular chamber 
and gate.  The full height of the structure shown is 200 Å, and the width is 155 Å.  Reproduced 
from Nature (Reichow et al., 2010) 
 
The channel formed in the outer membrane is made of dodecamers of the secretin protein, GspD.   
The secretin from Vibrio cholerae has been shown by cryo-electron microscopy to form an elegant 
cylindrical barrel-like structure with 12 fold symmetry, as shown in Figure 1.14 (Reichow et al., 
2010).    The V. cholerae GspD resembles an upturned cup, and has a large periplasmic vestibule, 
separated from a small extracellular chamber by a periplasmic gate.  The extracellular chamber is 
itself closed by an extracellular gate (Reichow et al., 2010).  The outer membrane secretin is linked 
to the inner membrane platform by a trans-periplasmic protein, the bitopic inner membrane located 
GspC.  GspC has an N terminal cytoplasmic domain and a C terminal periplasmic domain separated 
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by a single transmembrane segment.  GspC interacts with the OM secretin in P. aeruginosa, and thus 
provides a link between the inner and outer membranes (Gérard-Vincent et al., 2002).  The traffic 
ATPase, GspE, contains conserved ATP binding and hydrolysis domains (Turner et al., 1993), and 
interacts with the inner membrane platform through interaction with GspL (Ball et al., 1999).   
 
A model is proposed in which T2SS substrates initially access the periplasm via the sec or tat 
systems, where they are able to interact with the periplasmic domain of the secretin and the 
pseudopilus tip.  This is proposed to stimulate GspE activity to add pseudopilin subunits to the 
pseudopilus, and the growing  tube functions as a piston pushing exoproteins through the secretin 
channel (Korotkov et al., 2012).  This is supported by observations that exoproteins interact with the 
periplasmic domain of GspD and GspC and components of the pseudopilus tip (Douzi et al., 2011), 
and  that the T2SS secreted cholera toxin is able to bind to the periplasmic side of the V. cholerae 
secretin (Reichow et al., 2011).  The T2SS lacks a counterpart for the retraction ATPase found in Type 
4 pilus systems, so it is unlikely that the retraction mechanism is conserved (Douzi et al., 2012). 
 
P. aeruginosa T2SS substrates 
 
A recent review described 12 secreted substrates dependant on the P. aeruginosa Xcp (extracellular 
protein) T2SS system, which are listed in Table 1 (Bleves et al., 2010).  A second T2SS is encoded on 
the P. aeruginosa genome, known as the Hxc T2SS (Homologous to Xcp).  The Hxc  system has been 
shown to be active under phosphate limiting conditions, and is responsible for the secretion of a low 
molecular weight alkaline phosphatase (Ball et al., 2002).   
 
The exoproteins secreted by the Xcp T2SS have a broad spectrum of activity including, but not 
limited to, proteolytic enzymes and lipid metabolism.  The secreted substrates are important in the 
infection process causing tissue damage, and allowing nutrient acquisition (Jyot et al., 2011).  These 
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include LasA and elastase  (LasB), which are able to degrade elastin, a major component of lung 
connective tissue (Braun et al., 1998). Elastase (LasB), is also able to cleave surfactant protein D, 
disrupting several immune functions and aiding in P. aeruginosa survival during infections (Alcorn 
and Wright, 2004).    LasA has additionally been shown to have specific activity against staphylococci 
(Kessler et al., 1993). 
 
 Gene  Characteristics Reference 
Proteolytic Enzymes 
LasA PA1871 Staphylolytic and elastolytic (Braun et al., 1998) 
LasB PA3724 Metalloproteinase (Elastase) (Braun et al., 1998) 
PaAP PA2939 Aminopeptidase (Braun et al., 1998) 
PrpL PA4175 Lysine specific endopeptidase (Protease IV) (Fox et al., 2008) 
Lipid Metabolism 
LipA PA2862 Triacyl glycerol acyl hydrolase (Jaeger et al., 1994) 
LipC PA4813 Lipase (Martinez et al., 1999) 
PlcN PA3319 Non hemolytic phospholipase C (Voulhoux et al., 2001) 
PlcH PA0844 Hemolytic phospholipase C (Voulhoux et al., 2001) 
PlcB PA0026 Phosphatidyl-ethanolamine specific phospholipase (Barker et al., 2004) 
Others 
PhoA PA3296 Alkaline phosphatase (Filloux et al., 1988) 
CbpD PA0852 Chitin-binding protein (Folders et al., 2000) 
ToxA PA1948 AB Toxin, ADP-ribosyl transferase (Lu et al., 1993) 
Table 1 P. aeruginosa T2SS substrates  
 
The P. aeruginosa Xcp T2SS also secretes a range of lipases and phospholipases which are targeted 
to the eukaryotic membrane.  The secreted phospholipases (Plc) are able to cause tissue destruction 
by hydrolysing phospholipids in the host epithelium or erythrocyte membranes (Schmiel and Miller, 
1999).  Phospholipases also play a role in disease through over-stimulating the immune response 
and promoting inflammation (Konig et al., 1997). 
 
The secreted alkaline phosphatase PhoA is capable of liberating free phosphate for utilisation by P. 
aeruginosa (Filloux et al., 1988).  A secreted chitin binding protein (CbpD) is degraded by a second 
T2SS secreted effector, elastase.  When bound to chitin, CbpD is protected from proteolysis.  Since 
CbpD is not able to degrade chitin, its role in pathogenicity is proposed to be as a chitin binging 
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adhesin and not a chitinase, although the precise role of this effector is yet to be shown (Folders et 
al., 2000). 
 
A well characterised Xcp T2SS substrate from P. aeruginosa is the AB toxin exotoxin A (ToxA), which 
is a highly toxic virulence factor.  The catalytic activity of ToxA is responsible for ADP ribosylation of 
elongation factor 2, which disrupts the protein synthesis of host cells, ultimately leading to cell death 
(Iglewski and Kabat, 1975).  Although the protein is secreted into the extracellular milieu, it is 
capable of self-targeting to eukaryotic cell membranes.  The linear protein sequence can be divided 
into several domains, including N terminal cell recognition and translocation domains (Theuer et al., 
1993), and a C terminal catalytic domain, responsible for the observed toxicity (Siegall et al., 1989).   
 
1.6.4 The Type III Secretion System (T3SS) 
 
The T3SS further extends the secretion capability of P. aeruginosa, allowing injection of proteins 
from the bacterial cytoplasm directly into host cells.  The T3SS translocates proteins across the 
bacterial inner and outer membranes, and the host cell plasma membrane, in a single step.  These 
proteins, called effectors, interfere with host cell signalling.  The T3SS apparatus is known as the 
‘injectisome’, and is evolutionarily and structurally related to the flagellum basal body apparatus 
(Saier, 2004).  The observation of a needle like injection apparatus from the T3SS of Salmonella spp. 
(Figure 1.15A) shows the elegant structure of this system (Schraidt et al., 2010). 
 
The T3SS was first characterised in P. aeruginosa by Yahr and colleagues (Yahr et al., 1996). A single 
copy of the T3SS is encoded within the P. aeruginosa genome, and the structural components of the 
system are contained within 5 operons containing 36 genes, clustered within one genetic locus.  
These structural genes can be categorised into structural components of the needle complex, 
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proteins involved in the translocation of effectors, regulatory elements and chaperones.  T3SS 
effector genes are scattered throughout the P. aeruginosa chromosome.   
 
Components and assembly of the T3SS 
 
The T3SS apparatus is shown in Figure 1.15.  The T3SS machinery is composed of a needle like 
filament, which is a straight hollow tube made up of PscF proteins (Pseudomonas secretion 
component) (Pastor et al., 2005).  The observation of PscF needles detached from cells showed they 
are 7 nm wide and 60-80 nm long (Pastor et al., 2005).   The PscF protein polymerises to form these 
long needles, and are prevented from doing so prematurely by two chaperones, PscE and PscG 
(Quinaud et al., 2005).  The length of the PscF needles is controlled by a molecular ruler, PscP, since 
deletion of this component in Yersinia spp. results in PscF needles varying in size from 45 – 1570 nm, 
and not the uniform  ~ 60 nm observed in the wild type strain (Journet et al., 2003). 
 
The components located at the base of the needle complex are less well characterised.  By 
comparison with components from Yersinia sp. it can be inferred that the PscN component, an 
ATPase, is responsible for energising the T3SS secretion process (Woestyn et al., 1994).  To allow the 
PscF needle access to the external milieu, a channel is formed in the outer membrane by the 
secretin protein PscC, which is able to polymerise and form a multimeric pore (Koster et al., 1997). 
 
The first components to be secreted through the assembled T3SS are PopB, PopD and PcrV.  These 
proteins are not true T3SS effectors, but are structural components important in the delivery of 
effectors to eukaryotic target cells.  PopB and PopD contain hydrophobic domains which promote 
their insertion into the eukaryotic plasma membrane, where they form a pore that is required for 
the delivery of T3SS effectors (Schoehn et al., 2003).  PcrV is an essential component for the 
assembly of the PopBD pore.  PcrV is not a structural component of the pore, as it does not interact 
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with either of the pore components (Goure et al., 2004).  PcrV has been shown to be located at the 
tip of the PscF needle, and may facilitate the assembly of the PopBD pore acting as a linker forming a 
continuous conduit between the PscF needle and the PopBD pore (Mueller et al., 2005).  Electron 
microscopy has been used to visualise the PcrV and two homologues (LcrV, from Yersinia spp. and 
AcrV from Aeromonas salmonicida).   The pcrV and acrV genes were used to complement lcrV 
deletion in Y. enterocolitica, and each produced distinct needle tip complexes as shown in Figure 
1.15 (Mueller et al., 2005). 
 
Figure 1.15 The T3SS  
A. Electron micrograph of the T3SS needle complexes from Salmonella typhimurium, reproduced 
from (Schraidt et al., 2010). B. Model of the T3SS from P. aeruginosa, showing the PscF needle 
extending from the bacterial cell into a neighbouring eukaryotic cell.  Components of the T3SS 
are described in the text.  C. The tip structure formed by LcrV in the T3SS needle from Yersinia 
enterocolitica (left). pcrV+ (middle) and acrV+ (right) genes from P. aeruginosa and Aeromonas 
salmonicida respectively were used to complement a Y. enterocolitica lcrV mutant.  Reproduced 
from (Mueller et al., 2005) with permission from AAAS.  
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The P. aeruginosa T3SS toxins 
 
There are four identified T3SS effectors in P. aeruginosa strains, known as exoenzymes; ExoS, ExoT, 
ExoU and ExoY.  These effectors are targeted in an unfolded state to the cytoplasm of eukaryotic 
cells, and play an important role in P. aeruginosa pathogenicity.  The nature of the T3SS signal is 
controversial, and proposed to be a non-cleavable N-terminal signal sequence.  However, the signal 
may be encoded within the corresponding mRNA molecule (Blaylock et al., 2008).  The trigger for 
T3SS effector delivery is contact with eukaryotic cells.  T3SS can be induced in-vivo under conditions 
of low Ca2+ availability, which results in the secretion of T3SS effectors into the supernatant (Vallis et 
al., 1999).  P. aeruginosa strains typically carry only three T3SS effectors, normally ExoT and ExoY, 
and either ExoS or ExoU (Wolfgang et al., 2003a).  The subset of T3SS effectors encoded by a P. 
aeruginosa strain determines its infectious potential.  Strains carrying exoU, encoded within a 
pathogenicity island (e.g. PA14), are cytotoxic and cause rapid host cell lysis (Schulert et al., 2003).  
Strains carrying exoS (e.g. PAK, PAO1), cause delayed cell death (Kaufman et al., 2000). 
 
ExoS and ExoT are 48 kDa and 49 kDa respectively, and share 76% amino acid identity and a common 
domain architecture.  The extreme amino termini of these two effectors encode amino acids 
required for targeting to the T3SS apparatus (Yahr et al., 1996), and a membrane localisation domain 
for eukaryotic plasma membranes follows the signalling domain (Zhang and Barbieri, 2005).  Both 
ExoS and ExoT are bifunctional enzymes, and have GTPase activating (GAP) domains and ADP ribosyl 
transferase activity (ADPRT).  The ExoS and ExoT GTPase activating proteins (GAP) domains target 
Rho, Rac and CDC42 host cell proteins, which are small GTPases (Goehring et al., 1999).  These 
proteins normally switch between a GTP-bound active state and a GDP-bound inactive state.  ExoS 
and ExoT render these proteins inactive in the GDP-bound state (Wurtele et al., 2001).  As GTPases 
normally regulate intracellular actin dynamics, the activity of ExoS and ExoT on GAPs disrupts the 
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actin cytoskeleton, leading to cell rounding and decreased internalisation into epithelial cells and 
macrophages (Garrity-Ryan et al., 2000).   
 
The ADPRT domain activity is located towards the C termini of ExoS and ExoT.  This domain requires 
the binding of a eukaryotic co-factor, thus self-toxicity in the bacterial cytoplasm is prevented.  The 
ADPRT domains are able to catalyse the transfer of ADP-ribose to specific target host proteins, 
interfering with signalling pathways involved in actin processes (Ganesan et al., 1999; Maresso et al., 
2004). The end results include cell rounding, inhibition of vesicular trafficking and inhibition of 
endocytosis (Barbieri et al., 2001).  Both ExoS and ExoT result in cell death, however, ExoS is a more 
potent toxin, mediating cell death in 2-5h compared to 10h for ExoT (Shafikhani et al., 2008). 
 
ExoY is a 42 kDa secreted protein with adenylyl cyclase activity (Yahr et al., 1998).  Injection of ExoY 
into host cell leads to an accumulation of cAMP, a global regulator of gene expression.  This cAMP 
accumulation leads to the differential expression of multiple genes, resulting in disruption of the 
actin cytoskeleton, inhibition of bacterial uptake, and increased membrane permeability (Cowell et 
al., 2005; Ichikawa et al., 2005).  Expression of ExoY in PAO1 promotes the formation and trafficking 
of P. aeruginosa to respiratory epithelial membrane blebs, dependent on the adenlylate cyalase 
activity of this protein.  ExoY adnelyate cyclase activity also promotes P. aeruginosa survival in mice 
cornea (Hritonenko et al., 2011). 
 
The largest P. aeruginosa T3SS effector is ExoU, which is a 74 kDa protein and a potent 
phospholipase (Sato et al., 2003).  ExoU is able to cause rapid death of eukaryotic cells within 1-2h 
due to the rapid loss of plasma membrane integrity (Finck-Barbancon et al., 1997).  Comparison to 
the other Exo proteins suggests it also has a secretion signal at its extreme N terminus.  The catalytic 
activity of this toxin is mediated by a patatin like phospholipase A2 domain, capable of the hydrolysis 
of a wide range of substrates (Banerji and Flieger, 2004).  This domain is followed by a C terminal 
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domain which has no homology to known motifs, but is essential for the cytotoxicity of the protein 
(Finck-Barbancon and Frank, 2001).   
 
Three classes of chaperones are associated with the T3SS.  Some of the P. aeruginosa T3SS toxins 
interact with chaperones prior to secretion, which facilitate storage of effectors in the bacterial 
cytoplasm and correct delivery to the secretion apparatus, known as Class I chaperones (Parsot et 
al., 2003).  ExoS and ExoT share the SpcS chaperone, which is required for their maximal secretions 
(Shen et al., 2008), while SpcU is the cognate chaperone of ExoU (Finck-Barbancon et al., 1998) and 
both interact with the effectors via interaction with the chaperone binding domain within the first 
100 amino acids of the effector.  No chaperone has yet been identified for ExoY.  Class II chaperones 
neutralise the potentially damaging effects of the hydrophobic translocators, such as PcrH binding of 
PopB and PopD (Schoehn et al., 2003).  Class III chaperones bind to structural subunits and prevent 
their polymerisation by masking polymerisation domains, known as PscE and PscG in P. aeruginosa, 
which bind to the PscF subunit of the T3SS needle in a 1:1:1 ratio (Quinaud et al., 2005). 
 
Regulation of T3SS in P. aeruginosa 
 
The T3SS is under global regulatory control of cAMP, quorum sensing and two component systems 
as described in Section 1.8.  The master regulator of T3SS is a transcriptional activator known as ExsA 
in a mechanism illustrated by Figure 1.16.  ExsA is a member of the AraC family of transcriptional 
activators (Hovey and Frank, 1995; Yahr and Frank, 1994; Yahr et al., 1995).  ExsA has an N terminal 
domain involved in self-association, and a c terminal helix-turn-helix DNA binding domain 
recognising a nucleotide consensus sequence in the promoter regions of T3SS operons (Brutinel et 
al., 2008; Brutinel et al., 2009).  The mechanism of regulation of ExsA occurs by a partner switching 
mechanism involving three additional proteins, ExsD, ExsC and ExsE (Brutinel and Yahr, 2008).  The 
activity of ExsA is inhibited by ExsD, an anti-activator which inhibits T3SS expression by disrupting 
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the self-association and DNA binding activities of ExsA (Brutinel et al., 2010).  ExsC is an anti-anti-
activator capable of disrupting the ExsA-ExsD interaction, binding and sequestering ExsD (Dasgupta 
et al., 2004).  However, ExsC is prevented from doing so due to a higher affinity binding to ExsE when 
secretion by the T3SS is not active (Dasgupta et al., 2004; Zheng et al., 2007).  Increased 
transcription of T3SS genes is coupled to secretion due to the export of ExsE, which is exported 
through the T3SS needle (Urbanowski et al., 2007).  This reduces bacterial ExsE levels, freeing ExsC to 
bind ExsD.  Under these conditions, ExsA is free to activate transcription of T3SS genes by binding to 
an ExsA box, leading to a rapid increase in the production of T3SS components under conditions 
where secretion is active.   
 
 
Figure 1.16 ExsE mediated regulation of the P. aeruginosa T3SS  
Off and on states of the P. aeruginosa T3SS mediated by the master regulator ExsA.  ExsA (A) is a 
transcriptional activator.  ExsD (D) is an anti-activator.  ExsC (C) is an anti-anti activator, and ExsE 
(E) is a secreted anti-anti-anti activator.  The mechanism of regulation is described in the text. 
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The expression of the T3SS is also regulated by the Ret/Gac/Rsm cascade which is described in more 
detail in Section 1.9.  Briefly, a retS mutant is defective in T3SS, while deletion of ladS has a 
reciprocal effect (Goodman et al., 2004; Ventre et al., 2006).  These sensors mediate their effects via 
the GacS/GacA two component systems. 
 
1.6.5 The Type IV Secretion System (T4SS) 
 
The T4SS is absent in P. aeruginosa, and so is not covered in detail here.  It is a well characterised 
secretion system involved in virulence in other Gram negative bacteria.  T4SS are evolutionarily 
related to systems involved in the conjugative transfer of DNA.  The T4SS are versatile, and are 
involved in both delivery of effectors and genetic exchange (Cascales and Christie, 2003; Christie and 
Vogel, 2000).  The T4SS is important in crown gall disease in plants mediated by the transfer of DNA 
by Agrobacterium tumefaciens (Christie, 1997), as well as delivery of effector proteins into the host 
by Legionella pneumophila (Nagai and Kubori, 2011)   Major advances have been made in the study 
of the T4SS through the elucidation of the structure of the core T4SS complex revealing a structure 
distinct from other known double membrane-spanning secretion systems (Fronzes et al., 2009) 
 
1.6.6 The Type V Secretion System (T5SS) 
 
The Type 5 secretion system is the simplest in terms of the number of components required for 
secretion, since the secreted protein and the mechanism required for secretion are either contained 
within one single or two separate protein(s).   T5SS is a two-step process, with secreted substrates 
utilising the Sec system for inner membrane translocation, and accordingly T5SS substrates encode 
an N terminal signal sequence.  Translocation across the outer membrane is through a channel 
formed by a β-barrel protein/domain.  T5SS substrates can be displayed at the cell surface, or 
released into the extracellular medium following proteolytic cleavage.  There are variations on the 
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mechanism of type 5 secretion, with different sub-classes being described.  Each is described in 
more detail below.    
 
Autotransporters (T5aSS) 
 
Autotransporters (AT) are single polypeptide molecules capable of auto-secretion without the 
requirement of any additional components, and have been classified as the T5aSS (Dautin and 
Bernstein, 2007).  AT proteins consist of an N terminal Sec signal peptide, and a C terminal β-strand 
domain.  A passenger domain is located between the signal peptide and C terminal β-domain, which 
is the secreted part of the protein, containing a catalytic domain.  The C terminal β-domain inserts 
into the outer membrane, forming a 12 stranded β-barrel (Oomen et al., 2004).  The formation of 
the β-barrel results in the exposure of the passenger domain at the cell surface, where it can remain 
cell-associated or be cleaved for release into the extracellular milieu.   
 
Three ATs are encoded within the genome of P. aeruginosa PAO1, (PA0328, PA3535 and PA5112).  
The best characterised is EstA (PA5112).  The passenger domain of EstA has lipolytic activity which 
can hydrolyse glycerol esters with short or long chain fatty acids (Wilhelm et al., 1999).  EstA is not 
truly a secreted protein since it remains anchored to the cell surface (Wilhelm et al., 1999).  Analysis 
of the structure of the full length EstA autotransporter reveals that the β-channel is too narrow to 
allow passage of the folded protein, and the translocation across the outer membrane must occur in 
an unfolded state (van den Berg, 2010).  The sequential folding of EstA during secretion may provide 
the energy required for the translocation of the full length protein (van den Berg, 2010).   
 
More recently two further P. aeruginosa ATs have been identified, although their characterisation is 
not as thorough as that of EstA.  AaaA (PA0328) is a surface tethered arginine-specific 
aminopeptidase of P. aeruginosa (Luckett et al., 2012).   Deletion of aaaA causes attenuation in a 
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mouse chronic wound infection model, and AaaA provides a growth advantage to P. aeruginosa 
when the sole nitrogen source is peptides with an amino terminal arginine (Luckett et al., 2012).  The 
third P. aeruginosa AT is EprS (PA3535), which contains a serine protease motif.  Studies on 
recombinant EprS expressed in E. coli confirmed that the protein is a serine protease, and that it is 
responsible for the cleavage of host inflammatory proteins, activating the host inflammatory 
response (Kida et al., 2013).  
 
Two partner secretion (T5bSS) 
 
The mechanism of T5bSS is similar to  T5aSS, except that the passenger domain and the β-domain 
are encoded within two separate proteins, TpsA and TpsB respectively (Jacob-Dubuisson et al., 
2001).  The TpsA protein contains a TPS secretion motif in addition to its functional domain.  The 
TpsB contains the β-domain preceded by a POTRA (polypeptide transport associated) domain.  The 
TPS secretion motif and POTRA domain are important for the interaction and recruitment of TpsA by 
TpsB (Clantin et al., 2007).  Both TpsA and TpsB cross the inner membrane via the Sec system, 
following which TpsB is inserted into the outer membrane, forming a 16 strand β-barrel (Clantin et 
al., 2007).  TpsA is translocated through the TpsB β-barrel and remains anchored to the cell surface, 
or is cleaved and released into the extracellular milieu.   
 
Five putative TPSs are encoded within the genome of P. aeruginosa PAO1, however they have not all 
been fully characterised.  The LepA/B (TpsA4/B4, PA4540/41) is involved in the outer membrane 
translocation of LepA, which has a trypsin-like serine protease motif, and demonstrated proteolytic 
activity (Kida et al., 2008).  The CdrA/B (TpsA3/B3, PA4624/25) is required for the outer membrane 
translocation of CdrA, a putative c-di-GMP regulated adhesin which promotes biofilm formation and 
bacterial aggregation (Borlee et al., 2010).  The remaining putative TPSs (Tps1 (PA2642/43), Tps2 
(PA0040/41) and Tps5 (PA0690/92) have not been characterised. 
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An orphan TpsA-like protein is encoded within the cupB gene cluster, which encodes cup fimbrial 
genes (Vallet et al., 2001).  The secretion of this TpsA-like protein, known as CupB5, has been shown 
to be dependent on CupB3, an usher protein involved in assembly of the Cup fimbriae (Ruer et al., 
2008).  However, further experiments suggest that CupB5 may be secreted by one of the other TpsB 
proteins encoded elsewhere on the chromosome (Daniela Muhl, Imperial College London, Personal 
Communication). 
 
T5cSS and T5dSS  
 
Following the classification of the T5aSS and T5bSS, additional systems were discovered which were 
similar to T5SS, but showed significant differences, resulting in the expansion of the T5SS class.  
T5cSS was created to describe autotransporter proteins with a β-barrel formed by the assembly of 
homo-trimers, with each monomer contributing 4 β-strands to the final outer membrane β-barrel 
(Kajava and Steven, 2006; Meng et al., 2006). 
 
A fourth auto transporter, PlpD, was discovered, which belongs to the lipolytic enzyme family of 
patatin-like proteins, as does the previously described ExoU, a T3SS secreted effector (Salacha et al., 
2010).  PlpD is a single polypeptide with a two domain architecture characteristic of T5aSS 
autotransporters.  However, the β-barrel domain is predicted to contain 16 β-strands, characteristic 
of the T5bSS TPS family.  Sequence analysis revealed the presence of a POTRA domain within the 
PlpD protein, which is also characteristic of the T5bSS family.  Due to the mixed nature of PlpD, it 
represents a novel secretion type known as the T5dSS (Salacha et al., 2010). 
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1.7 The Type VI Secretion System (T6SS) 
 
The Type Six Secretion System (T6SS) is the most recently characterised secretion system.  Despite 
lacking the T4SS, two T4bSS genes, icmF and dotU, are conserved in P. aeruginosa.  dotU and icmF 
are systematically found in P. aeruginosa and other Gram negative bacteria within gene clusters in 
which other T4SS homologous genes are not found.  Instead, a different set of conserved genes were 
found, which ultimately became known as the Type Six Secretion System (T6SS) (Mougous et al., 
2006; Pukatzki et al., 2006).   Three genetic clusters encode T6SS in P. aeruginosa. These clusters 
contain 13 core genes, essential for T6SS function (Zheng et al., 2011).  This section describes the 
components that make up the T6SS, how these components are assembled and the roles and 
regulation of characterised systems. 
 
1.7.1 Phage-like Components of the T6SS 
 
Components of the T6SS show homology to bacteriophage tail components, which has been 
instrumental in the advancement of our knowledge of the structure, function and mechanism of this 
secretion system (Leiman et al., 2009).   Bacteriophage are unique among viruses since they possess 
tails which allow host cell attachment, and the T6SS shows homology to the Myoviridae (Ackermann, 
2003).  The Myoviridae includes the T4 bacteriophage, which has a long contractile tail, as shown in 
Figure 1.17.  T4 bacteriophage tail is composed of a sheath, an internal tube, a base plate, located at 
the distal end of the tail, and both long and short tail fibres (Leiman et al., 2010).  During T4 infection 
the long tail fibres are extended and attach to the cell surface, increasing the probability for other 
fibres to locate host cell receptors, orientating the phage towards the cell surface (Kellenberger et 
al., 1996).   This binding results in conformational changes in the short tail fibres which bind 
irreversibly to the E. coli cell surface.  The baseplate changes confirmation, opening like a flower, and 
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the tail sheath contracts, causing propulsion of the tail tube which punctures the cell membrane 
(Leiman et al., 2010).  Phage DNA is then realises into the host cell cytoplasm through the tube. 
 
 
Figure 1.17 The T4 bacteriophage  
Schematic representation of bacteriophage T4.  The octahedral head containing DNA is shown 
on a contractile tail sheath, surrounding the tail tube.  The baseplate is found at the distal end of 
the tail tube.  Long tail fibres extend from the baseplate and allow recognition of host cells.  The 
mechanism of DNA injection is described in the text.  Reproduced from (Leiman et al., 2010). 
 
Many of the T6SS proteins show structural homology to components of bacteriophage, summarised 
in Figure 1.18, which shows key structural data confirming bacteriophage-like homologies.  Two key 
proteins with structural homology to bacteriophage components are Hcp and VgrG, which were also 
the first secreted substrates of the T6SSto be characterised.  The localisation of Hcp and VgrG in the 
supernatant of V. cholerae cultures is dependent on a complete T6SS cluster (Pukatzki et al., 2006), 
and their presence in the culture supernatants is a hallmark of a correctly assembled T6SS 
apparatus.  Despite initially being considered as secreted substrates, Hcp and VgrG are now 
considered as structural components of the system.  
 
The homology to the bacteriophage tail tube has been observed for two Hcp homologues from P. 
aeruginosa (Hcp1 and Hcp2) (Mougous et al., 2006; Osipiuk et al., 2011).  The Hcp proteins contains 
a fold similar to the major tail protein of bacteriophage λ gene product V (gpV) (Pell et al., 2009), and 
are evolutionarily related to the gp19 of T4-phage (Leiman et al., 2009).  Hcp forms hexameric rings 
as shown in Figure 1.18A which, in the crystal lattice, assembles into nanotubes composed of 
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hexamers arranged head to head (Hcp2), or head to tail (Hcp1). These tubes have an external 
diameter of 80 – 90 Å and an internal diameter of 35 – 40 Å (Ballister et al., 2008; Jobichen et al., 
2010; Osipiuk et al., 2011).  Formation of these nanotubes in vitro can be achieved by engineering 
disulphide bridges at the hexamer interface, as shown in Figure 1.18C, but their formation in vivo is 
yet to be confirmed, (Ballister et al., 2008).  
 
 
Figure 1.18 T6SS phage-like components: Hcp and VgrG 
A. Top and side views of a ribbon representation of the crystallographic Hcp1 hexamer, each 
monomer is coloured differently.  B. Single particle analysis of Hcp1.  C. Electron micrograph of 
representative Hcp1 nanotubes prepared from reduced subunits of tailored Hcp1 subunits.  D. 
structures of gp5 and gp27 monomers, extracted from the (gp5)3(gp27)3 complex.  E. Model of a 
prototypical VgrG created from the (gp5)3(gp27)3 complex, and removing the lysozyme domain.  
Panels A and B reproduced from (Mougous et al., 2006) with permission requested from AAAS.  
Panel C reproduced from (Ballister et al., 2008), and  Panels D and E reproduced from (Leiman et 
al., 2009). 
 
The structure of the N terminus of VgrG from E. coli CF T073 also resembles a bacteriophage 
component (Leiman et al., 2009).  Modelling of full length VgrG proteins shows structural homology 
to the trimeric (gp27/gp5)3 complex of the bacteriophage T4 (Figure 1.18 D and E).  While gp27 and 
gp5 are two separate proteins in the bacteriophage, they are a fused multi-domain protein in the 
T6SS.  The function of the trimeric bacteriophage (gp27/gp5)3 complex is to puncture the bacterial 
cell envelope, allowing insertion of the bacteriophage tail tube, and allowing injection of 
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bacteriophage DNA (Kanamaru et al., 2002).  It is proposed that this membrane puncturing function 
is conserved in the T6SS and mediated by trimeric VgrG (Leiman et al., 2009).  Mutlimerisation of 
VgrGs from P. aeruginosa has been observed, indicating that they may trimerise to perform their 
puncturing function (Hachani et al., 2011). 
 
 
Figure 1.19 The T6SS phage sheath-like component  
Cryo-electron micrographs of VipA/VipB complexes from V. cholerae (A) and TssB/TssC 
complexes from P. aeruginosa (B).  Inserts show the cogwheel cross section of the sheath-like 
tubules.  Panel A. reproduced from (Bonemann et al., 2009) with permission from Nature 
Publishing Group. Panel B. reproduced from (Lossi et al., 2013). 
 
A protein complex composed of two core T6SS proteins, VipA and VipB from V. cholerae, 
homologous to P. aeruginosa TssB and TssC (type six secretion) also shows structural homology to a 
bacteriophage structure.  Cryo-electron microscopy analysis of the VipA/VipB complex from V. 
cholerae shows that they form structures with cogwheel like cross sections, similar in architecture to 
the T4 viral tail sheath, encoded by gp18 (Figure 1.19A) (Bonemann et al., 2009).  The tubes formed 
have an external diameter of 300 Å, and an internal diameter of 100 Å (Bonemann et al., 2009).  The 
T4 tail sheath is made up of over 100 gp18 products, helically assembled into a sheath which 
accommodates viral tail tube proteins, and contraction of this outer tube provides the energy 
needed to push the phage needle through the target cell outer membrane (Aksyuk et al., 2009).  
Analysis of TssB/TssC from P. aeruginosa have shown that they also form a comparable structure 
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observable by cryo-electron microscopy, shown in Figure 1.19B, indicating that this is a conserved 
component of the T6SS (Lossi et al., 2013). 
 
The advances in structural biology of key T6SS components (Hcp, VgrG and VipA/VipB) have allowed 
the development of a model for T6SS mechanism based on that known for bacteriophage cell 
puncturing devices, illustrated by Figure 1.20A (Leiman et al., 2009).  The VgrG tipped Hcp tube can 
be accommodated within the tail sheath made of TssB/C.   Contraction of the sheath proteins 
provides the energy required for propulsion of the VgrG tipped Hcp tube across the bacterial 
membranes, in a one-step process.  This mechanism has been compared to an inverted 
bacteriophage, delivering proteins from the inside of the cell to the outside environment, as 
opposed to the delivery of DNA in the opposite direction by bacteriophage (Figure 1.20B).  This 
model has been supported by direct visualisation of sheath like tubules in Vibrio cholerae (Basler et 
al., 2012).  Time-lapse fluorescent microscopy and cryo electron microscopy was used to visualise 
tube like structures spanning the bacterial cells, existing in extended or contracted conformations, 
connected to the inner membrane (Basler et al., 2012).  Fluorescent microscopy was performed on 
strains expressing a vipA-gfp fusion which formed long, straight, sheath like structures, which were 
not visible in a vipB mutant, indicating that these structures are the hypothesised sheath like 
components (Bonemann et al., 2009; Leiman et al., 2009).  These structures were highly dynamic, 
cycling through states of assembly, contraction, and disassembly in the bacterial cytoplasm, with 
assembly occurring at a speed of 20 – 30 µms-1, contraction taking less than 5 ms, and disassembly 
occurring over 30 – 60 s (Basler et al., 2012). 
 
TagJ is a non-essential component of the T6SS, which is only found in the H1-T6SS of P. aeruginosa, 
absent from H2- and H3-T6SS (Lossi et al., 2012).  TagJ interacts with an alpha helix at the N-
terminus of TssB, a component of the sheath-like complex, suggesting that TagJ might modulate the 
incorporation of TssB into the mature T6SS (Lossi et al., 2012).  
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Figure 1.20 T6SS assembly model 
A. model showing the predicted assembly of T6SS components.  The Hcp1 tube (yellow) is 
topped by trimeric VgrG (green), which  sits inside the TssBC contractile sheath (blue).  TssJ is an 
outer membrane lipoprotein, while TssL and TssM form an inner membrane complex.  ClpV is a 
cytoplasmic protein.  B. The homologous components from the T4 bacteriophage are shown in 
the same colour as the T6SS components from Figure 1.20A, and shows the inverted orientation 
of the T6SS. 
 
1.7.2 Other components of the T6SS 
 
Unlike the components described thus far, ClpV is not evolutionarily related to known phage 
components and is implicated in the dynamics of sheath contraction.  It is a cytoplasmic protein, and 
a member of the Hsp100/Clp family of AAA+ ATPases, with the ability to form oligomeric rings 
(Schlieker et al., 2005).  Using the energy of ATP hydrolysis, this family of proteins is able to unfold 
target proteins.  ClpV forms discreet foci within P. aeruginosa cells, observed by fluorescent 
microscopy of strains carrying a clpV1-gfp fusion (Mougous et al., 2006).  ClpV selectively interacts 
with contracted VipA/VipB tubules and disassembles the sheath structure allowing the subunits to 
be recycled and reused in another T6SS event (Basler et al., 2012; Bonemann et al., 2009).  ClpV-gfp 
fusion protein was visualised in V. cholerae using time-lapse fluorescent microscopy, and was 
observed to assemble into short structures that disappeared in tens of seconds (Basler and 
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Mekalanos, 2012b).  These ClpV structures were dependent of the presence of VipA, a component of 
the sheath-like structure, since in a vipA mutant, ClpV-gfp was evenly distributed in the bacterial 
cytosol.  Co-visualisation of VipA-gfp and ClpV-mCherry showed that ClpV colocalised only with the 
contracted sheath, which were disassembled in a ClpV dependent manner (Basler and Mekalanos, 
2012b).   
 
Several of the remaining core T6SS components assemble a membrane complex of the T6SS.  TssL 
and TssM are prominent features of the T6SS, and show homology to DotU and IcmF proteins.  In 
the T4bSS these two proteins have been shown to interact and form a complex that stabilises the 
apparatus of this secretion machine, and the same function is proposed to be conserved in the T6SS 
counterparts (Nagai and Kubori, 2011). TssM is the IcmF homolog, and is an integral inner 
membrane protein carrying three transmembrane segments.  Part of TssM is located in the 
periplasm, consisting of a helical domain and a C terminal beta domain, which has been shown by 
yeast two hybrid to interact with the outer membrane located lipoprotein TssJ (Felisberto-Rodrigues 
et al., 2011).  A cytoplasmic TssM domain usually contains ATP-binding and hydrolysis Walker A 
motifs, but conflicting reports have been made regarding the requirement of these domains in the 
T6SS process.  The Walker A motifs are essential for assembly of T6SS machinery in Agrobacterium 
tumefaciens, but their mutation has no effect on T6SS activity in Edwardsiella tarda (Ma et al., 
2009c; Ma et al., 2012; Zheng and Leung, 2007a).  The cytoplasmic Walker A motifs are absent in 
many TssM homologues, indicating they are not an essential feature of the T6SS. 
 
TssL is homologous to DotU, and is also an integral inner membrane protein, with a single 
transmembrane segment.  The protein has a large C-terminal periplasmic domain encoding a 
peptidoglycan binding (PGB) motif of the OmpA family.  If this domain is absent from TssL an 
accessory protein, TagL (type six associated gene), is present which compensates by carrying the 
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PGB motif and interacting with TssL (Aschtgen et al., 2010b).  This PGB motif is likely to be 
responsible for tethering the T6SS apparatus to the cell wall (Aschtgen et al., 2010a). 
 
TssJ is a lipoprotein anchored to the outer membrane (Aschtgen et al., 2008).  TssM has been shown 
to interact with both TssL and TssJ, which are located at the IM and OM respectively, thus TssM is 
likely to span the periplasm and link the IM and OM.  It has been suggested that the role of the 
TssJLM membrane complex is to form a multimeric ring like structure, producing a channel spanning 
the cell membranes, and allowing the bacteriophage-like components to gain access to the external 
milieu (Silverman et al., 2012).  
 
TssE is a gp25-like component, essential for secretion by the H1-T6SS (Lossi et al., 2011).  Despite 
gp25 components of bacteriophage having lysozyme activity, no such activity could be detected for 
TssE (Lossi et al., 2011).  TssK is a trimeric cytoplasmic protein which interacts with TssL, Hcp and 
TssC, and is suggested to have a role in linking the phage-like complex with the trans-envelope 
complex of the T6SS (Zoued et al., 2013).  The remaining core components, namely TssA, TssF, and 
TssG are not characterised, but are likely to be homologues of the phage baseplate components.   
 
1.7.3 T6SS toxin delivery 
 
Several examples of T6SS mediated secretion have been described, but the exact method of effector 
delivery remains unclear.  While the nature of characterised effectors are described in the following 
sections, the proposed strategies used for their secretion are summarised in Figure 1.21.   
 
Scenario A depicts toxins that travel within the Hcp tube and are delivered following cell puncturing 
by VgrG.  The Hcp tube conduit is wide enough to carry globular proteins of less than 50 kDa, but the 
VgrG trimer is too narrow to allow proteins to pass through (Silverman et al., 2012).  In this scenario 
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the VgrG trimer must dissociate before toxin delivery, as occurs in bacteriophage DNA delivery.    
There is currently no experimental evidence to support this hypothesis. 
 
 
Figure 1.21 T6SS toxin delivery  
Three predicted scenarios of T6SS toxin (red) delivery, as described in the text.  A. Delivery of 
toxins into target cells mediated by VgrG (green) cell puncturing and toxin delivery through the 
Hcp tube (yellow).  B. Delivery of toxin domains covalently linked to VgrG.  C. delivery of toxins 
through non-covalent interaction with VgrG.  
 
Scenario B shows toxins being delivered at the tip of the needle, covalently linked to the VgrG.  
There are several examples of VgrG carrying these C terminal extensions, encoding diverse activities, 
and they have been named evolved VgrGs.  Limited examples exist of evolved VgrG targeted towards 
eukaryotic cells and bacterial cells, which are described further in the following sections. 
 
Scenario C shows toxins encoded by non-vgrG genes and interacting in a non-covalent manner with 
the VgrG tip.  This could allow one VgrG to deliver various toxins in a modular fashion.  A superfamily 
of PAAR proteins (proline-alanine-alanine-arginine repeat) has been shown to be an important part 
of the T6SS in a role as proposed by this scenario.  The crystal structures of PAAR proteins bound to 
VgrG partners have been solved, and the PAAR form a sharp conical extension to the VgrG spike 
(Shneider et al., 2013).  Inactivation of the two PAAR encoding genes in V. cholerae resulted in a 100-
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fold decrease in T6SS-dependednt killing of E. coli, and a 70% reduction in Hcp secretion, while 
inactivation of the three PAAR encoding genes from Acinetobacter baylyi led to a 10,000-fold 
decrease in T6SS-dependednt killing of E. coli and a 90% reduction in Hcp secretion (Shneider et al., 
2013).  PAAR genes modified to carry epitope tags fully restored T6SS mediated killing of E. coli in 
PAAR knockout strains of A. baylyi, suggesting that other effector proteins fused to PAAR domains 
could be targeted for secretion by binding to the VgrG tip, which could be decorated with multiple 
effectors which are delivered simultaneously (Shneider et al., 2013).  It is proposed that VgrGs which 
do not carry large C terminal extensions may carry shorter regions that act as adapter proteins for 
interacting with PAAR or other proteins to allow co-injection.  
 
1.7.4 T6SS effectors targeted into eukaryotic cells 
 
Many examples exist of T6SS required for or contributing to virulence and interaction with 
eukaryotic cells.  In most cases the molecular mechanism of virulence is not known, more 
particularly because the nature of the secreted effector is not known.  These include T6SS from 
plant, animal and human pathogens.  Table 2, reproduced from a recent review, lists the 
experimentally characterised roles for eukaryotic targeted T6SS (Coulthurst, 2013).   
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Organism T6SS T6SS-dependent phenotype Reference  
Aeromonas hydrophila Vas Cytotoxicity and inhibition of phagocytosis in cultured macrophages and epithelial cells; full virulence in septicaemic mouse 
model 
(Suarez et al., 2008) 
Avian pathogenic E.coli  Virulence in chick; adhesion to and actin rearrangement in cultured epithelial cells (de Pace et al., 2011) 
Burkholderia cenocepacia Bcs Resistance to Dictyostelium predation; virulence in rat model of chronic lung infection; induction of cytoskeletal rearrangements 
in cultured macrophages; inflammasome activation 
(Aubert et al., 2008; Gavrilin et al., 
2012; Rosales-Reyes et al., 2012) 
Burkholderia mallei T6SS-1 Virulence in Syrian hamster model; intracellular growth, actin polymerisation and mononuclear giant cell formation in cultured 
macrophages 
(Burtnick et al., 2010; Schell et al., 
2007) 
Burkholderia pseudomallei T6SS-1 Virulence in Syrian hamster model; growth and mononuclear giant cell formation in cultured macrophages; intercellular spread in 
cultured cells 
(Burtnick et al., 2011; French et al., 
2011) 
Burkholderia thailandensis T6SS-5 Virulence in mouse acute pneumonia model of melioidosis; mononuclear giant cell formation and intercellular spread in cultured 
cells 
(French et al., 2011; Schwarz et al., 
2010) 
Campylobacter jejuni  Colonisation of mouse; adhesion to and invasion of cultured colonic epithelial cells (Lertpiriyapong et al., 2012) 
Edwardsiella tarda Evp Virulence in blue gourami fish; virulence in several other fish models; invasion of cultured carp epithelial cells (Wang et al., 2009; Zheng and 
Leung, 2007b) 
Escherichia coli K1 Evf Adhesion to and invasion of human brain microvascular endothelial cells (Zhou et al., 2012) 
Francisella tularensis Igl Growth, phagosomal escape and cytopathogenicity in cultured macrophages; virulence in mouse model (Broms et al., 2009; Broms et al., 
2012) 
Francisella novicida Igl Intracellular growth in cultured murine macrophages (de Bruin et al., 2011; de Bruin et al., 
2007) 
Helicobacter hepaticus  Anti-inflammatory response in cultured intestinal epithelial cells and limitation of intestinal colonisation in mice (and perhaps 
therefore promotion of a tolerant, balanced relationship with host) 
(Chow and Mazmanian, 2010) 
Pectobacterium 
atrosepticum  
 Virulence in potato (stem and tuber infection models) (Liu et al., 2008) 
Pseudomonas aeruginosa H1-,H2-, 
H3-T6SS 
Virulence in rat model of chronic respiratory infection. Virulence (slow killing) in Caenorhabditis elegans model; enhancement of 
bacterial uptake into non-phagocytic cultured cells. Either H2- and H3-T6SS needed for full virulence in mouse lung and acute 
burn model; both for wild-type infection of Arabidopsis 
(Lesic et al., 2009; Potvin et al., 
2003; Sana et al., 2012) 
Pseudomonas syringae  Growth suppression of yeast (Haapalainen et al., 2012) 
Rhizobium leguminosarum Imp Host-specific inhibition of infection of pea plants (Bladergroen et al., 2003) 
Salmonella enterica 
serovar Gallinarum 
SPI-19  Colonisation of chicken ileum, caeca, liver and spleen (Blondel et al., 2010) 
S. enterica serovar 
Typhimurium 
Sci Contribution to pathogenesis and systemic dissemination in a mouse model of typhoid, intracellular replication in macrophages (Mulder et al., 2012) 
Vibrio cholerae Vas Cytotoxicity towards Dictyostelium and cultured mammalian macrophages; inflammatory response, diarrhoea and actin cross-
linking in mouse intestine 
(Ma et al., 2009a; Ma and 
Mekalanos, 2010; Pukatzki et al., 
2006) 
Vibrio parahaemolyticus  Adhesion to cultured cell monolayers (Yu et al., 2012) 
Table 2 Eukaryotic targeted T6SS  
Table reproduced from (Coulthurst, 2013)
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The T6SS was initially characterised in pathogenic V. cholerae and P. aeruginosa, which led to the 
hypothesis that the T6SS was important in virulence.  This appears true for the T6SS of V. cholerae, 
which targets eukaryotic cells.  V. cholerae encodes three VgrG, one of which has a C terminal 
extension which is similar to the actin cross-linking domain (ACD) of the cholera RtxA toxin, and is 
thus quoted an evolved VgrG (Sheahan et al., 2004).  The activity of this C terminal extension was 
shown by incubating purified recombinant VgrG1 with lysates from eukaryotic cells, which showed 
that VgrG1 was capable of cross-linking actin, as shown in Figure 1.22 (Pukatzki et al., 2007).  
Infection of J774 macrophages with a vgrG1 mutant showed that VgrG1 was required for actin cross-
linking in vivo, and that this phenotype was dependant on the T6SS cluster.  This confirms the role of 
VgrG1 as a T6SS-dependent effector (Pukatzki et al., 2007).  The actin crosslinking activity was 
localised to the C terminus of VgrG1 and deletion of this region abolished T6SS mediated toxicity 
while not effecting secretion (Ma et al., 2009a).   
 
Figure 1.22 V. cholerae T6SS actin cross-linking activity 
Extracts of cultured J774 macrophage, previously infected with the indicated strain, were 
separated by SDS-PAGE and probed with actin antiserum.  Molecular weight markers are 
indicated on both sides of the blot.  The V52 strain is responsible for significant actin cross-
linking, which is reduced by deleting rtxX, encoding the RtxA toxin (V52 ΔrtxA).  The residual 
actin cross-linking activity is abolished by deletion of vasK (icmF homolog), vgrG1, or hcp.  An 
rtxA mutant of a pandemic strain (El tor 01 N16961) did not cross-link actin.  Reproduced from 
(Pukatzki et al., 2007). 
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Direct observation of the delivery of the evolved VgrG1 from V. cholera into target cells was 
observed using β-lactamase fusions to the ACD, or by replacing this domain with β-lactamase.  These 
reporter fusions were detected inside the host cell, dependent on the N terminal region of the VgrG.  
This confirmed the role of the VgrG as a component of the secretion system, while the C terminus 
encodes the effector domain (Ma et al., 2009a).  An interesting observation in this study was that 
the T6SS activity of V. cholerae is dependent on internalisation into host cells, and therefore the 
T6SS may protect phagocytosed V. cholerae from macrophage killing (Ma et al., 2009a).  The 
pathogenic role of the V. cholerae T6SS was confirmed as the VgrG1 ACD causes inflammation and 
associated pathology in the intestines of mice (Ma et al., 2009a).   
 
A second example of T6SS involvement in pathogenicity is seen with the T6SS system from 
Aeromonas hydrophila, which also exerts its effect through the rearrangement of actin (Suarez et al., 
2010).  Supernatants from A. hydrophila were subjected to 2D gel electrophoresis, and using mass 
spectrometry a VgrG protein secreted in a T6SS dependent manner was detected.  The protein 
contains a vegetative insecticidal protein (VIP-1) domain at its C terminus, and is another example of 
an evolved VgrG.  Production of this VgrG in HeLa cells leads to disruption of the actin cytoskeleton 
and a decrease in cell viability (Suarez et al., 2010).  
 
The two examples from V. cholerae and A. hydrophila are the only known eukaryotic targeted 
evolved VgrG. Many other VgrG carry predicted evolved VgrG with diverse activities, as summarised 
in Table 3.  Evolved VgrG are not restricted to eukaryotic targeting, as shown by the experimentally 
demonstrated example of the peptidoglycan targeted VgrG3 from Vibrio cholerae, discussed in more 
detail in the next section (Brooks et al., 2013; Dong et al., 2013). 
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There are a limited number of non-VgrG effectors targeted towards eukaryotic hosts.  An example is 
VasX, a T6SS secreted effector of V. cholerae is required for virulence towards Dictyostelium 
discoideum by an unknown mechanism (Miyata et al., 2011).  For the other examples indicated in 
Table 2 the impact on virulence and T6SS-dependent secretion are yet to be characterised.   
 
 
Organism Activity  Reference 
Experimentally Demonstrated Evolved VgrG 
Aeromonas hydophila  ADP ribosylation of actin (Suarez et al., 2010) 
Vibrio cholerae Actin crosslinking (Pukatzki et al., 2007) 
V. cholerae  Peptidoglycan binding / hydrolysis  (Brooks et al., 2013; Dong et al., 
2013) 
Predicted Evolved VrgG 
Burkholderia cenocepacia Pe/ppe domain (Pukatzki et al., 2007) 
Erewinia tasmaniensis Chitosanase  (De Maayer et al., 2011) 
P. aeruginosa  Zinc metalloprotease  (Pukatzki et al., 2007) 
Pseudomonas 
entomophila 
YidB-like/Fibronectin-like domain (Pukatzki et al., 2007) 
Salmonella enterica S-type pyocin (Blondel et al., 2009) 
Yersinia intermedia  Mannose binding domain (Pukatzki et al., 2007) 
Yersinia pestis Tropomyosin-like domain (Pukatzki et al., 2007) 
Y. pestis YadA-like and pectactin-like domain (Pukatzki et al., 2007) 
 
Table 3 Experimentally demonstrated and predicted evolved VgrG 
 
 
1.7.5 Bacterial targeted T6SS toxins 
 
Genetic clusters encoding T6SS have been found in 25% of sequenced Gram negative bacterial 
genomes (Bingle et al., 2008).  T6SS are found in bacterial pathogens and symbionts.  However, non-
pathogenic, non-symbiont environmental bacteria also encode T6SS.  It is clear that the role of the 
T6SS is wider than pathogenesis alone.  Several T6SS have been experimentally shown to target 
competing bacteria by the direct injection of toxins which are discussed in detail below.  The 
currently known bacterial targeted T6SS toxins are listed in Table 4. 
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Toxin Organism Activity  Reference 
Peptidoglycan Targeting 
Tse1 P. aeruginosa Peptidoglycan amidase (Hood et al., 2010) 
Tse3 P. aeruginosa Peptidoglycan muramidase (Hood et al., 2010) 
Tae2BT Burkholderia thailandensis Peptidoglycan amidase (Russell et al., 2012) 
Ssp1, Ssp2 Serratia marcessecens Peptidoglycan amidases (English et al., 2012) 
Lipid Targeting 
Tle1BT B.thai Phospholipase A2 (Russell et al., 2013) 
Tle5PA P. aeruginosa Phospholipase D (Russell et al., 2013) 
TseL/Tle2VC Vibrio cholerae Phospholipase A1 (Dong et al., 2013) 
Other 
Tse2 P. aeruginosa Cytoplasmic toxin (Hood et al., 2010) 
Ssp3-6 S. marcessecens  Antibacterial toxins (Fritsch et al., 2013) 
 
Table 4 Experimentally demonstrated T6SS toxins  
 
 
Peptidoglycan targeting T6SS toxins 
 
Despite the initial assumption that the H1-T6SS of P. aeruginosa was involved in host cell interaction, 
it is now clear that this system targets bacterial cells.  A mass spectrometry approach was used to 
compare the secretome of P. aeruginosa strains with a constitutively active or disrupted H1-T6SS, 
and yielded three putative effectors, which were named Tse1-3 (type six effector) (Hood et al., 
2010). Tse1-3 are encoded distantly to the H1-T6SS, but are co-regulated by RetS.   
 
Further characterisation of Tse2 showed that production of this protein is toxic to yeast, mammalian 
cells and bacteria when produced within those cells (Hood et al., 2010).  Attempts to delete a gene 
downstream of Tse2 were unsuccessful in strains where Tse2 was intact, and thus this downstream 
gene was proposed to encode an antitoxin protein, preventing self-toxicity, named Tsi2 (type six 
immunity).  Eukaryotic cells were not affected by P. aeruginosa cells expressing Tse2, indicating that 
it is not translocated into eukaryotic hosts.  Conversely, P. aeruginosa cells lacking  Tse2/Tsi2 were 
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disrupted and outcompeted in co-culture with Tse2 producing cells (Hood et al., 2010).  Production 
of Tsi2 within target cells relieved the inhibition, confirming that Tsi2 is an antitoxin.  Tse2 is a 
bacteriostatic toxin, targeted to the cytoplasm of target cells where it affects their proliferation, but 
the exact mechanism of toxicity is not known (Hood et al., 2010). 
 
Unlike Tse2, the mechanism of toxicity mediated by Tse1 and Tse3 is characterised.  Tse1 and Tse3 
are lytic enzymes which degrade peptidoglycan.  Tse1 has amidase activity, and Tse3 has 
muramidase activity, each targeting a different bond within the peptidoglycan molecule (Russell et 
al., 2011).  Ectopic expression of Tse1 and Tse3 in the cytoplasm of E. coli did not affect the cells.  
Expression of periplasmic forms of Tse1 and Tse3 caused lysis of E. coli following induction (Russell 
et al., 2011), showing that Tse1 and Tse3 have a periplasmic target, but have no inherent means of 
accessing the periplasm.  Tse1 and Tse3 also have periplasmic immunity proteins encoded 
downstream of the toxin genes, which co-immunoprecipitate specifically with the cognate toxin, and 
act to neutralise the toxin activity (Russell et al., 2011).  These immunity proteins are delivered to 
the periplasm where they protect against injection of Tse1 and Tse3 from neighbouring cells, and 
not necessarily against toxins produced in the same cell.  
 
Other studies isolated a secreted effector from Burkholderia thailandensis, subsequently named 
Tae2BT for reasons described later (Russell et al., 2012).  Tae2BT is responsible for the intoxication of 
neighbouring bacteria in a T6SS dependent manner, and is a peptidoglycan amidase, confirming 
Tae2BT as a T6SS delivered toxin (Russell et al., 2012).  Russell and colleagues showed that Tae2BT was 
encoded adjacent to a specific immunity protein.  Tae2BT was thus a conserved T6SS amidase found 
in an organism other than P. aeruginosa. 
 
Following the discovery of peptidoglycan targeting proteins in P. aeruginosa and B. thai it was shown 
that these proteins were part of a phylogenetically diverse superfamily of T6SS-associated 
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peptidoglycan-degrading effectors (Russell et al., 2012).  Using parameters derived from the 
experimentally validated Tse proteins, the authors identified 51 putative peptidoglycan-degrading 
effectors in four distinct families, each family having a different specificity.  Thus Tae2BT was named 
due to its characterisation as a type VI amidase effector of the second family, from B. thai.  This work 
identified a large number of putative peptidoglycan targeting toxin and antitoxin pairs in a plethora 
of organisms, indicating that peptidoglycan is a common and conserved target of the T6SS.   
 
 
 
Figure 1.23 B. thai biofilm competition assay 
Fluorescence confocal microscopy images of B. thai (Green) and Pseudomonas putida (cyan) 
mixed biofilm formation in flow chambers at daily intervals following seeding with a 11 mixture 
of P. putida with either wild type B. thai (upper panels) or a B. thai ΔT6SS-1 mutant (lower 
panels).  Reproduced from (Schwarz et al., 2010) 
 
 
Burkholderia thailandensis (B. thai) is an interesting model for the study of T6SS as it carries five 
T6SS clusters within its genome.  Only one of these systems, the T6SS-5, is required for virulence in a 
mouse model, while the remaining four are dispensable for virulence (Schwarz et al., 2010). The 
T6SS-1 of B. thai is involved in antibacterial interactions, providing B. thai with a growth advantage in 
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mixed culture with other bacteria.  In a flow-cell biofilm assay, B. thai predominates when equal 
amounts of Pseudomonas putida and wild type B. thai are inoculated.  However, inoculation with a 
B. thai strain carrying a deletion in T6SS-1 allows the P. putida strain to dominate, as shown in Figure 
1.23 (Schwarz et al., 2010).  These observations indicate the importance of T6SS in the formation of 
complex communities within mixed biofilms.  The work carried out in B. thai serves as an important 
example since it shows multiple T6SS within one organism having distinct roles.   
 
Studies of Serratia marcescens have yielded two small secreted proteins, Ssp1 and Ssp2, which are 
two further members of the Tae family (English et al., 2012).  Ssp1 and Ssp2 belong to the fourth Tae 
family, and have accordingly also been named Tae4.1SM and Tae4.2SM.  These two toxins are encoded 
within the S. marcescens T6SS cluster, and were identified in the culture supernatant by 
immunoblotting, and by assessing their dependency on a functional T6SS.   They carry no sequence 
or structural homology to peptidoglycan hydrolases, but carry adjacent immunity proteins (English et 
al., 2012).  Despite not demonstrating peptidoglycan degrading activity, it was shown that non-
immune strains were susceptible to toxicity mediated by both Ssp1 and Ssp2. 
 
Lipid targeting T6SS toxins 
 
Alternative approaches have led to the discovery of T6SS effectors from different families.  A 
genomic analysis performed by Barret and colleagues showed that orphan VgrG, not associated with 
T6SS clusters, were often associated with additional genes encoded within genomic islands (Barret 
et al., 2011).  Each orphan vgrG was always associated with specific additional genes termed ‘cargo 
genes’ in all strains of P. aeruginosa carrying that vgrG (Barret et al., 2011).  Subsequent 
characterisation revealed that genes encoding predicted lipases/esterases were frequently linked to 
vgrG islands, with 34 genes encoding lipases or esterases found in the vicinity of 118 orphan vgrG 
across all of the genomes interrogated (Barret et al., 2011).  One of these vgrG islands encodes PldA, 
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and phospholipase activity has previously been shown for this protein (Wilderman et al., 2001).  The 
discovery of lipase genes within VgrG islands suggested that lipases were a novel family of T6SS 
secreted effectors.  It is also feasible that many of the other genes within vgrG islands encode 
diverse T6SS effectors, which are yet to be characterised but hold enormous potential to further our 
understanding of the T6SS.   
 
Experimental validation of the observations made by Barret et al. was provided by the discovery of 
phospholipases as a family of T6SS delivered antibacterial effectors (Russell et al., 2013).  In this 
work, Russell and colleagues extended the observations made by Barret and colleagues to uncover 
377 putative lipases from five families, named as type VI lipase effectors, Tle(1-5). Each tle gene was 
encoded adjacent to an immunity gene to protect from self-toxicity, indicating bacterial targeting of 
the lipase activity.  Tle5 from P. aeruginosa was shown to have phospholipase D activity catalysing 
the in vitro release of choline from phosphatidylcholine, a component of the bacterial membrane 
(Wilderman et al., 2001).  P. aeruginosa tle5/tli5 mutants, lacking both the Tle5 effector and cognate 
immunity protein, were susceptible to killing by a wild type P. aeruginosa competitor.   P. aeruginosa 
tle5/tli5 mutants survived incubation with P. aeruginosa tle5 deletion mutant,  confirming that Tle5 
is an antibacterial toxin against P. aeruginosa strains lacking the cognate immunity (Russell et al., 
2013).  Inactivation of the H2-T6SS by deleting clpV2 abrogated the Tle5PA dependent toxicity, 
indicating that the H2-T6SS was responsible for the delivery of Tle5PA.  Tle5PA is thus the first toxin to 
be shown to depend on the second P. aeruginosa T6SS cluster. 
 
In addition to the characterisation of Tle5 from P. aeruginosa, a lipase effector from B. thai, from the 
1st class of lipases, Tle1BT, was also characterised (Russell et al., 2013).  Tle1BT antibacterial activity 
was shown to be dependent on the T6SS-1, and was shown to have phospholipase A2 activity 
(Russell et al., 2013).  This work confirmed that phospholipases are a conserved effector family of 
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the T6SS, exerting their activity through targeting the cell membrane. The authors identified a large 
number of putative T6SS lipase effectors.   
 
A third Tle effector from V. cholerae was studied by Russell et al. (2013), and had previously been 
identified as an effector by Dong et al. (2013).  A high throughput analysis made use of transposon 
mutagenesis and subsequent sequencing to identify T6SS immunity proteins.  The authors used a 
screening approach to identify immunity genes by the fact they would be essential for survival in a 
wild type strains, but dispensable in a T6SS mutant (Dong et al., 2013).  This approach was successful 
in identifying three immunity proteins, and thus three adjacent effectors.  Two of these, VasX and 
VgrG3, were already known V. cholerae T6SS effectors, targeted towards eukaryotic cells as 
previously discussed (Miyata et al., 2011; Pukatzki et al., 2006).  The third candidate, named TseL 
(type six effector lipase), is a novel effector.  TseL was shown to be secreted in a T6SS dependent 
manner, and shown to be as T6SS dependent antibacterial effector (Dong et al., 2013).  TseL 
contained a predicted lipase domain, and site directed mutagenesis within the catalytic domain 
abolished the toxic activity of this protein.  Dong et al. were unable to detect lipase activity for TseL, 
but subsequent analysis showed that TseL, alternatively known as Tle2VC, has phospholipase A1 
activity (Russell et al., 2013).  An interesting observation is that TseL is able to act as an effector in 
both amoeba and interspecies bacterial competition, and it cannot be excluded that T6SS lipases are 
targeted to, and impact the viability of, eukaryotic cells.   
 
Bacterial targeted evolved VgrG 
 
Analysis of V. cholerae VgrG3, known to be a T6SS secreted effector, shows a predicted 
peptidoglycan binding domain (Pukatzki et al., 2007). In a subsequent study, VgrG3 was shown to be 
a T6SS dependent antibacterial effector (Brooks et al., 2013; Dong et al., 2013). Overexpression of 
vgrG3 under the control of a pBAD promoter in E. coli resulted in cell rounding and lysis. Site 
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directed mutagenesis of the predicted catalytic residues abolished this toxicity (Dong et al., 2013).  
This is an interesting example of an evolved VgrG targeted towards the bacterial cell wall.  VgrG3 is 
also protected by a cognate immunity protein (Brooks et al., 2013).A striking observation by Dong et 
al. was the direct interaction between TseL and VgrG3 by immunoprecipitation, strongly suggesting 
secretion and delivery of these components as a multi-protein complex.  
 
It is interesting to note that the T6SS encoded by V. cholerae targets both bacterial cells (TseL, 
VgrG3), but also eukaryotic cells (VasX, VgrG1).  This is a unique example of one T6SS targeting 
multiple hosts, and is in contrast to B. thai which has multiple T6SS which appear to have distinct 
eukaryotic or bacterial targets (Schwarz et al., 2010). 
 
Other characterised T6SS bacterial toxins 
 
Using a sensitive quantitative mass spectroscopy approach four novel T6SS effectors have been 
identified in Serratia marcescens (Fritsch et al., 2013).  This approach also identified the previously 
characterised Ssp1 and Ssp2, as well as Hcp and VgrGs, in the supernatant.  The four novel effectors 
discovered, Ssp3-6, severely impacted E. coli growth when expressed from an arabinose inducible 
promoter (Fritsch et al., 2013).  Ssp3-6 are protected by an adjacent, specific, immunity pair.  Ssp3 
was shown to act in the cytoplasm and Ssp4 in the periplasm, while the location of activity of the 
other effectors is unknown.  These newly discovered T6SS effectors show no similarity at the amino 
acid sequence level to previously characterised T6SS effectors, and carry no predicted functional 
domains (Fritsch et al., 2013).  The mechanism of their toxicity remains unclear, but is likely to reveal 
novel classes of T6SS dependent effectors. 
 
 
 
82 
 
1.7.6 Regulation of T6SS 
 
Ferric uptake regulator 
  
Several environmental signals have been shown to regulate the expression and activity of T6SS 
clusters.  The ferric uptake regulator (Fur) is involved in gene expression under iron limitation 
conditions, and is involved in the expression of some T6SS clusters.  When bound to iron, the Fur 
protein dimerises and represses transcription by binding to consensus DNA sequences known as Fur 
boxes located in target promoter regions (Carpenter et al., 2009).  Fur is involved in the regulation of 
genes involved in iron acquisition and metabolism, but also in virulence gene expression. 
 
Fur represses the expression of the T6SS in the fish pathogen E. tarda (Chakraborty et al., 2011).  Fur 
confers iron-dependent repression of the production of the Hcp homologue, and directly binds to a 
Fur box in the promoter region of the T6SS gene cluster.  Under the iron-limiting conditions 
experienced during infection, the expression of the T6SS is activated due to the alleviation of Fur-
dependent repression. 
 
Fur is also involved in the regulation of the Sci1-T6SS of the emerging enteropathogenic bacterium 
EAEC (Brunet et al., 2011).  Two Fur boxes and three DNA adenine methyltransferase (Dam) 
catalysed methylation sites are located in the Sci1-T6SS promoter region.  Under low iron conditions, 
Fur dissociates, allowing RNA polymerase access to the promoter.  Loss of Fur binding also allows 
Dam methylation, which prevents Fur re-association, generating a stable T6SS ‘on-state’. 
 
In P. aeruginosa, two Fur boxes have been identified upstream of the H2-T6SS, and the system is 
negatively regulated by iron, with expression of the cluster induced 2.2 fold in the absence of Iron 
(Sana et al., 2012).   
83 
 
 
Transcriptional Regulation: ơ54 
 
Sigma 54 dependent activator proteins, otherwise known as bacterial enhancer binding proteins 
(bEBPs) are encoded within many T6SS clusters.  Many T6SS clusters also contain Sigma 54 binding 
sequences located in their promoters, suggesting a general role for bEBPs and ơ54 in the regulation 
of T6SS (Bernard et al., 2011).  ơ54 factors modulate the activity of RNA polymerase and drive the 
expression of a distinct subset of genes.  ơ54 recruitment by RNA polymerase forms a closed 
complex, and the transition to a transcription competent open complex requires a bEBP protein 
(Rappas et al., 2007). 
 
Studies on bEBPs from a subset of T6SS have confirmed their role in ơ54 dependent transcriptional 
activation (Bernard et al., 2011).  The bEBP encoded within the T6SS of V. cholerae, VasH, is a key 
regulator of this system (Kitaoka et al., 2011), and is required for the T6SS mediated killing of E. coli 
by V. cholerae (MacIntyre et al., 2010). 
 
The H2-T6SS and H3-T6SS clusters of P. aeruginosa T6SS also encode bEBPs, and have consensus ơ54 
binding sequences in their promoter regions, which suggests that expression of these clusters also 
depends on ơ54.  However, this is yet to be demonstrated experimentally.  
 
Quorum Sensing 
 
Quorum sensing (QS) is a major regulatory mechanism for T6SS, with many diverse clusters showing 
QS dependent regulation.  The P. aeruginosa T6SSs are regulated by a complex quorum sensing 
system which is described further in Section 1.8. 
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Post-translational Regulation: Surface Association  
 
Early in the study of T6SS it was realised that growth on a solid medium was conducive to T6SS 
activity.  Subsequently, it has become clear that these conditions are favourable to the contact-
dependent mechanism of toxin delivery, now directly observed by Mekalanos and colleagues (Basler 
et al., 2013).   H1-T6SS from P. aeruginosa is post translationally activated by a threonine 
phosphorylation pathway in response to surface growth (Silverman et al., 2011).  Post translational 
regulation allows a rapid response to stimuli through the recruitment of ready-made components.  
This pathway involves the activity of PpkA, an inner membrane serine/threonine kinase, and Fha1, a 
forkhead associated domain.  Fha1 is activated by phosphorylation through Stk1, which promotes 
T6SS assembly and effector secretion (Mougous et al., 2007).  Cells grown on an agar surface 
assemble an activated apparatus and have elevated levels of phosphorylated Fha1 (Silverman et al., 
2011).  A cognate serine/threonine phosphatase antagonises the role of PpkA by dephosphorylation 
of Fha1 (Mougous et al., 2007).  The fact that around 30% of T6SS contain components of a 
threonine phosphorylation pathway suggests that this may be a general mechanism of T6SS 
regulation (Boyer et al., 2009). 
 
Additional accessory genes encoded by the P. aeruginosa H1-T6SS cluster, TagQRST have been 
shown to participate in the post translational activation of the H1-T6SS (Casabona et al., 2013).  TagR 
has already been characterised as a positive regulator of PpkA, promoting the phosphorylation of 
Fha1 (Hsu et al., 2009).  TagS, TagT and TagQ also act upstream of PpkA and are required for the 
optimal secretion of Hcp1, as well as for Tse1.  This effect is due to the requirement of TagS, TagT 
and TagQ for phosphorylation of Fha1, and the subsequent assembly and activity of the T6SS. While 
TagQ is an outer membrane lipoprotein, and TagR is associated with the OM, TagT and TagS form an 
inner membrane complex with ATPase activity (Casabona et al., 2013).  It is proposed that the 
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TagQRST is involved in the response to an unidentified signalling mechanism, resulting in activation 
of the T6SS. 
 
Post-transcriptional Regulation: Gac/Rsm 
 
The expression of the T6SS is also regulated by the Ret/Gac/Rsm cascade.  Briefly, a mutant in the 
retS regulatory protein has a hyperactive H1-T6SS, while deletion of the ladS regulator has a 
reciprocal effect (Goodman et al., 2004; Ventre et al., 2006).  These sensors mediate their effects via 
the GacS/GacA two component system.  This regulatory cascade also regulated the T3SS and biofilm 
formation, and is described in detail in section 1.9. 
 
1.7.7 Dynamics of the P. aeruginosa H1-T6SS 
 
Time-lapse fluorescence microscopy has been used to visualise the dynamics of the H1-T6SS of P. 
aeruginosa, providing remarkable live images of bacterial interaction.  Fluorescent microscopy has 
already been used to visualise the sheath component of the T6SS in contracted and extended 
conformations, providing insights into the mechanism of T6SS (Basler et al., 2012).  This technique 
has also allowed insights into the spatial and temporal activity of the H1-T6SS from P. aeruginosa 
and other organisms, as well as the interaction between different bacterial species.   
 
P. aeruginosa cells in monoculture respond to T6SS activity in a neighbouring sister cell, which leads 
to an increase in the T6SS activity of the responding cell at defined foci, as shown in Figure 1.24.  
These dynamics were visualised by live cell fluorescence microscopy of cells expressing a ClpV-gfp 
fusion  (Basler and Mekalanos, 2012b).  Basler and Mekalanos (2012) subsequently used the term 
‘T6SS duelling’ to explain the coincidence of T6SS activity between pairs of P. aeruginosa cells.  This 
duelling activity led to the hypothesis that a signal was being transferred between cells at the 
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location of T6SS attack (e.g. membrane perturbation, peptidoglycan hydrolysis of protein 
phosphorylation) which allowed P. aeruginosa to recognise the T6SS activity and launch a 
counterattack (Basler and Mekalanos, 2012b) .  This T6SS duelling behaviour is specific to P. 
aeruginosa since the same could not be observed for V. cholerae, which appears to have higher 
background levels of T6SS activity originating randomly within the cell (Basler and Mekalanos, 
2012b). 
 
 
Figure 1.24 P. aeruginosa T6SS duelling 
P. aeruginosa ΔretS expressing gfp tagged ClpV1, visualised by time-lapse fluorescent 
microscopy.  P. aeruginosa cells are shown to respond to T6SS activity in a neighbouring sister 
cell (5s and 20s) with an increase in their own T6SS dynamics (35S). Reproduced from (Basler and 
Mekalanos, 2012a) with permission from AAAS. 
 
The visualisation of T6SS dynamics between different species of bacteria has expanded our 
knowledge of P. aeruginosa T6SS activity, and yet again provided some remarkable live images of 
bacterial interactions (Basler et al., 2013).  The H1-T6SS killing activity of P. aeruginosa against V. 
cholerae cells is greatly increased by T6SS activity in those prey cells.  P. aeruginosa was observed to 
assemble its T6SS and counter attack at the point of attack from a T6SS+ prey cell, observed by 
imaging ClpV-gfp and ClpV-mCherry dynamics in the different bacterial species. A P. aeruginosa 
mediated T6SS attack resulted in Vibrio cell rounding, dependent on the VipA protein, one of the 
sheath-like components (Basler et al., 2013).  These V. cholerae morphological changes occurred 
predominantly in Vibrio cells directly in contact with P. aeruginosa.  The fact that rounding of Vibrio 
cells was absent when P. aeruginosa cells were incubated with T6SS negative V. cholerae (ΔvipA) led 
to the conclusion that the T6SS activity of a heterologous organism can trigger the duelling response 
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of P. aeruginosa.  This was confirmed by quantitative analysis of bacterial survival, since 100 times 
fewer surviving T6SS+ Vibrio were recovered in a competition assay compared to T6SS- cells 
competing against T6SS+ P. aeruginosa.  Thus, a T6SS duelling response is directed specifically 
towards T6SS+ Vibrio which have first initiated an attack towards P. aeruginosa (Basler et al., 2013).  
The evolutionary significance of this effect is proposed to allow P. aeruginosa to eradicate aggressive 
T6SS+ neighbours while co-existing with peaceful bystanders.  This is different to the T6SS strategy 
of V. cholerae which fires T6SS constantly, attacking all invading cells, and thus expends much more 
energy.  In P. aeruginosa the H1-T6SS is used as a defensive weapon, while the V. cholerae T6SS is an 
offensive weapon (Basler et al., 2013). 
 
1.8 Global Regulation of Pathogenicity in P. aeruginosa  
 
The wide variety of cell associated and secreted virulence factors described in previous section allow 
P. aeruginosa to be a prevalent nosocomial pathogen.  However, P. aeruginosa is also ubiquitous in 
natural and man-made environments.  Expression of these virulence factors in environmental 
settings must be tightly controlled to prevent their unnecessary production.  Additionally, upon 
entry to a susceptible human host, rapid and specific activation of virulence factors is required for 
successful colonisation.  In addition, virulence mechanisms need to be activated upon detection of 
eukaryotic predators or bacterial competitors in the environment.  Several complex and 
interconnected regulatory mechanisms have evolved in P. aeruginosa, allowing P. aeruginosa to 
launch efficient virulence attack.  The most extensively studied and best characterised of these 
regulation systems are described below. 
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1.8.1 Quorum Sensing 
 
Quorum sensing (QS) is a mode of cell-cell communication allowing bacterial populations to 
coordinate gene expression and synchronise behaviours at high cell density.  It was discovered in the 
bioluminescent marine bacterium Vibrio fischeri, where QS regulates light production (Engebrecht et 
al., 1983; Engebrecht and Silverman, 1984).  When population density reaches a critical level, light is 
produced in response to the accumulation of a diffusible signalling molecule (Engebrecht and 
Silverman, 1984).   This system allows V. fischeri to assess the density of neighbouring cells, and 
produce light only when cell density is high.  The process involves the regulation of the luxCDABE 
operon by LuxI and LuxR (Engebrecht and Silverman, 1984), which is regarded as the canonical 
quorum sensing system, shown in Figure 1.25.  LuxI is an enzyme responsible for the synthesis of the 
signalling molecule, which is an acylated homoserine lactone (AHL), namely N-(3-oxohexanoyl) 
homoserine lactone (Eberhard et al., 1981).  AHL is produced at all times and diffuses freely in and 
out of cells.  As the cell density increases, so does the concentration of this autoinducer molecule in 
the local environment.  Once the concentration of AHL is above a critical limit the molecules are able 
to bind to a cognate receptor, LuxR.  LuxR is also a transcriptional activator, but is only when bound 
to AHL.  LuxR has a modular structure containing a DNA binding domain with a helix-turn-helix motif, 
and an AHL binding domain. Binding of AHL leads to LuxR dimerization, allowing it to bind DNA and 
activate transcription, producing the enzymes required for light production (Stevens et al., 1994).   
An auto induction mechanism occurs, in which LuxR controls the expression of LuxI, amplifying the 
amount of AHL produced when the system is active. 
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Figure 1.25 The Lux quorum sensing system from V. fischeri 
Schematic representation of the LuxR/LuxI quorum sensing system from V. fischeri.  The acylated 
homoserine lactone (AHL) molecule (red triangle) is produced by the LuxI enzyme.  AHL diffuses 
freely into and out of the cell.  AHL binds to the LuxR receptor and activates expression of the 
luxICDABE operon, resulting in the production of light. 
 
A highly complex QS system exists in P. aeruginosa, which is likely the most studied and 
characterised QS system, together with V. cholerae.  In P. aeruginosa QS does not control 
bioluminescence, but is involved in the regulation of virulence.  P. aeruginosa has two complete 
systems homologous to the LuxI/LuxR systems (LasR/LasI and RhlR/RhlI) (Juhas et al., 2005; Schuster 
and Greenberg, 2006), and together these two systems regulate around 10% of the P. aeruginosa 
genome (Schuster and Greenberg, 2006).  An incomplete system composed of an orphan LuxR-like 
protein QscR also exists in P. aeruginosa (Chugani et al., 2001).   A third signalling system, PQS, is 
also involved in P. aeruginosa QS (Deziel et al., 2005; Wade et al., 2005).  These systems do not act 
alone, and are inter-linked through regulatory connections.  
 
The LasI/R and RhlI/R quorum sensing systems are summarised in Figure 1.26.  These systems are 
involved in the production of similar yet different acyl-homoserine lactone molecules (Brint and 
Ohman, 1995; Passador et al., 1993).  The AHL synthase LasI produces N-3-oxododecanoyl 
homoserine lactone (3OC12-HSL) (Pearson et al., 1994) , while RhlI produces N-butyryl-homoserine 
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lactone (C4-HSL) (Pearson et al., 1995).  The presence of both AHL molecules has been shown in 
samples taken from the lungs of chronically infected CF patients, indicating that these quorum 
sensing systems are important in infections (Erickson et al., 2002).   
 
 
Figure 1.26 The LasI/R and RhlI/R quorum sensing systems from P. aeruginosa 
3-oxo-C12-HSL is produced by LasI, and once a threshold concentration is reached, the 3-oxo-
C12-HSL-LasR complex binds to the promoters of multiple genes, activating their transcription, 
including the promoter of lasI, causing an autoinduction effect.  The rhlR promoter is also 
activated, increasing production of the RhlR response regulator, activating the second P. 
aeruginosa AHL quorum sensing pathway. The virulence factors regulated by these two systems 
are listed in Table 5.  Figure reproduced from (Jimenez et al., 2012)with permission  
 
The LasI/LasR system was first discovered as a regulator of the secreted virulence factor elastase or 
LasB (Gambello and Iglewski, 1991).  Once the P. aeruginosa population reaches a certain cell 
density, the LasI product 3OC13-HSL binds to the transcriptional activator LasR, which dimerises and 
binds to target promoters, activating their transcription (Schuster et al., 2004b).    The LasR target 
promoter sequences precede a number of secreted virulence factors important in the initiation of P. 
aeruginosa infections, listed in Table 5. These include elastase (lasB), LasA protease and exotoxin A, 
already described as virulence factors secreted by the T2SS in section 1.6 (Gambello and Iglewski, 
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1991; Jones et al., 1993; Passador et al., 1993).  Quorum sensing therefore controls virulence in P. 
aeruginosa by regulating the secretion of virulence factors when cell density is high enough to 
launch an attack.  Another target of the LasI-AHL complex is the expression of LasI itself, by an 
autoinduction mechanism (Seed et al., 1995). 
 
 
Table 5 P. aeruginosa quorum sensing regulated virulence factors 
Table reproduced from (Juhas et al., 2005) with permission.  
 
The second P. aeruginosa quorum sensing system, RhlI/R, was identified as a regulator of 
rhamnolipids (Ochsner et al., 1994).  The RhlI/R systems is itself controlled by the LasI/R system, 
since the expression of rhlI is a target of LasI-AHL, so the two systems are tightly linked in a 
hierarchical system (Figure 1.26) (Latifi et al., 1996).  The regulon of RhlR-AHL includes the 
expression of exoproducts already under LasI/R control (Brint and Ohman, 1995) but also a specific 
set of target genes listed in Table 5.  One of these is the gene encoding RpoS, the stationary phase 
sigma factor, which controls expression of genes for resistance to environmental stresses, and a 
specific set of virulence genes (Schuster et al., 2004a). The Rhl system regulates rhamnolipid 
biosurfactant, cyanide, and pyocyanin production (Latifi et al., 1995; Ochsner et al., 1994; Winzer et 
al., 2000). 
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The rhl system is responsible for the down-regulation of the T3SS (Bleves et al., 2005), which means 
that at high cell density the secretion of the potent toxins ExoU and ExoS is reduced.  This seems at 
odds with the role of quorum sensing to co-ordinately activate virulence factors.  However, this may 
indicate that T3SS is only required in the early stages of P. aeruginosa infection, when only a small 
number of cells are present.  The T3SS may help P. aeruginosa to disrupt host cells to allow and 
infection to establish, but is then down-regulated at later stages of infection (Willcox et al., 2008).  
There is also growing evidence that the three T6SS clusters encoded by P. aeruginosa are 
differentially regulated by quorum sensing.  Expression of the well-characterised H1-T6SS is 
repressed by LasR and MvfR (also known as PqsR, a regulator of the PQS system described below), 
while the H2- and H3-T6SS are positively controlled (Lesic et al., 2009).  However, the physiological 
significance of this effect is yet to be characterised.  Quorum sensing is important in P. aeruginosa 
biofilm formation, as lasI mutants are unable to form mature biofilm structures (Davies et al., 1998). 
 
The orphan LuxR-like protein QscR shares approximately 30% identity to both LasR and RhlR.  It 
contains both an AHL binding domain and a DNA binding domain (Chugani et al., 2001).  QscR has 
been shown to form complexes with C4-HSL and 3O-C12-HSL, or complexes with LasI or RhlR in the 
absence of AHLs, and thus may regulate quorum sensing by sequestering these molecules (Ledgham 
et al., 2003).  QscR is also a transcriptional regulator, with a regulon of over 400 genes, which 
overlap with the LasR and RhlR regulons (Lequette et al., 2006).  QscR directly binds DNA, and 
requires 3O-C12-HSL to do this, despite being able to bind both AI molecules (Lee et al., 2006).   
 
A third complete quorum sensing system in P. aeruginosa is dependent on the auto inducer 
molecule 2-heptyl-3-hydroxyl-4-quinolone, known as the Pseudomonas quinolone signal (PQS) (Pesci 
et al., 1999).  The expression of the PQS biosynthetic operon pqsABCDE is positively regulated by a 
regulator PqsR (corresponding to MvfR in PA14).  The synthesis and activity of PQS is mediated by 
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the las and rhl systems, linking this system to the hierarchical quorum sensing system of P. 
aeruginosa. LasR regulates PQS production, which is required for the transcription of rhlR and rhlI, 
providing a regulatory link between these systems (McKnight et al., 2000; Pesci et al., 1999).  PQS is 
produced maximally during late stationary phase, and around 90 genes have been found to be 
regulated by the pqs system, including genes involved in biofilm formation and several virulence 
factors including elastase and pyocyanin (Table 5) (Bredenbruch et al., 2006; Deziel et al., 2005). PQS 
is found in sputum and other samples taken from CF patients (Collier et al., 2002).  The P. aeruginosa 
PQS signal influence interspecies behaviour, affecting other Gram negative and Gram positive 
organisms.  In the presence of a PQS precursor molecule, motility was suppressed in a broad range 
of bacteria, and biofilm formation was repressed in Bacillus subtilis and Candida albicans (Reen et 
al., 2011).   Other bacteria in the vicinity interact with P. aeruginosa signal molecules, with the PQS 
system modulating polymicrobial communities, and not just influencing P. aeruginosa cells (Reen et 
al., 2011).    
 
Targeting quorum sensing has become an attractive strategy for treatment of P. aeruginosa 
infections.  The crystal structure of the PqsR protein from P. aeruginosa has been solved, and 
molecules generated which block the binding site.  Several novel potent QS inhibitors were 
discovered and shown to block virulence gene expression (Ilangovan et al., 2013). Garlic extracts 
have been shown to inhibit P. aeruginosa QS.  Fractionation of garlic extracts revealed ajoene was 
responsible for attenuation of QS-controlled virulence factors, as well as a synergistic antimicrobial 
effect with tobramycin on biofilm killing and a significant clearing of infecting P. aeruginosa in ajoene 
treated mice (Jakobsen et al., 2012).  By targeting and abolishing QS systems by therapeutic 
treatments, the devastating outcome of infections may be reduced if not eliminated.  The fact that 
bacterial cells are not killed suggests that resistance will not be selected, an advantage given the 
growing problem of antibiotic resistance.   
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1.8.2 cAMP 
 
Cyclic adenosine-3,5’ monophosphate (cAMP) is a second messenger important in signal 
transduction in eukaryotic cells, amoeba and bacteria.  cAMP is synthesised from ATP by adenylyl 
cyclase, and activates transcription factors of the CRP (cAMP regulator proteins) family (Harman, 
2001).  Three adenylyl cyclases are encoded by P. aeruginosa.  CyaA and CyaB are intracellular 
adenylyl cyclases (Wolfgang et al., 2003b).  The third adenylate cyclase is the T3SS secreted effector 
ExoY, already described in previous sections, exerting its affect following injection by the T3SS into 
host cells (Yahr et al., 1998).  Cellular cAMP levels are reduced in cyaA cyaB mutants, but CyaB is 
responsible for the majority of cAMP in P. aeruginosa (Wolfgang et al., 2003b).  A cyaB mutant is 
attenuated in a mouse model of infection, indicating an important role for cAMP in pathogenesis 
(Smith et al., 2004). 
 
The intracellular levels of cAMP influence gene expression in E. coli through interacting with a cAMP-
receptor protein, CRP.  CRP is a transcriptional regulator involved in carbon metabolism in response 
to glucose availability in a process known as catabolite repression (Gosset et al., 2004).  Binding of 
cAMP to CRP results in a conformational change allowing binding to DNA, and results in 
transcriptional activation or inhibition (Botsford and Harman, 1992).   Catabolite repression does not 
occur in P. aeruginosa, and CRP is not conserved.   Alternatively, a functional CRP homologue is 
found in P. aeruginosa, known as Vfr (virulence factor regulator) which shares 67% sequence identity 
with CRP (West et al., 1994). Vfr binds cAMP, effecting the expression of over 200 genes, including 
multiple virulence factors (Suh et al., 2002; Wolfgang et al., 2003b).  Exotoxin A, type IV pili and the 
T3SS are upregulated (Beatson et al., 2002; Wolfgang et al., 2003b), while flagellar gene expression is 
downregulated by Vfr (Dasgupta et al., 2002).  Quorum sensing and Vfr are tightly linked, since the 
transcription of lasR is directly regulated by Vfr binding (Albus et al., 1997).  The role of Vfr in 
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infection is clear, since P. aeruginosa vfr mutants are substantially attenuated in a mouse model of 
infection (Smith et al., 2004). 
 
1.8.3 The Stringent Response  
 
The stringent response allows bacteria to sense and respond to nutrient-poor environments via a 
pair of second messengers known as ppGpp and pppGpp (guanosine tetra and pentaphosphate 
respectively).  When P. aeruginosa encounters cellular stresses (e.g. amino acid starvation), the 
accumulation of these molecules modulates energetically costly cell processes, including protein 
translation, to preserve cellular resources (Srivatsan and Wang, 2008).  Levels of (p)ppGpp are 
controlled by RelA and SpoT which synthesises and degrade pppGpp respectively.  The stringent 
response in P. aeruginosa has been shown to be important in the regulation of virulence factors, 
since relA mutants show decreased virulence in a Drosophila melanogaster model (Erickson et al., 
2004).  The increase in ppGpp concentrations seen upon relA overexpression leads to activation of 
quorum sensing even in the absence of high cell density (van Delden et al., 2001).  An elevated basal 
level of ppGpp is correlated with an increased tolerance of relA and spoT mutants to quinolone 
antibiotics (Viducic et al., 2006). Thus, (p)ppGpp may act as a messenger, mediating the response of 
P. aeruginosa to stress conditions encountered upon host colonisation, promoting survival and 
virulence.   
 
1.8.4 c-di-GMP 
 
c-di-GMP is a secondary messenger involved in signalling in many species from all kingdoms. The 
levels of this intracellular messenger are modulated by two classes of enzymes, diguanylate cyclases 
(DGC) and phosphodiesterases (PDE), which synthesise and degrade c-di-GMP respectively.  These 
activities are mediated by conserved motifs, known as GGDEF motifs for DGCs and EAL or HD-GYP 
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domains for PDE, based on amino acid conservation.  The P. aeruginosa genome encodes 39 proteins 
with DGC, PDE or both domains, although this number varies in different strains (Kulasakara et al., 
2006).   Proteins have also been identified with degenerate GGDEF domains, which are not 
catalytically active, suggesting they act as allosteric sites or c-di-GMP receptors (Christen et al., 2005; 
Newell et al., 2009).  The levels of c-di-GMP influence a plethora of phenotypes in diverse bacterial 
species, including, but not limited to, biofilm formation, motility and cytotoxicity. 
 
There are several examples describing the effect of c-di-GMP on virulence phenotypes of P. 
aeruginosa.  One of the best characterised is WspR, a DGC linked to the chemosensory wsp operon.  
Loss of the wsp operon from P. aeruginosa results in the loss of swimming and swarming motility 
and a hyper-aggregative phenotype.  Deletion of wspF results in high c-di-GMP levels and increased 
biofilm formation, which could be restored to wild type upon wspR deletion (Hickman et al., 2005).  
This effect is mediated through higher expression of pel and psl operons, as well as cupA fimbrial 
genes, contributing to increased biofilm formation.  WspF is a negative regulator of the Wsp 
signalling, and it is proposed that loss of wspF leads to accumulation of phosphorylated, active 
WspR, leading to increased c-di-GMP (Hickman et al., 2005). 
 
Additional DGCs and PDEs are involved in P. aeruginosa biofilm formation.  One of these, SadC, has 
DGC activity and is important in the transition of cells from reversible to irreversible attachment.  
Deletion of sadC results in a hyper-swarming phenotype defective in biofilm formation (Merritt et 
al., 2007).  Deletion of the genetic region encoding BifA, which contains both DGC and PDE domains, 
results in an increase in the cellular pool of c-di-GMP, production of Pel polysaccharide, and 
abolishment of swarming activity (Kuchma et al., 2007). 
 
Twitching motility is also affected by c-di-GMP.    FimX is required for type IV pili formation, which 
are essential for twitching motility and adherence (Huang et al., 2003).  FimX contains both EAL and 
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GGDEF domains, however this GGDEF is degenerate and likely to perform as a c-di-GMP binding 
motif without catalytic activity.  FimX is able to degrade c-di-GMP via its EAL domain, but unable to 
synthesis c-di-GMP.  Binding of c-di-GMP to the degenerate GGDEF exerts an allosteric effect, 
controlling the function of FimX.  Deletion of fimX results in diminished twitching motility, and this 
effect could also be achieved by mutagenesis of either the EAL or degenerate GGDEF domains 
(Kazmierczak et al., 2006). 
 
A further example of the importance of c-di-GMP in the virulence of P. aeruginosa is seen in its 
effects on the T3SS and T6SS.  The RetS sensor (see section 1.9) is responsible for switching between 
T3SS and T6SS active phenotypes (Goodman et al., 2004). This switch is correlated with c-di-GMP 
levels.  Low levels of c-di-GMP correlate with an active T3SS and poor biofilm formation, while high 
levels of c-di-GMP cause a switch to high biofilm formation and an active T6SS.  These phenotypes 
can be influenced by artificial modulation of c-di-GMP levels, but specific DGCs or PDEs involved in 
this process are yet to be fully characterised (Moscoso et al., 2011). 
 
1.8.5 Global analysis of P. aeruginosa gene expression 
 
The complex regulatory mechanisms described here allow P. aeruginosa to respond adaptively to its 
environment.  To understand these responses, techniques have been developed to examine gene 
expression on a global scale.  Transcriptome studies allow a snapshot of an organisms response 
based on gene expression, by analysing the entire set of RNA transcripts produced by a population of 
cells at a given time. Large scale genome sequencing, and the publication of the P. aeruginosa PAO1 
genome (Stover et al., 2000) allowed the transcriptome of P. aeruginosa to be studied for the first 
time on a global level using microarray analysis.  Commercially available tools, such as the P. 
aeruginosa gene chip from affymetrix, allows the 5570 PAO1 open reading frames to be probed.   
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Genome-wide transcription analyses have provided important information on the physiology of P. 
aeruginosa.  Analysis of gene expression in lasI rhlI quorum sensing mutants have allowed genes 
regulated by quorum sensing to be discovered, providing an insight into the importance of quorum 
sensing in the regulation of virulence factors (Schuster et al., 2003; Wagner et al., 2003).  
Comparison of planktonic and biofilm cells have revealed that only 1% of the P. aeruginosa genome 
is differentially regulated in cells within biofilms (Whiteley et al., 2001), and that the expression 
profiles of developing biofilms is similar to that of log phase cultures, while mature biofilms have an 
expression profile similar to stationary cells (Whiteley et al., 2001).  This analysis has shown that 
type 4 pili are down regulated in mature biofilms, indicating that pili are not essential in the late 
stages of development.  Global analysis is clearly a powerful tool in elucidating the molecular 
mechanisms of P. aeruginosa involved in pathogenicity.   
 
Transcriptome analyses have also been applied to investigate the response of human lung epithelial 
cells to P. aeruginosa infection.  Analysis showed that 25% of 1500 human genes probed were 
differentially regulated upon P. aeruginosa infection (Ichikawa et al., 2000).  This experiment also 
discovered a novel signalling pathway involved in activation of the host immune response, 
highlighting the importance of transcriptome studies in elucidating the mechanism of pathogen-host 
interaction.  
 
1.9 P. aeruginosa lifestyles; regulatory aspects and mechanisms 
 
As previously described, P. aeruginosa is both an ubiquitous environmental organism, and a 
prevalent opportunistic pathogen.  In the environment P. aeruginosa can exist in a planktonic 
lifestyle or within multicellular biofilm communities (section 1.4).  Similar dual lifestyles are also 
thought to mediate the different outcomes of infections within a human host.  
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Acute P. aeruginosa infections are rapid in progression, and multiple virulence factors are expressed.  
Examples include the P. aeruginosa mediated breakdown of lung tissue in acute pneumonia, and 
dissemination into the blood stream (Driscoll et al., 2007).  The result is systemic infection, septic 
shock and death within days.  In such acute infections, P. aeruginosa undertakes an invasive and 
cytotoxic lifestyle, mediated by the production of a range of secreted proteins, including the T3SS 
secreted effectors, as described in section 1.6.4.   
 
Conversely, P. aeruginosa can also cause chronic lung infections, the characteristics of which are 
vastly different to acute pneumonia.  P. aeruginosa can persist for decades in the CF lung, and 
chronic inflammation ultimately leads to death (O'Sullivan and Freedman, 2009).  In these infections, 
P. aeruginosa remains non-invasive, non-cytotoxic and systemic infections do not occur.  P. 
aeruginosa undergoes phenotypic changes including the overproduction of alginate and mutations 
resulting in the loss of toxin secretion and motility (Jain et al., 2004; Mahenthiralingam et al., 1994).  
The production of biofilms is thought to be important in chronic CF lung infections due to the fact 
that the quorum sensing profile and signalling molecules detected in CF sputum are more similar to 
that of cells grown in in-vitro biofilms than to planktonic cells, and images of CF sputum shows 
polysaccharide-encased bacteria (Singh et al., 2000).   
 
In addition to the global virulence regulators already described in section 1.8, a dedicated and 
complex switch exists in P. aeruginosa to regulate the expression of genes involved in acute or 
chronic lifestyle and influence the outcome of infection.  This is mediated by the Gac/Rsm cascade, 
which is conserved among Gram-negative bacteria, and two additional components, LadS and RetS, 
specific to Pseudomonas species.  This section describes the components of this cascade, and the 
mechanisms employed to influence the outcomes of P. aeruginosa infections. 
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1.9.1 Conserved Gac/Rsm pathways 
 
The Gac/Rsm signal transduction pathway controls gene expression through modulating the 
translation of target small RNAs (sRNAs).  The components and mechanism of the pathway are 
described in more detail in the following sections, but a central component is an RNA binding 
protein of the CsrA/RsmA family.  CsrA/RsmA is capable of translational activation and repression.  
Homologs of the Gac/Rsm pathway are found in many of the γ-proteobacteria, and CsrA/RsmA 
regulate numerous unrelated biological pathways (Lapouge et al., 2008). 
 
In E. coli the RNA binding protein CsrA (carbon storage regulator) regulates central carbon pathways.  
CsrA positively regulates energy consumption through glycolysis, while negatively regulating energy 
storage by gluconeogenesis and glycogenesis (Sabnis et al., 1995).  CsrA is conserved in Salmonella 
Typhimurium, but its targets are different since it regulates maltose and acetate metabolism 
(Lawhon et al., 2003).   
 
CsrA and its homologues have been implicated in the regulation of social behaviour in bacterial cells, 
influencing phenotypes such as quorum sensing, biofilm formation and motility.  In Vibrio and 
Pseudomonas spp. CsrA interacts with quorum sensing by negatively regulating the production of 
AHL through an unknown mechanism (Lenz et al., 2005; Pessi et al., 2001).  In E. coli the formation of 
PGA, a linear homopolymer involved in attachment during biofilm formation, is negatively regulated 
by CsrA (Wang et al., 2005).  
 
CsrA/RsmA is also involved in the control of virulence.  In P. fluorescens the production of hydrogen 
cyanide synthase subunit A (hcnA) required for the synthesis of the antifungal exoproduct hydrogen 
cyanide, is under the direct control of RsmA (Lapouge et al., 2007), and was the only known direct 
target until subsequent publications by the Lory group (Brencic and Lory, 2009). The role of P. 
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aeruginosa RsmA (regulator of secondary metabolism), and the mechanism of this regulation and its 
effect on the lifestyle of P. aeruginosa are discussed in more detail in the following sections. 
 
1.9.2 The P. aeruginosa Gac/Rsm pathway 
 
An overview of the P. aeruginosa Gac/Rsm pathway is shown in Figure 1.27.  Briefly, the RsmA 
translational regulator positively influences phenotypes associated with acute infections (motility 
and T3SS), while repressing phenotypes associated with chronic infection (biofilm formation), and 
repressing the T6SS.  The activity of RsmA can be controlled by regulatory sRNAs RsmY and RsmZ 
which are able to bind and sequester RsmA.  The levels of these regulatory sRNAs are controlled by a 
two component system composed of GacA, a response regulator, and GacS, a membrane bound 
sensor kinase.  Two additional sensor kinases, RetS and LadS, specific to Pseudomonas, also 
influence this cascade.  The characteristics of each component and the molecular details of this 
cascade are described below. 
 
1.9.3 The Translational Regulator RsmA 
 
The P. aeruginosa translational regulator RsmA has a regulon of over 500 genes discovered by 
microarray analysis of gene expression in an rsmA mutant compared to the wild type strain (Brencic 
and Lory, 2009).  In the microarray the expression of a third of these 500 genes was positively 
affected by the mutation, the remainder negatively.  Expression of genes encoding structural and 
regulatory components of the T3SS, associated with acute infections, were decreased in the rsmA 
mutant (section 1.6.4). Genes which showed increased expression in the rsmA mutant included 
genes of pel and psl polysaccharide biosynthetic operons important in production of the biofilm 
matrix, associated with chronic infections (section 1.4), and genes of the H1-T6SS operon (Section 
1.7). 
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Figure 1.27 The P. aeruginosa RetS/Gac/Rsm cascade  
Schematic representation of the RetS/Gac/Rsm signalling cascade which antagonistically controls 
the phenotypic switches for biofilm/motility and T6SS/T3SS.  RetS, GacS and LadS are inner 
membrane (IM) located sensor, GacA is a cytoplasmic response regulator, RsmY and RsmZ are 
small regulatory RNAs, and RsmA is a translational regulator.  Pointed arrows indicate a positive 
effect, while blocked arrows indicate a negative effect.  Dashed lines indicated an indirect 
interaction.  An unknown activation signal is represented by the lightning bolt. 
 
The mechanism of negative regulation by CsrA has been shown for the CsrA/RsmA family protein 
from Pseudomonas fluorescens, known as RsmE in this case.  The crystal structure of RsmE bound to 
a 20 nucleotide sequence from a target RNA from the hcnA gene has been solved (Schubert et al., 
2007).  The hcnA gene encodes hydrogen cyanide synthase subunit A, which is translationally 
repressed by RsmE (Blumer et al., 1999). The work by Schubert et al. (2007) provides a direct 
visualisation of the mechanism of CsrA/RsmA repression, as shown in Figure 1.20.  A 20 nucleotide 
region of the hcnA RNA was produced, and was predicted to form a short hairpin, with an unpaired 
GGA motif in the loop region essential for the binding to CsrA/RsmA proteins (Figure 1.28A) (Liu et 
al., 1997).  This nucleotide section is seen bound as a stem loop within the RsmA molecule (Schubert 
et al., 2007). Within this loop, embedded within the RsmA protein, are five nucleotides of the Shine-
Dalgarno sequence of hcnA.  The negative regulation mediated by RsmA is clearly achieved at the 
post-transcriptional level through the interruption of the ribosome-mRNA interaction, blocking 
translation of specific mRNA molecules.    
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Figure 1.28 Binding of hcnA RNA to the translational repressor RsmE 
A. Predicted secondary structure of the 20 nucleotide hcnA sequence used for structure 
determination of the RsmE-RNA complex, with the location of the hcnA shine-dalgarno sequence 
underlined in purple. B. NMR solution structure of the RsmE-hcnA RNA complex.  Surface 
representation of RsmE dimer in complex with the hcnA 20 nucleotide RNA.  Blue colour 
indicates positive electrostatic potential, while red colour indicates negative electrostatic 
potential.  Reproduced with from  (Schubert et al., 2007) with permission.  
 
 
 
In P. aeruginosa Brencic & Lory (2009) were able to co-purify RsmA bound to mRNA corresponding 
to the H1-T6SS genes, expanding the known targets for CsrA/RsmA binding.  The mRNA sequences 
recovered contained the characteristic GGA motifs required for RsmA binding, as shown in Figure 
1.29a.  They confirmed that the negative regulation of RsmA on the H1-T6SS was due to the direct 
interaction of this protein with the leader sequence of the mRNA by performing gel shift assays on 
radiolabelled mRNA molecules as shown in Figure 1.29b (Brencic and Lory, 2009).   
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Figure 1.29 Direct binding of RsmA to H1-T6SS promoters 
A. secondary structures of leader sequences of H1-T6SS genes identified as targets of RsmA, 
predicted by M-fold (Zuker, 2003).  GGA sequences are underlined, and the RBS is indicated in 
each case.  B. RNA mobility shift assay with purified RsmA-H6, binding to the leader sequences of 
transcripts encoding PA0081 and PA0082 (tssA1 and fha1). Transcripts were radiolabelled and 
incubated in the absence or presence of various concentrations of RsmA-H6 for 30 minutes at 
room temperature, prior to analysis on 8% native polyacrylamide gel.  Lanes 1-3 contained 10 
nM of radiolabelled RNA, and 0, 1 and 3 µM of RsmA-H6 respectively.  Reproduced from (Brencic 
and Lory, 2009) with permission.  
 
 
CsrA/RsmA proteins are also responsible for the positive regulation of genes associated with the 
acute lifestyle of P. aeruginosa (including the T3SS).  The precise mechanism of positive regulation by 
this protein is not characterised.  Positive regulation of T3SS gene expression by RsmA is likely to be 
indirect, since RsmA bound to the mRNA of targets that were positively regulated were not isolated 
in the study by Brencic & Lory (2009).   More recently it has been shown that CsrA can lead to the 
activation of expression of flagella synthesis genes in E. coli.  CsrA binds to two regions in the leader 
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sequence of flhDC mRNA and protects the mRNA from cleavage by RNaseE (Yakhnin et al., 2013).  In 
P. aeruginosa, RsmA exerts a positive regulatory effect on ExsA, the master regulator of T3SS genes.  
RsmA controls expression of ExsA at the post-transcriptional level, with an exsA-lacZ translational 
fusion showing a 2-fold reduction in an rsmA mutant, dependent on a specific region of the leader 
sequence.  RsmA therefore relieves a block on ExsA translation, leading to higher T3SS activity (see 
section 1.6.4.3) (Timothy L. Yahr (University of Iowa), Poster Presentation, American Society for 
Microbiology 113th General Meeting, 2013).   
 
1.9.4 Small Regulatory RNAs RsmY and RsmZ 
 
The activity of the transcriptional regulator RsmA can be antagonised by non-coding small regulatory 
RNA molecules (sRNA).  sRNAs can be between 50 to 500 nucleotides and have important roles in 
bacterial gene expression.  They mostly act post transcriptionally to activate or repress translation 
initiation, or by stabilising / destabilising target mRNAs.  This effect is achieved by one of two 
mechanisms.   
 
The antisense mechanism involves base pairing interactions between the non-coding RNA and target 
mRNA, thereby inhibiting translation.  Anti-sense RNAs can repress the synthesis of many proteins.  
RyhB is one such anti sense RNA produced under iron limiting conditions in P. aeruginosa.  RyhB 
base pairs with the mRNAs from multiple operons encoding iron-binding proteins, leading to rapid 
degradation of the molecule by RnasE (Masse et al., 2003; Wilderman et al., 2004), reducing the 
cellular need for iron.  Multiple sRNAs are involved in the control of quorum sensing in V. cholerae.  
Multiple quorum sensing signals converge on a transcriptional regulator LuxO, which leads to 
negative regulation of another transcriptional regulator LuxR.  Mutant screens identified Hfq, an 
RNA chaperone, in the transduction of signals between LuxO and LuxR, suggesting that small RNAs 
were involved in the process.  Four homologous small RNAs were subsequently found in a 
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computational search, which were shown experimentally to each be sufficient to transduce the 
signals through the pathway, suggesting that they are redundant (Lenz et al., 2004).  
 
Within the Gac/Rsm cascade, sRNAs are able to sequester CsrA/RsmA RNA binding proteins.  The 
global transcriptional regulator of carbon metabolism (CsrA) from E. coli was co-purified by nickel-
affinity chromatography and shown to be a stable complex of around 20 CsrA subunits bound to a 
single 350-nucleotide sRNA molecule, subsequently named CsrB.  By generating cDNA clones of this 
RNA molecule and determining the nucleotide sequence they were able to identify the genetic locus 
encoding this molecule (Liu et al., 1997).  The genetic locus of csrB contained no predicted open 
reading frames, indicating that CsrB was not a messenger RNA, and RNA structure predictions show 
it contains multiple GGA motifs in stem loop structures (Liu et al., 1997).  A second sRNA, CsrC, was 
subsequently found in E. coli, which also binds and antagonises CsrA at a lower affinity than CsrB 
(Weilbacher et al., 2003). 
 
An RNA molecule bound to the purified RsmA protein from P. fluorescens was identified and named 
RsmZ (regulator secondary metabolism), which is conserved in P. aeruginosa (Heeb et al., 2002).  A 
second small regulatory RNA, RsmY, was subsequently detected in Pseudomonas sp. in silico and 
shown to be required for Gac/Rsm dependent regulation (Valverde et al., 2003).  RsmY is a 118 
nucleotide molecule, while RsmZ is 127 nucleotides, and each has multiple GGA motifs, located in 
predicted stem-loop structures.  Multiple single stranded GGA motifs are a common feature of 
sRNAs that bind RsmA/CsrA proteins, and are essential for the binding of RsmY to RsmA in P. 
aeruginosa (Sorger-Domenigg et al., 2007).  In the P. fluorescens RsmY homolog discrete complexes 
are formed with RsmA in gel mobility assays, and these complexes are lost when the GGA motifs are 
disrupted by mutation (Figure 1.30) (Valverde et al., 2004).  Once bound to RsmY or RsmZ, RsmA is 
sequestered and unable to bind to target mRNAs, thus relieving any positive or negative effect on 
translation of the target mRNA molecule.  A third sRNA was found in P. fluorescens, RsmX, but is 
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absent from P. aeruginosa (Kay et al., 2005).  In P. aeruginosa the two sRNAs RsmY and RsmZ are 
functionally redundant for the repression of T3SS genes, and deletion of both is required to observe 
a phenotype (Bordi et al., 2010). 
 
 
Figure 1.30 Interaction between RsmA and GGA motifs of Pseudomonas fluorescens RsmY  
RsmY and a RsmY mutant in which the conserved RsmY GGA motifs were modified (GGA-5) were 
synthesised in the presence of radiolabelled UTP.  RsmY (A) and GGA-5 (B) were incubated with 
different concentrations of purified RsmA-His6 before running on native gels and autoradiography.  
The postilion of free (F) and bound (B) RNA is indicated.  Arrows indicate RNA-protein complexes 
with reduced mobility when compared to free RsmY or GGA-5.  Reproduced with from (Valverde 
et al., 2004) with permission.  
 
The mechanism of RsmY and RsmZ in P. aeruginosa has been shown by gel shift assays.  As described 
previously, Brencic & Lory (2009) were able to show that RsmA binds directly to the promoter 
regions of H1-T6SS specific genes, repressing their translation.  RsmY and RsmZ are able to compete 
with H1-T6SS RNA for RsmA binding, as shown in Figure 1.31. Incubation of RsmA with RNA specific 
to the promoter region of PA0082 (the first gene in the H1-T6SS cluster) causes a band shift, 
indicative of direct binding.  Titration with either RsmY or RsmZ inhibits this binding, indicating that 
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RsmA preferentially binds to RsmY or RsmZ.  Thus, when present, RsmY and RsmZ sequester RsmA 
from T6SS target genes, relieving its repression (Brencic and Lory, 2009). 
 
 
Figure 1.31 RsmY and RsmZ compete with target mRNA for RsmA binding 
RNA mobility shift assay with purified RsmA-H6, binding to the leader sequences of transcripts 
encoding PA0081 (fha1). 10 nM of labelled PA0081 transcript and 0 (lane 1) or 2.5 µM (lanes 2-8) 
of purified RsmA-H6 monomer.  Lane two shows the reaction between RmsA-H6 and PA0081 
RNA in the absence of competitor RNA.  Reactions shown in lanes 3-8 were incubated in the 
presence of unlabelled transcripts of RsmY (lanes 3 and 4), RsmZ (lanes 5 and 6) and lolB (lanes 7 
and 8) at two folds (lanes 3,5,7) or 200 fold (lanes 4,6,8) excess relative to the labelled transcript.  
Reproduced from (Brencic and Lory, 2009) with permission.  
 
 
1.9.5 Two component systems: GacS/GacA 
 
The expression of RsmY and RsmZ is controlled by a two-component system made up of GacS and 
GacA.  Two component systems (TCS) are signal transduction pathways that allow bacteria to sense 
their external environment and respond accordingly by modulating their behaviour.  The 
characteristic components of TCS are illustrated in Figure 1.32.  The two central components are 
known as a sensor kinase, and a cognate response regulator.  Sensor kinases contain an input 
domain, activation of which leads to the autophosphorylation of a conserved histidine residue 
following ATP hydrolysis.  This phosphoryl group is subsequently transferred to a conserved 
aspartate residue on the receiver domain of a response regulator.  Phosphorylation of the response 
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regulator causes a conformational change within this protein, promoting its activity, usually as a 
transcriptional regulator.  The incorporation of one or more transmembrane domains in the sensor 
kinase molecule allows periplasmic localisation of the sensing domain and sensing of external 
stimuli, although sensor kinases are often cytoplasmic.  Characterised examples of sensor kinases 
respond to diverse signals.  The PhoP-PhoQ system regulates virulence and stress response in E. coli, 
and the sensor kinase PhoQ senses divalent cations (Cheung et al., 2008).  The sensor kinase CitA 
from Klebsiella pneumonia regulates the transport and anaerobic metabolism of citrate in response 
to its extracellular concentration, and directly binds citrate (Sevvana et al., 2008).  Oxygen can also 
be sensed by binding to heme groups within proteins, as seen for the DosT histidine kinase (Podust 
et al., 2008). 
 
 
Figure 1.32 Canonical two component systems 
Classical, hybrid and unorthodox two component systems.  Response regulators are shown, each 
with input domains (left).  Phosphate groups are indicated by P, conserved histidine residues by 
H, and receiver domains with conserved aspartate residues by (green oval, D). P(Hpt) are shown 
in blue. The differences between each type of system is outlined in the text.  Response 
regulators are shown with output domains (right). 
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Adaptations to the classical two component systems have resulted in complex phosphorelay 
systems, where hybrid histidine kinase molecules autophosphorylate and transfer the phosphoryl 
group to an internal receiver domain (Figure 1.32).  Since phosphotransfer must occur subsequently 
from histidine to aspartate, a shuttle molecule known as histidine phosphotransfer domain (Hpt) is 
required to shuttle the signal from hybrid sensors to the cognate response regulator.  In unorthodox 
sensor kinases, this Hpt domain is fused to the sensor kinase protein (Figure 1.32). These 
phosphorelay pathways allow fine-tuning of responses, allowing many sensors to converge into the 
activity of a single response regulator, or the divergence of signal sensing from one sensor kinase 
into the activity of several output domains, resulting in complex, multicomponent signalling 
pathways. 
 
An archetypal two-component system is the E. coli EnvZ-OmpR system, involved in osmoregulation 
in E. coli.  This system responds to osmotic change and regulates the expression of outer membrane 
porins, OmpF and OmpC.  Upon changes in osmolality, the inner membrane sensor kinase EnvZ is 
activated and autophosphorylated at a conserved histidine residue.  This phosphate is transferred to 
a conserved aspartate residue on OmpR, a cytoplasmic response regulator and transcription factor.  
OmpR-P is then able to bind upstream regions of ompF and ompC promoters, activating their 
transcription (Comeau et al., 1985).  Examples of two component systems in bacterial virulence 
include the PhoP-PhoQ system, which is a master regulator of virulence in Salmonella (Groisman, 
2001).  The periplasmic concentration of Ca2+ and Mg2+ is detected by the membrane sensor kinase 
PhoQ, and results in PhoP autophosphorylation.  PhoP-P is able to act as a transcriptional regulator, 
activating the expression of genes involved in Mg2+ uptake and reducing the Mg2+ requirement of the 
cell.  Since the ionic concentration of the phagosome is low, it is thought that the PhoP-PhoQ system 
has evolved to detect internalisation of Salmonella by eukaryotic cells (Groisman, 2001).  Salmonella 
encodes a T3SS which functions only inside eukaryotic cells.  The expression of this system depends 
on a second two component system, SsrB/SpiR.  PhoPQ controls intramacrophage expression of this 
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T3SS by directly regulating the transcription of the response regulator SsrB, and post translationally 
controlling SpiR (Bijlsma and Groisman, 2005).    
 
Specifically within the P. aeruginosa GacS/GacA system, GacS is an unorthodox sensor kinase, 
composed of an input domain and a phosphotransferase domain, and has two transmembrane 
domains (Figure 1.33).  The phosphotransfer domain is paired with a response regulator protein, 
GacA.  The first evidence that GacS and GacA form a TCS came from a genetic study in Pseudomonas 
syringae, which showed that GacA was important for lesion formation and production of 
extracellular products while showing similarity to known response regulators (Rich et al., 1994).  
Work on the homologous BarA/UvrY system in E. coli confirmed that BarA was able to auto 
phosphorylate, and pass on this phosphoryl group to UvrY, but not to other response regulators 
(Pernestig et al., 2001).  Direct transfer of a labelled phosphate from GacS to GacA has since been 
demonstrated in vitro (Goodman et al., 2009).  Once phosphorylated, the GacA response regulator is 
able to bind to a conserved upstream element, the predicted GacA box (TGTAAGN6CTTACA) in the 
promoter region of GacA targets (Kulkarni et al., 2006).   
 
 
Figure 1.33 The GacS /GacA Two Component System 
The sensor kinase (GacS) and response regulator (GacA) are shown.  GacS contains two 
transmembrane domains (red), a conserved histidine (H, yellow), receiver domains with 
conserved aspartate residues (D, green) and a Hpt domain (Blue) required for phosphotransfer.  
The GacA response regulator has a conserved aspartate (D, green), which receives a phosphate 
group from GacS, which modulates the activity of the output domain.  
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In P. aeruginosa, the targets of the phosphorylated GacA response regulator have been shown to be 
exclusively rsmY and rsmZ, via binding to conserved GacA boxes  (Brencic et al., 2009).  Due to the 
fact that the genes regulated in a gacA microarray showed a near complete overlap with those 
regulated in the microarray of an rsmYZ mutant, the authors suggest that the regulon of GacA is 
dependent on RsmYZ alone, thus RsmY and RsmZ are the sole targets of GacA.  This was confirmed 
using a genome wide DNA-protein interaction analysis where only two genomic regions, located 
upstream of rsmY and rsmZ open reading frames, interacted with GacA (Brencic et al., 2009). 
 
1.9.6 Additional sensor kinases RetS and LadS 
 
In P. aeruginosa, a higher level of control on the Gac/Rsm pathway is mediated by two proteins of 
the sensor kinases hybrid family, known as RetS and LadS, which are not conserved in other 
Gac/Rsm pathways.  LadS and RetS are both members of the hybrid family of sensor kinases, shown 
in Figure 1.34, and share a very similar domain architecture.  The N terminus of both proteins 
contains 7-transmembrane and 7-transmembrane associated extracellular domains (Anantharaman 
and Aravind, 2003).  These are followed by characteristic histidine kinase domain characteristic of 
sensor kinases.  The C termini of LadS and RetS contain one or two fused response regulator 
domains, respectively (Ventre et al., 2006).  There are no genes for cognate response regulators 
encoded in the proximity of either retS or ladS, so they are termed orphan sensor kinases, indicating 
that their activity is mediated via signal transduction integrated into another pathway or through 
orphan response regulators encoded elsewhere on the chromosome (Goodman et al., 2009; Ventre 
et al., 2006).  It is has become clear that the latter scenario is unlikely due to the evidence 
supporting the integration of RetS and LadS signals into the Gac/Rsm cascade, as described below. 
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Figure 1.34 RetS and LadS: Additional Sensor kinases influencing the Gac/Rsm cascade. 
The RetS and LadS sensor kinase each have multiple transmembrane domains (red) and a 7 
transmembrane associated domain (white rectangle).  RetS has one conserved Histidine residue, 
followed by two receiver domains with conserved aspartate residues.  LadS has a similar 
organisation, but has only one receiver domain. 
 
RetS was discovered in a transposon mutagenesis screen of 39 genes encoding predicted response 
regulators (Goodman et al., 2004).  Disruption of a gene encoding what became known as RetS 
caused a hyperbiofilm phenotype, as well as decreased cytotoxicity shown by reduced levels of 
lactate dehydrogenase released from Chinese hamster ovary cells.  This was due to a reduction in 
expression of the T3SS by measuring the activity of a lacZ fusion to a known T3SS toxin gene, exoS.  A 
retS mutant was also attenuated in a mouse model of chronic disease (Goodman et al., 2004).  The 
discovery of RetS was concurrently reported by Kasmierczack and colleagues, with RetS being named 
RtsM in their work.  They reported that RtsM was necessary for expression of the T3SS, and 
identified RtsM as being a two-component signalling protein (Laskowski et al., 2004).  retS mutants 
were shown to have delayed disease development and altered pathology in a murine model of 
corneal infection, which coincided with loss of ExsA-regulated T3SS secretion, reduced epithelial 
adherence and invasion, and reduced intracellular survival (Zolfaghar et al., 2005).   
 
To comprehensively characterise the effect of retS deletion Goodman and colleagues performed a 
microarray, comparing global gene expression in a wild type P. aeruginosa PAK strain to that of a 
retS deletion mutant.  Of the 5678 genes included in the array, 397 were significantly altered by the 
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retS deletion, including many virulence factors (Goodman et al., 2004).  Genes which were 
downregulated by retS deletion included all 40 structural and regulatory genes of the T3SS, eight 
genes encoding components of the xcp T2SS machinery, as well as lipA and toxA, toxins secreted by 
the T2SS (section 1.6.3).  Many genes associated with the expression of type IV pili were also 
downregulated under these conditions.  Upregulated genes included exopolysaccharide biosynthetic 
operons, responsible for the production of biofilm matrix components, including both pel and psl 
operons (section 1.4).  The involvement of the psl operon in the retS mediated biofilm phenotype 
was confirmed by the observation that biofilm formation was drastically reduced in a PAK ΔretS Δpsl 
mutant.  Given these observations, the name Regulator of exopolysaccharide and Type 3 Secretion 
(RetS) was given.  Following the discovery of the T6SS it was noticed that the H1-T6SS was also 
upregulated in a retS mutant (Mougous et al., 2006).  The effect of retS on the biofilm, T3SS, and 
T6SS phenotypes of PAK are shown in Figure 1.35. 
 
Figure 1.35 Phenotypes of a PAK ΔretS strain 
The effect of retS deletion on PAK biofilm formation, T3SS and T6SS are shown.  Crystal violet 
solution is used to stain biofilm biomass in glass test tubes.  Antibodies directed against the tip of 
the T3SS needle (anti – PcrV) and against the T6SS tail tube (anti Hcp1) are used as reporters for 
T3SS and T6SS activity respectively.  Images and blots were produced in our laboratory by Joana 
Moscoso.  
 
A transposon mutagenesis strategy was used to screen for suppressors of hyperadhesion and of 
T3SS repression mediated by retS deletion.  Goodman et al (2004) selected transposon mutants in 
the retS background which were unable to adhere to the walls of culture flasks, but which exhibited 
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blue colonies on X-gal plates through the activation of an exoS-lacZ fusion.  Their screen yielded four 
insertion mutants in the promoter of gacS, seven insertions in the promoter of gacA and two located 
within the rsmZ gene, strongly suggesting that the RetS sensor exerts its effect by incorporation into 
the Gac/Rsm pathway (Goodman et al., 2004). A further suppressor mutation mapped to PA4332, 
which encodes the sadC gene.  SadC is involved in production of c-di-GMP, which links the biofilm 
deficient phenotype of a sadC mutation to the Gac/Rsm cascade (Merritt et al., 2007) (section 1.8.4), 
and may also play a role in the other c-di-GMP responsive phenotypes dependent on this pathway 
(Moscoso et al., 2011). 
 
A second hybrid sensor kinase, known as LadS, has also been shown to be important in the switch 
between chronic and acute lifestyles of P. aeruginosa.  This loss of adherence sensor was discovered 
in a transposon screen for strains unable to form biofilm in the absence of type IV pili (Ventre et al., 
2006). PAKΔladS has a biofilm deficient phenotype, the opposite of a PAKΔretS mutant.  
Overexpression of LadS leads to thick bacterial aggregates associated with exopolysaccharide over 
production.  As with RetS, the LadS biofilm phenotype involves the pel operon as the activity of a pel-
lacZ fusion is reduced four fold in a PAK ΔladS strain compared to the wild type parent (Ventre et al., 
2006). In contrast to RetS, LadS is a positive regulator of biofilm formation. 
 
In addition to regulating biofilm formation, LadS also regulates the T3SS.  Consistent with the inverse 
regulation by RetS and LadS on biofilm formation, these two sensors also inversely regulate the 
T3SS, which LadS represses (Ventre et al., 2006).  This is shown by the increase in the activity of an 
exoS-lacZ fusion in PAKΔladS, and additionally an increased abundance of the secreted toxin ExoS in 
the supernatant of this ladS mutant strain (Ventre et al., 2006).  In terms of cytotoxicity a ladS 
deleted strain is hyper-cytotoxic, correlating with the data collected on the activity of the T3SS.  It is 
interesting to know that the PA14 strain of P. aeruginosa is a spontaneous mutant of ladS, displaying 
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reduced levels of biofilm formation, and has increased cytotoxicity towards eukaryotic cells 
(Mikkelsen et al., 2011a). 
 
The LadS sensor has also been implicated in the Gac/Rsm cascade.  The promoter of rsmZ was fused 
to a lacZ reporter, and the activity of this promoter analysed in strains carrying deletions in 
components of the Gac/Rsm cascade (retS, ladS, gacS, and rsmA), as shown in Figure 1.36.   Deletion 
of retS led to a significant increase in the expression of the rsmZ-lacZ fusion, which is consistent with 
the observations made by Goodman et al. (2004) (Ventre et al., 2006).  Deletion of ladS abolished 
the activity of the rsmZ-lacZ fusion, as does deletion of gacS and gacA.  This incorporates LadS into 
the Gac/Rsm cascade, and also provides a molecular explanation for the effects on biofilm formation 
and T3SS (Ventre et al., 2006).   
 
 
Figure 1.36 rsmZ-lacZ fusion activity in PAK and mutants of the Gac/Rsm regulatory cascade. 
The activity of the rsmZ-lacZ fusion was measured in different PAK backgrounds, as indicated 
below the graph.  Levels of β-galactosidase were measured in cultures of each strain.  Due to the 
high levels in a retS mutant, the y axis scale is broken between 300 and 2000 Miller units.  
Reproduced from (Ventre et al., 2006). 
 
 
Comparison of the microarray data from a P. aeruginosa PAK ΔretS mutant with PAK ΔladS reveals 
that a substantial amount of genes are reciprocally regulated in the two data sets, but also that a 
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number of genes are regulated independently by both proteins.  Of the 79 genes significantly 
affected by deletion of ladS, 49% were oppositely regulated by deletion of retS.  Similarly, although 
only 27% of the genes affected by deletion of retS were also affected in the ladS microarray, 91% of 
these were reciprocally regulated (Ventre et al., 2006).   
 
1.9.7 Signalling and Sensing by the RetS/LadS sensors 
 
The precise nature of the environmental signals activating the RetS, LadS and GacS sensor kinases 
are not known, but significant advances have been made in deciphering the mechanism of signalling 
and sensing in this cascade.   Following from their work identifying the RetS sensor, Goodman and 
colleagues further characterised the interaction of RetS with GacS.  Following incubation of GacS 
with radiolabeled ATP, autophosphorylated GacS was observed by SDS-PAGE and autoradiography.  
Phosphotransfer from GacS to GacA was shown, since an accumulation of phosphorylated GacA was 
observed after five minutes of incubation of GacA with radiolabelled GacS (Goodman et al., 2009).  A 
direct interaction between RetS and GacS was shown by co-purification experiments, and two hybrid 
analysis showed that the core kinase domains of GacS and RetS were sufficient for their interaction 
(Goodman et al., 2009).  Incubation of RetS and GacS with radiolabelled ATP leads to a significant 
decrease in the autophosphorylation of GacS, in a manner that did not require any of the classical 
phosphorelay domains of RetS, or result in phosphorylation of RetS. The authors conclude that RetS 
regulates its downstream targets by a novel mechanism in which it forms heterodimers by 
interacting with GacS, blocking its autophosphorylation independent of the conserved RetS 
phosphorelay residues. This is supported by the fact that mutation of the conserved RetS 
phosphorelay domains does not affect the levels of rsmZ-lacZ fusions (Goodman et al., 2009).  
 
Advances were made in the understanding of RetS signalling by the determination of the crystal 
structure of the RetS periplasmic sensing domain (RetSp) (Jing et al., 2010; Vincent et al., 2010).  The 
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sensing domain crystal structure of RetS has been solved, and predictions of a β-sandwich fold, 
similar to a family of carbohydrate binding domains, were confirmed.  The proposed carbohydrate 
binding domain found in RetSp displays an additional alpha helix which is located directly above the 
β-sandwich fold (Jing et al., 2010).  Despite being able to map a predicted ligand binding site through 
comparison with known carbohydrate binding proteins the natural ligand binding to RetSp is not 
known, and its interactions with RetSp could not be assessed.   
 
Additional insights into RetS sensing have been obtained by observations that the RetSp sensing 
domain is able to form multimeric complexes.  A dimer was observed in the crystal environment for 
RetSp, which was formed by interactions between β-sheet regions of the two monomers.  The 
formation of a RetSp dimer was confirmed by crosslinking experiments (Jing et al., 2010).  In their 
work, Jing et al (2010) propose that in the absence of a ligand at the binding site, RetS is likely to 
dimerise, thus RetS-GacS interactions are prevented.  Upon ligand binding, RetS dimers are 
disrupted and RetS-GacS interactions are preferred, blocking the downstream phosphorelay of GacS 
(Goodman et al., 2009). 
 
The dimer observed by Jing et al. (2010) was also observed by Vincent et al. (2010), who observed 
further multimeric forms of RetSp.  A second dimeric form was observed which constituted a 
domain-swap between two RetSp monomers, where the final three β-strands are exchanged 
between monomers.  A tetrameric form was also observed in the crystal environment which was 
shown to be present in small amounts under physiological solution conditions (Vincent et al., 2010). 
 
The analysis of the RetSp crystal structure also revealed the presence of a second putative substrate-
binding site for an unknown ligand. It is proposed due to the conservation of aromatic residues on 
the surface of RetSp.  This binding site is located at the opposite face of the carbohydrate binding 
domain, but is located at the RetSp dimerization interface (Vincent et al., 2010).  In an update to the 
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previous model, it is proposed that binding of an unknown molecule at this dimer interface may 
have the effect of destabilising RetS homodimers and favouring RetS-GacS heterodimers, and the 
subsequent blocking of the phosphotransfer, as shown in Figure 1.37. This model takes into account 
that the alpha helix found above the β-sandwich fold may block the carbohydrate binding site, which 
may not be accessible, but may become accessible following conformational changes.    
 
Figure 1.37 A model for RetS signalling mechanism 
Membrane bound GacS and RetS sensors are shown with histidine kinase (brown) and response 
regulator receiver domains (green). A.  In the absence of an activating signal, RetS is found as a 
homodimer, leading to phosphorylated GacS and subsequent phosphorylation of GacA (red), 
resulting in increased biofilm formation and repression of the T3SS.  B. An unknown activating 
signal (yellow star) binds to the second ligand binding site within the RetS sensing domain, 
disrupting RetS homodimers and promoting RetS/GacS heterodimers, which prevents GacS and 
subsequent GacA phosphorylation.  The resulting phenotype is an increase in T3SS activity, and 
repression of biofilm formation, the opposite of A.  Reproduced from (Vincent et al., 2010) with 
permission. 
 
 
Although the structure of the LadS sensing domain has not been solved, it has a similar domain 
architecture and 35% sequence identity to RetS, and also exerts its effects via the Gac/Rsm pathway.  
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Vincent et al. (2010) were able to model the structure of the LadS sensing domain using the solved 
structure of RetSp.  The model shows that LadS may form a similar overall fold, and that the 
proposed carbohydrate binding motif is conserved.  The second binding site at the dimer interface is 
lacking in the LadSp model.  Due to these differences, the mechanism of LadS signalling is likely not 
the same as that proposed for RetS (Vincent et al., 2010).  Further investigations into the mechanism 
of LadS may provide insights into the inverse effect of these two sensors on the Gac/Rsm cascade 
and resultant phenotypes.  Additionally the characterisation of the exact molecules binding to the 
RetS and LadS ligand binding sites will complete our understanding of this mechanism.  
 
1.9.8 Additional components influencing the cascade 
 
Additional components have been shown to modulate the RetS/LadS/Gac/Rsm pathway and may be 
important in the regulatory cascade.  The HptB signalling pathway controls biofilm and T3SS, and 
intersects at the GacA response regulator, exclusively regulating rsmY expression (Bordi et al., 2010).  
Additionally, a further hybrid sensor kinase encoded by PA1611 directly interacts with RetS and 
controls the expression of genes associated with acute and chronic infections (Kong et al., 2013). 
This is only the second observation of heterodimerisation of sensors used for regulatory control.  
Expression of PA1161 represses T3SS and promotes biofilm formation, via rsmY and rsmZ.  The 
multimerisation state of RetS may therefore be modulated by PA1611, affecting its ability to interact 
with GacS (Kong et al., 2013).  These examples show that regulation via the Gac/Rsm cascade is 
highly complex, with many components and multiple inputs influencing the outcome of the 
regulatory cascade.  
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1.10 Conclusions  
 
P. aeruginosa is a highly versatile organism, capable of growth in most natural environments.  It is 
also prevalent in man-made environments, and is a successful nosocomial pathogen.  These 
infections range from self-limiting otitis media, to long-term infection of the CF lung, associated with 
high mortality. 
 
The ability of P. aeruginosa to cause such devastating infections is due to its large arsenal of cell-
associated and secreted virulence factors.  P. aeruginosa can form either acute or chronic infection, 
which mirror closely the environmental lifestyles of this organism, being either planktonic or sessile.  
The secretome of P. aeruginosa is large, and it possesses five out of six of the characterised Gram-
negative secretion systems.  The secreted effectors of these systems are largely studied, but the 
newly discovered T6SS clusters of P. aeruginosa remain only partly characterised.   
 
The success of P. aeruginosa as a pathogen is associated with its ability to tightly control the 
expression of potent virulence factors.  Many regulatory mechanisms are encoded and allow 
regulation of different virulence factors.  These systems are often intertwined, affecting each other, 
resulting in highly complex regulatory cascades.  P. aeruginosa is able to sense and respond to many 
environmental signals and tailor its response specifically to different environmental stimuli.  While 
the mechanisms of these regulatory systems are generally well understood, the nature of specific 
stimuli is often unknown.  
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Chapter 2 Materials and Methods 
 
2.1 Bacterial strains, culture conditions and reagents  
 
2.1.1 Bacterial strains  
 
Pseudomonas aeruginosa PAK or P. aeruginosa PA14 were used as model organisms in this study, 
with PAO1 occasionally used for comparison.   Isogenic deletion mutants and other genetic 
modifications were generated in these backgrounds.  A full list of P. aeruginosa strains used and 
generated in this work is presented in Table 6.  P. aeruginosa strains were routinely grown in 
tryptone soya broth (Oxoid) with agitation at 37 °C, or on LB agar (Merck) plates incubated at 37 °C.  
P. aeruginosa strains were isolated on Pseudomonas Isolation Agar (BD Difco).  E. coli strains and 
plasmids used in this work are listed in Table 7.  E. coli strains were routinely grown in Luria Broth 
(Merck) with shaking at 37 °C or on LB agar (Merck) plates incubated at 37 °C. 
 
2.1.2 Planktonic cultures  
 
Planktonic growth curves were produced by following the growth of bacterial cultures initially 
inoculated at an OD600nm of 0.1 in sterile glass Erlenmeyer flasks.  Growth medium was 
supplemented with antibiotics or other reagents as required, and incubated with agitation.  Growth 
was analysed by taking measurements of the optical density (OD600nm) at 1-2 h intervals using a 
handheld spectrophotometer and plotting log10 OD600nm against time.   
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Strain Name Characteristics Source/Ref. 
PA14 Wild type P. aeruginosa PA14 Lab collection 
PA14-DP PA14 carrying divergent arabinose inducible pBAD promoters upstream of hsiA2 and hcp2, 
interspaced by a single copy of the araC regulator. 
This study 
PA14-DP ΔH2 PA14-DP strain carrying a deletion of H2-T6SS from mid-hsiA2 to mid-hcp2 This study 
PA14-DP vgrG14-v5 PA14-DP producing a V5-Hisx6 tagged version of VgrG14 (PA14_43080) following the chromosomal 
introduction of the required sequence.  
This study 
PA14-DP rhsG14-v5 PA14-DP producing a V5-Hisx6 tagged version of Rhs14 (PA14_43100) following the chromosomal 
introduction of the required sequence.  
This study 
PA14::pscC PA14 carrying a transposon insertion in PA14_42350 (pscC) Liberati et al. 2006 
PA14 ΔpscC A clean deletion of PA14_43250 This study 
PA14 ΔpscC ΔH2 A clean deletion of PA14_43250 and deletion of the H2-T6SS cluster This study 
PA14-DP Δstp2 vgrG14-v5  PA14-DP producing a V5-Hisx6 tagged version of VgrG14 in a Δstp2 background This study 
PA14-DPΔstp2 rhsG14-v5 PA14-DP producing a V5-Hisx6 tagged version of Rhs14 in a Δstp2 background This study 
PAK Wild type P. aeruginosa PAK Lab collection 
PAK Wild-type P. aeruginosa  Laboratory collection 
PAK H1-T6SS In-frame deletion of H1-T6SS from mid HsiA1 (PA0082) to mid VgrG1a (PA0091) in Pseudomonas 
aeruginosa PAK wild type strain 
This study 
PAK retS In-frame deletion of retS (PA4856) in P. aeruginosa PAK wild-type strain Goodman et al. 
(2004) 
PAK ladS In-frame deletion of ladS (PA3974) in PAK  Ventre et al. (2006) 
PAK gacS In-frame deletion of gacS (PA0928) in PAK  Bordi et al. (2010) 
PAK gacA In-frame deletion of gacA (PA2586) in PAK  Bordi et al. (2010) 
PAK rsmYZ In-frame deletions of rsmY (PA0527.1) and rsmZ (PA3621.1) in PAK  Bordi et al. (2010) 
PAK::pCTX-PA0082-lacZ PAK PA0082 Transcriptional fusion Brencic & Lory (2009) 
PAK ΔrsmA ::pCTX-PA0082-
lacZ 
PAK rsmA PA0082 Transcriptional fusion Brencic & Lory (2009) 
PAK::pUC18-mini-Tn7-
PA0082-lacZ20 
PAK PA0082 Translational fusion Brencic & Lory (2009) 
PAK ΔrsmA ::pUC18-mini-
Tn7-PA0082-lacZ20 
PAK rsmA PA0082 Translational fusion Brencic & Lory (2009) 
PAO1 Wild type P. aeruginosa PAO1 Lab collection 
Table 6 P. aeruginosa strains used in this study. 
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Name Characteristics Source 
E. coli 
One-shot® TOP10 Used for interbacterial competition assay.  Invitrogen 
CC118 λpir Host strain for pKNG101 replication Lab collection 
1047 Carrying conjugative plasmid pRK2013, helper 
strain for conjugation 
Figurski & Helinski 
(1979) 
BL21 DE3 Host strain for expression of pET vectors Lab collection 
Plasmids 
pSB302 Based on pMP220 containing 211 bp region of exoT 
promoter-lacZ reporter. 
Bleves et al. (2005) 
pSB305 Based on pMP220 containing 219 bp region of pcrD 
promoter-lacZ reporter 
Bleves et al. (2005) 
pCdrA::gfpS 
 
pUCP22Not-PcdrA-RBS-CDS-RNaseIII-gfp(Mut3)-T0- 
1, AmprGmr 
Rybtke et al. 
(2012) 
pCR2.1-araCpBAD cloning vector containing the pBAD araC region 
from the arabinose inducible pJN105 vector 
Mikkelsen et al. 
(2013) 
pCR2.1-
pBADaraCpBAD 
cloning vector containing divergent pBAD 
promoter regions interspaced by a single copy of 
the araC gene. 
This study 
pCR2.1 v5-hisx6 Cloning vector containing the v5-hisx6 sequence 
from pDEST42 
This study 
pET28a hsiB2 Plasmid for over expression of his tagged HsiB2 This study 
pDEST42-hcpA Plasmid for over expression of PA1512 (HcpA), 
identical to Hcp2. 
This study 
Table 7 E. coli strains and plasmids used in this study 
 
The response to antibiotics by P. aeruginosa during planktonic growth was assessed by adding 
various concentrations of antibiotics to cultures at the start of growth experiments.  Kanamycin, 
gentamycin, and tobramycin (Sigma) were prepared in water and filter sterilised.  Tetracycline 
(Sigma) was dissolved in ethanol.  Antibiotic stocks were stored at -20 °C until use.  
 
Growth media was supplemented with arabinose (Sigma) for induction of gene expression in strains 
carrying genes under the control of pBAD promoters.  Arabinose was prepared as a 20% w/v stock, 
filter sterilised, and used routinely at a concentration of 2% (w/v) unless otherwise stated.  
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2.2 Bioinformatics and computational approaches  
 
P. aeruginosa DNA and protein sequences were obtained from the Pseudomonas genome database 
at pseudomonas.com (Winsor et al., 2011).  Geneious pro 5.4.5 software (Biomatters Ltd) was used 
for routine sequence analysis and to design cloning strategies.  Sequence alignments were 
performed using ClustalW (Larkin et al., 2007), and similarity searches performed using NCBI basic 
nucleotide blast or protein blast. 
 
Protein sequences were analysed for conserved domains using ExPASy prosite (Artimo et al., 2012), 
or using the pfam database (Punta et al., 2012).  Protein secondary structure predictions were made 
using psipred (Buchan et al., 2010). The Phyre 2.0 server was used to predict protein structural 
homology (Kelley and Sternberg, 2009). Phylogenetic trees were built using the ‘one-click’ method at 
phylogeny.fr (Dereeper et al., 2008).  
 
2.3 PCR and cloning  
 
2.3.1 Purification of P. aeruginosa gDNA 
 
Genomic DNA from P. aeruginosa strains was prepared using a PureLink genomic DNA kit 
(Invitrogen).  1 ml of P. aeruginosa overnight culture was used for purification, following the 
manufacturers guidelines, and gDNA was eluted in 100 µl of molecular biology grade water. gDNA 
was stored at -20 °C and used as a template for cloning reactions. 
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2.3.2 Cloning PCR 
 
Cloning of genes and genetic regions from P. aeruginosa genomic DNA was performed using high 
fidelity DNA polymerases.  The Expand High Fidelity Plus PCR system (Roche) was used for 
generating PCR products with overhanging residues, and KOD DNA polymerase (Novagen) was used 
for the generation of blunt ended PCR products.  Reactions were performed as per manufacturer’s 
instructions, using dNTP master mix (Eurogentec) and the addition of betaine (Sigma) at a final 
concentration of 1 M to disrupt the formation of secondary structures (Henke et al., 1997).  Custom 
primers were obtained from Eurogentec and are listed in Table 8. 
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Table 8 Cloning primers used in this project  
 
ID Primer Purpose Sequence (5’-3’) 
Divergent Promoter Engineering 
OAL771 5’ pBAD region duplication GGAATTCCATATGTCAGAGAAGAAACCAATTGTCCATATTG 
OAL772 3’ pBAD region duplication GGAATTCCATATGAAAACGGGTATGGAGAAACAGTAGAG 
OAL601 5’ Upstream of H2-T6SS Promoter GGGCCCGATCGGTACGTTCTCGT 
OAL586 3’ Upstream of H2-T6SS Promoter GCAGCTAGCTTTCATATGGTTAAGATATTCATTGGCGCAC 
OAL587 5’ Downstream H2-T6SS Promoter AACCATATGAAAGCTAGCTGCGAGGGGTGGTCCAACC 
OAL588 3’ Downstream H2-T6SS Promoter ACTAGTTCGTCGGAGCCGGAG 
OAL589 5’ OUT H2-T6SS Promoter CTTCAGCCACCAGGCG 
OAL590 3’ OUT H2-T6SS Promoter CTGCCTGGCGCGGG 
OAL591 pBAD promoter screening primer CGCGTAACAAAAGTGTC 
Cloning of V5-hisx6 region 
OAL599 5’ amplify V5-hisx6 encoding region GCTAGCCCATTCGAAGCTTGAAGGTAAGCCTAT 
OAL600 5’ amplify V5-hisx6 encoding region GCTAGCTCAATGGTGATGGTGATGATGACC 
Mutation of vgrG14 (PA14_43080) stop codon 
OAL602 5’ Upstream vgrG14 stop codon CACCAACGCCACGACACC 
OAL597 3’ Upstream vgrG14 stop codon TTTGCTAGCTTTGGGAGGTCACAGGCACCGTC  
OAL598 5’ Downstream vgrG14 stop codon CCAAAGCTAGCAAACGCCCTCTCCCCGCG   
OAL603 3’ Downstream vgrG14 stop codon CTTGCACTTCTCGCACTC 
OAL808 5’ OUT vgrG14 stop codon GCTACAACGAGCTGCGCATCGAGG 
OAL809 3’ OUT vgrG14 stop codon GCAGGTTGTCGATAGCGGTAGTCG 
PCR screen for presence of arr 
OAL1085 5’ arr probe (PA2818) AGCGCATCACCCCCAGCAAC 
OAL1086 3’ arr probe (PA2818) CGCCAAGTGCGAGCCACTGA 
Mutation of rhs14 stop codon 
OAL1136 5’ Upstream rhs14 stop codon AATAAAACTCGCTGTCCCGAAGCATTAG 
OAL1137 3’ Upstream rhs14 stop codon CATGAGTTTTCTGCTAGCGGGTCTATTACTTCGAAGTCTATTAGGTTCTTGTTG 
OAL1138 5’ Downstream rhs14 stop codon GAAGTAATAGACCCGCTAGCAGAAAACTCATGAAAACCATTTATAACTTCAAACAGCG   
OAL1139 3’ Downstream rhs14 stop codon TTCATTTGCTTCTGTCTTTTGGTTTTTTATATAACC 
OAL1160 5’ OUT rhs14 stop codon CGGGACGCTACCTGACCCCC 
OAL1161 3’ OUT rhs14 stop codon GATGCGTGAACTTCCTGAGCCAGG 
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Table 8 Cloning primers used in this project. Primer categories indicated with * were designed by Ms. Kailyn Hui 
hsiB2 cloning into pET28a 
OAL1171 5’ hsiB2 GCCATATGGCCAAAGAAGGCTCGGTAGCC 
OAL1172 3’ hsiB2 GCCTCGAGGGCGTCCTGGGAGGGGGC 
deletion of pscC 
OAL1389 5’ Upstream pscC ACGCAACCTGTGCCAGGCACAGG 
OAL1399 3’ Upstream pscC CTAATTCCCGCGGCGCATCAGGGACGCC 
OAL1400 5’ Downstream pscC ATGCGCCGCGGGAATTAGCATGGCCTGGAAGATCC 
OAL1401 3’ Downstream pscC TAGGCGCGCACCCTCGCC 
OAL1484 5’ OUT pscC GAGGTCCTCGAATGCCTCTGG 
OAL1485 3’ OUT pscC TTGTCCTCCAGGTAGCCGCC 
Deletion of H2-T6SS (mid hsiA2 to mid clpV2)* 
OAL996 5’ Upstream H2-T6SS GACTGGTTGAAAATCCTGGAAAAC 
OAL997 3’ Upstream H2-T6SS TCAGGCGAACGGCCTCCTGCTGGGCGC 
OAL998 5’ Downstream H2-T6SS AGGAGGCCGTTCGCCTGAGGTGGGTGC 
OAL999 3’ Downstream H2-T6SS CAACACGGTATAGGGGTTGTG 
OAL1000 5’OUT H2-T6SS GAATTGTTAAGATATTCATTGGCGCAC 
OAL1001 3’OUT H2-T6SS TCGAGCAGCAGGGTTCCGCCATCCGCG 
Deletion of stp2 
OAL346 5’ Upstream stp2 CTTCTTCGAAACCTACATGCG 
OAL347 3’ Upstream  stp2 TCATTGGCTGCGTTGCATCAGAGCTGC 
OAL348 5’ Downstream  stp2 ATGCAACGCAGCCAATGAACGAACCGC 
OAL349 3’ Downstream  stp2 CGTGGACGTAGGCCAGAA 
OAL350 5’OUT  stp2 TACCTGTATCTCAACCAGCGC 
OAL351 3’OUT  stp2 CAAGCGGGACAAGATGTTAAT 
Vector specific primers 
M13 F sequencing from pCR2.1 TGTAAAACGACGGCCAGT 
M13 R sequencing from pCR2.1 CAGGAAACAGCTATGACC 
RpKN Screening of pKNG constructs CATATCACAACGTGCGTGGA 
UpKN Screening of pKNG constructs  CCCTGGATTTCACTGATGAG 
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PCR reactions were initiated with a 5 minute 95 °C  denaturing step, followed by 20 cycles of 
denaturing (95 °C, 30 sec), annealing (55 °C, 30 sec, depending on the primers used) and elongation 
(72 °C, 1min/kb).  A final extension step at 72 °C for ten minutes was performed.   
 
PCR products were visualised using 1% TAE-agarose gel electrophoresis (TAE: 40 mM Tris, 20 mM 
acetic acid, 1 mM EDTA) containing SYBR safe DNA gel stain (Invitrogen).  1 µl of 6 x DNA loading dye 
(NEB) was added to 5 µl of the PCR product prior to loading, and a 1 kb DNA ladder (NEB) was used 
for molecular weight determination.  Correctly amplified PCR fragments were purified using a DNA 
purification kit (Qiagen) and PCR products were routinely subcloned into the pCR2.1 vector for 
storage and propagation using the TA cloning kit (Invitrogen).   
 
Subcloning was performed by digesting the required insert and vector using appropriate restriction 
enzymes and buffers (Roche).  Following digestion, products were checked by agarose gel 
electrophoresis and PCR or gel purified using the kits provided by Qiagen.  If required, cut vectors 
were dephosphorylated using calf intestinal alkaline phosphatase (NEB) for 1 hour at 37 °C.  T4 DNA 
ligase (NEB) was used to ligate insert and vector overnight at 16 °C.   
 
Following ligation plasmids were transformed into the required E. coli strain.  Cells were previously 
made competent using a calcium chloride based method.   100 µl of cells were added to the ligation 
mix and incubated on ice for 30 minutes.  Cells were then heat shocked for 2 minutes at 42 °C, and 
returned to ice.  500 µl of SOC medium (Invitrogen) was added and cells incubated at 37 °C for 1 
hour.  Cells were then plated onto appropriate selective media and incubated overnight. 
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2.3.3 Colony PCR 
 
Positive clones obtained following transformation were screened by colony PCR to confirm the 
presence of the required insert. Taq polymerase (Life Technologies) and dNTP master mix 
(Eurogentec) were used for colony PCR, and DMSO added to minimise secondary structure 
formation.  Plasmid specific or custom primers (Eurogentec), as listed in Table 3, were used. 
 
An isolated colony of the strain being tested was resuspended in 100 µl of molecular biology grade 
water.  The resuspended colony was lysed by one freeze-thaw cycle of freezing at – 80 °C for ten 
minutes followed by boiling at 95 °C for ten minutes.  The lysate was centrifuged at maximum speed 
in a benchtop centrifuge to pellet insoluble cell debris.  The DNA contained in the supernatant was 
used as a template for subsequent PCR reactions. 
 
A typical reaction set up contained 5 µl of the colony DNA preparation, 3 µl of Taq buffer, 2 µl of 
each primer (from a 10 µM stock), 2 µl of dNTPs (from a 20 mM stock), 14.3 µl of molecular biology 
grade water, 0.7 µl of Taq polymerase and 1 µl  of DMSO.   PCR reactions were initiated with a 5 
minute 95 °C  denaturing step, followed by 30 cycles of denaturing (95 °C, 30 sec), annealing (55 °C, 
30 sec, depending on the primers used) and elongation (72 °C, 1min/kb).  A final extension step at 72 
°C for ten minutes was also performed.  PCR products were visualised by agarose gel electrophoresis 
to identify positive clones. 
 
Plasmids from positive clones were purified using a plasmid purification kit (Qiagen).  The presence 
and orientation of inserts was confirmed using restriction digest (Roche).  30 - 100 ngµl-1 of purified 
plasmid DNA from positive clones was sent to GATC Biotech (Germany) for sequence confirmation. 
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A similar approach was used to test DNA from P. aeruginosa for genetic changes, however this 
required two freeze thaw cycles to obtain the required template DNA.  All subsequent steps were as 
described above. 
 
2.4 Genetic manipulation of P. aeruginosa  
 
2.4.1. Construction of P. aeruginosa deletion mutants  
 
Clean deletion mutants of P. aeruginosa genes were generated by amplifying 500 base pairs 
homologous regions either side of the target gene.  These regions were fused by overlap extension 
PCR, generating a 1 kb mutator fragment, cloned into the pCR2.1 vector and confirmed by 
sequencing.  The mutator fragment was subcloned into the broad host range suicide vector 
pKNG101 (Sarker and Cornelis, 1997), generating the mutator plasmid, which was transformed into 
E. coli cc118 λpir as previously described.   
 
Mutator plasmids were mobilised into P. aeruginosa by three partner conjugation using the required 
P. aeruginosa receiver strain, the E. coli cc118 donor strain carrying the mutator plasmid, and the E. 
coli 1047 pRK2013 helper strain.  20 µl aliquots of the donor and helper strain from an overnight 
culture were spotted together onto an LB agar plate and incubated at 37 °C for 2 hours, and 100 µl 
of the receiver strain was incubated for 2 hours at 43 °C.  After 2 hours, 40 µl of the receiver strain 
was added to the donor and recipient spot, and incubated for a further 4 hours at 37 °C.  Following 
incubation, the spot was resuspended in 100 µl of LB and plated onto Pseudomonas isolation agar 
supplemented with 2000 µgml-1 streptomycin. 
 
Due to the non-replicative nature of pKNG101 in P. aeruginosa, selection of colonies by 
streptomycin resistance indicated integration of the mutator plasmid into the chromosome of the 
132 
 
recipient strain by homologous recombination, which was then confirmed by PCR.  The backbone of 
the mutator plasmid was ejected by plating the strain onto LB agar supplemented with 5% sucrose, 
since the pKNG101 vector carries the levansucrase gene, conferring sucrose sensitivity.  A second 
recombination event allowed ejection of the vector backbone permitting growth on sucrose plates, 
and the colonies obtained were either wild type or deletion mutants.  This was confirmed by PCR 
using primers external to the mutation site. 
 
2.4.2 P. aeruginosa chromosomal insertions  
 
Insertions of genetic sequences at defined regions of the P. aeruginosa chromosome were achieved 
in a similar way to the deletion of open reading frames as described above.  500 base pair regions 
were amplified either side of the required location of the insertion.  These regions were fused by 
overlap extension, and suitable restriction sites were incorporated into the overlap region allowing 
DNA regions to be inserted into the overlap region by restriction digest. The homologous regions 
and inserted sequences were subcloned into the pKNG suicide vector, and conjugated into P. 
aeruginosa as previously described.  Selection of two events of homologous recombination 
subsequently resulted in reversion to wild type or insertion of the required sequences at the desired 
chromosomal location.  Chromosomal insertions were confirmed using a combination of primers 
specific to the inserted region and a primer specific to a chromosomal location external to the 
modified region. 
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2.5 RNA analysis  
 
2.5.1 RNA extraction and purification  
 
Total RNA from P. aeruginosa cells was isolated using an RNeasy kit (Qiagen).  Cultures were 
incubated under required growth conditions, and 2ml of culture at the mid-log growth phase were 
resuspended in 1 ml of RNAlater for preservation of RNA prior to extraction.  Prior to extraction, RNA 
was thawed on ice, and RNA was extracted from a volume of cells corresponding to 1 OD unit of 
bacteria. Harvested cells were resuspended in 1 mg/ml lysozyme (Sigma) in water and incubated for 
13 minutes at room temperature.  RNA extraction was performed using the RNeasy kit (Qiagen) 
following the suppliers bacterial protocol.  Following extraction RNA was purified following the 
‘purification of total RNA from bacterial lysates’ protocol. 
 
Following purification, RNA was treated with Turbo DNAse (Ambion).  RNA sample volume was 
adjusted to 100 µl. 10 µl of Turbo DNase buffer and 1.5 µl of Turbo DNase was added prior to 
incubation at 37 °C.  After 30 minutes an additional 1.5 µl of DNase was added and samples were 
incubated for a further 30 minutes at 37 °C.  The reaction was stopped by adding 20 µl of 
resuspended DNase inactivation agent for 5 minutes at room temperature with occasional mixing.  
The inactivation agent was sedimented by centrifugation at 10,000 rpm for 1.5 minutes, and the 
supernatant containing the RNA was transferred to a fresh tube and stored at -80 °C prior to 
analysis.  Prior to freezing, 10 µl was removed for quality control testing. 
  
2.5.2 RNA quality control 
 
RNA concentration was measured using a NanoDrop spectrophotometer, to ensure a concentration 
of 20 ngµl-1 or higher, and a 260/280 ratio above 1.8.  RNA samples were also checked by agarose gel 
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electrophoresis where bands of 23S and 16S ribosomal RNA, but not genomic DNA, were visible.  
DNA contamination was also tested using primers known to amplify a short region of genomic DNA, 
a positive result therefore indicated dsDNA contamination.   
 
2.5.3 cDNA generation 
 
cDNA was generated from RNA using SureScript II RNase H-reverse transcriptase (Invitrogen).   200 
ng of RNA was used for each reaction, in a total volume of 10 µl RNA free water.  RNA secondary 
structures were disrupted by heating samples to 65 °C for 5 min, and chilling on ice.  Reverse 
transciptase reactions were set up by adding 4.0 µl first strand buffer, 0.1 M DTT, 1.0 µl dNTPs, 0.5 µl 
RNA guard (Roche), and 1.0 µl random hexamer oligonucleotides (Amersham), 1.5 µl nuclease free 
water and 1 µl of the reverse transcriptase. Reverse transcriptase negative controls were also set up.  
Samples were incubated for 5 minutes at 25 °C, 50 minutes at 42 °C and 15 minutes at 70 °C to 
generate cDNA.  Following reverse transcription, cDNA samples were diluted 1/5 with RNAse free 
water and stored at -20 °C prior to analysis. 
 
2.5.4 q-RT-PCR  
 
Quantitative reverse transcriptase PCR was performed to measure the relative amount of RNA 
transcripts in different samples.  q-RT-PCR reactions were performed in an ABI 7300 real time PCR 
system machine using the CYBR green reporter.  Primers used were designed to probe for the 
expression of specific genes, yielding 100 base pair amplicons, and are listed in Table 9.   
 
Reactions were set up in ABI prism 96 well-optical reaction plates.  Reverse transcriptase negative 
controls were included to test for contaminating DNA. In each well 5 µl of cDNA was added to 12.5 µl 
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of ABI SYBR green PCR master mix (Applied Biosystems), 1.25 µl of each primer and 5.0 µl of 
nuclease free water.  Plates were sealed with ABI prism optical adhesive covers. 
 
40 amplification cycles were performed, each consisting of a 95 °C incubation for 15 seconds and 60 
°C incubation for 1 minute.  Fluorescence measurements were recorded at each cycle and processed 
to produce threshold values (Ct) for each sample.  All samples were normalised to the reference 
gene rpoN. 
 
 
ID Target Gene Sequence (5’-3’) 
OAL920 fw-stk2 CCGCTGGTAGCATTGAAGCT 
OAL921 rv-stk2 GGCGAACTCGCTATAGAGCAA 
OAL922 fw-hsiG2 GTGTTCGCTTCGGTTCTGAAC 
OAL923 rv-hsiG2 GTGCTCCTCACCCGCAACT 
OAL924 fw-hsiF2 ACTACGGGTTGCCCGATCTC 
OAL925 rv-hsiF2 GGTTCGTAAGCCTCGATGAAAC 
OAL926 fw-PA14_43090 GCCGTCACCTGCTACCGATA 
OAL927 rv-PA14_43090 GATCAGGTAACGGCCGAACA 
OAL928 fw-rhs14 GACAAGGACGCCAACATCCT 
OAL929 rv-rhs14 CGAAAGTATGCAGCAGTTTCAGTT 
OAL511 fw-hsiA2 GGTTGACCTGGGCCCTCTAC 
OAL512 rv-hsiA2 GATGGATCTCGACCCAATGC 
OAL540 fw-hcp2/A/B/C CCAAGGTCGAGATCCAGTGGTA 
OAL541 rv-hcp2/A/B/C GTAGTCCTTGATGTCGACGATGAT 
OAL542 fw-vgrG14 TCACCCCGGCCCAGAT 
OAL543 rv-vgrG14 TCTCGCACTCTTCGCAGAAG 
OAL820 fw-rpoD (reference gene)* AGGCCGTGAGCAGGGATAC 
OAL821 rv-rpoD (reference gene)* TCCCCATGTCGTTGATCATG 
OAL538 fw-vgrG5 GCCCGAAGGGTGAGGAA 
OAL539 rv-vgrG5 CTCGCGATCCCAGTGGAAT 
OAL536 fw-vgrG2b GGAGCCGGGAAAGACGTT 
OAL537 rv-vgrG2b AGGCTTCCCCGAACTCGTT 
OAL721 fw-pelA* CCTTCAGCCATCCGTTCTTCT 
OAL722 rv-pelA* TCGCGTACGAAGTCGACCTT 
OAL822 fw-tse3* GGCACGCAATGCCTTGAT 
OAL823 rv-tse3* GCAGATGTCGAAGAAGGTGATG 
Table 9 qPCR primers used in this project.   
Primers indicated by * were designed by Helga Mikkelsen.  
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2.6 Protein analysis  
 
2.6.1 Preparation of whole cell lysates  
 
P. aeruginosa whole cell lysates were prepared by harvesting 1 ml of planktonically grown cells of a 
known optical density, by centrifugation at 14,000 rpm for 1 minute.  Cells were resuspended to an 
optical density of 0.1 OD equivalent unit per 10 µl in SDS gel-loading buffer (45 mM Tris pH 6.8, 0.7% 
SDS, 0.7 mg/ml sucrose, 3.5% beta-mercaptoethanol, trace bromophenol blue)  and analysed by SDS 
page.   
 
2.6.2 Protein Secretion Assay 
 
Supernatants were separated from cells by centrifugation.  Overnight cultures of P. aeruginosa 
strains were subcultured to OD600nm 0.1 and inoculated into 30 ml of tryptone soya broth (Oxoid) in 
250 ml glass flasks.  Cells were incubated with agitation at 37 °C and samples were taken at various 
points during growth.  Before sampling, the optical density of the culture was noted.  Cells were 
harvested for preparation of whole cell lysates as previously described.  For supernatant 
preparation, 10 ml of culture was pelleted by centrifugation at 4000 rpm at 4 °C for 15 min.  The 
uppermost 7 ml of the supernatant was transferred to a fresh tube, and spun again under the same 
conditions for 20 min.  1.8 ml of the uppermost supernatant was harvested.  200 µl of trichloro 
acetic acid (Sigma) was added to the supernatant and proteins were precipitated on ice at 4 °C 
overnight.  Following precipitation, supernatant proteins were pelleted by centrifugation at 16,000 x 
g for 30 minutes at 4 °C.  Supernatants were removed and discarded, and the pellet washed in 1 ml 
of cold 90% acetone for 15 minutes on a vortex shaker.  After washing, the proteins were pelleted by 
centrifugation.   The supernatant was removed and the pellet air dried for 30 min, prior to 
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resuspension in SDS-gel loading buffer at a concentration of 1 OD unit per 10 µl.   This resulted in 10 
x concentrated supernatants, compared to cell extracts. 
 
In experiments involving the T3SS, this system was induced by the chelation of calcium ions.  Cells 
cultures were supplemented with 5 mM EGTA to chelate calcium, and 20 mM MgCl2 (Soscia et al., 
2007).  Cell extracts and supernatants were prepared as described. 
 
2.6.3 SDS-PAGE 
 
Whole cell and supernatant protein samples were separated by SDS-PAGE.  Prior to loading, 
resuspended samples were boiled for 10 min at 95 °C.  Proteins were analysed on 8-12% Tris-glycine 
SDS-PAGE gels prepared using the min-protean kits (Bio-rad).  Resolving gels contained 8-12 % 39:1 
acrylamide : bisacrylamide, 375 mM Tris pH 8.8, 0.1 % SDS, 0.5 % APS and 0.7 % TEMED.  Stacking 
gels contained 5 % 39:1 acrylamide : bisacrylamide, 62.5 mM Tris pH 6.8, 0.1 % SDS, 0.1 % APS and 
0.24 % TEMED.  Gels were immersed in Tris-Glycine-SDS (TGS) electrophoresis buffer (25 mM Tris, 
192 mM glycine, 0.1 w/v SDS).  10 µl of each sample was loaded onto the gels along with 
Kaleidoscope protein marker (Bio-Rad) for molecular weight determination, and a constant voltage 
of 150 V was applied for 1 hour.  Following electrophoresis proteins were transferred to 
nitrocellulose membranes for immunoblotting.  
 
2.6.4 Western blotting  
 
Following separation by SDS-PAGE, proteins were analysed by western blotting.  Whatman 
nitrocellulose membrane and filter paper and the electrophoresed gels were soaked in transfer 
buffer (20% ethanol, 10% TGS buffer, 70% H2O).  Proteins were transferred using a semi-dry transfer 
cell (Bio-rad) at a constant voltage of 24V, 3 mAmp per cm2 for 45 minutes.  Following transfer, 
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membranes were briefly stained with ponceau (Sigma) to visualise proteins.  Ponceau stain was 
removed by washing in TBS Tween (0.5 M Tris, 1.5 M NaCl, pH 8.0, 0.1% Tween20). 
 
Membranes were blocked for one hour at room temperature in blocking buffer (TBS Tween + 5% 
milk powder).  Primary antibodies were added to the membrane at a suitable dilution in blocking 
buffer for 1-2h.  Following incubation with primary antibody membranes were washed three times 
in TBS Tween.  Secondary antibody (anti-mouse or anti rabbit, conjugated to HRP (Sigma)) was 
added at 1/5000 dilution in blocking buffer and incubated for 45 minutes at room temperature.  
Membranes were washed three times in TBS Tween prior to detection. 
 
Antibodies were detected using SuperSignal West pico chemiluminescence substrate (Thermo) and a 
LAS3000 Fuji imager.  Equal volumes of the peroxide solution and enhancer solution were mixed and 
applied to the membrane, and incubated for 2 minutes prior to visualisation.  
 
2.6.5 Antibodies  
 
A list of antibodies used in this project, along with their source, is shown in Table 10.  Antibodies 
generated specifically for use in this project were raised against purified full length proteins carrying 
his tags.  The genes encoding the required proteins were either cloned into pET28a or obtained in 
pET-Dest42 expression vectors.  These constructs were transformed into E. coil BL21 DE3 cells as 
described, and protein expression induced by addition of 0.5 mM 1-thio-β-D-galactopyranoside 
when subcultures reached an optical density of 0.6 OD600nm.  Following induction, cultures were 
incubated at 18 °C overnight with agitation.  Cells were harvested and resuspended in 50 mM HEPES, 
500 mM NaCl, 200 mM imidazole, complete EDTA-free protease inhibitors, pH 7.2 and lysed by 
French Press.  The lysate was centrifuged at 3000 x g for 15 minutes.   The supernatant was applied 
to His-trap columns (GE healthcare) for purification by imidazole gradients.  Proteins were 
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subsequently purified by size exclusion chromatography into final buffer conditions of 50 mM Tris, 
250 mM NaCl2, pH8.  Purified proteins were concentrated and sent for antibody production in 
rabbits (Eurogentec).  
 
Antibody Comments Source  / Reference  
Primary Antibodies 
α -V5 Commercial antibody against the V5 epitope tag, raised in 
mice. 
Invitrogen  
α-RNAP Commercial antibody directed against the RNA polymerase β 
subunit of E. coli origin, raised in mice 
Neoclone  
α-Hcp1 Peptide antibody raised in rabbits against Hcp1 peptides,  (Hachani et al., 2011) 
α-VgrG1a Antibody raised against purified full length VgrG1a-V5-his in 
rabbits 
(Hachani et al., 2011) 
α-Tse3 Peptide antibody raised in rabbits against Tse3 peptides,  (Hachani et al., 2011) 
α-PcrV Antibody raised against recombinant His6 tagged PcrV in 
rabbits. 
(Goure et al., 2004) 
α-LasB Antibodies against purified P. aeruginosa elastase raised in 
rabbits. 
(Jaffar-Bandjee et al., 
1995) 
α-XcpY Antibodies raised against a GST-XcpY fusion protein in rabbits. (Ball et al., 1999) 
α-Hcp2 Antibody directed against purified full length Hcp2-V5-his in 
rabbits 
This work 
α-HsiB2 Antibody raised against purified full length HsiB2-V5-his in 
rabbits 
This work 
Secondary Antibodies 
α-rabbit anti-rabbit IgG (whole molecule)-peroxidase conjugate  Sigma 
α-mouse anti-mouse IgG (whole molecule)-peroxidase conjugate Sigma 
Table 10 Antibodies used in this project. 
 
2.6.6 Protein localisation studies  
 
For protein localisation studies, cellular proteins were initially separated into soluble and insoluble 
fractions.  An overnight culture of the required strain was subcultured to early stationary phase.  A 
cell sample was removed for preparation of whole cell lysates as previously described.  A volume of 
cells equivalent to 20 OD600nm units was harvested and resuspended in 1 ml 50 mM Tris pH 8.0 
supplemented with complete protease inhibitor cocktail (Roche) and 1 mM EDTA.  Cells were lysed 
by sonication (3 x 30 s, amplitude 35%) on ice.  Intact cells were removed by three spins at 4000 x g 
for 5 minutes at 4 °C, retaining only the uppermost supernatant each time.  The insoluble fraction 
was separated from the soluble fraction by ultracentrifugation at 100,000 x g for 1 h at 4 °C, 
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following which samples of the supernatant and the pellet, containing soluble and insoluble proteins 
respectively, were resuspended in SDS gel loading buffer. 
 
Proteins contained in the insoluble pellet were further fractioned into inner and outer membrane 
proteins.  This was achieved by resuspending the insoluble pellet in 500 µl of sodium N-
lauroylsarcosinate buffer (2% w/v SLS, 15 mM tris-HCl, pH 7.4) to solubilise proteins from the inner 
membrane.  Samples were incubated for 30 minutes at 4 °C with gentle mixing.   Solubilised inner 
membrane proteins were separated from insoluble outer membrane proteins by ultracentrifugation 
at 100,000 x g   for 1 h at 4 °C, following which samples of the supernatant and pellet, containing 
inner membrane and outer membrane proteins respectively, were resuspended in SDS gel loading 
buffer. 
 
Periplasmic proteins were isolated through selective disruption of the outer membrane.  Cells were 
subcultured to early stationary phase and a volume corresponding to 10 OD600nm equivalent units 
was harvested.  Cells were washed in 1 ml of ice cold 50 mM Tris pH7.6 and centrifuged at 8000 x g 
for 10 min.  The supernatant was removed and pellet resuspended in 0.5 ml spheroplasting buffer 
(0.2 M MgCl2 Tris pH 7.6), incubated for 30 min at 30 °C, 5 min on ice, then 15 min at room 
temperature.  Following incubation samples were centrifuged at 8,000 x g at 4 °C for 10 min.  The 
supernatant was carefully removed, and the cell pellet, containing spheroplasts was resuspended in 
SDS gel loading buffer.  The supernatant was centrifuged twice more, removing the uppermost 
supernatant each time, to remove all remaining spheroplasts.  The resulting supernatant, containing 
the periplasmic content, was resuspended in SDS gel loading buffer. 
 
Each of the resulting cell fractions were analysed by SDS-PAGE and western blotting, as described.   
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2.7 Biofilm assays 
 
2.7.1 Quantitative analysis of biofilm production 
 
The ability of P. aeruginosa strains to form biofilms was quantitatively measured in 48 well 
microtitre plates (BD Falcon).  Overnight cultures of P. aeruginosa strains were sub-cultured to an 
optical density of 0.1 OD600nm in LB broth, with the addition of antibiotics as required.  700 µl of 
bacterial culture was added to each well, and plates were placed in a static incubator at 37 °C for 16 
hours. 
 
Following incubation, 70 µl of crystal violet solution (VWR) was added to each well, and plates were 
stained for ten minutes at room temperature.  Liquid was removed from wells by aspiration, and the 
wells were washed three times with water.  The remaining stained biofilm was dissolved in 95% 
ethanol with rocking for ten minutes.  The optical density of the dissolved stain was measured by 
reading OD600nm using a hand-held spectrophotometer. 
 
2.7.2 Visual biofilm assay 
 
Biofilm production was visualised in glass test tubes.  Overnight cultures of P. aeruginosa strains 
were sub-cultured to an optical density of 0.1 OD600nm in LB broth, with the addition of antibiotics as 
required.  3 ml of the required culture was added to each test tube, and tubes were placed in a static 
incubator at 37 °C for 16 h.  Following incubation, 300 µl of crystal violet solution was added, and the 
tubes were stained for ten minutes at room temperature.  Liquid was removed by aspiration and 
test tubes were washed three times with water.  The remaining stained biofilm was photographed 
using a digital camera.   
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2.8 Reporter Assays 
 
2.8.1 β-galactosidase assays 
 
β-galactosidase assays were performed on strains containing appropriate lacZ reporter fusions, as 
indicated in Table 6.  Cells were cultured as previously described, and at appropriate time points 1 
ml of each culture was harvested by centrifugation, and the optical density of the culture recorded.    
Cell lysates were prepared by resuspending the pelleted cells in 1 ml of Z- buffer + beta-
mercaptoethanol (0.06 M Na2HPO4, 0.04 M NaH2PO4, 0.01 M KCl, 0.001 M MgSO4, 0.05 M beta-
mercaptoethoanol), 50 µl of 0.1 % SDS and 100 µl chloroform.  Samples were lysed in a vortex mixer 
for 2 min, and then left to stand for 2 min to allow separation of the chloroform. 
 
Assays were performed in 96-well microtitre plates (BD Falcon).  200 µl buffer Z was added to the 
first row as a control.  To other wells, 180 µl buffer Z and 20 µl cell lysate was added.  40 µl ONPG (4 
mg/ml, Sigma)) was added to each well, and plates were incubated at 28 °C until a yellow colour was 
detectible, at which point the duration of incubation was noted.  The reaction was stopped at this 
point by the addition of 100 µl 1M Na2CO3.  Absorbance at 405 and 540 nm was measured.  Samples 
were blank corrected, and β-galactosidase activity for each sample was calculated using the 
following formula.  
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2.8.2 Measurement of c-di-GMP levels 
 
Relative levels of c-di-GMP were measured using the c-di-GMP responsive cdrA-gfp fusion plasmid 
(Rybtke et al., 2012).  The plasmid was mobilised into P. aeruginosa strains by electroporation.  The 
reporter plasmid was prepared from the E. coli host strain using a QIAgen miniprep kit.  1.5 ml from 
an overnight culture of the recipient P. aeruginosa strain was harvested on ice, and washed twice in 
300 mM sucrose, and resuspended in 100 µl 300 mM sucrose.  150 ng of purified plasmid was added 
to the cells in a chilled, sterile, electroporation cell.  The cells were pulsed at 2.5 kV, and 1 ml of SOC 
media (Invitrogen) was added to cells, which were incubated at 37 °C for 1.5 h and plated onto 
selective media. 
 
P. aeruginosa strains carrying the reporter plasmid were subcultured for 6h with shaking, and three 
200 µl samples were removed into a black 96-well plate with a translucent base (BD Falcon).  The 
absorbance (620 nm, gain 1000) and fluorescence (excitation 485 nm, emission 520 nm, gain 2000) 
of the cells was measured using a Fluostar Optima plate reader.  Relative fluorescence was 
measured by normalising to 1 ml and by optical density of the original bacterial culture.   
 
2.9 T6SS Bacterial Killing Assay 
 
A visual assay was used to assess T6SS mediated bacterial killing of E. coli by P. aeruginosa, as 
previously described (Hachani et al., 2013).  P. aeruginosa cells were incubated with E. coli carrying 
the pCR2.1 empty vector (Invitrogen) allowing alpha complementation of β-galactosidase.  The 
required P. aeruginosa strain was incubated in a mixed patch with equivalent numbers of E. coli 
pCR2.1 cells, on an LB agar plate for 5 h at 37 °C.  Following incubation, the mixed patches were 
recovered and resuspended in 1 ml of LB broth.  A dilution series ranging from 100 to 10-3 was plated 
in triplicate on LB plates supplemented with 100 µg/ml X-gal (Invitrogen), and incubated at 37 °C 
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overnight.  A qualitative assessment of LacZ positive E. coli survival was achieved by visualisation of a 
blue colour in the plated dilution series. 
 
2.10 Cytotoxicity Assay 
 
The cytotoxicity of P. aeruginosa strains was measured by monitoring the release of lactate 
dehydrogenase (LDH) from a murine RAW 264.7 macrophage cell line (ATCC TIB-7).  RAW 
macrophages were routinely grown in Dulbecco modified Eagle medium, GlutaMAX I, sodium 
pyruvate, and phenol red (Gibco), supplemented with 10% foetal bovine serum and non-essential 
amino acids (Gibco).  Macrophages were grown to 80% confluence in 96 well plates and washed with 
sterile phosphate-buffered saline (PBS), and incubated with RPMI1640 without phenol red for 1 h 
prior to infection.   
 
Macrophages were infected with late exponential phase P. aeruginosa at a multiplicity of infection 
of 10 for 3 h at 37 °C, in the presence of 5% CO2.  The macrophage infection was synchronised by 
sedimenting bacteria with a 5 minute centrifugation step at 200 x g.   
 
Following 3h of infection, plates were centrifuged again for 5 minutes at 200 x g to sediment cell 
debris and bacteria.  The release of cytosolic LDH into the culture supernatant was measured with 
the CytotTox 96 non-radioactive cytotoxicity assay (Promega).  Cytotoxicity was calculated relative to 
that of non-infected cells, set to 0% cytotoxicity, and that of cells lysed with 1% triton X-100, set to 
100% cytotoxicity.   
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2.11 Internalisation Assay 
  
Internalisation of P. aeruginosa into HeLa cells was assessed by gentamycin protection assay.  HeLa 
cells were cultured to 70% confluence in 24-well plates in Eagle’s minimal essential medium (MEM), 
supplemented with 10% foetal bovine serum (Gibco).  The cells were washed twice with sterile PBS 
and infected with P. aeruginosa strains grown to early stationary phase at a multiplicity of infection 
of 10 in MEM with FBS, to a final volume of 1ml.  The infection was synchronised by sedimenting 
bacteria with a 5 minute centrifugation step at 200 x g prior to incubation for 3 h min at 37 °C in the 
presence of 5% CO2.  Following infection, cells were washed twice with sterile PBS and incubated 
with MEM supplemented with 300 µg/ml gentamycin (Sigma) for 75 min, to kill extracellular 
bacteria.  Cells were subsequently washed three times with room temperature PBS and osmotically 
shocked with ice cold sterile water containing 0.05% triton x-100 (Sigma) for 30 min on ice.  
Eukaryotic cell lysates were collected, and serial dilutions in sterile LB were plated onto 
Pseudomonas isolation agar and colony forming units enumerated following overnight incubation at 
37 °C. 
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Chapter 3 P. aeruginosa response to subinhibitory 
antibiotics 
 
3.1 Introduction   
  
As previously described, P. aeruginosa is capable of existing as one of two diverse lifestyles, thriving 
as a motile organism in a planktonic lifestyle, or establishing multicellular communities known as 
biofilms.  Biofilm cells are embedded in a matrix of exopolysaccharides attached to surfaces, as 
described in detail in section 1.4.  Biofilm formation occurs in the natural environment as well as 
during infections, and results in persistent infections that are difficult to eradicate. Regulation of 
biofilm formation is highly complex, and involves the interplay of several regulator components, 
including two-component systems, small regulatory RNAs and post-transcriptional regulators 
(Mikkelsen et al., 2011b).  Biofilm formation has also been closely linked to the second messenger c-
di-GMP (Harmsen et al., 2010).  The precise nature of the environmental stimuli which activate these 
regulatory cascades, leading to biofilm formation, are uncharacterised.  
 
It has been observed that sub inhibitory concentrations of several different antibiotics can induce P. 
aeruginosa biofilms.  Hoffman and colleagues were able to show that subinhibitory concentrations 
of the aminoglycoside tobramycin, a clinically important antibiotic, increased P. aeruginosa PAO1 
biofilm formation (Hoffman et al., 2005).  Incubation of PAO1 with a concentration of tobramycin 
equivalent to 0.3 times its minimum inhibitory concentration resulted in a 3.4 fold increase in the 
levels of biofilm formation, compared to incubation without antibiotics.  This effect was also 
observed with subinhibitory concentrations of amikacin, streptomycin, and gentamycin, although 
the level of induction was not as high using these aminoglycosides.   
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Incubation with subinhibitory concentrations of polymyxin B, a peptide antibiotic which is cationic 
like the aminoglycosides and alters membrane permeability, does not induce P. aeruginosa PAO1 
biofilm formation, indicating that the effect of the aminoglycosides is not related to its cationic 
nature (Hoffman et al., 2005).  Like aminoglycosides, chloramphenicol acts by disrupting protein 
synthesis, however, subinhibitory concentrations of chloramphenicol do not induce biofilm 
formation, indicating that the effect of aminoglycosides on biofilm formation is also not related to its 
role as an inhibitor of protein synthesis (Hoffman et al., 2005).  Carbenicillin, a cell wall synthesis 
inhibitor, also does not induce bacterial biofilm.  These observations led the authors to conclude that 
the effect seen with subinhibitory concentrations of aminoglycosides is not a non-specific response 
to antibiotic challenge, but a specific response to aminoglycoside molecules.  
 
Subinhibitory aminoglycosides were also shown to induce E. coli biofilm formation, and it was 
proposed that a signalling pathway common to P. aeruginosa and E. coli was involved in the 
phenotypes observed.  A transposon screen identified a P. aeruginosa phosphodiesterase, encoded 
by arr, responsible for tobramycin induced biofilm formation via the modulation of c-di-GMP levels.  
The discovery of a conserved regulatory pathway suggests that biofilm formation by tobramycin is a 
specific and defensive reaction to the presence of this antibiotic. 
 
A similar effect is seen with antibiotics which inhibit bacterial DNA replication, since P. aeruginosa 
PAO1 was shown to form biofilms in response to subinhibitory concentrations of quinolone 
antibiotics (Gotoh et al., 2008).  Induction of biofilm formation by quinolones was also suppressed by 
mutation of arr, indicating a broad role for Arr in the biofilm response.  A publication by Linares et al. 
(2006) shows that tobramycin, tetracycline, and norfloaxin can induce biofilm formation at 
subinhibitory concentrations.  Additionally, they show that tobramycin increases bacterial motility 
and tetracycline triggers expression of the T3SS (Linares et al., 2006).  This paper discusses the 
notion of antibiotics as signalling molecules that regulate bacterial behaviour, and not simply as 
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weapons used for fighting competitors.  These examples show that subinhibitory concentrations of 
antibiotics can result in beneficial adaptations by P. aeruginosa, leading to biofilm formation as a 
protective strategy.   This has obvious implications in the treatment of infections, since sub-lethal 
antibiotic concentrations or incorrect dose administration may have the unexpected effect of 
promoting persistent P. aeruginosa infections.   
 
The Ret/Gac/Rsm cascade is a key regulatory system involved in P. aeruginosa virulence, as 
described in detail in section 1.9 (Coggan and Wolfgang, 2012).  The cascade is involved in a switch 
between two different lifestyles, which ultimately result in different outcomes of infection.  A highly 
motility lifestyle and active secretion by the T3SS is associated with acute infections, while biofilm 
formation and high activity of the H1-T6SS are associated with chronic P. aeruginosa infections.  
Both subinhibitory concentrations of aminoglycosides and the RetS/Gac/Rsm cascade regulate 
biofilm formation (Goodman et al., 2004; Hoffman et al., 2005), however, it is not known if these 
two regulatory mechanisms interact, or if they represent two distinct regulatory pathways 
converging on a common phenotype.  The precise signals required to activate the RetS/Gac/Rsm 
cascade are not known.   Uncovering the exact signals that are sensed by this cascade will lead to a 
greater understanding of how P. aeruginosa responds to its environment, and mediate different 
types of infection.  Additionally, it is not known if aminoglycosides influence other phenotypes which 
are controlled by the RetS/Gac/Rsm cascade or if the cascade has a role in biofilm induction by 
subinhibitory concentrations of aminoglycosides.   
 
3.2 Specific aims of the study 
 
This work presented in this chapter aims to investigate the response of P. aeruginosa PAK to 
subinhibitory antibiotics, focusing on the response to aminoglycosides, which have previously been 
reported to influence P. aeruginosa PAO1 biofilm formation (Hoffman et al., 2005).   The effect of 
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subinhibitory concentrations of antibiotics will be tested on phenotypes known to be regulated by 
the RetS/Gac/Rsm cascade, including biofilm formation, T3SS, and H1-T6SS.  The role of the 
RetS/Gac/Rsm cascade in the molecular mechanism of the response of P. aeruginosa PAK to 
subinhibitory concentrations of antibiotics will be investigated.  The main aims of the chapter are 
outlined below: 
 
 Investigate the induction of biofilm formation by P. aeruginosa PAK in response to 
subinhibitory concentrations of various aminoglycosides, and other antibiotics. 
 
 Evaluate the role of arr in P. aeruginosa PAK, and investigate the change in c-di-GMP levels 
following incubation with subinhibitory concentrations of aminoglycosides. 
 
 Extend the analysis to phenotypes co-regulated with biofilm formation via the 
RetS/Gac/Rsm cascade by investigating the effect of subinhibitory concentrations of 
aminoglycosides on the T3SS and H1-T6SS. 
 
 Investigate if the RetS/Gac/Rsm cascade is required for the response of P. aeruginosa PAK to 
subinhibitory concentrations of aminoglycosides. 
 
3.3 Subinhibitory aminoglycosides and biofilm formation 
 
It has been shown that subinhibitory concentrations of antibiotics induce formation of biofilms by P. 
aeruginosa, notably tobramycin and P. aeruginosa PAO1 (Gotoh et al., 2008; Hoffman et al., 2005).  
The first clinically used aminoglycoside was streptomycin, derived from bacteria of the Streptomyces 
genus, and subsequently additional aminoglycosides have been isolated or synthesised.  This class of 
antibiotics is useful in the treatment of infections involving aerobic Gram negative bacteria.  
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Aminoglycosides are highly potent, bactericidal, broad spectrum antibiotics which act primarily by 
impairing bacterial protein synthesis by binding to the 30s subunit of the prokaryotic ribosome, 
causing misreading of the mRNA resulting in premature termination of translation (Mingeot-Leclercq 
et al., 1999).  Since other antibiotics that interfere with protein synthesis, such as tetracycline, are 
bacteriostatic in their action, it is not thought that the protein synthesis inhibition of 
aminoglycosides is responsible for the bactericidal activity of the aminoglycosides. It is proposed 
that aminoglycosides have an additional site of action at the bacterial outer membrane, where they 
form fissures which lead to leakage of cellular contents (Davis, 1987).   
 
3.3.1 Establishment of subinhibitory aminoglycosides concentration 
 
To investigate the role of aminoglycosides in inducing P. aeruginosa PAK biofilm formation, it was 
necessary to establish suitable concentrations of aminoglycosides which did not significantly affect 
growth. The growth of P. aeruginosa PAK, under a range of different concentrations of 
aminoglycosides (tobramycin, kanamycin and gentamycin) is shown in Figure 3.1.  The 
aminoglycosides used are closely related, and share structural similarity.  The main core of these 
molecules is the same, with variation in the side groups.   
 
The growth of P. aeruginosa PAK under a range of different concentrations of kanamycin is shown in 
Figure 3.1A.   The growth curves show that P. aeruginosa PAK, in the absence of kanamycin, has a 
typical bacterial growth pattern, reaching a stationary phase optical density of around 10 OD after 7 
h of growth.  Upon addition of kanamycin to the growth medium the growth of P. aeruginosa PAK 
responds in a dose dependent manner.  At lower kanamycin concentrations (10 to 50 µgml-1) the 
growth of P. aeruginosa is equivalent to growth without kanamycin.  At concentrations of 70 µgml-1 
and above the rate of exponential growth P. aeruginosa PAK is slowed, and concentrations of 100 
and 110 µgml-1 significantly impact bacterial growth.  At a concentration of kanamycin up to 70 µgml-
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1 the final cell density of stationary phase growth is equivalent to cells grown without kanamycin, 
indicating that concentrations below this do not significantly impact the growth of P. aeruginosa 
PAK.  Dr Luke Allsopp is acknowledged for his assistance in generating the data used showing P. 
aeruginosa PAK growth with increasing concentrations of kanamycin. 
 
 
Figure 3.1 Growth of P. aeruginosa PAK in response to aminoglycosides  
Planktonic growth (OD600) of P. aeruginosa PAK incubated with increasing concentrations of 
kanamycin (A), gentamycin (B) and tobramycin (C) are shown over a ten-hour period.  The 
chemical structure of each aminoglycoside is included for comparison.  The concentration of 
antibiotic used is shown to the right of each growth curve. 
 
Figure 3.1B shows that the concentrations of gentamycin tested are all sub inhibitory towards P. 
aeruginosa PAK.  The highest concentration tested, 3 µgml-1, has a small impact on the growth of 
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PAK after 2 hours, but the resulting final OD is equivalent to cells grown without gentamycin.  Figure 
3.1C shows the growth of PAK with increasing concentrations of tobramycin.   At a concentration of 
1.75 µgml-1 and above PAK growth stops after 2 hours.  The lower concentrations of tobramycin, at 
around 0.25 to 1.0 µgml-1 represent concentrations sub inhibitory to the growth of P. aeruginosa 
PAK.   
 
In conclusion, concentrations of kanamycin at 60 µgml-1, gentamycin at 2 µgml-1 and tobramycin at 2 
µgml-1 can be considered the maximum subinhibitory concentrations of these antibiotics that do not 
impact the growth of P. aeruginosa PAK. 
 
3.3.2 Subinhibitory aminoglycosides and biofilm formation 
 
Using the information gathered on the subinhibitory concentrations of kanamycin, gentamycin and 
tobramycin, their effect on biofilm P. aeruginosa PAK biofilm formation was investigated.  Figure 
3.2A shows the formation of biofilm by PAK incubated with a range of concentrations of each of 
these aminoglycosides. Visualisation of crystal violet stained biofilm biomass in glass test tubes 
indicates that PAK without kanamycin forms very low levels of biofilm, and that there is a dose 
dependent induction of biofilm formation between 10 and 60 µgml-1 of kanamycin.  This result is 
confirmed by quantifying the absorbance of the dissolved crystal violet stain (Figure 3.2A).  At 60 and 
70 µgml-1 kanamycin there is a statistically significant increase in biofilm formation (students T-test, 
P<0.01), with biofilm levels 2.58 and 2.49 times higher respectively than PAK grown without 
kanamycin. Dr Luke Allsopp is acknowledged for his assistance in generating the data used showing 
biofilm formation by kanamycin. 
 
Analysis of biofilm formation by P. aeruginosa PAK grown with increasing concentrations of 
gentamycin and tobramycin are shown in Figure 3.2B and 3.2D respectively, which show that 
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subinhibitory concentrations of gentamycin and tobramycin induce higher levels of biofilm 
formation compared to kanamycin.  The maximum effect on biofilm induction by gentamycin occurs 
at 0.6 µgml-1 where an induction of 3.25 fold is observed (Students T Test, P<0.05). A maximum 
induction of 4.05 fold (Students T Test, P<0.05) occurs at 0.5 µgml-1 of tobramycin.  Biofilm assays 
using gentamycin and tobramycin were performed by Mr John Horlick (Undergraduate project 
student). 
 
 
Figure 3.2 Induction of PAK biofilm formation by subinhibitory aminoglycoside concentrations   
Biofilm formation upon addition of kanamycin (A), gentamycin (B) and tobramycin (C).  A. top 
panel shows staining of biofilm biomass with crystal violet in glass test tubes.  The concentration 
of kanamycin used (in μg/ml) is shown above each tube.  Biofilm production is quantified (lower 
panel, B and C) by measuring the optical density of the dissolved crystal violet stain.  Error bars 
show standard deviation.  Antibiotic concentration is indicated below each bar.  * indicates a 
statistically significant difference compared to biofilm formation without antibiotic (student’s T 
Test, P<0.05). 
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These results indicate that the induction of biofilm formation by aminoglycosides reported for P. 
aeruginosa PAO1 also occurs in P. aeruginosa PAK.   Kanamycin, gentamycin, and tobramycin induce 
biofilm formation in this strain. 
 
3.3.3 Dependence on arr and ci-di-GMP 
 
In P. aeruginosa PAO1 the induction of biofilm formation by aminoglycosides and quinolone 
antibiotics has been shown to depend on a gene encoding Arr, a predicted inner-membrane 
phosphodiesterase (Gotoh et al., 2008; Hoffman et al., 2005).  When arr is disrupted, P. aeruginosa 
PAO1 no longer forms biofilms in response to aminoglycosides.  Arr, is shown to cause a decrease in 
the c-di-GMP pool upon addition of aminoglycosides, since membranes from strains where arr is 
disrupted have reduced phosphordiesterase activity (Hoffman et al., 2005). 
 
It has already been confirmed in the previous section that aminoglycosides induce biofilm formation 
in P. aeruginosa PAK, similar to published observations in P. aeruginosa PAO1 (Hoffman et al., 2005).  
However, since the genome sequence of the PAK strain is not currently available, the conservation 
of the arr gene in this strain is not known.  Genomic DNA from PAK was probed by PCR for the 
presence of a fragment of arr 686 bp in length, as was genomic DNA from PAO1, known to encode 
arr, and PA14, which lacks arr.  The result of this reaction can be seen in Figure 3.3A.  The positive 
product is clearly amplified from PAO1 genomic DNA, but not from PAK and PA14 gDNA.  This 
indicates that the arr gene is absent from PAK, and therefore the biofilm formation observed in this 
strain occurs in an arr independent mechanism.  Interestingly, the gene encoding arr is only 
conserved in three of the thirteen P. aeruginosa genomes available for comparison at 
pseudomonas.com, which are P. aeruginosa PAO1, M18, and PA7.  The lack of arr in PAK is therefore 
not surprising since it is not conserved in the majority of P. aeruginosa strains. 
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Figure 3.3 Analysis of c-di-GMP levels in P. aeruginosa PAK strains 
A. Result of PCR screening for a 686 base pair region of arr in PAK, PAO1 and PA14. B. Relative 
fluorescence values shown for strains carrying the c-di-GMP reporter plasmid (cdrA-gfp fusion).  
Levels shown for wild type PAK, PAK incubated with kanamycin at 30 μg/ml kanamycin, and a 
control strain (PAK ΔretS), known to have elevated levels of c-di-GMP.  RFU indicates arbitrary 
relative fluorescence units corrected for optical density.  Error bars show standard deviation. 
 
The biofilm phenotype induced by subinhibitory concentrations of aminoglycosides in P.  aeruginosa 
PAK may still be dependent on c-di-GMP, despite the absence of arr, involving instead other c-di-
GMP modifying enzymes.  This was investigated using a cdrA-gfp promoter fusion reporter which is 
responsive to c-di-GMP levels (Rybtke et al., 2012).  Measurements of relative c-di-GMP were made 
to see if they correlated with biofilm formation upon addition of aminoglycosides.  P. aeruginosa 
PAK carrying the reporter plasmid was incubated with or without kanamycin, and a PAK ΔretS 
control also carrying the reporter plasmid was included  since it is known to have elevated c-di-GMP 
levels (Moscoso et al., 2011).  Figure 3.3B shows the relative fluorescence units, corrected for optical 
density, for each condition tested.  A clear increase is observed in the PAK ΔretS strain, indicating 
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that the assay is capable of detecting increases in ci-di-GMP levels.  A comparison of PAK grown with 
or without kanamycin shows no detectible change in c-di-GMP levels upon addition of this antibiotic. 
 
The fact that arr is absent from PAK, and that there is no change in the c-di-GMP levels in this strain 
upon addition of kanamycin, suggests that the increased biofilm formation in this strain is arr and c-
di-GMP independent, and occurs via an uncharacterised mechanism.  These observations indicate 
that PAO1 and PAK both respond to subinhibitory aminoglycosides by forming biofilms, but the 
precise mechanism of this response is not the same in each strain. 
 
3.4 Sub inhibitory aminoglycosides and the H1-T6SS 
 
In addition to being induced by subinhibitory concentrations of aminoglycoside antibiotics, P. 
aeruginosa biofilm formation is also regulated by the RetS/Gac/Rsm cascade (Goodman et al., 2004).  
The RetS/Gac/Rsm cascade co-regulates biofilm formation and the H1-T6SS (Mougous et al., 2006).  
Due to this co-regulation by the regulatory cascade it was hypothesised that these two phenotypes 
may also be co-regulated by subinhibitory concentrations of aminoglycosides, and that the H1-T6SS 
may also be activated under these conditions.  
 
 3.4.1 Subinhibitory aminoglycosides and production of H1-T6SS 
components   
 
The production of a key structural component of the H1-T6SS, Hcp1, was tested upon addition of 
subinhibitory concentrations of various aminoglycosides.   As described in section 1.7, Hcp forms 
hexameric rings, which stack on top of each other to form a structure similar to the tail tube of 
bacteriophage, strictly required for the activity of the T6SS (Mougous et al., 2006).  Antibodies 
directed towards specific  Hcp1 peptides have previously been generated and were available for use 
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(Hachani et al., 2011). Western blots were performed on cell extracts from P. aeruginosa cultures 
grown with subinhibitory concentrations of kanamycin, gentamycin, and tobramycin.  The resulting 
western blots can be seen in Figure 3.4.  Figure 3.4A shows that increasing concentrations of 
kanamycin result in a dose dependent increase in the intensity of a band corresponding to a protein 
of around 17 kDa, proposed to be Hcp1 (with an expected molecular weight of 17.5 kDa).  Analysis of 
Figure 3.4B and 3.4C shows that increasing the concentration of gentamycin and tobramycin do not 
result in a comparable band.  This suggests that under the conditions tested, kanamycin, but not 
gentamycin or tobramycin, is able to induce production of a core component of the H1-T6SS.   
 
 
Figure 3.4 Effect of subinhibitory concentrations of aminoglycosides on Hcp1 production 
Western blots probing whole cell lysates with anti-Hcp1 antibody.  Cells were previously 
incubated with kanamycin (A), gentamycin (B) or tobramycin (C) at concentrations indicated in 
μg/ml above each blot.  The expected location of Hcp1 is indicated on the right of each blot, and 
molecular weight standards (in kDa) on the left. 
 
 
The positive effect of kanamycin on the H1-T6SS was tested further by investigating the production 
of Hcp1, and another core component of the H1-T6SS, VgrG1a.  VgrG, as described in section 1.7, 
forms the trimeric puncturing device of the T6SS system, essential for T6SS function (Leiman et al., 
2009).  An antibody raised against full length VgrG1a, also able to recognise other closely related 
VgrG associated with the H1-T6SS cluster (VgrG1b and VgrG1c), was used in this experiment 
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(Hachani et al., 2011). The locations of the genes encoding these H1-T6SS components are indicated 
in Figure 3.5A. 
 
 
Figure 3.5 Kanamycin induces components of the H1-T6SS in P. aeruginosa PAK 
A. Genetic organisation of the H1-T6SS cluster.  The region deleted in the PAK ΔH1-T6SS strain is 
indicated by the hatched box.  B. western blot of PAK whole cell extracts from cultures incubated 
with increasing concentrations of kanamycin, indicated in μg/ml below the blots.   Cell extracts 
were probed with anti-VgrG1a antibody (upper blot) and anti-Hcp1 antibody (lower blot).  The 
expected position of the proteins of interest are indicated on the right of the blot, and molecular 
weight standards (in kDa) are indicated on the left.  Cell extract from a PAK ΔH1-T6SS strain is 
included as a control to confirm the identity of VgrG1a and Hcp. 
 
 
Cell extracts from cultures of P. aeruginosa PAK grown with increasing concentrations of kanamycin 
were analysed by western blot.  The resulting blots can be seen in Figure 3.5B.  The upper panel 
shows blots probed with anti-VgrG1a antibody, and the lower with anti-Hcp1.  P. aeruginosa PAK 
cells grown without kanamycin have very low levels of Hcp1 and VgrG1a production.  Upon addition 
of kanamycin, the intensity of bands corresponding to VgrG1a and Hcp1 increases, with maximum 
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induction occurring at 60 µgml-1 of kanamycin, confirming that subinhibitory concentrations of 
kanamycin induce the production of two core H1-T6SS components.     
 
The identity of bands corresponding to Hcp1 and VgrG1a are confirmed using an isogenic PAK strain 
in which part of the H1-T6SS cluster has been deleted (PAK ΔH1-T6SS).  This strain carries a clean 
deletion of genes from hsiA1 to vgrG1a, as indicated by the hatched box in Figure 3.5A.  When PAK 
ΔH1-T6SS is incubated with 60 µgml-1 kanamycin, the bands observed in the wild type strain under 
the same conditions are absent, confirming the identity of these proteins as Hcp1 and VgrG1a 
(Figure 3.5B). 
 
A second band recognised by the VgrG1a antibody shows a dose dependent increase in intensity 
with increasing kanamycin concentration, which migrates with a molecular weight higher than that 
of VgrG1a.  Comparisons with previously published observations indicate that this band likely 
corresponds to VgrG1c, which is also recognised by this antibody (Hachani et al., 2011). However, 
the exact identity of this protein cannot be confirmed since the gene encoding VgrG1c is not 
disrupted by the mutation used. 
 
This data shows that in addition to inducing biofilm formation, sub inhibitory concentrations of 
kanamycin also induce the production of core components of the H1-T6SS.  This observation 
suggests that biofilm formation and the H1-T6SS are co-regulated by subinhibitory concentrations of 
kanamycin, which is of interest, since they have previously been shown to be co-regulated by the 
RetS/Gac/Rsm regulatory cascade (Goodman et al., 2004).    However, the same cannot be said for 
gentamycin and tobramycin, which induce biofilm formation but do not appear to have an effect on 
the production of H1-T6SS components under the conditions tested. 
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3.4.2 Dependency on the Ret/Gac/Rsm pathway  
 
The results previously discussed in this chapter show that kanamycin is responsible for the induction 
of two phenotypes; biofilm formation and production of core H1-T6SS components.  These two 
phenotypes are also co-regulated by the RetS/GacS/Rsm cascade, as described in section 1.9.  
However, it is not known if the regulatory cascade and kanamycin converge in a single regulatory 
pathway, or if both act independently to control these phenotypes. To address this question the 
dependency of the kanamycin induced phenotypes on the components of the cascade was 
investigated.   
 
The components and hierarchy of the Ret/Gac/Rsm cascade is shown in Figure 3.6A.  P. aeruginosa 
PAK strains carrying clean deletions in components of the cascade have previously been generated 
and were available for testing (Bordi et al., 2010; Ventre et al., 2006).  The parental wild type PAK 
strain and isogenic deletion mutants in components of the regulatory cascade were incubated with 
and without kanamycin at 30 µgml-1, and cell extracts were analysed by western blot.  Kanamycin 30 
µgml-1 was used, since at this concentration the growth of all strains was not significantly affected by 
addition of kanamycin, as shown in Figure 3.6B. 
 
The western blot obtained can be seen in Figure 3.6B.  Cell extracts of the wild type PAK strain shows 
that production of VgrG1a, VgrG1c, and Hcp1 are induced upon addition of kanamycin, as expected.  
Cell extracts from mutants in two membrane bound sensor kinases (ladS and gacS), the response 
regulator gacA, and a double mutant in the regulatory RNAs rsmY and rsmZ incubated with or 
without kanamycin, are shown.  Addition of kanamycin to the growth media of each deletion mutant 
tested does not result in increased production of VgrG1a, VgrG1c or Hcp.  This observation suggests 
that in the absence of a functional RetS/GacS/Rsm regulatory cascade the induction of the H1-T6SS 
by subinhibitory concentrations of kanamycin is unable to occur.   
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Figure 3.6 Kanamycin induction of the H1-T6SS requires a functional LadS/Gac/Rsm pathway 
A. Schematic representation of the Gac/Rsm signalling cascade, as previously introduced.  B. 
Planktonic growth of PAK and isogenic mutants in components of the LadS/Gac/Rsm cascade 
with and without kanamycin at 30 μg/ml.  Western blot of whole cell extracts from PAK and 
isogenic deletion mutants in components of the regulatory cascade as indicated above the blot.  
Strains were incubated with or without kanamycin at 30 μg/ml as indicated below the blot.  Cell 
extracts were probed with anti-VgrG1a (upper blot) or anti-Hcp1 (lower blot).  The expected 
positions of the proteins of interest are indicated on the right of the blot, with molecular weight 
markers (in kDa) on the left. 
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To place induction of H1-T6SS components by subinhibitory kanamycin concentrations into context, 
the levels observed under these conditions were compared to the levels seen by deletion of retS.  
Deletion of the membrane sensor retS is known to strongly activate the H1-T6SS (Goodman et al., 
2004; Mougous et al., 2006). PAK and PAK ΔretS were incubated with or without kanamycin, and cell 
extracts probed with anti-Hcp1 antibody.  The resulting blot can be seen in Figure 3. 7.  The levels of 
Hcp1 produced in response to kanamycin are much lower than observed in the retS mutant, which is 
considered to be a constitutively active T6SS.  Addition of kanamycin to a retS mutant does not 
affect the level of Hcp1 produced.  From this observation it is clear that although kanamycin results 
in increased Hcp1 production, the induction is at quite a low level compared to PAK ΔretS. 
 
 
 
Figure 3.7 Impact of kanamycin on Hcp1 production in various P. aeruginosa backgrounds 
Western blot showing Hcp1 production in whole cell lysates of P. aeruginosa PAK, PAKΔretS, 
PAKΔladS and P. aeruginosa PA14.  Each strain was grown with or without kanamycin at 30 
μg/ml, as indicated below the blots.  The position of Hcp1 is indicated on the right, with 
molecular weight markers indicated on the left (in kDa). 
 
 
In addition, Figure 3.7 shows the effect of subinhibitory concentrations of kanamycin on the 
production of Hcp1 in PAK ΔladS and P. aeruginosa PA14.  The lack of induction of Hcp1 production 
in a ladS mutant confirms previous observations.  Hcp1 production is not observed in PA14 with or 
without kanamycin, indicating that kanamycin induction of the H1-T6SS is not conserved in all P. 
aeruginosa strains.  The PA14 strain has a similar phenotype to a PAK ΔladS mutant, and PA14 
carries a defective ladS gene encoding a truncated LadS protein (Mikkelsen et al., 2011a).  Given that 
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PA14 is a ladS mutant, this confirms the observation that in the absence of a functional 
RetS/Gac/Rsm cascade, the induction of the H1-T6SS by subinhibitory concentrations of kanamycin 
is unable to occur.  The PAO1 strain already has a high basal level of H1-T6SS activity in the absence 
of kanamycin, and the addition of kanamycin does not affect Hcp levels (data not shown).  The 
genetic basis for the increased H1-T6SS production in PAO1 compared to PAK is unknown. 
 
3.4.3 Effect of kanamycin the transcription and translation of the H1-T6SS  
 
As previously described in section 1.8, the Ret/Gac/Rsm pathway influences the H1-T6SS at the 
translational level by reducing the levels of free RsmA, a translational repressor of H1-T6SS mRNA.  
Transcriptional and translational fusions of lacZ to hsiA1, the first gene of the H1-T6SS cluster, at 
neutral chromosomal locations, were obtained from Dr Stephen Lory (Harvard University) and used  
to investigate the impact of kanamycin at the transcriptional and translational levels of H1-T6SS 
expression (Brencic and Lory, 2009).  The activity of these fusions was tested under varying 
concentrations of kanamycin.  A strain carrying the transcriptional or translational fusion in an rsmA 
mutant background, in which the H1-T6SS is de-repressed and constitutively active, was included as 
a positive control.   
 
The result of β-galactosidase assays performed on cell lysates is shown in Figure 3.8.  Figure 3.8A 
shows the activity of the transcriptional lacZ-hsiA1 fusion.  Addition of kanamycin to strains carrying 
this construct does not result in a detectable increase in the transcription of hsiA1.  At 15 µgml-1 
kanamycin the activity of the fusion is equivalent to that with no kanamycin.  At 30 and 50 µgml-1 
there seems to be a reduction in the activity of this transcriptional fusion, which is not consistent 
with increased production of H1-T6SS components.  Therefore, it is not likely that the effect of 
kanamycin on the production of the H1-T6SS occurs at the transcriptional level.   
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Figure 3.8 Effect of kanamycin on expression of PA0082 (hsiA1) 
Levels of β–galactosidase activity in PAK carrying chromosomal transcriptional (A) or 
translational (B) fusions of the hsiA1 gene (PA0082) to lacZ with increasing concentrations of 
kanamycin as indicated on the x-axis.  Both fusions introduced into PAK ΔrsmA background were 
included as a positive control showing increased transcription and translation.  * indicates a 
reproducible statistically significant difference compared to incubation without kanamycin 
(Student’s T Test, P <0.05).  C. Western blot showing levels of Hcp1 in the translational fusion 
strain under corresponding kanamycin concentrations.   
 
Figure 3.8B shows the activity of a translational hsiA1-lacZ fusion.  At lower concentrations of 
kanamycin (15 and 30 µgml-1) there is no detectible increase in the activity of the hsiA1-lacZ fusion.  
However, at 50 µgml-1 there is a small, but statistically significant and reproducible, increase in the 
activity of this fusion.  This suggests that the induction of H1-T6SS by kanamycin may be due to 
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increased translation of H1-T6SS mRNA.  This correlates with the levels of Hcp1 produced under 
these conditions, as shown in Figure 3.8C, with the small increase in hsiA1 translation corresponding 
to a small increase in the amount of Hcp1 produced under the same conditions, in the strain carrying 
the translational reporter construct.   
 
The kanamycin induced production of H1-T6SS components seem to occur, at least in part, at the 
translational level.  This corresponds to the regulation of the H1-T6SS at the translational level by the 
Gac/Rsm pathway.  However, it cannot be concluded that the induction by these two mechanisms 
occurs via the same regulatory pathway. 
 
3.5 Sub inhibitory aminoglycosides and the T3SS 
 
Two RetS/Gac/Rsm cascade regulated phenotypes (biofilm formation and the H1-T6SS) are induced 
by subinhibitory concentrations of kanamycin.  Because of this, the effect of kanamycin on a third 
cascade dependent phenotype, the T3SS, was investigated.  The T3SS is inversely regulated with 
biofilm formation by this cascade as discussed in section 1.9.  The P. aeruginosa T3SS is responsible 
for cytotoxicity during acute infections, and secretes potent effectors, as described in Section 1.6.   
 
To monitor T3SS activity cell extracts and purified supernatants were probed with an antibody 
targeted towards a core structural T3SS component, PcrV. PcrV, is the tip of the T3SS needle, and is 
found in the supernatant of cells with an active T3SS.  P. aeruginosa PAK cells were incubated with 
increasing concentrations of kanamycin, and the resulting western blot can be seen in Figure 3.9. 
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Figure 3.9 Kanamycin represses the T3SS 
A. Western blots of whole cell extracts (left) and supernatant fractions (right) from PAK cells 
grown under increasing levels of kanamycin, as indicated below the blots. Upper blots are 
probed with anti-RNA polymerase, and lower blots are probed with anti-PcrV.  The expected 
position of these proteins is indicated on the left of the blots, while molecular weight markers in 
kDa are shown on the right.  B. Effect of kanamycin on the activity of lacZ transcriptional fusions 
with exoT or pcrD.  β–galactosidase activity (Miller units) is shown for PAK strains carrying these 
plasmid borne fusions, incubated with increasing kanamycin concentration, as indicated on the x 
axis.  * indicates a statistically significant difference in activity compared to the strain incubated 
without kanamycin.  Error bars show standard deviation.  C. and D. show western blots probing 
whole cell extracts from cell incubated with gentamycin (C) and tobramycin (D) with anti-PcrV 
antibody. 
 
167 
 
Analysis of whole cell fractions in Figure 3.9A reveal a background level of PcrV production in P. 
aeruginosa PAK incubated without kanamycin, observed as a band at 32 kDa.  With increasing 
kanamycin concentration the intensity of this band decreases, indicating that production of PcrV is 
reduced with increasing kanamycin.  This effect can also be observed in the supernatant fractions, 
where the level of secreted PcrV decreases as the concentration of kanamycin is increased.  RNA 
polymerase, a cytoplasmic protein, is observed at a constant level in all cell extracts, but is not see in 
the supernatant samples, indicating that the localisation of PcrV in the supernatant is due to 
secretion and not an artefact of cell lysis. 
 
In addition to western blot analysis, the effect of kanamycin on the transcription of T3SS genes was 
analysed, with fusions of T3SS promoters to the lacZ gene as previously described (Bleves et al., 
2005).  Two fusions were tested, a fusion to the promoter region of exoT, a secreted effector of the 
T3SS, and a fusion to the promoter region of pcrD, a structural component of the T3SS.  Cells 
containing the indicated plasmid borne gene fusion were incubated with increasing kanamycin 
concentration, and the resulting beta-galactosidase activity measured, as shown in Figure 3.9B.  It is 
clear that as kanamycin concentration increases, the activity of both fusions is reduced.  The activity 
of the exoT fusion is reduced 1.9 fold upon addition of 30 µgml-1 and 5.0 fold at 60 µgml-1 (Students T 
Test, P <0.05 in both cases).  Similarly, the activity of the pcrD fusion is reduced 2.8 fold at 30 µgml-1 
and 5.7 fold at 60 µgml-1 (Students T test, P<0.05 in both cases).  
 
Two other aminoglycosides, gentamycin and tobramycin, were also tested for their effect on the 
T3SS by analysing the amount of PcrV in the supernatant with increasing concentrations of these 
antibiotics, as seen in Figure 3.9C and 3.9D.  The amount of secreted PcrV decreases with increasing 
concentrations of both tobramycin and gentamycin, similar to the effect seen with kanamycin.  
Unlike that seen with induction of the H1-T6SS, which was only seen with kanamycin, the repression 
of the T3SS seems to be common to all of the aminoglycosides tested. 
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These results show that the addition of aminoglycosides has a negative effect on the T3SS and leads 
to a reduction in the production and secretion of PcrV, and in the expression of exoT and pcrD.  This 
observation is similar to the downregulation of the T3SS by the RetS/Gac/Rsm cascade.  All of the 
aminoglycosides tested are able to induce biofilm formation and repress the T3SS, but only 
kanamycin induces the H1-T6SS under the conditions tested.  It is clear that the response to 
subinhibitory aminoglycosides, especially kanamycin, shows striking similarity to regulation by the 
RetS/Gac/Rsm cascade.  It still remains to be shown whether these two mechanisms converge into a 
single pathway or are distinct regulatory mechanisms.   
 
3.6 Effect of tetracycline, a non-aminoglycoside  
 
To further understand the response of P. aeruginosa PAK to subinhibitory aminoglycosides, the 
response of P. aeruginosa PAK to tetracycline was investigated in order to observe the broader 
effects of antibiotic challenge.  Tetracycline has a different chemical structure to the antibiotics 
described thus far, as shown in Figure 3.10A. Tetracycline targets protein synthesis, binding to the 
30S subunit of the microbial ribosome, but unlike aminoglycosides, prevents the introduction of new 
amino acids into the growing polypeptide chain at the A-site, rather than causing misreading of the 
mRNA.  Tetracycline is bacteriostatic, and inhibits bacterial growth.   
 
The effect of a range of tetracycline concentrations was tested on the growth of P. aeruginosa PAK, 
and the resulting growth curves are shown in Figure 3.10B.   At concentrations of tetracycline below 
1.5 µgml-1 P. aeruginosa PAK growth is not affected.  At concentrations between 3.0 µgml-1 and 10.0 
µgml-1 tetracycline has a small impact on the growth of this strain; however, even at the highest 
concentration tested the final cell density is equivalent to cells grown in the absence of tetracycline.   
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Figure 3.10 Response of PAK to subinhibitory concentrations of tetracycline 
A. Molecular structure of tetracycline.  B. Planktonic growth of PAK grown with increasing 
concentrations of tetracycline over a ten-hour period.  C. Biofilm formation by PAK incubated 
with increasing concentrations of tetracycline. D. and E. Hcp1 and PcrV production, respectively, 
in  PAK cells incubated with increasing concentrations of tetracycline.   
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A biofilm production assay was performed with P. aeruginosa PAK, using a suitable range of 
tetracycline concentrations.  The result of this assay is shown in Figure 3.10C. As observed with 
aminoglycosides, tetracycline also induces biofilm formation in P. aeruginosa PAK.  At tetracycline 
concentrations of 10 µgml-1 and 20 µgml-1 the level of biofilm formation is 1.7 fold higher (P<0.05, 
students T test), and 2.6 fold higher (P<0.05, students T test) respectively.  This suggests that the 
impact on biofilm formation may be a general response by P. aeruginosa PAK to antibiotic induced 
stress or protein synthesis inhibition, and the specific chemical structure of the antibiotic may not be 
important. 
 
The effect of tetracycline on the H1-T6SS phenotypes of P. aeruginosa PAK is shown in Figure 3.10D.  
There is no production of Hcp1 in cells incubated with tetracycline, even at the highest 
concentration used.   The effect on production of H1-T6SS components appears specific to 
kanamycin, and not due to a reduction in growth rate or protein synthesis inhibition, since other 
aminoglycosides and tetracycline do not show a similar effect on Hcp production, despite similarly 
impacting the growth of PAK. 
 
Secreted levels of PcrV are constant with increasing tetracycline concentration, as shown in Figure 
3.10E, suggesting that the T3SS is not repressed by subinhibitory concentrations of this antibiotic.  
This is a striking observation, since the T3SS was seen to be downregulated with kanamycin, 
gentamycin, and tobramycin (Figure 3.9).  However, even though the range of tetracycline 
concentrations used produces a similar effect on the growth rate as other antibiotics tested, there is 
no similar reduction in the secretion of PcrV, indicating that the reduction of T3SS activity is a 
specific feature of aminoglycosides.  The reduction of T3SS is not caused by a slowed growth rate or 
protein synthesis inhibition, since it is not seen when tetracycline induces similar effects.   
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In summary, the results outlined show a complex effect of subinhibitory antibiotics on various 
phenotypes of P. aeruginosa PAK.  Biofilm formation is induced by all aminoglycosides tested and 
tetracycline and is likely a non-specific effect of reducing growth rate or protein synthesis inhibition.  
The effect on secretion phenotypes is not as clear.  Induction of the H1-T6SS components appears to 
be specific to kanamycin, since other aminoglycosides and tetracycline do not induce a similar 
response.  Repression of the T3SS system appears to be aminoglycoside specific, as kanamycin, 
gentamycin, and tobramycin cause decreased PcrV secretion, whereas tetracycline does not. 
 
3.7 Kanamycin as an activator of H1-T6SS 
 
The H1-T6SS is known to be regulated by the Ret/Gac/Rsm cascade, but the precise signals required 
for its activation are unknown.  The observation that kanamycin causes an increase in production of 
core H1-T6SS components, Hcp1 and VgrG1a, led to the hypothesis that kanamycin may be a natural 
signal activating this secretion system.  Additional H1-T6SS mediated phenotypes were tested to 
investigate the role of kanamycin in the secretion and activity of the H1-T6SS. 
 
3.7.1 Effect of kanamycin on Hcp1 and VgrG1a Secretion  
 
Production of Hcp1 and VgrG1a has been shown to increase in response to the addition of 
subinhibitory concentrations of the aminoglycoside antibiotic kanamycin.  Despite being structural 
parts of the secretion machinery, these components are routinely found in the culture supernatant 
in a T6SS dependent manner, and Hcp secretion is a hallmark of an active T6SS (Hachani et al., 2011; 
Mougous et al., 2006).  The secretion of Hcp1 and VgrG1a was investigated upon addition of 
kanamycin to test if these components are also secreted. 
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Figure 3.11 Kanamycin does not induce H1-T6SS-dependent secretion 
A secretion assay performed on PAK cells incubated with increasing concentrations of kanamycin 
as indicated above the blots.  Whole cell extracts are shown on the left, while supernatants are 
shown on the right.  Blots are probed with anti-Hcp1 (upper blot) or anti-VgrG1a (lower blot).  
The expected location of each protein is indicated on the right, and molecular weight standards 
shown on the left.  The PAKΔretS strain is included as a positive control for secretion.  * denotes 
that the PAKΔretS sample has been diluted 1 in 10 with loading buffer to reduce Hcp1 signal in 
this strain. 
 
 
Analysis of the western blot shown in Figure 3.11 shows that production of this Hcp1 is increased as 
kanamycin concentration increases, as expected.  However, Hcp1 is not detectible in the 
supernatant fractions of PAK strains incubated with kanamycin.  A retS mutant is included as a 
positive control, as it is known to produce and secrete Hcp1 abundantly.  Detection of Hcp1 in the 
supernatant of the retS control indicates that the secretion assay was successfully performed, and 
confirms that Hcp1 is not secreted in response to subinhibitory concentrations of kanamycin.   
 
Production of VgrG1a and VgrG1c are also increased upon arabinose induction, but as with Hcp1, 
their presence in the supernatant fraction is not detectible.  VgrG1a and VgrG1c are detectible in the 
cell fraction of the retS mutant, however, only traces of these proteins are detected in the 
supernatant.  This is possibly due to the lower abundance of these proteins compared to the 
multicopy Hcp tubes.  Although components of the H1-T6SS are produced in response to incubation 
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with subinhibitory concentrations of kanamycin, their secretion into the supernatant cannot be 
detected.  This suggests that the system is not functional under these conditions, when compared to 
the activated H1-T6SS activated by the deletion of retS.   
 
3.7.2 Effect of kanamycin on H1-T6SS toxin production 
 
Three toxins, Tse1-3, are known to be bacterial targeted secreted substrates of the H1-T6SS, 
described in details in Section 1.7 (Hood et al., 2010).  Tse1-3 are encoded distantly to the core H1-
T6SS cluster, but are known to be coregulated with it via retS  (Hood et al., 2010).  To further 
investigate the role of kanamycin as a signal for the activation of the H1-T6SS, the production of 
Tse3, a H1-T6SS peptidoglycan targeting substrates was tested in response to kanamycin (Russell et 
al., 2011).  If the H1-T6SS is activated in response to subinhibitory kanamycin concentrations, the 
levels of Tse3 will be expected to be higher under the same conditions. 
 
 
Figure 3.12 Kanamycin does not induce Tse3 production  
Western blot performed with anti-Tse3 antibody on whole cell extracts prepared from PAK cells 
grown with increasing concentrations of kanamycin. PAKΔretS, is included as a control as it is 
known that Tse3 is induced in this background. 
 
 
Antibodies were previously generated against specific peptides within Tse3 (Hachani et al., 2011).  
Cell extracts from cultures incubated with increasing kanamycin concentration were probed by 
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western blotting for production of Tse3, as shown in Figure 3.12.  A retS deletion mutant shows a 
band of high intensity corresponding to Tse3, confirming the specificity of this antibody.    
 
Comparison of cell extracts from wild type PAK with this retS control shows that a corresponding 
Tse3 band is absent, even at the highest concentration of kanamycin.  This suggests that even 
though Hcp1 and VgrG production is increased, Tse3 production is not induced by subinhibitory 
concentrations of kanamycin, again suggesting these conditions may not induce a functionally active 
H1-T6SS.    
 
 3.7.3 Effect of kanamycin on H1-T6SS mediated bacterial killing 
 
The killing of competing bacteria through T6SS mediated puncturing and toxin delivery has been 
shown to be the role of the P. aeruginosa H1-T6SS (Basler et al., 2012).   Investigating bacterial H1-
T6SS mediated bacterial killing is therefore a useful alternative phenotype to observe the effect of 
kanamycin on the activity of the H1-T6SS.  A visual assay has been developed in our laboratory to 
observe T6SS mediated E. coli killing by P. aeruginosa (Hachani et al., 2013).  This assay was used to 
investigate if incorporation of subinhibitory concentrations of kanamycin to the growth medium 
improved the ability of P. aeruginosa PAK to kill competing E. coli cells in a H1-T6SS dependent 
manner. 
 
In this experiment P. aeruginosa PAK or an isogenic PAK ΔretS was co-incubated with E. coli carrying 
a plasmid allowing alpha complementation of β-galactosidase, causing colonies to appear blue on X-
gal plates.  The individual strains used in the assay can be seen in Figure 3.13A.  The E. coli prey 
strain shows a clear blue colour, while the P. aeruginosa strains do not. Each of these strains also 
grew to comparable levels on plates containing 50 µgml-1 of kanamycin (data not shown). 
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The co-incubation steps were performed on agar plates either without kanamycin or with 50 µgml-1 
kanamycin for five hours, to allow bacterial competition to take place.  Following co-incubation, cells 
were harvested and serially diluted onto LB plates supplemented with X-gal, but without kanamycin.   
 
 
Figure 3.13 Kanamycin does not improve P. aeruginosa H1-T6SS mediated bacterial 
competition 
E. coli cells carrying to pCR2.1 vector were co-incubated with either PAK wild type or PAKΔretS.  
Panel A. shows the strains input into the assay in monoculture.  Panel B shows the result of 
mixed culture competition assays on LB plates without antibiotics or in the presence of 
kanamycin at a concentration of 50 µg/ml for five hours.  Following competition, cells were 
harvested and resuspended in LB broth, and a dilution series ranging from 10
0
 to 10
-3
 was plated 
in triplicate onto LB plates supplemented with X-gal, as indicated by the white box in each 
corner.  Visualisation of a blue colour gives an indication of E. coli survival. 
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Figure 3.13B shows the output of this bacterial competition assay.  A blue colour, indicating recovery 
of viable E. coli, is observed when PAK is co-incubated with E. coli, indicating that this strain does not 
kill E. coli, as previously observed, due to low T6SS activity in the PAK strain (Hachani et al., 2013).  E. 
coli is not recoverable when co-incubated with PAK ΔretS due to the constitutively active H1-T6SS in 
this strain.  When PAK is co-incubated with E. coli in the presence of 50 µgml-1 kanamycin, there is no 
change in the levels of E. coli recovered, indicating that kanamycin does not enhance the E. coli 
killing activity of the P. aeruginosa PAK H1-T6SS under the conditions tested. It is clear from this 
assay that addition of kanamycin does not result in activation of the H1-T6SS. 
 
In conclusion, despite activating the production of core components of the H1-T6SS, Hcp and VgrG, 
subinhibitory concentrations of kanamycin do not result in activation of other H1-T6SS dependent 
phenotypes.  Although produced, Hcp and VgrG are not localised to the supernatant, indicating that 
the system is either not correctly assembled or not active.  Production of a toxin associated with the 
system is not increased upon incubation with kanamycin, and the killing of E. coli by the P. 
aeruginosa PAK H1-T6SS is not improved in the presence of this antibiotic. 
 
3.8 Discussion 
 
The results presented in this chapter describe the response of P. aeruginosa to subinhibitory 
concentration of antibiotics.  It has previously been reported that subinhibitory concentrations of 
aminoglycosides induce biofilm formation in P. aeruginosa PAO1 (Hoffman et al., 2005), and this 
response was tested here in P. aeruginosa PAK.  The effect of subinhibitory aminoglycosides on 
additional phenotypes, namely the activity of the T3SS and T6SS, known to be coregulated with 
biofilm formation, was also tested.  The data collected shows that P. aeruginosa PAK responds in 
different ways to subinhibitory concentrations of antibiotics.   
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All antibiotics tested caused increased levels of PAK biofilm formation at subinhibitory 
concentrations, however, an increase in the production of the T6SS was only observed with 
kanamycin, and not other very similar aminoglycosides.  The T3SS system was downregulated in 
response to the aminoglycosides tested, but not when exposed to subinhibitory concentrations of 
tetracycline.  These observations support the conclusions by Linares and colleagues that antibiotics 
are able to act as signalling agents as well as antibacterial weapons (Linares et al., 2006).  The 
molecular mechanism of the response was also tested, and our data suggest that it is independent of 
c-di-GMP, while requiring a functional Gac/Rsm cascade. 
 
3.8.1 PAK biofilm response to subinhibitory antibiotic concentrations 
 
The results presented here show that subinhibitory concentrations of three aminoglycosides, namely 
kanamycin, gentamycin, and tobramycin, induce biofilm formation in P. aeruginosa PAK.     This 
supports the observation by Hoffman and colleagues that aminoglycosides, namely tobramycin, 
amikacin, streptomycin, and gentamycin, induced biofilm formation in P. aeruginosa PAO1 (Hoffman 
et al., 2005).  The fact that non-aminoglycosides (polymyxin B, carbenicillin and chloramphenicol) did 
not induce biofilm formation led to the conclusion that the response was specific to aminoglycosides 
(Hoffman et al., 2005).  Additional studies, and data presented in this chapter show that non-
aminoglycosides such as tetracycline and members of the quinolone family also induce bacterial 
biofilm formation in P. aeruginosa PAO1 and PAK (Gotoh et al., 2008; Linares et al., 2006), indicating 
that the biofilm response is likely not specific to one class of antibiotics.  
 
A limited microarray probing the expression of 555 PAO1 genes in response to subinhibitory 
concentrations of tobramycin, ciprofloxacin, and tetracycline has been previously performed 
(Linares et al., 2006).  A distinct expression profile was obtained for each of these antibiotics, which 
are from distinct classes and have different modes of action.  It is likely that the response by P. 
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aeruginosa is a general response to antibiotic induced stress, and not due to specific recognition of 
such a diverse group of antibiotic molecules with varying cellular targets.  Given the current 
evidence it is not clear why some antibiotics can and others cannot induce biofilm formation, and 
the effect of any untested antibiotics is unpredictable.  
 
The biofilm experiments performed in this chapter are focused on the early stages of biofilm 
formation (attachment), since the crystal violet assays measure the ability of P. aeruginosa to attach 
to surfaces.  To test the influence of aminoglycosides on mature biofilm formation, flow cell assays 
could be employed, which would allow direct microscopic visualisation of biofilm development 
(Sternberg and Tolker-Nielsen, 2006) 
 
3.8.2 The molecular determinants of the biofilm response  
 
A striking observation in this work is that P. aeruginosa PAK lacks the arr gene, which was shown to 
be involved in the P. aeruginosa PAO1 biofilm response to subinhibitory concentrations of 
tobramycin.  The induction of biofilm formation induced by tobramycin does not occur when arr is 
disrupted by a transposon insertion, and can be restored by the expression of arr from a plasmid 
(Hoffman et al., 2005).  Membranes from cells in which the arr is disrupted show reduced 
phosphodiesterase activity, confirming a role for Arr in the degradation of the second messenger c-
di-GMP in the biofilm response (Hoffman et al., 2005).      This remains the only example of low levels 
of c-di-GMP increasing biofilm formation, since low levels of c-di-GMP usually reduce biofilm 
formation. 
 
It is proposed that in PAK the biofilm response is independent of c-di-GMP, since a change in the 
levels of this second messenger could not be detected upon addition of kanamycin by the methods 
employed, despite this antibiotic having a significant effect on biofilm formation.   The levels of c-di-
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GMP in wild type PAK were low, it is reported that the fusion is not sensitive enough to detect small 
changes in c-di-GMP levels (Rybtke et al., 2012).  To confirm that biofilm formation in PAK in 
response to subinhibitory antibiotics is independent of c-di-GMP a more sensitive assay should be 
employed, such as measuring the levels using mass spectroscopy techniques such as LC-MS/MS 
(Simm et al., 2009), which would also represent a direct approach compared to using the Gfp 
reporter assay. 
 
In the publication of Hoffman et al, arr is shown to be required for biofilm formation in response to 
subinhibitory concentrations of tobramycin, and to have phosphodiesterase activity, but it was not 
directly shown that subinhibitory tobramycin concentrations resulted in a measurable change in 
cellular c-di-GMP levels in PAO1.  To confirm that using the cdrA-gfp fusion reporter is a suitable 
approach, it should be shown, using this fusion, that c-di-GMP levels are measurably affected by 
tobramycin in P. aeruginosa PAO1.  Even though Arr has phosphodiesterase activity, the changes 
induced by antibiotics may not be detectible.   
 
The fact that arr is absent from PAK indicates that other regulatory components mediate the 
response to subinhibitory antibiotics in this strain.  The role of arr in the biofilm response of PAO1 
was identified in a screen of transposon mutants in each of the 38 PAO1 GGDEF/EAL domain 
proteins, which were unable to form biofilms in response to subinhibitory tobramycin 
concentrations.  A similar screen in the PAK strain would reveal if GGDEF or EAL proteins other than 
Arr are required for the response in this strain, especially if there is such a protein encoded by PAK 
which is absent in PAO1.  If all GGDEF/EAL proteins are dispensable in the PAK biofilm response to 
aminoglycosides then this confirm a c-di-GMP independent response.  If the screen reveals a 
GGDEF/EAL is required for the aminoglycoside biofilm response, then this would confirm c-di-GMP 
dependence, and suggest the Arr function is conserved by a different EAL protein.  An alternative 
approach would be to perform a random transposon mutagenesis screen to identify genes required 
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for the response of P. aeruginosa PAK to aminoglycosides.  This approach would not be focused on 
the GGDEF/EAL proteins alone, and should provide information on other regulatory proteins 
involved, which would be particularly interesting if the PAK response is c-di-GMP independent.   
 
3.8.3 The T3SS response to subinhibitory antibiotics  
 
Kanamycin, gentamycin, and tobramycin were shown to reduce the expression of the T3SS. 
Strikingly, the levels of PcrV, a core T3SS component, did not decrease upon increasing 
concentrations of tetracycline, despite a similar impact on bacterial growth.  This may suggest that 
the aminoglycosides specifically repress the T3SS. However, Linares et al (2006) have shown using 
semi-quantitative RT-PCR, that a subinhibitory concentration of tetracycline induces the expression 
of exsA, the master regulator of the T3SS, and exoS, a secreted effector, in P. aeruginosa PAO1.  The 
expression of these genes is not affected by subinhibitory levels of tobramycin or ciprofloxacin.  The 
cytotoxicity of bacteria exposed to subinhibitory concentrations of tetracycline is increased, 
correlating with the increased expression of the T3SS (Linares et al., 2006).  Considering these 
observations, it is likely that the reduction of the T3SS by aminoglycosides may be a non-specific 
effect on the growth of P. aeruginosa PAK, which is not observed with tetracycline due to a specific 
induction of the T3SS which compensates for the growth effect.  
 
3.8.4 The H1-T6SS response to subinhibitory antibiotics  
 
In contrast to that observed for biofilm formation and expression of the T3SS, only kanamycin had 
an effect on the production of components of the H1-T6SS.  Despite having a similar chemical 
structure, neither gentamycin nor tobramycin showed an effect on the H1-T6SS.  The subinhibitory 
concentration of kanamycin (around 50 µgml-1) is around 100 fold higher than those of either 
tobramycin or gentamycin (around 0.5 µgml-1).  P. aeruginosa is much more resistant to kanamycin 
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than to the other aminoglycosides tested, which may enhance the ability of kanamycin to induce the 
H1-T6SS.  
 
The effect observed in response to the addition of subinhibitory concentrations of kanamycin 
mirrors that observed following the addition of subinhibitory concentrations of bile (Reen et al., 
2012).  Subinhibitory concentrations of bile salts induce biofilm formation and the H1-T6SS in P. 
aeruginosa PAO1, while negatively influencing the expression of the T3SS, which the authors 
concluded represents a switch towards a chronic P. aeruginosa lifestyle.  However, the effect of bile 
on the H1-T6SS was tested at the transcriptional level and it remains to be shown if this results in a 
fully assembled and active H1-T6SS. Subinhibitory concentrations of both bile and kanamycin have a 
strikingly similar effect on the lifestyle of P. aeruginosa, but it is not known if this response is 
mediated via the same regulatory pathway.   
 
Exact elucidation of the molecular mechanism in both of these cases is essential to understand the 
responses observed.  This could be investigated by comparing the microarray data from cells 
incubated with either kanamycin or bile. Since the regulatory mechanism responsible for the 
response of P. aeruginosa to bile is not characterised, it would be interesting to investigate if this 
involves either c-di-GMP or the Gac/Rsm pathway.  It was reported that quorum sensing was 
activated in response to bile, while swarming motility was reduced, and effect on these phenotypes 
by subinhibitory concentrations of kanamycin should be tested to see if the response is conserved.  
 
3.8.5 Dependency of the H1-T6SS response on the RetS/Gac/Rsm cascade 
 
A striking observation of this work is that the effect of subinhibitory concentrations of kanamycin is 
very similar to those observed upon activation of the RetS/Gac/Rsm cascade.  Either subinhibitory 
concentrations of kanamycin or deletion of retS activates biofilm formation and the H1-T6SS, while 
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simultaneously repressing the T3SS, phenotypes which promote a chronic P. aeruginosa lifestyle.  
Due to this similar effect it was proposed that kanamycin may exert its effects by directly signalling 
into the regulatory cascade, or intersecting at some point within the network.    
 
The dependency of kanamycin on the cascade was tested by observing the induction of the H1-T6SS 
in a panel of clean deletion mutants, in which components of the cascade were absent.  A functional 
cascade is required for the effects of kanamycin on the H1-T6SS to be observed.  The only significant 
effect of kanamycin upon transcriptional and translational fusions to hsiA1, the first gene of the H1-
T6SS cluster, was a small increase in the translation of hsiA1 at 50 μg/ml of kanamycin, which 
correlated with the levels of Hcp1 in this strain.  The effect of the cascade and kanamycin on the H1-
T6SS is thus likely exerted at the translational level.  These observations alone do not confirm that 
the effect of kanamycin is directly mediated through the RetS/Gac/Rsm cascade, only that the 
functional cascade is required for the kanamycin response.  The possibility remains while the T6SS is 
repressed by RsmA, addition of kanamycin has no effect, and is unable to relieve this dominant 
repression. 
 
To further understand the link between the kanamycin response and the cascade, the impact of 
antibiotics on the expression of cascade components could be investigated.  Addition of kanamycin 
may result in increased expression of the regulatory RNAs, RsmY and RsmZ, if the mechanism of 
T6SS activation by kanamycin is the same as the activation of the cascade achieved by deleting retS.   
Similarly, kanamycin may exert its effect through reduced expression of the translational regulator 
rsmA.  These effects could be tested using β-lactamase reporter fusions to the promoter regions of 
these genes.   
 
It is interesting to note that in the limited microarray performed by Linares et al (2006), the 
expression of rsmA is affected by each of the antibiotics tested.  rsmA expression is upregulated 
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3.12-fold by tobramycin, but modestly downregulated 1.26-fold by ciprofloxacin, and 1.42-fold by 
tetracycline (Linares et al., 2006).  Despite indicating a possible role for the Gac/Rsm cascade in the 
response to different antibiotics, the data does not correlate with what is observed, since although 
rsmA is inversely regulated by tobramycin and tetracycline, we observe biofilm formation in both 
cases, and only observe T3SS activation with tetracycline.  Consistent with what is known about the 
cascade, increased rsmA expression by tobramycin should lead to suppression of biofilm formation, 
while the downregulation observed in response to tetracycline should result in downregulation of 
the T3SS.  These inconsistencies suggest complex regulation of responses to antibiotics, involving 
numerous pathways depending on the antibiotic and strain used.  
 
It was also observed that the tolerance of RetS/Gac/Rsm cascade mutants to antibiotics is lower 
than that of the wild type strain, suggesting that a response mediated via this cascade is protective 
to P. aeruginosa upon antibiotic stress.  It has been reported that a gacS mutant has a minimum 
inhibitory concentration for gentamycin four fold lower than the wild type strain, and is more 
sensitive to amikacin, chloramphenicol, and cefpirome (Brinkman 2001).  This observation provides 
indirect evidence that the RetS/Gac/Rsm cascade is important in the survival of P. aeruginosa 
exposed to antibiotics, however it is still unclear whether this effect is due to the inability to respond 
by adopting a protective biofilm lifestyle with associated secretion phenotypes.   
 
The recent reporting of the crystal structure of the RetS periplasmic sensing domain revealed 
homology to a carbohydrate sensing domain (Vincent et al., 2010).  It could be suggested that 
kanamycin directly binds to the sensing domain of RetS, since kanamycin is essentially a 
trisaccharide carbohydrate molecule.  Once bound, kanamycin could potentially influence the 
oligomerisation and subsequent activity of RetS, acting as a direct signal for activation of the cascade 
and inducing the associated phenotypes.  However, due to the diverse chemical nature of the 
antibiotics influencing the biofilm phenotype is it unlikely that this is the correct model. 
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3.8.6 Kanamycin as a signal for H1-T6SS activation 
 
The observation that incubation with subinhibitory concentrations of kanamycin leads to increased 
production of H1-T6SS components is noteworthy, since the exact signals required for H1-T6SS 
activation remain elusive.  The initial observation of the effect on production of both VgrG1a and 
Hcp1, core H1-T6SS components, led to further investigation of the role of kanamycin as a signal for 
H1-T6SS activation.  
 
Despite our promising observation, it became clear that the H1-T6SS was not fully activated by 
subinhibitory concentrations of kanamycin.  VgrG1a and Hcp1 could not be detected in the 
supernatant, indicating that the system was unlikely to be assembled and functional.  In support of 
this, the production of a toxin transported by the H1-T6SS and coregulated by the RetS/Gac/Rsm 
cascade, was not induced by kanamycin in contrast to VgrG1a and Hcp1.  Another test to probe the 
activity of the system showed that the H1-T6SS mediated killing of E. coli by P. aeruginosa was not 
enhanced when kanamycin was included in the growth media. 
 
Comparison of the levels of Hcp1 produced following incubation with kanamycin with those of a retS 
mutant, in which the H1-T6SS is constitutively active, indicates that the kanamycin-induced levels 
are far lower.  It is therefore unclear whether this low level of induction is sufficient to observe a 
biologically relevant phenotype.  However, deletion of retS represents an artificially over-active H1-
T6SS, and the native levels of H1-T6SS are likely much lower. 
 
The observation that components of the system are up regulated in response to kanamycin is still an 
important observation.  Despite not resulting in an active H1-T6SS, production of the components 
may result in an intermediate state where the T6SS is produced in readiness for an H1-T6SS attack.  
P. aeruginosa has co-existed with natural antibiotic producers in the soil for much longer than 
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antibiotics have been used clinically.  Therefore, the response of P. aeruginosa to subinhibitory 
concentrations of antibiotics may represent a mechanism that has evolved to allow P. aeruginosa to 
sense bacterial competitors in the soil environment.  The recognition of diffusible antibiotic 
molecules would indicate to P. aeruginosa that an antibiotic producing organism is in the vicinity.  
Up-regulation of H1-T6SS components would therefore be advantageous in allowing a rapid 
response should P. aeruginosa subsequently come into direct contact with antibiotic producing 
competitors.  Streptomyces spp. are responsible for the production of many antibiotics, but the 
activity of the T6SS on Gram-positive organisms is yet to be observed.  Preliminary experiments were 
performed using co-cultures of P. aeruginosa with Streptomyces kanamyceticus, the natural 
producer of kanamycin (data not shown).  It was observed that P. aeruginosa was able to 
outcompete S. kanamyceticus, but this ability was independent of a functional H1-T6SS. 
 
Observations by the Mekalanos laboratory have shown that the P. aeruginosa H1-T6SS is activated 
as a defensive response to a T6SS attack from a competing organism (Basler et al., 2013).  The lack of 
competing organisms in the secretion assays performed with kanamycin may explain why H1-T6SS 
components are not secreted, since this would be a wasteful use of resources by P. aeruginosa.  It is 
likely that additional regulatory mechanisms are in place to prevent H1-T6SS activity in the absence 
of an aggressive competitor.  The direct contact with competing bacteria may represent one such 
regulatory mechanism, involving activation of the PpkA/PppA post-translational regulation of the 
H1-T6SS (Silverman et al., 2011), which is likely not affected by kanamycin.  It would therefore be 
interesting to observe the effect of kanamycin on H1-T6SS secretion in a strain in which the 
PpkA/PppA system is de-regulated.   
 
Experiments investigating the effect of kanamycin on the H1-T6SS mediated killing of E. coli failed to 
show an effect upon the addition of kanamycin.  This evidence does not support the hypothesis that 
a kanamycin induced H1-T6SS is primed for attack and capable of a fast response targeted against 
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competing bacteria.  However, observations at the cellular level of H1-T6SS dynamics indicate that P. 
aeruginosa does not attack E. coli cells routinely, and launches T6SS attacks only following T6SS 
attacks from competing bacteria (Basler et al., 2013).  E. coli may not be the most suitable prey cell 
for testing the effect of kanamycin, since it is not an aggressive competitor.  A prey that provokes a 
P. aeruginosa T6SS attack, e.g. Vibrio cholerae, could be used and the effect of kanamycin in 
increasing the speed or efficiency of the P. aeruginosa counterattack could be tested.  
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Chapter 4 Characterisation of the H2-T6SS 
 
4.1 Introduction 
 
The genome of P. aeruginosa encodes three Type Six Secretion systems, known as the H1-, H2- and 
H3-T6SS (Hcp-secretion Island 1-3). The most widely studied of these is the H1-T6SS, which is 
responsible for the secretion of three toxins (Tse1-3), and has a role in bacterial killing, as described 
in section 1.7.  Study of the H1-T6SS has been possible since this cluster is known to be regulated by 
the Ret/Gac/Rsm pathway, and deletion of the retS sensor kinase results in overproduction of the 
H1-T6SS components and hyper-secretion of its substrates, as described in section 1.8.  A P. 
aeruginosa retS deletion mutant is sufficient to allow for the study of the H1-T6SS under normal 
laboratory culture conditions.  Analysis of microarray data shows that the genes of the H2- and H3-
T6SS are not affected by retS deletion, indicating that the three P. aeruginosa T6SS clusters are not 
co-regulated (Goodman et al., 2004; Mougous et al., 2006).  The P. aeruginosa H2- and H3-T6SS 
remain poorly characterised in comparison to the H1-T6SS.  The H2- and H3-T6SS are not active 
under normal laboratory conditions, and the conditions required for their activation are not fully 
understood.  Despite this, a number of studies have investigated the regulation and role of these 
systems.   
 
Regulation of the H2-T6SS 
 
The publication by Lesic and colleagues (2009) was the first to report on the regulation and function 
of the H2-T6SS, which is the focus of this chapter.   Their work shows that quorum sensing is 
involved in the regulation of the H2-T6SS in P. aeruginosa PA14 (Lesic et al., 2009).  The authors 
reviewed earlier microarray data from a PA14 mvfR mutant and find that the expression of genes 
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encoded within the H2-T6SS cluster is repressed between 2- and 12-fold in an mvfR mutant 
compared to the wild type strain (Deziel et al., 2005).  This indicates that MvfR, also known as PqsR, 
and consequently the PQS quorum sensing system which it regulates, both positively influence H2-
T6SS expression.  They confirmed by RT-qPCR analysis, showing that hcp2 expression was reduced in 
an mvfR mutant.  Expression of hcp2 was also reduced in a lasR mutant, implicating the Las quorum 
sensing system in the regulation of H2-T6SS.  The discovery of LasR binding sites in the H2-T6SS 
promoter provides further evidence for quorum sensing regulation of this system (Lesic et al., 2009). 
Despite this information, how strong and efficient the effect of quorum sensing is on the production, 
assembly and activity of the H2-T6SS system remains to be investigated, especially since no 
phenotypic assays were readily available for this system.   
 
The regulation of the H2-T6SS was also studied in another P. aeruginosa isolate, PAO1 (Sana et al., 
2012).  In this case, a transcriptional fusion was generated between the promoter region of hsiA2, 
the first gene in the H2-T6SS cluster, and lacZ.  The activity of this fusion was increased around 10-
fold at the transition to stationary phase, and this effect was significantly delayed in quorum sensing 
mutants, with maximal levels reduced 22-fold in a lasR mutant and 8.5-fold in a rhlI mutant (Sana et 
al., 2012).  However, the impact of MvfR/PqsR, which was shown to impact the H2-T6SS in PA14, has 
not been investigated in this study using the PAO1 strain.   
 
In their study, Sana and colleagues also emphasise another regulatory pathways impacting H2-T6SS 
expression.  They observed that the activity of the hsiA2 transcriptional fusion is modestly increased, 
around 2-fold, under iron limiting conditions (Sana et al., 2012).  The discovery of Fur boxes in the 
promoter region of the H2-T6SS provides further evidence that iron limitation may be an 
environmental signal important in the activation of the H2-T6SS.  As with the previous study by Lesic 
et al, this study clearly identified regulatory pathways which modulate expression of the H2-T6SS, 
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but whether, and to what extent, they influence the production, assembly and activity of the H2-
T6SS was not clearly addressed. 
 
The role of the H2-T6SS 
 
A phenotype associated with the H2-T6SS is the involvement in virulence, which was observed using 
several infection models (Lesic et al., 2009).   For example, virulence in plants was tested using an 
Arabidopsis thaliana model, and leaves were infiltrated with wild type P. aeruginosa PA14, or an 
isogenic mutant in the H2-T6SS. Colony forming units recovered from leaves showed that the H2-
T6SS mutant exhibited significantly decreased growth at 2 and 3 days post infection compared to the 
wild type strain (Lesic et al., 2009).  Furthermore, virulence in a mammalian model was tested using 
an acute mouse lung infection model.  Mortality was delayed when mice were infected with a H2-
T6SS mutant, compared to mice infected with wild type PA14, however survival of mice was not 
affected.  Finally, in a model of mouse burn wound infection, deletion of H2-T6SS did not affect 
mortality (Lesic et al., 2009), suggesting it is not a central player in all infections.  Nevertheless, the 
authors concluded that the H2-T6SS plays an important role in P. aeruginosa virulence.  The 
molecular mechanism of the H2-T6SS contribution to virulence remains unclear, since firstly, the 
effects observed could be due to direct interaction with eukaryotic cells, or indirect effects due to 
the fitness of P. aeruginosa strains, and secondly, the specific effectors delivered by the H2-T6SS 
responsible for these phenotypes were not described in this work. 
 
Sana and colleagues also present evidence for the involvement of the H2-T6SS in interaction with 
the host, and more specifically with eukaryotic cells (Sana et al., 2012).  The internalisation of P. 
aeruginosa PAO1 into HeLa cells was investigated using gentamycin protection assays.  Deletion of 
clpV2, a core gene of the H2-T6SS cluster, results in an invasion defect, since the internalisation of 
this mutant is 75% lower than the wild type strain, although only 1.7% of wild type cells were 
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internalised.  This internalisation defect was shown to depend on the Akt phosphorylation pathway, 
also known as protein kinase B, a component of a host cell pathway involved in P. aeruginosa 
internalisation from the apical surface (Kierbel et al., 2005).  Infection with a clpV2 mutant resulted 
in a 50% decrease in Akt phosphorylation, compared with the wild type strain (Sana et al., 2012).   
 
H2-T6SS effectors 
 
Despite the extensive work presented in the papers by Lesic et al (2009) and Sana et al (2012), 
neither of these studies described the effector proteins responsible for the H2-T6SS associated 
phenotypes in host cell interactions.  Bioinformatic analyses have previously uncovered putative 
lipase effectors associated with the H2-T6SS, due to the presence of lipase encoding genes in genetic 
clusters with vgrG genes (Barret et al., 2011).  One of these lipases, PldA, was shown to have 
phospholipase activity, but was not shown to be T6SS dependent at the time (Wilderman et al., 
2001).   
 
The first experimental evidence of a H2-T6SS dependent effector, known as Tle5PA, a type VI lipase 
effector, was recently reported (Russell et al., 2013).  The observation that vgrG genes are often 
linked with genes encoding putative lipases was expanded and a bioinformatic approach uncovered 
377 putative lipases from five families.  It was also noticeable that each lipase gene is adjacent to a 
gene encoding a putative periplasmic localised immunity protein, required to protect P. aeruginosa 
from self-toxicity, indicating that the activity of the H2-T6SS may not be restricted to eukaryotic cells, 
but may also be involved in bacterial competition. 
 
Tle5PA was shown to catalyse the in vitro release of choline from phosphatidylcholine, a component 
of the bacterial membrane.  P. aeruginosa tle5/tli5 mutants, lacking both the Tle5 effector and 
cognate immunity protein, were susceptible to killing by a wild type P. aeruginosa competitor.  
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However, they survived incubation with P. aeruginosa Δtle5,  indicating that Tle5 is an antibacterial 
toxin against P. aeruginosa strains lacking the cognate immunity (Russell et al., 2013).  Inactivation of 
the H2-T6SS by deleting clpV2 abrogated the Tle5PA dependent toxicity, indicating that the H2-T6SS 
was responsible for the delivery of Tle5PA.   
  
Previous studies on the H2-T6SS provide clues to conditions activating the transcription of this gene 
cluster, but defined conditions resulting in a fully assembled and active system are yet to be shown.  
However, regulatory controls involving quorum sensing or iron limitation have a very global effect on 
bacterial cell physiology, and might not be best appropriate to specifically study the role and 
function of the H2-T6SS.  Engineering strains in which the H2-T6SS is tightly controllable would allow 
the system to be activated on demand and studied in more detail.  
 
4.2 Specific aims of the study 
 
The work presented in this chapter aims to further characterise the H2-T6SS, to control the 
production of H2-T6SS components, investigate their assembly and study the role of the system.  An 
important feature that has driven the rational of the work is a major difference between the H2-
T6SS clusters from PAO1 and PA14.  Indeed, we observed that in PA14, additional genes are present 
which may provide a clue on the nature of the H2-T6SS effectors and thus on the role and function 
of the system.  The chapter is split into four main sections covering genetic characterisation of the 
H2-T6SS cluster, artificial activation of the H2-T6SS, analysis of the production and secretion of 
putative substrates, and investigation of the role of the H2-T6SS.  The aim of each section is 
described below. 
 
 To characterise the P. aeruginosa H2-T6SS genetic cluster and highlight similarities 
and differences to the well characterised H1-T6SS. 
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 To engineer a strain in which the H2-T6SS can be artificially activated under standard 
laboratory culture conditions, generating a tool to allow in vitro study of this system.  
 
 To define and characterise putative secreted substrates or effectors of the H2-T6SS, 
and follow their production and secretion under conditions where the H2-T6SS is 
artificially activated. 
 
 Perform experiments to investigate the role of the P. aeruginosa PA14 H2-T6SS in 
bacterial and eukaryotic targeting.  
 
4.3 Characterisation of the H2-T6SS gene cluster 
 
The P. aeruginosa PAO1 H2-T6SS cluster  
 
The genetic arrangement of the H1- and H2-T6SS clusters from PAO1 are shown in Figure 4.1.  
Comparison of the two clusters reveals a set of components common to both systems (white 
arrows) which have previously been reported as core T6SS components (Zheng et al., 2011), but one 
may see that the arrangement of these genes varies greatly between the two clusters.  Only one 
gene, sfa2 is encoded within the H2-T6SS and absent from the H1-T6SS (blue arrow) (Figure 4.1).  
sfa2 encodes a sigma factor activating protein.  These proteins have been shown to interact with 
sigma factors and RNAP, driving the expression of specific genes as described in section 1.7.5.  This 
suggests an alternative regulation of the H2-T6SS and H1-T6SS. 
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Figure 4.1 Comparison of the P. aeruginosa PAO1 H1-T6SS and H2-T6SS gene clusters 
Arrows represent the direction of open reading frames at the H1-T6SS (top) and H2-T6SS 
(bottom) gene clusters of P. aeruginosa PAO1.  The gene identifiers (PA numbers) are given for 
the first and final genes in each cluster, and each gene is annotated with a short identifier.  Grey, 
yellow and green shaded arrows represent genes that are present in the H1-T6SS but absent in 
the H2-T6SS, while blue shaded arrows represent the gene present specifically in the H2-T6SS. 
 
13 genes present in the H1-T6SS are absent in the H2-T6SS cluster (grey, yellow and green arrows) 
(Figure 4.1).  Five of these genes are type six associated genes (tag) and are not core T6SS 
components.  The tagQRST genes encode proteins involved in the post-translational regulation of 
the H1-T6SS, described in section 1.7.5.  The absence of these tag genes in the H2-T6SS again further 
highlights the different regulation of these two systems.  H1-T6SS also encodes a gene annotated as 
hsiE1 (tagJ) which is not essential for H1-T6SS function, although its product interacts with the tail 
sheath component hsiB1 (tssB1) (Lossi et al., 2012).  Recent data observed in our laboratory suggest 
that HsiE1 may be responsible for actively targeting ClpV1 to the HsiBC sheath, and therefore 
catalyse recycling of the sheath (Filloux personal communication).  The lack of hsiE in the H2-T6SS 
shows that this function is not conserved (Lossi et al., 2012). 
 
More strikingly, some of the remaining H1-T6SS genes not found in the PAO1 H2-T6SS encode core 
components, essential for T6SS activity, namely hcp (yellow arrow) and vgrG (green arrows) (Figure 
4.1).  The Hcp and VgrG proteins form the tail tube and puncturing device respectively, and are 
required for the secretion of T6SS toxins (section 1.7.1).  An H2-T6SS cluster lacking these proteins 
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would be non-functional, unless genes encoded elsewhere on the chromosome must provide these 
essential functions.  Several orphan vgrG and hcp genes are found on the PAO1 genome, as 
described further in Section 4.6, but their involvement in the H2-T6SS remains to be demonstrated 
experimentally.  
 
The H2-T6SS in other P. aeruginosa strains 
 
The H2-T6SS cluster is conserved in the thirteen sequenced P. aeruginosa strains currently available 
for comparison at pseudomonas.com (Winsor et al., 2011).  The PAO1 H2-T6SS genes, from hsiA2 to 
stk2, and their genetic organisation, are conserved in all of the available strains, while differences 
are apparent in the region upstream of hsiA2 (Figure 4.2).  The genetic arrangement of the H2-T6SS 
shown on the top in Figure 4.2 is the most common, found in PAO1 and eight other strains (PA2191, 
C3719, DK2, LESB58, M18, PA7, PACS2 and RP73).  The genetic arrangement of the 39016, B136-33, 
NCGM2.S1 and PA14 strains show some striking differences.  In PA14 and B136-33 there is an 
insertion of four genes into the genome, orientated in the opposite direction to the core cluster, and 
absent from the majority of the other strains analysed.  The organisation in P. aeruginosa 39016 and 
NCGM2.S1 represent a hybrid between PAO1 and PA14, since it involves some but not all of the 
additional genes.  Such organisation may represent an evolutionary step in the acquisition or loss of 
this four gene cluster.   
 
Two of the additional genes present in PA14 and B136-33 encode core T6SS components (Barret et 
al., 2011; Lesic et al., 2009).  These components are a hcp gene and a vgrG gene, essential for T6SS. 
In contrast to PAO1, orphan Hcp and VgrG may not be required to build a functional H2-T6SS in 
these strains.  The P. aeruginosa PA14 strain thus presents a H2-T6SS cluster which encodes a 
complete set of the core T6SS components, and for this reason is our chosen model for the present 
study.  
195 
 
 
 
Figure 4.2 Comparison of the H2-T6SS across 13 P. aeruginosa strains 
The genetic arrangement of the H2-T6SS cluster in the 13 P. aeruginosa genomes currently 
available for comparison, the strain name is indicated to the right.  Gene clusters are taken from 
pseudomonas.com.  A diagrammatic representation of the core H2-T6SS cluster is shown above 
(white arrows).  While the core cluster (right) is conserved in all of the strains analysed, the 
genes encoded adjacent to the cluster (left) show some variability.  The gene boxed with thick 
black lines is hsiA1 in each case. 
 
Because of its location adjacent to the H2-T6SS cluster, this Hcp is referred to here as Hcp2, and the 
VgrG is referred to as VgrG14 as it was originally found in the PA14 strain.  The other two genes 
found in PA14 are not similar to any characterised T6SS components, and their potential role is 
discussed later in this chapter. 
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Figure 4.3 Characterisation of the PA14 specific Hcp 
A.  The names of each Hcp protein from PAO1 and the corresponding protein from PA14 are 
shown, along with their associated T6SS cluster, or orphan if not, and the gene identifier of the 
corresponding hcp gene.  B. Pairwise comparison of the percentage amino acid similarity of the 
six Hcp proteins from PA14. C. Structural comparison of the Hcp2 structure (left, coloured) with 
Hcp2 (right, black and white (Mougous et al., 2006).  Hcp monomers (above) and the ring 
complex formed from Hcp hexamers (below).  Reproduced from (Osipiuk et al., 2011) with 
permission. 
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Characterisation of Hcp2 
 
Whereas hcp1 is located within the H1-T6SS, and hcp3 within the H3-T6SS, no hcps are encoded in 
the vicinity of the H2-T6SS in PAO1.  The presence of the hcp2 gene adjacent to the H2-T6SS cluster 
is an important feature of P. aeruginosa PA14.  The PA14 strain is equipped with six Hcps, as it also 
contains a homolog of each of the five PAO1 Hcps (Figure 4.3A), including three orphan hcp genes 
are encoded distantly to the T6SS clusters. 
 
The protein sequence of Hcp2 was compared to the sequences of the other five PA14 Hcps, and 
protein identity scores are shown in Figure 4.3B.  Hcp2 shows 100% identity to the three orphan 
Hcps (ABC), while only being 8.7% and 17.58% identical to Hcp1 and Hcp3 respectively.    A 
publication reporting the structure of Hcp3 from P. aeruginosa in fact shows the solved structure of 
the protein encoded by PA0263, which is annotated as hcpC on the P. aeruginosa genome, and is not 
hcp3 (encoded by PA2367) (Osipiuk et al., 2011).  The protein sequence of the protein analysed in 
this publication is 100% identical to Hcp2 from PA14, and the structure for this protein is shown in 
Figure 4.3C.  Comparison with the solved structure of Hcp1 shows that these proteins have strong 
structural homology, despite having low sequence similarity, indicating that the tail tube function is 
likely conserved by Hcp2, in the PA14 H2-T6SS, but also for each of the identical Hcp proteins 
(Mougous et al., 2006; Osipiuk et al., 2011).   
 
4.4 Activation of H2-T6SS 
 
4.4.1 Engineering H2-T6SS promoters 
 
A system in which the H2-T6SS in P. aeruginosa PA14 could be artificially controlled was proposed, 
allowing the H2-T6SS to be studied under standard laboratory culture conditions.  Such a system has 
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already been successfully used to activate a T6SS cluster from Citrobacter rodentium (Gueguen and 
Cascales, 2013).  A promoter engineering approach was adopted to control artificial expression of 
the H2-T6SS.  A pBAD promoter under the control of the AraC transcriptional regulator was the 
preferred choice and allowed the system to be expressed upon addition of arabinose to the growth 
medium.  This promoter is found in E. coli, controlling the expression of arabinose uptake and 
metabolism genes in the presence of arabinose (Gallegos et al., 1997).  It has subsequently been 
used in Pseudomonas species for which broad host range expression vectors, e.g. pJN105, allowing 
tightly controlled protein production, have been engineered (Newman and Fuqua, 1999).  
 
A strategy was designed to introduce the pBAD promoter and araC gene onto the PA14 
chromosome, immediately upstream of the H2-T6SS cluster.  Due to the divergent arrangement of 
the H2-T6SS clusters in P. aeruginosa PA14 two copies of the pBAD promoter were introduced, 
acting in opposite orientations, interspaced by one copy of the araC gene, represented 
diagrammatically in Figure 4.4A.   
 
Figure 4.4 Design of the divergent promoter strategy  
A.  Final organisation of the PA14 strain carrying two copies of the pBAD promoter (curved black 
arrows) and a single copy of the araC gene (white arrow) in the promoter region of the H2-T6SS 
cluster.  B. pCR2.1 strain carrying the araC gene and a single copy of the pBAD promoter, flanked 
by Nde1 and Nhe1 restriction sites.  C. The pCR2.1 vector manipulated to contain two copies of 
the pBAD promoter, acting divergently, either side of the araC gene, flanked by Nde1 and Nhe1 
restriction sites. 
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The cloning strategy for generation of the divergent promoter is shown in Figure 4.4.  Briefly, a 
pCR2.1 vector containing the araC gene with a single pBAD promoter was obtained from Dr Helga 
Mikkelsen (Figure 4.4B) (Mikkelsen et al., 2013).  The pBAD promoter and operator regions were 
amplified by PCR and duplicated into this construct upstream of the araC gene, generating divergent 
copies of the pBAD promoter, generating pCR2.1-DP, as shown in Figure 4.4C. 
 
 
Figure 4.5 Introduction of the divergent promoter into the H2-T6SS promoter region 
A. 500 base pair regions defining the H2-T6SS promoter region were amplified by PCR, with Nde1 
and Nhe1 restriction sites incorporated into the primers.  B. The two 500 bp regions were fused 
by overlap extension PCR and cloned into the pCR2.1 vector, with Nhe1 and Nde1 sites 
separating the two regions. C. The divergent pBAD promoter araC construct was subcloned into 
the Nde1 and Nhe1 sites, generating the mutator fragment required for mutagenesis of PA14. 
 
In order to insert the divergent pBAD promoter region into the required chromosomal location, the 
strategy outlined in Figure 4.5 was used. 500 base pair regions upstream and downstream of the 
native H2-T6SS promoter region were amplified as indicated in Figure 4.5A.   50 base pairs upstream 
of the start codons of hsiA2 and hcp2 were maintained in order to retain any cis-acting elements.  
The two fragments were fused by overlap extension PCR, and ligated into pCR2.1 (Figure 4.5B). The 
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overlapping region contained appropriate restriction sites (Nde1/Nhe1) to allow insertion of the 
divergent pBAD promoter sequence (Figure 4.5C).  
 
The resulting DNA fragment was subcloned into the broad host range suicide vector pKNG101 
(Sarker and Cornelis, 1997).  Standard mutagenesis protocol using pKNG101 derivatives was 
followed, which allowed insertion of the divergent promoter region into the H2-T6SS promoter 
region of the P. aeruginosa PA14 chromosome, and, following two events of homologous 
recombination, a strain referred to as P. aeruginosa PA14-DP (divergent promoter) was generated.   
 
4.4.2 Testing of the activity of the Divergent Promoter 
   
Quantitative Reverse transcriptase PCR analysis (q-RT-PCR) was performed on the newly constructed 
P. aeruginosa PA14-DP strain to test the activity of the pBAD promoters, and to observe if arabinose 
induction resulted in significantly increased expression of H2-T6SS encoded genes.  Transcript levels 
of H2-T6SS genes from the PA14-DP were compared in the absence and presence of arabinose (2%), 
and in the parental PA14 strain (Figure 4.6a).  Primers specific to 100 base pair amplicons of several 
H2-T6SS encoded genes were designed, as detailed in Table 9.   Expression of these genes was 
measured relative to the expression of the reference gene rpoD, encoding the housekeeping sigma 
factor of RNA polymerase. 
 
Expression of the first gene of the H2-T6SS cluster, hsiA2, is increased 8.5-fold upon induction with 
arabinose (Figure 4.6a), compared to the un-induced sample, and similarly induced when compared 
to the parental strain lacking the inducible promoter.  The hsiF2 gene transcription is increased 
about 19-fold, and hsiG2 around 8-fold upon arabinose induction.  Finally, expression of stk2, the 
distal gene of this cluster, is increased around 5-fold upon arabinose addition.   
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Figure 4.6 Expression of H2-T6SS genes upon arabinose induction  
The expression of H2-T6SS genes were tested in wild type PA14 (white bars) uninduced PA14 DP 
and PA14 DP induced with 2% arabinose.  The fold change in expression of genes encoded in the 
core H2-T6SS is shown in A, expression of the additional genes encoded adjacent to the H2-T6SS 
cluster in PA14 is shown in B, and a control showing genes encoded outside the H2-T6SS cluster 
are shown in C, where hsiA2 expression was included as a positive control.  Error bars show the 
standard deviation of three replicates.  Primers used in this experiment are defined in Table 1. 
 
 
 
 
The expression levels of genes encoded within the PA14 specific cluster adjacent and divergent to 
the H2-T6SS, were also tested and compared in PA14 and PA14-DP (Figure 4.6b).  Expression of all 
four of these genes is increased in response to arabinose induction.  The first gene in the cluster, 
hcp2, is upregulated around 15-fold, as is vgrG14.  The PA14_43090 open reading frame, currently 
un-named, is upregulated 3.6-fold, and the last gene in this cluster, named rhs14, characterised 
further in the upcoming sections, is upregulated 14-fold.   
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As a control, the expression of genes located outside the H2-T6SS was tested (Figure 4.6c).  None of 
these, including vgrG5, vgrG2b, tse3 and pelA, were upregulated upon arabinose addition, in 
contrast to the hsiA2 gene.  
 
These results show that the control of the divergent arabinose inducible promoter on H2-T6SS gene 
expression was effective and specific, and the PA14-DP strain can be used for experiments requiring 
activation of the H2-T6SS cluster.  
 
 4.4.3 Production of H2-T6SS components 
 
Although qPCR analysis using the PA14-DP strain has shown significant expression of the H2-T6SS 
gene cluster upon arabinose addition, further evidence is required to confirm that the H2-T6SS multi 
protein complex is produced, assembled and active under these conditions.  
 
Antibodies were generated against two H2-T6SS proteins, namely Hcp2 and HsiB2, encoded on 
opposite sides of the divergent promoter construct and within the two divergent transcriptional 
units.  The gene encoding a his tagged Hcp2 homolog (PA1512), cloned into pDEST42 vector was 
provided by Dr A. Hachani from our laboratory.  The hsiB2 gene was amplified and cloned into a 
pET28a vector using primers defined in Table 8, generating a his-tagged version of HsiB2.  Both 
genes were over-expressed in E. coli grown in terrific broth, and corresponding proteins purified 
using nickel affinity and size exclusion chromatography.  Protein purification was performed in the 
lab by Miss E. Manoli, and purified proteins were injected into rabbits for production of a polyclonal 
antibody (Eurogentec).  Both antibodies were shown to specifically detect Hcp2 or HsiB2 when 
tested on whole cell extracts of E. coli overexpressing the corresponding genes and on purified 
protein (data not shown).  
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The production of Hcp2 and HsiB2 was then tested in PA14-DP upon arabinose induction.  The 
western blot presented in Figure 4.7 shows that Hcp2 and HsiB2 are not produced in significant 
amounts in cell extracts from a wild type PA14 culture, and this is not influenced by addition of 
arabinose or glucose to the medium.  However, analysis of cell extracts from PA14-DP cultures 
shows that upon addition of arabinose at concentrations above 0.1% significant production of Hcp2 
and HsiB2 is observed, which is not the case in the absence of arabinose or the presence of glucose.  
This confirms the q-PCR data, and also confirms that arabinose induction of the divergent promoters 
results in tightly controlled production of H2-T6SS proteins.   
 
 
Figure 4.7 Production of HsiB2 and Hcp2 proteins upon arabinose induction  
Western blot analysis of Hcp2 (top) and HsiB2 (bottom) production from whole cell extracts from 
PA14 and PA14-DP derivative.  The strain used is indicated below the blot, while glucose or 
arabinose concentrations are indicated above the blot.  Molecular weight markers are indicated 
to the left of the blot, and expected sizes of Hcp2 and HsiB2 are indicated on the right. 
 
4.4.4 Secretion of Hcp2 
 
An assay often used to demonstrate that the T6SS is active and functional is to follow the 
appearance of Hcp in culture supernatant (Mougous et al., 2006).  Although Hcp is no longer 
considered to be a true secreted effector, but rather a structural component of the T6SS machinery, 
its localisation in the supernatant is a hallmark for a correctly assembled T6SS. 
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To investigate the fate of Hcp2, a secretion assay was performed.  Cells were separated from the 
extracellular medium and subjected to Western blot analysis, the result of which is shown in Figure 
4.8A.  As previously shown, induction of the PA14-DP strain with arabinose results in the production 
of Hcp2.  Analysis of the supernatant fraction indicates that Hcp2 is also located in the extracellular 
medium of PA14-DP cells.  The absence of RNA polymerase in the supernatant indicates that the 
Hcp2 protein in the supernatant is not the result of cell lysis, but likely due to specific secretion.  
 
 
Figure 4.8 Hcp2 is secreted in a H2-T6SS dependent manner  
A. Western blot analysis of whole cell extracts and supernatant from PA14 DP and PA14 DP 
strain carrying a deletion in the H2-T6SS cluster as indicated by the hatched box in the H2-T6SS 
cluster diagram.  Cells were probed with either Hcp2 (top) or RNA polymerase (bottom) 
antibody.  The strain used is indicated above, and the sample type is indicated below the blot.  
Molecular weight standards are indicated to the left of the blot, and the expected sizes of Hcp2 
and RNAP are indicated to the right of the blot. B.  The location of the region deleted to 
generated PA14ΔH2-T6SS is shown in the hatched red box. 
 
 
To further show that the Hcp2 secretion is specific and dependent on the H2-T6SS a strain lacking 
the core H2-T6SS genes was generated.  The DNA region spanning from hsiA2 to mid-clpV2 was 
deleted in the PA14-DP background, yielding PA14-DP ΔH2-T6SS (PA14-DP ΔH2).  However, in this 
strain, the operon encoding Hcp2, VgrG14 and the two downstream gene products was left intact, as 
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shown in Figure 4.8B.  The arabinose-induced production of Hcp2 is unaffected in the PA14-DP ΔH2 
strain, but its secretion is drastically reduced when compared to PA14-DP. Overall, this suggests that 
arabinose induction of the divergent promoters in PA14-DP leads to the correct assembly of a 
functioning H2-T6SS.   
 
4.5 Quorum Sensing and Iron Limitation  
 
Now that we have tools to monitor production of H2-T6SS components, we revisited the impact of 
quorum sensing and iron limitation, which were shown in previous studies to control the expression 
of H2-T6SS genes (Lesic et al., 2009; Sana et al., 2012). PA14 wild type cells were grown in tryptone 
soya broth (TSB) in the presence or absence of 2,2′-bipyridyl (250 μM) to chelate iron, and samples 
were taken at various time points during growth.  Cell lysates were prepared and analysed by 
western blot for the production of Hcp2.   
 
As shown in Figure 4.9, the presence of absence of iron chelators makes no difference to the amount 
of Hcp2 produced.  Bands of weak intensity appear at the expected size of Hcp2 at the stationary 
phase of growth (6h and 7.5h), and the intensity of these bands is not affected by the availability of 
iron.  In contrast, the production of Hcp2 by arabinose induction in PA14-DP is much higher.   
 
In conclusion, iron limitation does not result in significant production of Hcp2 in P. aeruginosa PA14.  
Interestingly, the traces of Hcp2 production from cultures at high cell density suggest that quorum 
sensing may have a visible impact on production of H2-T6SS components such as Hcp2, yet the levels 
of Hcp2 production obtained by the divergent promoter construct in PA14-DP are significantly 
higher. 
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Figure 4.9 Effect of population density and iron limitation on Hcp2 production 
Western blot probing for Hcp2 production in wild type PA14 cultures at various times of growth 
(shown above the blot in hours), with or without bipyridil (shown below the blot).  Molecular 
weight markers are shown (left), and the expected size of Hcp2 is indicated (right).  The PA14-DP 
strain, incubated in the presence of arabinose, is included as a positive control for Hcp2 
production. 
 
 
 
 
4.6 VgrG14: A Putative H2-T6SS Secreted Substrate  
 
4.6.1 P. aeruginosa VgrG proteins 
 
A gene encoding a VgrG protein is encoded directly downstream of the hcp2 gene in P. aeruginosa 
PA14, and is named VgrG14 to recognise its presence in this strain, and absence in PAO1 (Figure 
4.10).  VgrG proteins are usually described as a puncturing device, and are essential for T6SS activity 
(Hachani et al., 2011).  P. aeruginosa encodes multiple copies of vgrG genes which are often found 
scattered on the chromosome in so-called vgrG islands containing few other genes (Barret et al., 
2011).  The distribution of vgrG in the PAO1 genome is shown in Figure 4.11. 
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Figure 4.10 Comparison of the PAO1 and PA14 H2-T6SS 
The H2-T6SS cluster is shown from P. aeruginosa PAO1 (upper) and PA14 (lower).  Genes present 
in the PA14 strain but absent in PAO1 are highlighted in red. 
 
 
 
 
 
Figure 4.11 Distribution of vgrG in PAO1 
Graphical representation of the genomic distribution of the three T6SS genetic clusters (white 
arrows), five hcp genes (yellow arrows) and ten vgrG genes (green arrows) on the genome of P. 
aeruginosa PAO1. 
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The additional vgrG14 gene equips P. aeruginosa PA14 with 11 vgrG genes, while 10 are found in 
PAO1, as listed in Figure 4.12.  These genes encode proteins ranging from 72.0 kDa to 113 kDa (Table 
11).  VgrG proteins are composed of two conserved domains, structurally similar to the 
bacteriophage gp27 and gp5 gene products, fused into a single peptide (Leiman et al., 2009).  In 
addition, variable C termini are often found following the gp5 domain.  The domain organisation of 
the 21 VgrGs from PA14 and PAO1 are shown in Table 11, defined using structural homology 
predicted by the Phyre server (Kelley and Sternberg, 2009).  Approximately 450 residues of the VgrG 
N terminus comprise the gp27-like domain, and the next 200 amino acids comprise the gp5-like 
domain (table 11). 
 
 
 
Figure 4.12 Comparison of VgrG from PAO1 and PA14 
The names of each VgrG protein from PAO1 and the corresponding proteins from PA14 are 
shown, along with their association with a T6SS cluster, or ‘orphan’ if not, and the gene identifier 
of the corresponding hcp gene. 
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VgrG  
Name 
MWt 
(kDa) 
No Amino 
Acids 
gp27 
region  
gp5 
region 
ct length 
PAO1 
VgrG1a 72.0 643 8-447 439-639 4 
VgrG1b 82.7 741 11-451 442-649 92 
VgrG1c 81.7 726 48-488 479-725 1 
VgrG2a 93.6 842  9-451 442-668 174 
VgrG2b 113.0 1019 9-451 442-757 262 
VgrG3 71.9 668 10-433 424-668 0 
VgrG4a 77.0 688 10-457 449-641 47 
VgrG4b 90.6 808 10-457 449-666 142 
VgrG5 76.7 680 10-453 444-648 32 
VgrG6 87.8 790 10-457 449-653 137 
PA14 
VgrG14 75.7 680 10-452 444-651 29 
Table 11 Characteristics of P. aeruginosa VgrG 
The size of each protein in kilodaltons and number of amino acids is indicated.  The start and end 
of regions showing structural homology to the bacteriophage gp27 and gp5 proteins are shown, 
as is the number of amino acids remaining at the c terminus of the protein, following the region 
of gp5 homology (ct length). 
 
In this analysis the C terminal extensions are defined by the end of structural homology to the gp5 
domain, and vary in length. VgrG1a, VgrG1b and VgrG3 terminate at, or soon after, the end of the 
gp5 domain, and have no C terminal extension.  The other VgrG contain extension ranging from 47 
amino acids (VgrG4a) to 262 amino acids for VgrG2b.  As previously described in section 1.7, VgrG C 
terminal extensions may carry a domain with catalytic or toxic activities, exemplified by the actin 
cross linking domain of VgrG from V. cholerae and A. hydrophila (Pukatzki et al., 2007; Suarez et al., 
2010), and the peptidoglycan targeting domain of VgrG3 from V. cholerae (Brooks et al., 2013; Dong 
et al., 2013). To date, no experimentally characterised examples of VgrG with catalytic activity from 
P. aeruginosa has been reported.  VgrG2b has been predicted to have zinc dependent 
metallopeptidase activity due to the presence of a HExxH motif, which is a conserved feature of this 
protein family (Jongeneel et al., 1989; Pukatzki et al., 2007).  No other obvious activity can be 
predicted for the remaining VgrG carrying C terminal extensions.  These shorter extensions may 
alternatively act as adaptor domains allowing interaction of VgrG with other proteins, including the 
recently characterised PAAR domain proteins, allowing VgrG to act as transporter proteins (Shneider 
et al., 2013). 
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Given that the subset of VgrGs found in PAO1 and PA14 differ, the VgrGs found in 13 sequenced 
genomes currently available for comparison at www.pseudomonas.com were analysed.  VgrG 
proteins belong to a cluster of orthologous group (COG) numbered COG3501.  All COG3501 proteins 
from the 13 genomes were identified, yielding 133 proteins.  Each protein was classified by length, 
and compared to the named VgrG from PAO1, and the presence or absence of genes encoding each 
VgrG protein is indicated in Table 12. If comparison of protein length was not sufficient for 
classification, the genetic arrangement of vgrG genes was analysed and compared to PAO1.  This 
search yielded no additional VgrG proteins, and the 11 VgrG found in PA14 is the maximum found in 
any single strain.  Many strains are lacking several VgrGs, for example, P. aeruginosa PA7 has only 7 
VgrGs, lacking VgrG4a, VgrG4b, and VgrG6 compared to PAO1.  Analysis of the genome of P. 
aeruginosa 39016 yielded only 3 VgrG, but due to the draft nature of this genome additional VgrG 
may be uncovered.  The number of VgrG vary in different strains of P. aeruginosa, but since not all 
VgrGs have been characterised it is difficult to understand the significance of this variation. The VgrG 
proteins which have been characterised are described in some depth below 
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vgrG1a + + + + + + + + + + + + - 12 
vgG1b + + + + + + + + + + + - - 11 
vgrG1c + + + + + + + + + + + - - 11 
vgrG2a + + + + + + + + + + + + - 12 
vgrG2b + - + + + + + + + - + + - 10 
vgrG3 + + + + + + + + + + + + + 13 
vgrG4a + + + + + + - + + + + + - 11 
vgrG4b + + - - - + - - + + - - - 5 
vgrG5 + + + + + + + + + + + + + 13 
vgrG6 + + + + + + - + + + + + + 12 
vgrG14 - + - - - + - - + - - - - 3 
TOTAL 10 10 9 9 9 11 7 9 11 9 9 7 3 113 
Table 12 Distribution of vgrG genes across sequenced P. aeruginosa strains. 
Presence (+) or absence (-) of each vgrG gene within P. aeruginosa genomes.  Draft genomes are 
indicated by * and alternative shading.  All proteins belonging to COG3501 group were obtained 
and the gene size and chromosomal locations were compared to classify each VgrG 
corresponding to the PAO1 notation. 
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4.6.2 VgrG subgroups 
 
VgrG1a/b/c 
 
The 11 VgrGs found in P. aeruginosa PA14 are compared in Figure 4.13.  Phylogenetic analysis shows 
that VgrG1a/b/c are closely related to each other (Figure 4.13A), and share around 75% sequence 
identity (Figure 4.13B).  These VgrG have been shown experimentally to be associated with the H1-
T6SS (Hachani et al., 2011).  Hcp1 secretion requires VgrG1a or VgrG1c, but not VgrG1b.  The 
secretion of VgrG1a and VgrG1c is dependent on the H1-T6SS cluster, while VgrG1b is not.  However, 
vgrG1b is co-regulated with vgrG1a, vgrG1c and the whole H1-T6SS gene cluster by the previously 
described RetS cascade.  The vgrG1b gene is located at the same chromosomal location as vgrG1a, 
separated only by three genes (Hachani et al., 2011).  Therefore, VrgG1a/b/c are a closely related, 
and may define a functional subgroup of VgrGs.  The function of the other P. aeruginosa VgrGs have 
not been experimentally studied, and remain unknown. 
 
VgrG14 
 
VgrG14 is phylogenetically distinct from VgrG1a, VgrG1b and VgrG1c (Figure 4.13A) suggesting 
VgrG14 is not associated with the H1-T6SS cluster.  The chromosomal location of the vgrG14 gene, 
adjacent to the H2-T6SS cluster in PA14, strongly suggests its role is connected to this system.  
VgrG14 is most similar to VgrG5 from PAO1, and is closely related to VgrG6, VgrG4a and VgrG4b.  
VgrG14 is 96.62% identical to VgrG5 at the amino acid level, the highest similarity observed between 
any pair of VgrGs (Figure 4.13B).  VgrG14 is also ~70% identical to VgrG4a, VgrG4b and VgrG6, while 
it is only ~30% identical to the remaining VgrGs.  This high similarity could suggest that these five 
VgrGs (4a, 4b, 5, 6 and 14) also represent a functional subgroup, and may all be associated with the 
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H2-T6SS.  This hypothesis is supported by global phylogenetic analysis performed by Barret et al. 
who showed that this subset of VgrG are distributed within a single phylogenetic clade that 
corresponds to a phylogenetic cluster containing the H2-T6SS, and that VgrG4a and VgrG4b are co-
regulated with the H2-T6SS cluster (Barret et al., 2011). Additionally, the recent publication 
describing an H2-T6SS dependent substrate, Tle5, encoded downstream of VgrG4b, provides 
experimental evidence for such a link (Russell et al., 2013).   
A 
 
B 
 
Figure 4.13 Phylogenetic and amino acid sequence comparisons of P. aeruginosa VgrG  
A. Phylogenetic tree of VgrG protein sequences from P. aeruginosa PA14 and PAO1 using 
phylogeny.fr.  A graphical representation of the inferred tree is shown.  The position of the PA14 
specific VgrG14 is indicated by the grey arrow. B. Pairwise comparison of the percentage amino 
acid similarity of the six Hcp proteins from PA14.  Subsets of VgrG showing high sequence 
similarity to each other are boxed in red and highlighted in green. 
PA14 VgrG1a VgrG1b VgrG1c VgrG2a VgrG2b VgrG3 VgrG4a VgrG4b VgrG5 VgrG6 VgrG14
VgrG1a 74.03 74.81 29.24 29.24 32.97 32.19 33.28 32.19 31.57 31.88
VgrG1b 74.03 75.19 25.51 25.64 35.03 30.67 28.34 31.32 28.21 31.03
VgrG1c 74.81 75.19 27.72 27.72 32.49 31.4 31.06 31.47 30.33 31.18
VgrG2a 29.24 25.51 27.72 90.74 26.65 29.36 26.24 31.91 28.61 31.76
VgrG2b 29.24 25.64 27.72 90.74 28.29 29.36 27.23 33.24 29.37 32.65
VgrG3 32.97 35.03 32.49 26.65 28.29 29.79 29.97 30.39 29.94 29.94
VgrG4a 32.19 30.67 31.4 29.36 29.36 29.79 94.33 72.94 64.53 72.94
VgrG4b 33.28 28.34 31.06 26.24 27.23 29.97 94.33 72.21 58.48 72.06
VgrG5 32.19 31.32 31.47 31.91 33.24 30.39 72.94 72.21 69.71 96.62
VgrG6 31.57 28.21 30.33 28.61 29.37 29.94 64.53 58.48 69.71 69.26
VgrG14 31.88 31.03 31.18 31.76 32.65 29.94 72.94 72.06 96.62 69.26
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VgrG2a and VgrG2b 
 
It is currently unclear as to which system VgrG2a and VgrG2b associate; although their similarity 
indicates that they too should belong to a functional-subgroup, since they are over 90% similar to 
each other (figure 4.13B).  VgrG2a was initially thought to be functionally associated to the H2-T6SS, 
since vgrG2a is encoded close to the H2-T6SS cluster.  Due to its high similarity at the protein 
sequence level, vgrG2b was also proposed to be associated with the H2-T6SS cluster. 
 
Preliminary experiments were performed to examine the secretion of VgrG2a and VgrG2b, 
dependent on the H2-T6SS cluster in P. aeruginosa PAO1.  Antibodies were generated against the 
full length VgrG2a protein, and directed against a mix of two specific peptides within VgrG2b 
(QRRFVLKQLDGQTA and YRLEPGKTLKDYNIEQ), and deletion mutants of vgrG2a and vgrG2b were 
generated.  However, production of neither VgrG2a nor VgrG2b could be detected by western blot 
performed on whole cell extracts, while antibodies successfully recognised these proteins when 
overexpressed in E. coli.  VgrG2a and VgrG2b were clearly not produced under the conditions tested, 
and their functional association with the H2-T6SS cluster remains to be confirmed.  
 
4.6.3 Chromosomal tagging of vgrG14 
 
The vgrG14 gene is encoded adjacent to the H2-T6SS cluster, and is likely to have a functional link 
with this system, providing one of the missing core T6SS components.  VgrG14 might still be seen as 
a secreted substrate for the H2-T6SS, similar to VgrG1a/c for the H1-T6SS (Hachani et al., 2011).  
Much like Hcp, the localisation of VgrG proteins in the supernatant in a T6SS dependent manner is a 
characteristic of a functional T6SS (Hachani et al., 2011).  In order to monitor the production and 
secretion of VgrG14, the vgrG14 locus in the PA14-DP strain was genetically manipulated so that the 
VgrG14 protein contained a C terminal V5 epitope and a poly-histidine tag. The V5 tag is an epitope 
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tag found in the P and V proteins of the paramyxovirus SV5 and is composed of a fourteen amino 
acid sequence GKPIPNPLLGLDST (Southern et al., 1991).  Combined with arabinose induction, this 
strategy will allow detection of VgrG14 with commercial antibodies against the V5 or His tag.   
 
 
Figure 4.14 Cloning strategy used for chromosomal tagging of rhs14 
A. The genetic sequence encoding the V5 sequence was amplified from pDEST42, flanked with 
Nhe1 restriction sites, and cloned into the pCR2.1 cloning vector.  B. 500 base pair regions either 
side of the vgrG14 stop codon were amplified and fused by overlap extension, with a Nhe1 site 
incorporated into the overlapping region.  The previously cloned genetic sequence encoding the 
V5 tag was subcloned into the overlapping region, generating the mutator plasmid required for 
mutagenesis.  Subcloning into the pKNG101 suicide vector and subsequence homologous 
recombination resulted in a strain producing a V5 tagged version of the VgrG14 protein. 
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The cloning strategy to introduce the genetic sequence encoding the V5-His tag at the 3’end of the 
vgrG14 gene is outlined in Figure 4.14.  Briefly, a mutator plasmid was generated by amplifying 500 
base pair regions either side of the TGA stop codon of vgrG14, which were fused by overlap 
extension incorporating a suitable restriction site into the overlap region.  The V5-His epitope was 
amplified from the pDEST vector (Invitrogen) and inserted between two regions of homology, in 
frame with vgrG14.  This construct was transferred to the suicide vector pKNG101 and the V5-His tag 
introduced to the required chromosomal location following two events of homologous 
recombination, generating PA14-DP vgrG14-V5. 
 
4.6.4 Production and secretion of VgrG14-V5 
  
 
Figure 4.15 V5-tagged VgrG14 is produced but not secreted 
Western blot analysis of whole cell extracts and supernatant from PA14-DP strain carrying a 
chromosomal tagged version of vgrG14 (PA14 DP vgrG14-v5).  The upper blot is probed with 
anti-Hcp2, the central blot is probed with anti-V5, and the lower blot is probed with anti-RNAP 
antibody.  The molecular weights standards are indicated on the left of each blot, and the 
expected location of each protein indicated on the right.  The type of sample (cells or 
supernatant) is indicated above each set of blots, and the addition of arabinose to the growth 
medium is indicated below. 
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A secretion assay was performed to check for production and secretion of VgrG14-V5.  The PA14-DP 
vgrG14-v5 strain was grown in the presence or absence of arabinose.  Cell extracts and supernatants 
were prepared and analysed by western blot, the result of which is shown in Figure 4.15. 
 
Analysis of the cell fractions show that upon arabinose induction, Hcp2 is produced and its secretion 
has not been affected by the genetic manipulation at the vgrG14 locus.  Analysis of cell extracts with 
an anti-V5 antibody reveals a band, at around 75 kDa, specifically produced upon arabinose 
induction.  The band has the expected size of the VgrG14-V5 protein (75.7 kDa native, 77 kDa with 
tag), which indicates that the chromosomal tagging strategy was successful.  Despite Hcp2 being 
secreted, VgrG14-V5 is not detectable in the supernatant fraction, suggesting it is not secreted.  
Other possibilities are that it is secreted in very low abundance, or that the tag has interfered with 
VgrG14 transport.   
 
 
4.6.5 Localisation of VgrG14 
 
Despite not being located in the supernatant, VgrG14-V5 could potentially be targeted to an 
extracytoplasmic subcellular location as part of T6SS assembly, including the inner or outer 
membranes, or the periplasm.  To investigate this, proteins from whole cell extracts were separated 
into a soluble fraction (containing the cytoplasm and periplasm), and an insoluble fraction 
(containing the total membranes).  Spheroplasts were prepared to recover the periplasmic content.  
Differential solubilisation of the membrane fraction in detergents was performed to isolate inner 
and outer membrane proteins.  The protein content of these various fractions was analysed by SDS-
PAGE and western blotting, and the resultant blots are shown in Figure 4.14.   
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A series of controls was used to confirm that the fractionation experiments were successful, 
including detection of RNA polymerase in the cytoplasm, LasB, an enzyme secreted by the T2SS and 
XcpY, an inner membrane protein of the T2SS.  Antibodies directed against an outer membrane 
located protein were not available at the time of testing.   
 
 
Figure 4.16 Sub cellular fractionation of VgrG14-V5 
Fractionation experiments from PA14 DP cells producing V5 tagged versions of VgrG14.  Cell 
fraction indicated above the blots, and the presence or absence of arabinose is indicated below 
the blots.  Samples are probed with (from top to bottom) anti-V5, anti-RNAP, anti-LasB and anti-
XcpY, the expected locations of which are indicated to the right of the blots.   
 
 
VgrG14-V5 is observed in the soluble fraction and in the spheroplasts.   The data further confirmed 
that VgrG14-V5 is not detected in the supernatant fraction.  It is associated with the spheroplast 
fraction, but not detectible in the periplasmic fraction.  VgrG14-V5 is absent from the membrane 
fractions, and thus mostly is a soluble cytoplasmic protein under the conditions tested.   
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The fact that Hcp2 is secreted suggests that VgrG-dependent membrane puncturing occurs under 
these conditions, since previous work suggests that Hcp secretion is dependent of the puncturing 
activity of the VgrG protein (Hachani et al., 2011), though the membrane puncturing role of VgrG14 
remains to be shown. 
 
4.7 Rhs14: A Putative H2-T6SS Secreted Effector  
 
One of the four genes found in PA14, adjacent to the H2-T6SS gene cluster, is predicted to encode a 
182 kDa protein of the Rhs family. The rhs genes were first described in E. coli K12, originally 
classified as ‘recombination hot spots’ due to the observation of chromosomal rearrangements 
between rhs elements (Lin et al., 1984). However, it is now clear that recombination is not a 
biologically relevant function of rhs genes, and that they encode a family of structurally related 
proteins with diverse activities (Jackson et al., 2009).   
 
4.7.1 Characterisation of Rhs proteins 
 
A comprehensive analysis of enterobacterial rhs genes provides a detailed overview of the structure 
and function of these genes and the proteins they encode (Jackson et al., 2009).  RHS proteins are 
composed of distinct domains as shown in Figure 4.17.  Rhs proteins from enterobacteriaceae 
contain an N terminal domain, a core YD-peptide repeats domain, a highly conserved 61 amino acid 
motif ending in PxxxxDPxGL, and a C-terminal tip of 21 to 168 amino acids (Jackson et al., 2009).  
These C-terminal ‘core extensions’ are highly variable, with GC content and codon bias that differs 
from the sequences encoding the N terminal region, suggesting the insertion of horizontally 
transferred core extension sequences, described further below (Jackson et al., 2009).  A key feature 
of rhs genes is that they are often, but not exclusively, found in the vicinity of vgrG and hcp genes, 
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and thus are potentially linked to the T6SS.  The rhs genes are distributed throughout the β- γ- and δ-
proteobacteria, and more distantly related YD repeat proteins are found in Gram-positive bacteria, 
some fungi and higher metazoans (Jackson et al., 2009). 
 
Figure 4.17 Model of Rhs protein domains 
 A model of a characteristic Rhs protein, as described by (Jackson et al., 2009).  The central core 
domain contains a 61 amino acid hyper-conserved region (red line), and terminates in a 
conserved consensus sequence as shown.  Models were generated using ExPaSy MyDomains 
image creator. 
 
 
4.7.2 RhsT from P. aeruginosa 
  
The role of an Rhs protein from P. aeruginosa PSE9, has been described (Kung et al., 2012).  P. 
aeruginosa PSE9 is a highly virulent clinical strain isolated from a patient with ventilator associated 
pneumonia (Battle et al., 2009).  PSE9 contains genomic islands absent from PAO1, and one such 
island (P. aeruginosa genomic island PAGI-9) encodes for an Rhs protein, named RhsT (Battle et al., 
2009).  RhsT production was not detected in wild type PSE9, but production and secretion was 
confirmed when RhsT was expressed from an arabinose inducible plasmid (Kung et al., 2012). 
Indirect immunofluorescence experiments using fixed, but not permeabilised, cells revealed that 
RhsT is exposed on the bacterial surface, as shown in Figure 4.18A (Kung et al., 2012).   
 
The CCF2 reporter system was used to investigate the translocation of RhsT into eukaryotic cells.  
J774 macrophages were loaded with CCF2, a green fluorogenic substrate, consisting of two 
fluorophores separated by a β-lactam ring.  In the presence of β-lactamase the substrate is cleaved, 
and loss of fluorescence resonance energy transfer results in a change to blue fluorescence 
(Charpentier and Oswald, 2004).  A PSE9 strain was generated that expressed RhsT fused to β-
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lactamase, and was used to show that RhsT is translocated into macrophages as previously 
described (Kung et al., 2012).   
 
 
Figure 4.18 P. aeruginosa PSE9 RhsT is surface localised and causes pulmonary inflammation 
A. Visualisation by indirect immunofluorescence microscopy of RhsT in PSE9ΔrhsT containing the 
empty pHERD vector (upper) or overexpressing rhsT form pRHST (lower).  Bacteria were fixed 
but not permeabilised.  B. Pulmonary inflammation associated with RhsT in a mouse model of 
acute pneumonia.  Hematoxylin and eosin stained mouse lung sections taken at 26h post-
infection with PSE9, PSE9ΔrhsT, PSE9ΔrhsT + RHST or PBS. 
 
  
Histological examination of mouse lung tissue shows marked inflammatory cell infiltrates in mice 
infected with PSE9, while rhsT mutant strains show modest levels of inflammatory infiltrates in 
comparison, as shown in Figure 4.18B.  The impact of RhsT on macrophages is clearly demonstrated 
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by the observation that disruption of rhsT results in a 50% reduction in lactate dehydrogenase 
release compared to infection with wild type PSE9. Pre-treatment with a caspase-1 inhibitor 
abrogated RhsT-dependent cytotoxicity, indicating that killing involved inflammasome signalling 
(Kung et al., 2012).   Mice infected with PSE9 strains lacking rhsT showed increased survival from 
infection, confirming a role for RhsT in pathogenicity.   
 
The mechanism involved in the transport or secretion of RhsT to the cell surface and translocation 
into eukaryotic cells is not known.  RhsT does not possess an N-terminal Tat or Sec signal sequence, 
and secretion by a one-step mechanism is likely (Kung et al., 2012).  One possibility is that RhsT is 
directly injected into host cells by the T6SS, but there is no evidence to support this (Kung et al., 
2012).  Alternatively, RhsT may not be secreted but directly inserted into host cells similar to that 
seen for contact-dependent inhibition proteins, described in the next section (Aoki et al., 2005).   
 
4.7.3 Contact-dependent inhibition  
 
Bacteria are able to successfully outcompete neighbouring bacteria through a mechanism known as 
contact dependent growth inhibition (CDI).  The first example was described in E. coli EC93 which 
inhibits the growth of E. coli K12 strains, a common laboratory strain.  This growth inhibition was 
mediated by CdiAB proteins (Aoki et al., 2005).  cdiA and cdiB encode a two partner secretion 
system, with CdiB forming a β-barrel pore in the outer membrane, allowing CdiA transport.  CdiA is 
predicted to extend from the cell surface and bind to receptors on target bacteria, as shown in 
Figure 4.19.  Upon contact the C terminal domain appears to be cleaved and translocated into target 
cells, but the precise mechanism is not known.  Expression of the CdiA-Ct inside E. coli K-12 cells 
results in dissipation of the proton motive force, indicative of pore formation in the inner membrane 
(Aoki et al., 2009).  It has been shown that CdiA recognises and binds to the BamA outer membrane 
protein on target cells, since E. coli K12 strains lacking bamA are resistant to CdiA mediated killing 
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(Aoki et al., 2008).  Self-toxicity is avoided due to the presence of a third protein, CdiI, which 
provides specific immunity by binding to CdiA (Aoki et al., 2005).  CdiI contains two predicted 
transmembrane domains, and its localisation to the inner membrane may inhibit the toxic activity of 
CdiA.  The presence of the cdiABI locus thus confers a competitive advantage over cdi negative E. coli 
strains. 
 
 
Figure 4.19 Contact dependent growth inhibition  
Contact dependent inhibition (CDI) in E. coli.  CDI
+
 cells (centre) express cdiBAI gene clusters and 
present CdiB/CdiA on the cell surface.  CdiA binds to receptors on neighbouring cells and delivers 
a toxin derived from its C terminus, which inhibits the growth of CDI
-
 cells.  Isogenic CDI
+
 cells are 
protected from toxicity by cognate immunity proteins.  Reproduced from (Ruhe et al., 2013) with 
permission. 
 
Similar to rhs genes, cdi genes are found in many different bacteria, with variation between different 
strains of a given species (Aoki et al., 2010).  While the N termini of CdiA homologues share 
sequence identity, their C termini, demarcated by a VENN peptide motif, vary greatly, similar to that 
already described for the highly variable C terminal (Ct) tips of Rhs proteins (Aoki et al., 2010).  The 
Ct tips of CdiA proteins can be exchanged between CdiA homologues from different organisms 
without loss of activity of the toxin domain, suggesting that CdiAs are modular and capable of 
delivering different CdiA-Ct toxins (Poole et al., 2011).    
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The large sequence diversity of CdiA-Ct suggests a broad range of toxin activity, and several have 
been predicted bioinformatically.  These include domains similar to colicins, predicted to have 
activity similar to their homologous protein (Aoki et al., 2010).  CDI toxins have also been predicted 
to be nucleases, adenosine deaminases, ADP-ribosyl cyclases and metallopeptidases (Iyer et al., 
2011; Zhang et al., 2012; Zhang et al., 2011).   
 
CdiABI loci often contain DNA fragments containing additional cdIA-ct/cdiI pairs, known as orphan 
modules, which lack the gene region encoding the N terminal part of the CdiA protein (Poole et al., 
2011).  These orphan CdiA-Ct lack secretion signals or TPS secretion domains, and are likely not 
transported.  They also lack translational initiation signals suggesting that they are not synthesised.  
In contrast, it has been shown that orphan CdiI proteins are fully functional, and may persist to 
confer immunity to multiple CDI toxins (Poole et al., 2011).  Expression of orphan CdiA-Ct in E. coli 
leads to toxicity, indicating that the activity of these toxins is conserved.  Their presence may 
indicate alternative reserve toxin domains, with orphan modules being fused to cdiA by homologous 
recombination, resulting in a CdiA protein with an alternative toxic activity and confer a competitive 
advantage to that bacterium (Poole et al., 2011).    
 
A remarkable observation is that CDI-associated toxin domains are also found in members of the 
Rhs/YD repeat family, indicating a tight link between these two systems, and cognate immunity 
genes are also associated with rhs genes.  The repertoire of toxin-immunity proteins are shared by 
both CDI and Rhs systems, suggesting that Rhs proteins also mediate bacterial competition.   rhs loci  
also encode orphan rhs-ct/rhsI modules and are likely capable of toxin exchange by homologous 
recombination (Poole et al., 2011).  A clear difference between CDI and Rhs systems is that rhs loci 
lack the gene encoding the CdiB transporter of the two-partner system, suggesting distinct methods 
of delivery of Rhs toxins.  
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4.7.4 Connecting bacterial targeting, Rhs proteins and the T6SS 
 
An example of Rhs mediated toxicity towards bacteria, in the absence of a two-partner delivery 
system, has recently been shown in the plant pathogen Dickeya dadantii 3937 (Koskiniemi et al., 
2013; Poole et al., 2011).  Three rhs genes are encoded by this organism, and two of these inhibit the 
growth of neighbouring bacterial cells.  Strains in which rhsA and its cognate immunity genes were 
deleted exhibited sensitivity to wild type D. dadantii during co-culture on solid media, as did strains 
lacking rhsB and its cognate immunity gene, suggesting that both RhsA and RhsB are involved in 
intercellular competition (Koskiniemi et al., 2013).  Reintroduction of the cognate immunity genes 
protected target cells from growth inhibition, confirming that RhsA and RhsB toxicity is neutralised 
by cognate immunity proteins.   Separation of competing strains by a membrane allowing only 
secreted substances, but not whole bacterial cells, to pass, abrogated the Rhs mediated toxicity, 
indicating that this was a contact dependent process (Koskiniemi et al., 2013).   
 
The C termini of RhsA and RhsB show homology to endonucleases, suggesting a mechanism for the 
observed cytotoxicity.  The C terminus of RhsA carries a NS_2 family endonucleases (PF13930), and 
the C terminus of RhsB contains a HNH endonuclease motif (PF01844) (Koskiniemi et al., 2013).  To 
confirm nuclease activity, the predicted toxins were expressed inside E. coli strains stained with 
DAPI, allowing visualisation of DNA by microscopy.  The resulting images are shown in Figure 4.20.  
Target cells, in which either RhsA or RhsB and their cognate immunity proteins had been deleted 
were labelled with GFP, and incubated with unlabelled rhs+ prey cells. DAPI staining showed that 40-
50% of target cells lost DNA after 12 hours of culture with prey cells, confirming that RhsA and RhsB 
mediate toxicity by targeting DNA.  Expression of the cognate immunity protein within the target cell 
prevented the observed DNA loss.  
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Figure 4.20  RhsA and RhsB from D. dadantii degrade the DNA of susceptible neighbouring cells 
Fluorescence microscopy of D. dadantii 3937 cocultures. Inhibitors expressing RhsA 
(rhsA
+
/∆rhsB) or RhsB (∆rhsA/rhsB
+
) were cocultured at a 1:1 ratio with GFP-labelled target cells 
lacking both rhsAIA and rhsBIB loci. Targets were complemented with either rhsIA or rhsIB where 
indicated. Samples from 0 and 12 h were stained with DAPI to visualize genomic DNA. Anucleate 
target cells are indicated by white arrows.  Reproduced from (Koskiniemi et al., 2013) 
 
 
Rhs proteins and T6SS are possibly linked since delivery of RhsA and RhsB from D. dadantii was 
shown to be dependent on vgrG genes.  Briefly, RhsA and RhsB lack recognisable signal sequences.  
However, these Rhs are encoded in the vicinity of hcp and vgrG genes, connecting them to a T6SS-
related function.  Deletion of both vgrGa and vgrGb, adjacent to rhsA and rhsB respectively, 
abrogated Rhs mediated toxicity (Koskiniemi et al., 2013).    Deletion of vgrGb alone had no effect, 
and the toxicity was restored when vgrGb alone was reintroduced to the double mutant, indicating 
that either VgrGa or VgrGb is required for Rhs mediated toxicity in D. dadantii.  This strongly 
suggests that RhsA and RhsB are exported using a T6SS mechanism (Koskiniemi et al., 2013).  
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4.7.5 Rhs14: A putative P. aeruginosa Rhs toxin 
 
Considering the connection between D. dadantii Rhs proteins and VgrG, and the location of the 
rhs14 open reading frame in a vgrG cluster; it is tempting to propose that Rhs14 from P. aeruginosa 
PA14 might be a virulence factor and a putative secreted effector of the H2-T6SS, next to which it is 
encoded.   Rhs14 was further characterised by comparison to known Rhs proteins. 
 
Rhs14 is a characteristic Rhs family protein, containing similar domain architecture to the 
characterised Rhs proteins shown in Figure 4.21.  The Rhs14 core domain terminates with 
PTGWVDPLGL, conforming to the PxxxxDPxGL motif.  This motif defines an Rhs14 C terminus tip of 
169 amino acids, predicted to have toxic activity, similar to characterised C terminal tips.  No 
putative conserved domains are recognisable within this region (NCBI pBLAST), and no significant 
structural homology is predicted using a PHYRE search (Kelley and Sternberg, 2009).   
 
Studies of an ABC toxin complex from Yersinia entomophaga have provided a remarkable insight 
into the structure of Rhs proteins (Busby et al., 2013).  ABC toxins have been shown to have potent 
insecticidal activity (Bowen et al., 1998), and are composed of three proteins, A, B and C.  The C 
terminus of the C protein is responsible for cytotoxicity (Lang et al., 2010). A model is proposed 
where A binds to the surface of target cells, is endocytosed, and forms a transmembrane channel 
allowing the translocation of the C protein into the cytoplasm, leading to target cell disruption (Lang 
et al., 2010).   
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Figure 4.21 Rhs14 domain architecture  
Model of P. aeruginosa PA14 Rhs14 and the three examples described in the text (P. aeruginosa 
PSE9 RhsT, and Dickeya dadantii 3937 RhsA and RhsB).  The number of amino acids defining each 
domain is shown below each model.  N terminal domains shown in orange, core domains in 
green and C terminal domains in blue.  The sequence of the PxxxxDPxGL motif defining the end 
of the core domain is indicated for each protein.  Accession numbers are shown in brackets. 
Protein length is not to scale. 
 
 
The structure of a complex composed of the BC proteins from Yersinia entomophaga was recently 
reported, and shows an unprecedented large hollow structure, as shown in Figure 4.22A (Busby et 
al., 2013).  The structure is said to resemble the shell of an egg, and has a large hollow central cavity, 
closed at both ends.  It is proposed that this encapsulation device sequesters the cytotoxic C 
terminal region of the C protein, preventing self-cytotoxicity prior to delivery.  An important 
observation is that the C protein contains Rhs repeats as found in Rhs proteins, and the work by 
Busby et al. (2013) presents the first structural example of a protein containing such repeats.  The 
observed architecture is likely conserved across Rhs and YD-repeat containing proteins (Busby et al., 
2013). 
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Figure 4.22 Structural predictions for the Rhs14 core domain  
The Rhs14 core domain is predicted to adopt a structure homologous to the Yersinia 
entomophaga BC toxin RHS core. A. Side view of the B-C
NTR
 complex of the BC toxin from Y. 
entomophaga.  Components of the B proteins are coloured in red purple or green.  The CNTR 
region is coloured blue and the conserved RHS-associated core domain is cyan.  Image 
reproduced from (Busby et al., 2013) with permission from Nature publishing group. B. structural 
predictions of the Rhs14 core domain, showing 100% structural homology to the region of the Y. 
entomophaga BC toxin coloured in blue and cyan.  The Rhs14 model is rainbow coloured, with 
the blue section representing the N terminus and the red section representing the C terminus of 
the RHS core.  The C terminal of Rhs14 would continue from the red region, and would be 
located centrally.  The left image is looking from the top down, and is rotated 90 degrees to 
produce a side view (right).  Protein structural predictions were made using the PHYRE server 
(Kelley and Sternberg, 2009)and images generated using PYMOL education build.  
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The protein sequence of Rhs14 was uploaded to the Phyre server to predict structural homologies 
(Kelley and Sternberg, 2009).  The results show a strong similarity between the Rhs core region of 
Rhs14 and the structure reported by Busby et al, as shown in Figure 4.22B.  Homology was predicted 
for 38% of the Rhs14 sequence (619 amino acids), corresponding to the central Rhs core.  Structural 
homologies were not found for the N terminal and C terminal regions.  The structure of the Rhs14 
core was modelled on C terminal region of the Y. entomophaga C protein with 100% confidence, 
indicating that these two proteins are structural homologues.  It is very likely therefore that these 
proteins are also functional homologous, and the core of Rhs14 is important in the encapsulation 
and delivery of a proposed C terminal Rhs14 tip.   
 
4.7.6 Production and localisation of Rhs14 
 
Based on the above suggestion that Rhs14 may be a T6SS effector, a similar strategy was employed 
to investigate the production and secretion of Rhs14 as to that used for VgrG14.  PA14-DP strain was 
genetically engineered so that the Rhs14 protein contained a C terminal V5 epitope and poly-
histidine tag to allow its detection, in a similar way to that shown for VgrG14-V5, yielding the PA14-
DP rhs14-V5 strain.  
 
The production and secretion of Rhs14-V5 was investigated and the resulting Western blot is shown 
in Figure 4.23.  Hcp2 production and secretion is observed upon arabinose induction, and is not 
influenced by the genetic manipulation of rhs14.  A band corresponding to the size of Rhs14-V5 (182 
kDa) is observed in samples probed with the anti-V5 antibody suggesting that the chromosomal 
tagging strategy was successful.  However, Rhs14 cannot be detected in the supernatant fraction, as 
was the case for VgrG14-V5. 
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Figure 4.23 V5 tagged Rhs14 is produced but not secreted 
Western blot analysis of whole cell extracts and supernatant from PA14-DP strain carrying a 
chromosomal tagged version of rhs14 (PA14 DP rhs14-v5).  The upper blot is probed with anti-
Hcp2, the central blot is probed with anti-V5, and the lower blot is probed with anti-RNAP 
antibody.  The molecular weights standards are indicated on the left of each blot, and the 
expected location of each protein indicated on the right.  The type of sample (cells or 
supernatant) is indicated above each set of blots, and the addition of arabinose to the growth 
medium is indicated below. 
 
 
The previously described RhsT protein is surface localised (Kung et al., 2012), therefore it was 
proposed that Rhs14 may also be located at the cell surface and not secreted.  A fractionation 
experiment was performed to investigate the subcellular location of Rhs14-V5.  The resulting 
western blots shown in Figure 4.24 indicate that the subcellular localisation of Rhs14-V5 is similar to 
that observed for VgrG14-V5, only clearly detectible in the cytoplasmic fraction.  Rhs14-V5 does not 
co-localise with membrane fractions as would be expected for a surface associated protein, as 
previously shown for RhsT (Kung et al., 2012).   
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Figure 4.24 Sub cellular fractionation of Rhs14-V5 
Fractionation experiments from PA14 DP cells producing V5 tagged versions of Rhs14.  Cell 
fraction indicated above the blots, and the presence or absence of arabinose is indicated below 
the blots.  Samples are probed with (from top to bottom) anti-V5, anti-RNAP, anti-LasB and anti-
XcpY, the expected locations of which are indicated to the right of the blots.   
 
 
 
4.7.7 Rhs14 transfection 
 
Preliminary experiments have been performed in our laboratory by Dr A. Hachani, investigating the 
activity of Rhs14 when expressed ectopically in HeLa cells (data not shown).  Full length rhs14 was 
cloned into the pRK5 mammalian expression vector to allow production in HeLa cells.  HeLa cells 
transfected with the pRK5-rhs14 vector were cultured on microscope slides for 24 hours, allowing 
constitutive expression of Rhs14.  Rhs14 is proposed to be highly toxic under these conditions, since 
its expression resulted in the death of HeLa cells, with no viable cells visible by microscopy.  Cells 
expressing non-related proteins showed healthy growth under the same conditions.  These 
observations suggest that Rhs14 may possess eukaryotic cell targeted toxicity, and additional 
experiments to confirm this observation and subsequently characterise the mechanism of toxicity 
are required.  
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4.7.8 Putative Rhs14 immunity protein 
 
A characteristic of contact dependent inhibition and Rhs C-terminal toxic domains is the association 
of a cognate anti-toxin, which prevents self-intoxication, or intoxication by neighbouring cells.  If 
Rhs14 exhibits toxic activity it would also be expected to be associated with a specific immunity 
protein.  The annotated genome sequence of P. aeruginosa PA14 at pseudomonas.com does not 
show an open reading frame downstream of rhs14, where an 800 base pair region of un-annotated 
DNA is found.  This region was analysed by ORF Finder (NCBI) and found to contain a predicted 435 
base pairs open reading frame.  The DNA and protein sequences of this proposed orf are shown in 
Figure 4.25.  Translation of this sequence yields a 16.5 kDa protein that we propose to be a specific 
immunity protein for Rhs14.  No putative conserved domains are encoded within this protein (NCBI 
pBLAST), and no significant structural homology is predicted using a PHYRE search (Kelley and 
Sternberg, 2009), which is not surprising given the diverse nature of immunity proteins.  Further 
experiments to confirm these observations are currently underway in the laboratory.  
 
Figure 4.25 Putative Rhs14 immunity protein  
Genetic sequence of the region downstream of the rhs14 stop codon on the PA14 chromosome.  
The open reading frame predicted to encode a Rhs14 immunity protein is highlighted in yellow, 
and the translated protein sequence is highlighted in cyan. 
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4.7.9 Proteins encoded by genes adjacent to rhs14 
 
In addition to hcp2, vgrG14 and rhs14, another gene is encoded within this cluster linked with the 
PA14 H2-T6SS genes.  This gene is located between vgrG14 and rhs14, and is annotated as 
PA14_43090.  The protein encoded by this open reading frame contains a predicted domain of 
unknown function (DUF4123/PF13503), but the role of this protein and its involvement in the T6SS is 
not known. There are no predicted transmembrane domains (TMPred server) or secretion signals 
(Signal P) within this protein. 
 
Analysis of the PF13503 family shows that homologs are found in V. cholerae, encoded by VCA0019 
and VC1417.  Interestingly,  VCA0019 and VC1417 are found within V. cholerae T6SS cluster, 
upstream of genes encoding two characterised T6SS toxins, vasX and tseL, respectively, and 
downstream of a vgrG in each case, as indicated by Figure 4.26.    Although the precise role of the 
protein encoded by PA14_43090 is not known, it is clearly conserved in diverse T6SS clusters, and 
can be proposed to have a central role in the system.  The fact that in each case this gene is encoded 
between a vgrG and a toxin gene suggests that the gene product may interact with one or both VgrG 
and the toxin, and therefore may be required for their delivery to target cells.   
 
Figure 4.26 Location of PF13504/DUF4123 proteins in vgrG islands 
The presence of genes encoding proteins with PF13503/DUF4123 domains within vgrG islands is 
shown in blue.  Top: vgrG-1 island form V. cholerae, middle: vgrG-2island from V. cholerae, 
bottom: the vgrG14 island from P. aeruginosa PA14. 
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4.8 Post-translational regulation of the H2-T6SS 
 
The fact that we were not able to observe VgrG14 or Rhs14 secretion, whereas we expect the H2-
T6SS to be assembled because of Hcp2 secretion, led us to consider that the system may not be fully 
active.  As described in section 1.7.5 several T6SS clusters encode for kinase/phosphatase pairs 
important in post-translational control of the secretion mechanism, and we investigated whether 
post-translational regulation of the H2-T6SS might play a role in Rhs14 or VgrG14 secretion.  
 
Briefly, a previous study of the H1-T6SS showed that manipulation of the kinase/phosphatase system 
could activate secretion (Mougous et al., 2007).  The H1-T6SS cluster encodes a serine/threonine 
kinase (PpkA) and a serine/threonine phosphatase (PppA).  The target of these two proteins is the 
FHA domain containing protein, Fha1.  Under conditions where the H1-T6SS was active (in a retS 
mutant) Mougous and colleagues showed that deletion of the kinase abrogated Hcp1 secretion due 
to a decrease in phosphorylated Fha1.  Deletion of the phosphatase increased Hcp1 secretion, due 
to an increase in stable phosphorylated Fha1. (Mougous et al., 2007).  
 
A similar post-translational regulation may occur in the H2-T6SS, since conserved kinase genes 
(stk2), phosphatase (stp2) and fha2 are encoded within the cluster.  To investigate the effect of post-
translational regulation on the activity of the H2-T6SS the gene encoding the phosphatase, stp2, was 
deleted from the chromosome of both PA14-DP vgrG14-v5 and PA14-DP rhs14-v5 strains.  The 
deletion of stp2 should favour Fha2 phosphorylation and therefore the activity of the H2-T6SS.  
Secretion of each putative substrate was re-evaluated in this background, and the resulting western 
blots are shown in Figure 4.27.   
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The stp2 deletion does not affect arabinose induced VgrG14-V5 production, but also does not 
promote secretion since VgrG14-V5 is not detectible in the supernatant of this strain (Figure 4.27A).  
A similar result is seen for Rhs14-V5 (Figure 4.27B), which is not secreted even following deletion of 
stp2.  Despite using various approaches, we were not able to demonstrate the secretion of VgrG14-
V5 or Rhs14-V5 in this study.  However, based on the hypothesis that VgrG14, if similar to other 
VgrGs, should be recovered from the supernatant, it is still an open possibility that Rhs14 may be a 
true H2-T6SS substrate, and the addition of the tag may interfere with recognition by the H2-T6SS. 
  
Figure 4.27 Secretion of VgrG14-V5 and Rhs14-V5 in an stp2 mutant 
Western blot analysis of whole cell extracts (Cells) and supernatants (SN) from PA14-DPΔstp2 
strain encoding a chromosomal tagged version of either vgrG14(A) or rhs14(B). In both cases, the 
upper blot is probed with anti-V5, the central blot with anti-RNAP (cytoplasmic control), and the 
lower blot is probed with anti-LasB antibody (a T2SS dependent secreted protein). The expected 
position of each protein is indicated on the right.  The sample type (cells or supernatant), and the 
absence (-) or presence (+) of arabinose is indicated above each set of blots. 
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4.9 A role for H2-T6SS: Bacterial Killing 
 
The H1-T6SS is involved in the delivery of toxins and killing of target bacterial cells (Hood et al., 
2010).  Monitoring bacterial killing has subsequently become a way of monitoring the activity of 
T6SS, and for investigating the mechanism of the machinery (Hachani et al., 2013).  A recent 
publication has implicated the H2-T6SS in bacterial killing through the discovery of a H2-T6SS 
dependent toxin, Tle5, in P. aeruginosa PAO1, shown to be a toxin lethal to susceptible P. aeruginosa 
strains (Russell et al., 2013). The E. coli killing assay developed in our laboratory was therefore used 
to investigate the role of the P. aeruginosa PA14 H2-T6SS in bacterial killing. 
 
An assay was set up to investigate the survival of E. coli cells in contact with wild type PA14, or a 
PA14 strain in which the H2-T6SS cluster, from hsiA2 to clpV2, was deleted, generating PA14 ΔH2.  
As previously described, the E. coli strain carries the pCR2.1 vector, allowing alpha complementation 
of the lacZ gene, allowing it to be detected on X-gal agar plates by visualising the blue colour of the 
colony (Hachani et al., 2013).   
 
The results of this experiment is shown in Figure 4.28.  In figure 4.28A, the top row of images shows 
X-gal plates inoculated with serial dilutions of monocultures of each strain used in the assay.  The 
two P. aeruginosa strains do not generate the blue colour since they lack the lacZ gene, while the E. 
coli carrying the pCR2.1 is viable and develops a strong blue colony.  The lower images show strains 
recovered from mix culture competition assay where each P. aeruginosa strain was incubated with 
the E. coli reporter strain.  In both cases no blue colour is observed following the competition assay, 
that is upon mixing E. coli and P. aeruginosa, and colonies show a similar colour to the P. aeruginosa 
monocultures.  This suggests that E. coli is not recovered when incubated with P. aeruginosa PA14, 
and this phenotype is not associated with the H2-T6SS, since deletion of the cluster has absolutely 
no effect on the survival of E. coli.   
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Figure 4.28 P. aeruginosa PA14 outcompetes E. coli in a H2-T6SS independent manner 
A. Top row shows monoculture strains used in this assay, incubated for 5h on LB plates, 
resuspended, and subsequently plated onto LB X-gal plates in triplicate in a serial dilution from 
10
0
 to 10
-3
.  Second row shows the resulting colony growth from mixed cultures of two strains, as 
indicated, which were co-incubated for 5h on LB plates and subsequently plated as described 
onto LB X-gal plates.  B. A typical result from a bacterial competition assay showing survival of E. 
coli pCR2.1 incubated with wild type PAK, and loss of the E. coli population following co-
incubation with a retS mutant. 
 
This result is different to that previously reported for a different P. aeruginosa strain, since E. coli is 
reported to survive competition with P. aeruginosa PAK, and is only susceptible to killing when the 
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H1-T6SS is activated by retS deletion, as shown in Figure 4.28B (Hachani et al., 2013).  Under the 
conditions used for this assay PA14 is likely to produce another toxic compound, such as pyocyanin, 
which is sufficient to outcompete E. coli, and therefore will mask any impact of the T6SS.   
 
4.10 A role for H2-T6SS: Bacterial Internalisation   
 
Although recent suggestions that the H2-T6SS is involved in bacterial killing, two publications have 
previously reported that this system is important in P. aeruginosa pathogenesis, and interaction with 
eukaryotic cells, as described in section 4.1.  The work by Lesic and colleagues provided indirect 
evidence that the H2-T6SS cluster from P. aeruginosa PA14 was involved in virulence in different 
infection models, but did not identify any secreted effectors associated with the process (Lesic et al., 
2009).  Similarly, Sana et al. showed a direct effect of the H2-T6SS system on internalisation of P. 
aeruginosa PAO1 into HeLa cells (Sana et al., 2012), but also no effectors were identified as being 
responsible for such a phenotype.  Here we performed experiments to investigate the role of the 
PA14 H2-T6SS in cytotoxicity and internalisation of PA14.  All tissue culture work described in this 
section was carried out in collaboration with Dr A. Hachani. 
 
4.10.1 Generation of a non-cytotoxic PA14 strain 
 
As described in section 1.6, PA14 is highly cytotoxic due to the secretion of the T3SS effector ExoU, a 
potent phospholipase encoded in the pathogenicity island PAPI-1, that causes rapid host cell lysis 
(Sato et al., 2003; Schulert et al., 2003). A prerequisite to testing the internalisation of P. aeruginosa 
PA14 was thus to engineer a non-cytotoxic strain.  Previous studies have indicated that disruption of 
the pscC gene, which encodes the T3SS outer membrane secretin, is sufficient to abrogate the T3SS 
mediated cytotoxicity of P. aeruginosa PA14 (Mikkelsen et al., 2011a; Urbanowski et al., 2007). A 
strategy was designed to generate a clean deletion of pscC, yielding PA14ΔpscC.   
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Figure 4.29 Secretion profile and cytotoxicity of a PA14 pscC mutant 
A. T3SS secretion profile in supernatants of wild type PA14, a clean pscC deletion mutant, and a 
PA14::pscC transposon mutant, as indicated above the blots.  Blots are probed with anti-RNAP 
(upper) or anti-PcrV (lower), with the expected position of each protein indicated on the right, 
and molecular weight markers shown on the left.  The presence or absence (+/-) of calcium 
chelation used to induce the T3SS is indicated below the blots.  A whole cell extract of a calcium 
chelated PAK culture is included as a positive control for RNAP production (*).  B. Cytotoxicity 
assay measuring lactate dehydrogenase release from RAW macrophages infected with strains 
indicated below the chart at an MOI of 10 during a 3h infection.  Percentage of cytotoxicity is 
shown on the vertical axis.  Error bars show standard deviation. 
 
The T3SS phenotype of PA14 ΔpscC was tested by isolating supernatants from this strain, and 
comparing with the transposon mutant from the Ausbel collection, PA14::pscC (Liberati et al., 2006), 
and the wild type PA14 strain.  Secretion of PcrV, the tip of the T3SS needle, was used as a reporter 
to monitor T3SS activity. The resulting western blot using anti-PcrV is shown in Figure 4.29A, and 
indicates that PcrV is not detected in the supernatant of the PA14 wild type strain.   Calcium 
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chelation is a known trigger for the in-vitro activation of the T3SS, and upon addition of 5 mM EGTA 
to the growth medium a strong induction of PcrV secretion is then observed in wild type PA14.  This 
effect is abrogated in both the PA14::pscC transposon mutant and the clean deletion of PA14ΔpscC 
strain, although there may be a background level of PcrV secretion in the transposon strain that is 
absent in the clean deletion.  For this reason, we use both strains for further investigations.    
 
The cytotoxicity phenotype of the pscC mutants was tested by measuring lactate dehydrogenase 
release from RAW macrophages.  The result of this assay can be seen in Figure 4.29B.  The PA14 wild 
type strain is highly cytotoxic, causing 75% LDH release, whereas disruption of pscC by transposon 
insertion or clean deletion totally abrogates this cytotoxicity, confirming that both mutants are T3SS-
deficient and that the cytotoxicity of the PA14 strain is entirely mediated by the T3SS.  Now that we 
have a non-cytotoxic PA14 strain available, the role of the H2-T6SS in internalisation can be studied. 
 
4.10.2 Internalisation of PA14 
 
Internalisation into eukaryotic cells is an alternative strategy of infection to cytotoxicity, allowing 
cells to survive within the nutrient-rich protective environment of host cells, subverting host cell 
processes to prevent their eradication or evading the host immune system.  As described before, the 
H2-T6SS has been reported to be partly involved in the process since internalisation of a PAO1 
ΔclpV2 mutant into HeLa cells was shown to 75% lower than the wild type strain.  This suggested 
that in this strain the H2-T6SS acts to promote internalisation (Sana et al., 2012).   
 
Similar gentamycin protection assays were performed to confirm the phenotype observed by Sana 
et al. as shown in Figure 4.30A.  The PAO1 ΔclpV2 strain shows lower levels of internalisation than 
the parental PAO1 strain, confirming that the H2-T6SS cluster of P. aeruginosa PAO1 promotes the 
internalisation. 
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Internalisation in HeLa cells was then measured with the P. aeruginosa PA14ΔpscC strain, and a 
newly generated double mutant, PA14ΔpscCΔH2, in which the H2-T6SS cluster is deleted in the pscC 
background.  Surprisingly, when the H2-T6SS is disrupted, internalisation is increased around 4-fold, 
which is clearly is different to what is observed in the PAO1 strain, and suggests that in PA14 the H2-
T6SS acts to limit internalisation, and not to promote it (Figure 4.30B).   
 
The internalisation phenotype of the H2-T6SS was also tested in the PA14-DP background to 
investigate the effect of artificial activation of the system on internalisation.  The pscC mutation was 
introduced into PA14-DP, generating PA14-DPΔpscC.  The levels of internalisation of the PA14-DP 
ΔpscC mutant was equivalent to PA14ΔpscCΔH2 (Figure 4.30B).  This suggests that in the original 
PA14 strain the H2-T6SS may be activated upon contact with HeLa cells, and thus a phenotype can 
be observed when comparing the H2-T6SS mutant with the parental strain.  In the PA14-DPΔpscC 
strain the H2-T6SS promoter is disrupted, and expression of the H2-T6 SS genes may no longer 
respond to HeLa cell contact, hence this strain behaves like a H2-T6SS mutant, and display increased 
internalisation compared to PA14Δpsc.  Upon addition of arabinose to the PA14-DP ΔpscC strain, the 
level of internalisation drops to levels similar to the PA14ΔpscC strain.  This indicates that artificial 
activation of H2-T6SS by arabinose induction results in H2-T6SS activation and mediates prevention 
of internalisation in HeLa cells, just like the PA14ΔpscC strain. 
 
The opposite effects on internalisation observed between PAO1 and PA14 are interesting, and 
suggest that the H2-T6SS system performs different roles in these two strains.  As described in 
section 4.3, the presence of genes encoding putative effector proteins VgrG14 and Rhs14 in the 
PA14 cluster may be responsible for this difference, which will need further investigation.   
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Figure 4.30 The H2-T6SS of PA14 inhibits bacterial internalisation in HeLa cells 
A.  Relative internalisation in HeLa cells of an isogenic mutant PAO1ΔclpV2 compared to its 
parental strain PAO1. (B) Relative internalisation of PA14ΔpscCΔH2-T6SS double mutant, and the 
PA14-DPΔpscC strain (carrying an inducible H2-T6SS), incubated with (+ara) and without 
arabinose is shown compared to the parental strain PA14ΔpscC. In all cases the internalisation of 
the isogenic mutants is shown relative to the invasion level exhibited by the corresponding 
parental strain (normalised to 1.0). The strain tested is indicated below each bar. Error bars show 
standard deviation of three replicates, and the results shown are representative of three 
different experiments. * indicates a statistically significant difference compared to the 
corresponding parental strain (Student’s T-test, P<0.001). 
 
4.11 Discussion 
 
This chapter presents a study investigating the activation and function of the second Type VI 
secretion system (H2-T6SS) from P. aeruginosa PA14, and highlights an important feature of this 
strain; the presence of four additional genes associated with this cluster. This feature is striking, 
since it includes genes encoding Hcp and VgrG proteins, which are missing in the H2-T6SS of PAO1.  
The absence of core components from the PAO1 H2-T6SS challenged our concept of how this system 
was working and which were the true core components. An additional feature specific to the PA14 
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strain is the presence of a gene, which encodes a member of the Rhs protein family, for which recent 
studies have shown might be a genuine effector for the T6SS.  In this work, the H2-T6SS is genetically 
engineered by the introduction of arabinose inducible promoters allowing simultaneous activation 
of both gene clusters and a tight and full control on the expression of these genes.  This has 
successfully allowed the study of the H2-T6SS under standard bacterial culture conditions, and is 
comparable to what was achieved in other studies with Citrobacter rodenitum, for example 
(Gueguen and Cascales, 2013). Furthermore, this work represents the first study of the H2-T6SS at 
the protein level and investigating production and secretion of H2-T6SS-related proteins. 
 
4.11.1 Hcp2 and VgrG14 Secretion 
 
Hcp is a core functional component of the T6SS machinery, and its localisation in the supernatant is 
considered a hallmark of a functioning T6SS.  Hcp secretion was a key phenotype in the early 
characterisation of the T6SS in both P. aeruginosa and V. cholerae (Mougous et al., 2006; Pukatzki et 
al., 2006).  We demonstrate using our engineered strain that upon arabinose induction Hcp2 
secretion is observed, and is dependent on the H2-T6SS cluster.  This indicates that in these 
conditions H2-T6SS assembles into a functional secretion machinery, and confirms a link between 
the two adjacent gene clusters.  Since previous studies on this system have been exclusively 
performed at the transcriptional level, this is the first report of production and assembly of the H2-
T6SS at the protein level.   
 
The Hcp tube is proposed to be topped by VgrG proteins, which puncture the cell membranes, 
allowing both Hcp and VgrG to be propelled from the cell into the supernatant.  An obvious 
hypothesis was that VgrG14 has such a role and should provide Hcp2 with access to the outside of 
the cell.  While arabinose induction allowed detection of a C terminal tagged version of VgrG14, its 
presence in the supernatant was not detected.  This is somewhat surprising, since it suggests that 
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Hcp2 is gaining access to the supernatant independent of the puncturing device function of VgrG14, 
although it might suggest that VgrG14-lacking H2-T6SS, may still be functional using an alternative 
Hcp/VgrG device, as would be the case in PAO1.  However, the lack of VgrG14 in the supernatant 
may be due to the fact that the amount of VgrG secreted is below the limit of detection.  The Hcp 
tube is a multimeric structure formed of stacks of hexamers, proposed to be topped by a single 
trimeric VgrG tip, as seen in the corresponding bacteriophage components.  It is clear therefore that 
the abundance of Hcp in the supernatant will be much higher than that of VgrG, which may explain 
why secretion of VgrG14 is not observed.   
 
Alternatively, the presence of the C terminal V5-his tag could prevent secretion of VgrG14.  The C 
termini of VgrG are amenable to modification, as seen by various C terminal extensions (Section 1.7).  
VgrG1 in V. cholerae encodes an actin crosslinking domain, which is required for cytotoxicity 
(Pukatzki et al., 2007), and is accommodated by the secretion machinery, whereas VgrG2b of P. 
aeruginosa encodes a large C terminal extension of over 260 amino acids.  These examples provided 
justification that a C terminal V5-his tag of only 30 amino acids would not affect VgrG14 secretion.  
However, the nature of the V5-his tag may disrupt the secretion process, resulting in VgrG14-V5-his 
being retained.  Synthesis of antibodies directed against purified, full length VgrG14 would allow 
production and secretion of VgrG14 to be investigated without the need for an artificial tag.  It has 
recently been shown that PAAR domains are able to interact with VgrG proteins, acting as an 
adaptor, sharpening the T6SS needle and allowing the co-delivery of toxin domains, and the C 
terminus of the VgrG protein is required for this interaction (Shneider et al., 2013).  Introduction of 
the V5 tag may therefore have interrupted the formation of mature protein complexes and 
disrupted the secretion process.    
 
An alternative approach to investigate a functional link between Hcp2 and VgrG14 would be to 
investigate the secretion of Hcp2 in a vgrG14 deletion mutant, which is currently being performed in 
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our laboratory.  If deletion of vgrG14 abrogates Hcp2 secretion, then the puncturing activity of 
VgrG14 is clearly required for Hcp2 secretion, and these two proteins are functionally linked.  This 
approach would provide important information on the role of VgrG14 without the need to detect it 
in the supernatant, and could confirm a role for VgrG14 in the mechanism of the H2-T6SS.     
 
If Hcp2 secretion is VgrG14 independent then there is a possibility that other VgrG homologs provide 
the required membrane puncturing activity of the H2-T6SS.  There are 11 VgrG encoded by PA14, 
and three have been associated with the H1-T6SS (Hachani et al., 2011).  As described in section 4.6, 
there are at least 5 VgrGs that are similar to VgrG14 at the protein level, any of which could 
potentially be associated with the H2-T6SS.  Sequential deletion of these vgrG and re-evaluation of 
Hcp2 secretion will provide experimental evidence for a functional link between orphan vgrGs and 
the H2-T6SS cluster.  Not only would this approach potentially identify new H2-T6SS associated 
VgrGs, but it may also uncover new candidate H2-T6SS secreted substrates, since orphan VgrGs are 
invariably encoded within genetic islands with putative secreted proteins not currently associated 
with a T6SS system (Barret et al., 2011). 
 
4.11.2 Rhs14 as a putative secreted effector  
 
Production of Rhs14, encoded by the rhs14 gene found adjacent to the PA14 H2-T6SS, was activated 
following induction of the divergent promoter.  Rhs14 is a member of a diverse family of proteins, 
which remain poorly characterised.  Its location downstream of, and potentially in an operon with, 
vgrG14 led to it being proposed as a secreted H2-T6SS effector.  However, the presence of Rhs14 
could not be observed in the supernatants under the conditions tested, and the role of Rhs14 as a 
H2-T6SS substrate cannot be confirmed.  As suggested for VgrG14, the addition of a V5-his tag to 
Rhs14 to allow detection may interfere with the secretion process.  An alternative approach with 
peptide antibodies directed against the C terminus of Rhs14 was attempted but did not allow 
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detection of this protein (data not shown). Antibodies directed against the full-length protein may 
allow production and secretion to be tested without the requirement for an artificial tag.   
 
The genetic location of the rhs14 gene strongly suggests that Rhs14 is associated with the H2-T6SS 
system.  This involvement should be investigated by means other than protein secretion assays.  An 
important experiment to perform is to establish if Rhs14 and VgrG14 (and the gene encoded 
between these two proteins), interact with each other to form a functional complex.  Confirmation 
of a VgrG14-Rhs14 complex could be achieved through bacterial two hybrid analysis or co-
purification experiments, and a positive result could indicate that Rhs14 is delivered through 
interaction with the VgrG puncturing device.    
 
Examples of characterised T6SS systems describe a mechanism of direct effector delivery to 
eukaryotic or bacterial cells (Hood et al., 2010; Pukatzki et al., 2007). The dynamics observed for H1-
T6SS firing is precise and involves cell contact (Basler et al., 2013).  With this in mind, the localisation 
of T6SS effectors into the bacterial supernatant is not likely to be biologically relevant and is likely a 
waste of resources.  As with the H1-T6SS, secretion by the H2-T6SS could be activated upon target 
detection, ensuring efficient toxin delivery.  Although Rhs14 expression is activated via the divergent 
promoter, additional signals are likely to be required to allow for its delivery into host cells, and to 
restrict the non-targeted delivery of Rhs14 into the supernatant.  This is supported by the fact that a 
phenotype is observed dependent on the H2-T6SS in the internalisation experiments performed, 
suggesting that the presence of a eukaryotic cell activates the H2-T6SS. 
 
An alternative approach to testing Rhs14 delivery by the H2-T6SS may be to monitor its direct 
delivery into eukaryotic or bacterial target cells.  Similar experiments have already been performed 
to monitor the delivery of RhsT into phagocytic cells (Kung et al., 2012).  Generating a fusion of 
Rhs14 to β-lactamase would allow visualisation of translocation of this protein into target cells due 
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to the change in colour of an intracellular fluorogenic substrate containing a beta lactam ring.  
Cleavage of the beta lactam ring by the translocated Rhs-β-lactamase fusion will result in a change in 
the fluorescence resonance energy transfer of the fluorogenic substrate, seen as a colour change by 
fluorescence microscopy (Charpentier and Oswald, 2004).  This direct approach of monitoring T6SS 
effector delivery may be more biologically relevant than investigating secretion into liquid culture in 
the absence of a target cell.  This experiment could be extended to investigate the translocation of 
VgrG14 into target cells.  If either Rhs14 or VgrG14 are found to be translocated, the dependence of 
translocation on various components of the H2-T6SS should be investigated using the appropriate P. 
aeruginosa mutants.   
 
The presence of conserved Rhs/VgrG pairs in other organisms suggests a common role for Rhs in the 
T6SS.  There are at least two such pairs in PA14 (VgrG14/Rhs14 and Vgr1c/Rhs).  Investigating the 
delivery of Rhs proteins into eukaryotic cells, the dependency on T6SS clusters, and the effects of 
such delivery may reveal Rhs proteins to be a broad family of T6SS delivered effectors in addition to 
the previously described peptidoglycan targeting effectors (Tse) (Russell et al., 2011) and lipid 
targeting effectors (Tle) (Russell et al., 2013).  This role for Rhs proteins has already been suggested 
in studies of the DNA degrading activity of RhsA and RhsB from Dickeya dadantii (Koskiniemi et al., 
2013). 
 
The role of the protein encoded by PA14_43090, located between vgrG14 and rhs14, should also be 
investigated, although it has been overlooked in this study due to the absence of homology with 
characterised proteins.  Its location suggests that PA14_43090 is functionally linked to both VgrG14 
and Rhs14, but its role is unknown.  Study of the protein encoded by PA14_43090 is essential to fully 
understand the link between Rhs14 and VrgG14, and how the proteins encoded within this 
additional gene cluster interact with the H2-T6SS.  
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4.11.3 Translational regulation of the H2-T6SS  
 
The introduction of the divergent promoter only overcomes transcriptional regulation of the H2-
T6SS.  It is likely that there are several additional levels of control on the H2-T6SS beyond 
transcriptional regulation, as is seen for the H1-T6SS, which may be involved in full activation of the 
system, and necessary for VgrG14 and Rhs14 secretion.  The presence of conserved kinase and 
phosphatase genes in the H2-T6SS suggests that this system may be translationally regulated in a 
similar manner to the H1-T6SS (Mougous et al., 2007). Manipulating this phosphatase/kinase 
pathway by deleting the gene encoding the Stp2 phosphatase might have resulted in higher activity 
of the H2-T6SS.  Our data showed it is not the case and the deletion of stp2 did not result in 
secretion of VgrG14 and Rhs14.  However, this observation alone is not enough to confirm if the 
stp/stk system is not involved in regulation of the H2-T6SS and further work will be done.   
 
To confirm a role for stp2/stk2 in the H2-T6SS some alternative strategies should be employed.  
Since Hcp2 is secreted following arabinose induction of the divergent promoter, its secretion could 
be used as a reporter for stp2/stk2 activity.   In addition to testing if deletion of stp2 increases the 
secretion of Hcp2, the effect of stk2 deletion in reducing Hcp2 secretion should also be investigated.  
If the amount of Hcp2 secretion is affected by the stk/stp system, then over expression of the kinase 
may be an alternative to stp2 deletion as a means of up-regulating the H2-T6SS. 
 
4.11.4 Alternative approaches for the study of the H2-T6SS 
 
The divergent promoter strategy is limited to activation of genes immediately downstream of the 
promoters.  Other genes associated with the H2-T6SS but encoded at distinct chromosomal 
locations, will not be activated by induction of the divergent promoter.  The expression of the core 
H1-T6SS cluster, in a retS mutant for example, is co-regulated with vgrG and toxin genes located 
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distantly to the H1-T6SS locus.  If such additional loci exist for the H2-T6SS, then the divergent 
promoter construct would be insufficient for their activation, and the H2-T6SS produced under these 
conditions may not represent a fully assembled system.   
 
A random transposon mutagenesis screen could be employed to identify regulators of the H2-T6SS, 
screening for changes in the activity of a reporter fusion between β-lactamase and H2-T6SS 
promoters.  Following identification of important regulatory genes, their deletion or overexpression 
could be used to influence the expression or activity of the H2-T6SS, and allow its study without the 
requirement of an artificial divergent promoter.    
 
If such regulators are found, and conditions resulting in high H2-T6SS activity demonstrated, then a 
non-targeted approach should be used to identify proteins secreted by this system.  Mass 
spectroscopy has already been used to identify substrates of the H1-T6SS by Hood et al (2011), and 
would be a powerful tool for identification of H2-T6SS substrates.  Mass spectroscopy analysis could 
be used to compare the supernatants from cells with active H2-T6SS with those in which the H2-
T6SS has been disrupted by gene deletion.  This will identify all of the proteins secreted by the H2-
T6SS, but relies first on the establishment of conditions in which the H2-T6SS is active.  Mass 
spectroscopy could have been used to analyse the secretome of induced and uninduced PA14-DP 
cultures, and may have identified novel secreted substrates which were not targeted for analysis by 
western blot, and without the need for the addition of protein tags.  However, since the divergent 
promoter does not act globally, the result of such an experiment is likely to be an 
underrepresentation of the H2-T6SS secretome. 
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4.11.5 The diverse roles of the H2-T6SS 
 
The H2-T6SS has been reported to target bacterial and eukaryotic cells (Russell et al., 2013; Sana et 
al., 2012).  While a defined secreted toxin (Tle5) has been implicated in the H2-T6SS bacterial killing 
phenotype, no effectors have been identified which are involved in host cell subversion.   
 
While the published data implicates the H2-T6SS in the killing of susceptible P. aeruginosa strains, 
we investigated its ability to kill E. coli.  The assay employed has previously been successfully used to 
investigate the role of the P. aeruginosa PAK H1-T6SS system in E. coli killing. Results presented here 
indicate that this assay is inappropriate for PA14 due to the fact that E. coli is unable to survive co-
culture with PA14, while PAK does.  The mechanism of PA14 mediated E. coli killing is not known.   
To optimise the assay, conditions need to be found in which E. coli can survive co-culture with PA14, 
such as deletion of the H1-T6SS or other virulence factors which may be responsible for E. coli killing.  
Alternatively, the role of putative PA14 H2-T6SS toxins could be tested in an inter-pseudomonas 
competition assay.   
 
Investigations into the role of the PA14 H2-T6SS in eukaryotic cell interactions showed that unlike 
the PAO1 system, the H2-T6SS does not promote the internalisation of PA14 into HeLa cells, but 
represses it.  Due to different phenotypes, it is likely that the H2-T6SS from PAO1 and PA14 secrete 
different effectors, which have different effects on internalisation.  This observation is interesting, 
and highlights the fact that ultimately the phenotype of a secretion system is mediated by the 
effectors which it secretes.  The work on PAO1 did not identify an effector responsible for the 
phenotypes observed, which is an important question remaining in the characterisation of the H2-
T6SS. 
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Despite no direct evidence, it is tempting to propose that the PA14 specific VgrG14 and Rhs14 may 
be responsible for the different internalisation phenotypes observed, since this is the one major 
difference in the genetic arrangement of these two systems.   Experiments could be performed to 
confirm this hypothesis.  Testing the internalisation of PA14 strains in which either vgrG14 or rhs14 
are deleted would reveal if either is responsible for the internalisation phenotypes of this strain, and 
confirm their involvement with the H2-T6SS.   
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Chapter 5 General Discussion 
 
5.1 The Type VI Secretion System   
 
The Type VI Secretion system has, in less than a decade, firmly established itself among the protein 
secretion systems in Gram-negative bacteria, and attracted the attention of a large scientific 
community. Since the first reports of the delivery of VgrG and Hcp proteins by the T6SS in 2006 
(Mougous et al., 2006; Pukatzki et al., 2006), developments in the field have been rapid.  It was soon 
uncovered that the T6SS resembles an inverted bacteriophage puncturing device, and the molecular 
mechanisms of toxin delivery are beginning to be elucidated (Leiman et al., 2009).  Early reports 
hypothesised the involvement of the T6SS in bacterial virulence, and while direct roles in 
pathogenesis have been observed (Pukatzki et al., 2007; Suarez et al., 2010), the activity of the T6SS 
system is much wider, targeting both eukaryotic and bacterial cells (Hood et al., 2010).   
 
T6SS allow bacteria to disrupt host cell and kill competing bacteria. Such diverse activity is clearly 
exemplified by V. cholerae, which encodes one T6SS which is able to disrupt eukaryotic cell actin 
(Pukatzki et al., 2007), but also degrade peptidoglycan, inhibiting the growth of competing bacteria 
(Dong et al., 2013).  In the case of Burkholderia thailandensis, which is able to target both bacterial 
and eukaryotic cells, distinct T6SS machineries are employed for each target (Schwarz et al., 2010).  
Whereas it is clear how disruption of host cell actin is important in subverting host defences, the 
T6SS may also contribute to the establishment of infections by promoting the colonisation of T6SS+ 
bacteria by eliminating competitors.  This is demonstrated by the importance of the T6SS in the 
formation of mixed species biofilms, in which B. thai requires a functional T6SS to outcompete 
Pseudomonas putida (Schwarz et al., 2010).  The influence of T6SS at multiple stages of infection 
thus amplifies its importance in pathogenesis.  
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An important step in the characterisation of a secretion system is to identify the proteins that are 
secreted.  The first report of P. aeruginosa T6SS dependent toxins was made in 2010 (Hood et al., 
2010), and in the last three years significant advances have been made in our knowledge of T6SS 
secreted toxins.  The toxins described so far target conserved molecules among diverse bacteria, 
including peptidoglycan and phospholipid components of cell membranes, indicating broad 
susceptibility to the T6SS among bacteria (Russell et al., 2013; Russell et al., 2012).   
 
5.2 P. aeruginosa response to subinhibitory antibiotics 
 
T6SSs are generally not active under standard bacterial culture conditions, requiring target cell 
contact for activation.  Study of the first P. aeruginosa T6SS cluster, the H1-T6SS, is aided by the fact 
that manipulation of the RetS/Gac/Rsm regulatory cascade, upon deletion of the retS gene, results in 
a highly active, hyper-secretive, phenotype (Mougous et al., 2006).  The precise signals sensed by the 
components of the cascade that activate the H1-T6SS are not known, and were investigated in 
Chapter three.  
 
Subinhibitory concentrations of aminoglycosides have been previously shown to activate biofilm 
formation (Hoffman et al., 2005), and biofilm formation is co-regulated with the H1-T6SS via the 
RetS/Gac/Rsm cascade (Goodman et al., 2004).  It was therefore a unique opportunity to 
hypothesise that the H1-T6SS may also be activated by subinhibitory concentrations of 
aminoglycosides.  The results obtained indicate that subinhibitory kanamycin concentrations do 
activate production of core H1-T6SS components (Hcp and VgrG), but secretion and bacterial killing 
activity were not observed under these conditions.  Importantly, the response did require a 
functional RetS/Gac/Rsm cascade.  However, it is still unclear whether it involves a direct sensing of 
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the antibiotic by the regulatory cascade, or whether antibiotic sensing occurs via another route, 
which cannot overcome an established RsmA repression exerted on the T6SS. 
 
Comparisons with similar experiments indicate that P. aeruginosa does not respond in a predictable 
way to subinhibitory concentrations of antibiotics from different classes.  For example, biofilm 
formation, previously reported to be induced by aminoglycosides alone, has also been shown to be 
induced by non-aminoglycosides (Hoffman et al., 2005; Linares et al., 2006).  The work presented in 
this thesis shows that while kanamycin induces production of the H1-T6SS, the closely related 
aminoglycosides tobramycin and gentamycin, do not.  It is thus likely that the responses observed 
represent more broadly a non-specific stress responses and the mechanistic detail of the signalling 
cascade might be highly variable and complex depending on the antibiotic used, and unlikely to be 
directly connected to the structure or function of the antibiotic.  
 
The fact that kanamycin induces production of two core H1-T6SS components, but in these 
conditions the T6SS does not display secretion activity, remains an interesting and novel 
observation.  Similarly, the H1-T6SS was shown to be up-regulated in response to subinhibitory 
concentrations of bile (Reen et al., 2012).  It is tempting to propose that sensing low-level stresses 
results in a self-defence response by P. aeruginosa, in which the H1-T6SS is primed for activity, and 
ready to fire whenever P. aeruginosa encounters a competing organism. 
 
5.3 Characterising the H2-T6SS 
 
Advances in the study of the second P. aeruginosa T6SS cluster, the H2-T6SS, has been slower owing 
to the fact that the regulatory mechanisms leading to activation of this cluster are not fully 
characterised.  While it is known that quorum sensing and iron limitation increase the expression of 
the H2-T6SS in P. aeruginosa PAO1, it has not been shown that either result in production of an 
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active system (Lesic et al., 2009; Sana et al., 2012).  To overcome repression on the H2-T6SS a 
promoter swapping strategy was employed, and successfully resulted in production of H2-T6SS 
proteins.  The system was shown to be active, by observing Hcp2 secretion dependent on the H2-
T6SS cluster.   
 
While three toxins have been reported so far for the H1-T6SS (Tse1-3) (Hood et al., 2010), only one 
example of a H2-T6SS dependent toxin, a phospholipase, has been reported (Russell et al., 2013). 
The work presented in Chapter four of this thesis aimed to uncover additional H2-T6SS dependent 
toxins, and was focused on a four gene cluster encoded adjacent to the H2-T6SS cluster in P. 
aeruginosa PA14.  This cluster contains genes encoding two core T6SS components (hcp and vgrG), 
as well as two additional genes, one of which encodes a large protein of the Rhs family (Rhs14), 
considered to be a putative secreted effector.  While production of Rhs14 was observed, its 
secretion was not.  Rhs14 remains to be confirmed as a H2-T6SS dependent effector, but the 
discovery of a putative immunity protein downstream of rhs14 suggests it may have toxic activity. 
Rhs14 has been predicted in this work to structurally resemble a protein encapsulation device, which 
may be important in the delivery of an Rhs14 C terminal toxin domain (Busby et al., 2013)  While 
further work is required to confirm the secretion of Rhs14 by the H2-T6SS, it is hypothesised that 
Rhs14 is a novel effector with uncharacterised activity, as experimentally demonstrated for Rhs-
proteins from Dickeya dadantii, which are likely delivered by the T6SS (Koskiniemi et al., 2013). 
 
The H2-T6SS has been implicated in both eukaryotic cell interaction (Lesic et al., 2009; Sana et al., 
2012), and in the secretion of an anti-bacterial phospholipase toxin (Russell et al., 2013).  The 
example given for the V. cholerae T6SS indicates that targeting of eukaryotic and bacterial cells by 
the same T6SS is possible, although mediated by different toxins.  To date, no secreted effectors 
have been uncovered which are responsible for the eukaryotic cell targeting activity of the H2-T6SS.   
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The H2-T6SS was specifically shown to promote the internalisation of P. aeruginosa PAO1 into 
eukaryotic cells (Sana et al., 2012).  The investigations using P. aeruginosa PA14 in this thesis have 
remarkably shown that in this strain the H2-T6SS has the opposite effect, and inhibits internalisation 
of PA14.  The presence of the additional gene cluster adjacent to the H2-T6SS in PA14, including the 
proposed effector Rhs14, is potentially responsible for the observed differences in the activity of 
PAO1 and PA14, and this still requires experimental validation.  
 
While much of the work presented in this thesis is focused on single gene manipulation and 
investigation of the effects, the importance of genome-wide studies should not be overlooked.  
Global approaches could be utilised to further investigate the T6SS of P. aeruginosa.  Studies have 
previously been performed using large sets of genomic data, which revealed the distribution of T6SS 
clusters in Pseudomonas strains (Barret et al., 2011).  This analysis also accurately predicted the 
presence of effector proteins which were subsequently experimentally demonstrated.  Comparison 
of the H2-T6SS gene cluster in a wider set of genomes could reveal more information regarding the 
presence and conservation of the VgrG14/ Rhs14 containing cluster and may provide an insight into 
its acquisition.  Genomic approaches of P. aeruginosa strains could also be used to investigate the 
presence of other conserved rhs genes associated with T6SS cluster to understand the wider 
association of this putative effector family with P. aeruginosa and other T6SSs 
 
Transcriptomics studies would be useful to uncover genes co-regulated with the H2-T6SS clusters, 
and additional genes important for the function of the H2-T6SS cluster.  This is highlighted by the 
fact that the regulation of the H1-T6SS by the RetS/LadS cascade was identified through microarray 
studies (Goodman et al., 2004), a powerful tool which also identified co-regulated effector genes.  
No such regulators of the H2-T6SS are known. Transcriptome analysis of the effect divergent 
promoter strain constructed in this work has limited value however, since this system is artificial and 
its effect is not global but limited to a precise chromosomal location.  Once conditions are uncovered 
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in which the H2-T6SS core cluster is fully activated, transcriptome analysis would be useful to 
discover co-regulated genes, and potential novel effectors.  Similarly, proteomic studies could be 
used to identify H2-T6SS secreted proteins in a non-targeted way, using comparative analysis of 
conditions in which the system is active and inactive.   
 
5.4 Hcp as a chaperone  
 
During the preparation of this thesis, work published by Silverman and colleagues (2013) presented 
some interesting observations on the role of the core T6SS component, Hcp.  This work suggests a 
role for Hcp as a receptor and chaperone for T6SS effectors (Silverman et al., 2013).  Tse2, a H1-T6SS 
secreted substrate, was shown to interact with Hcp1. Observation by electron microscopy shows 
that Tse2 binds within the central pore of the hexameric Hcp ring.  Mutation of key residues on the 
inner surface of Hcp1 hexamers abrogated this binding, and resulted in a loss of Tse2 secretion.  It 
was further shown that Tse1 and Tse3 also required direct interactions with the Hcp1 central pore 
for secretion (Silverman et al., 2013).   
 
Until now, Hcp has been hypothesised to form a static tail-tube like structure allowing the conduit of 
secreted substrates, due to its homology to the gp19 component of bacteriophage (Leiman et al., 
2009).  Hcp1 forms stacked nanotubes in the crystal lattice, and also when tubes are stabilised by 
the introduction of artificial disulphide bonds (Ballister et al., 2008; Jobichen et al., 2010; Mougous 
et al., 2006; Osipiuk et al., 2011).  However, Hcp nanotubes have not been observed in vivo, 
questioning their biological significance.  Silverman et al. thus propose that Hcp is responsible for 
direct binding of effectors, protecting them from proteolysis, and potentially trafficking them to the 
T6SS apparatus (Silverman et al., 2013).  This potentially changes the current model of T6SS, which 
hypothesises that upon contraction of the tail-sheath like TssBC components,  a VgrG tipped Hcp 
tube is propelled to the outside of the cell.  Silverman et al. suggest that if such a tube does exist, 
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internally to the TssBC sheath, it would be loaded internally with secreted effectors, and could be 
considered as a stack of Hcp containing toxins, and not a continuous tube (Silverman et al., 2013).  
However, the localisation of Hcp within the TssBC sheath is yet to be demonstrated, and advances in 
this area would clarify the mechanism of T6SS toxin delivery and the role of Hcp.  
 
5.5 Perspectives and future work  
 
In this work the H2-T6SS cluster was investigated using an artificial promoter-swap strategy.  While 
this has provided meaningful new data, the conditions activating the H2-T6SS remain poorly 
understood in comparison to the H1-T6SS.  Experiments are currently underway in our laboratory 
using non-targeted random transposon mutagenesis and β-lactamase fusions to H2-T6SS promoters, 
which will potentially uncover major regulators of the H2-T6SS system. Their manipulation may 
allow constitutive activation of the H2-T6SS and other co-regulated genes, similar to that observed 
with a retS mutant and the H1-T6SS.  This approach has several advantages over the promoter-swap 
strategy since it may allow the discovery of distantly encoded H2-T6SS effectors, which could then 
be identified using a mass spectroscopy approach, as used in the discovery of the H1-T6SS Tse1-3 
toxins (Hood et al., 2010).  
 
While conditions activating the H2-T6SS are sought, further characterisation of Rhs14 could be 
performed to confirm a role for this protein as a H2-T6SS effector.  Preliminary data suggests that 
transfection of Rhs14 in eukaryotic cells is highly toxic.  This effect should be confirmed and the 
mechanism of Rhs14 toxicity investigated.  The expression of Rhs14 in eukaryotic cells should be 
controlled using an inducible plasmid or by examining cells over a shorter time course, so that the 
effects of Rhs14 can be observed prior to total cell lysis.  The putative immunity protein uncovered 
in this work could also be used, since co-transfection of Rhs14 and the putative immunity protein 
should protect HeLa cells from toxicity. 
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In addition to the effects on eukaryotic cells the role of Rhs14 in bacteria should also be investigated.  
Preliminary experiments using E. coli as a target cell indicated that PA14 kills E. coli in a H2-T6SS 
independent manner, and is not a suitable target strain.  Alternatively, an inter-pseudomonas 
approach could be used, co-incubating PA14 with strains lacking the putative immunity protein.  This 
would confirm if Rhs14 is also capable of bacterial intoxication.   
 
If Rhs14 is found to be an effector of the H2-T6SS, how it is delivered remains an open question.  
Replacing the C terminal domain with a β-galactosidase reporter would allow direct injection into 
eukaryotic cells to be investigated, as previously described (Kung et al., 2012), and the dependency 
of translocation on components of the H2-T6SS should be evaluated.  The recent discovery of PAAR 
domain proteins indicates that they are able to interact with VgrG proteins, sharpening the needle, 
and suggest that they are co-delivered by injection (Shneider et al., 2013).  The interaction of Rhs14 
and VgrG14 should be investigated to test if these two components are co-delivered as a complex, 
and could be address using a bacterial two-hybrid approach.  While the RHS core region of Rhs14 has 
been predicted to form a structure reminiscent of a protein encapsulation device, uncovering the 
structures formed by C and N terminal domains of Rhs14 and their involvement with the core 
domain structure may provide and insight into the T6SS delivery of Rhs toxins. 
 
To comprehensively understand the T6SS activity of P. aeruginosa it is important to consider the 
third cluster, the H3-T6SS. The H3-T6SS is not co-regulated with the H1-T6SS, and is likely to be 
active under distinct conditions.  It is likely to have its own effectors, and may target specific hosts.  
Similarly to the H2-T6SS, conditions activating the H3-T6SS are not known, which has impeded the 
study of this system.  Employing strategies to artificially activate the H3-T6SS by promoter swap or 
using transposon screens to identify regulators, is likely to also improve our understanding of the 
third cluster.  Ultimately, the full complement of T6SS effectors secreted by all three P. aeruginosa 
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clusters will be understood, revealing how P. aeruginosa utilises each cluster differently, and how 
each system contributes to the success of P. aeruginosa as a ubiquitous environmental organism and 
a prevalent opportunistic pathogen. 
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